{"idB": "1347613_12_item1_p13_s0", "idA": "1347613_11_item1_p10_s0", "sentA": "Patients in all plecanatide dose levels reported significant decreases in time to first bowel movement after dosing as compared to patients receiving placebo.", "sentB": "Patients in all but the 0.3 mg plecanatide dose levels reported significant decreases in time to first bowel movement after dosing as compared to patients receiving placebo.", "type": 2, "words": ["<tag1>", "Patients", "in", "all", "plecanatide", "dose", "levels", "reported", "significant", "decreases", "in", "time", "to", "first", "bowel", "movement", "after", "dosing", "as", "compared", "to", "patients", "receiving", "placebo.", "<tag2>", "Patients", "in", "all", "but", "the", "0.3", "mg", "plecanatide", "dose", "levels", "reported", "significant", "decreases", "in", "time", "to", "first", "bowel", "movement", "after", "dosing", "as", "compared", "to", "patients", "receiving", "placebo.", "<tag3>"], "wordsA": ["Patients", "in", "all", "plecanatide", "dose", "levels", "reported", "significant", "decreases", "in", "time", "to", "first", "bowel", "movement", "after", "dosing", "as", "compared", "to", "patients", "receiving", "placebo."], "wordsB": ["Patients", "in", "all", "but", "the", "0.3", "mg", "plecanatide", "dose", "levels", "reported", "significant", "decreases", "in", "time", "to", "first", "bowel", "movement", "after", "dosing", "as", "compared", "to", "patients", "receiving", "placebo."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_12_item1_p14_s0", "idA": "1347613_11_item1_p11_s0", "sentA": "The next clinical trial of plecanatide to treat chronic idiopathic constipation patients is planned to begin in the second half of 2011 and is being designed as a Phase II/III trial.", "sentB": "We are presently dosing patients in an 800-patient Phase II/III clinical trial of plecanatide to treat CC.", "type": 2, "words": ["<tag1>", "The", "next", "clinical", "trial", "of", "plecanatide", "to", "treat", "chronic", "idiopathic", "constipation", "patients", "is", "planned", "to", "begin", "in", "the", "second", "half", "of", "2011", "and", "is", "being", "designed", "as", "a", "Phase", "II/III", "trial.", "<tag2>", "We", "are", "presently", "dosing", "patients", "in", "an", "800-patient", "Phase", "II/III", "clinical", "trial", "of", "plecanatide", "to", "treat", "CC.", "<tag3>"], "wordsA": ["The", "next", "clinical", "trial", "of", "plecanatide", "to", "treat", "chronic", "idiopathic", "constipation", "patients", "is", "planned", "to", "begin", "in", "the", "second", "half", "of", "2011", "and", "is", "being", "designed", "as", "a", "Phase", "II/III", "trial."], "wordsB": ["We", "are", "presently", "dosing", "patients", "in", "an", "800-patient", "Phase", "II/III", "clinical", "trial", "of", "plecanatide", "to", "treat", "CC."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_12_item1_p14_s2", "idA": "1347613_11_item1_p11_s0", "sentA": "The next clinical trial of plecanatide to treat chronic idiopathic constipation patients is planned to begin in the second half of 2011 and is being designed as a Phase II/III trial.", "sentB": "Once these data have been evaluated, we plan to have an End-of-Phase 2 meeting with FDA in early 2013 to discuss the clinical plan for further development of plecanatide to treat CC.", "type": 2, "words": ["<tag1>", "The", "next", "clinical", "trial", "of", "plecanatide", "to", "treat", "chronic", "idiopathic", "constipation", "patients", "is", "planned", "to", "begin", "in", "the", "second", "half", "of", "2011", "and", "is", "being", "designed", "as", "a", "Phase", "II/III", "trial.", "<tag2>", "Once", "these", "data", "have", "been", "evaluated,", "we", "plan", "to", "have", "an", "End-of-Phase", "2", "meeting", "with", "FDA", "in", "early", "2013", "to", "discuss", "the", "clinical", "plan", "for", "further", "development", "of", "plecanatide", "to", "treat", "CC.", "<tag3>"], "wordsA": ["The", "next", "clinical", "trial", "of", "plecanatide", "to", "treat", "chronic", "idiopathic", "constipation", "patients", "is", "planned", "to", "begin", "in", "the", "second", "half", "of", "2011", "and", "is", "being", "designed", "as", "a", "Phase", "II/III", "trial."], "wordsB": ["Once", "these", "data", "have", "been", "evaluated,", "we", "plan", "to", "have", "an", "End-of-Phase", "2", "meeting", "with", "FDA", "in", "early", "2013", "to", "discuss", "the", "clinical", "plan", "for", "further", "development", "of", "plecanatide", "to", "treat", "CC."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_12_item1_p4_s0", "idA": "1347613_11_item1_p11_s0", "sentA": "The next clinical trial of plecanatide to treat chronic idiopathic constipation patients is planned to begin in the second half of 2011 and is being designed as a Phase II/III trial.", "sentB": "On October 24, 2011, we initiated dosing of patients in a Phase II/III clinical trial of plecanatide to treat CC.", "type": 2, "words": ["<tag1>", "The", "next", "clinical", "trial", "of", "plecanatide", "to", "treat", "chronic", "idiopathic", "constipation", "patients", "is", "planned", "to", "begin", "in", "the", "second", "half", "of", "2011", "and", "is", "being", "designed", "as", "a", "Phase", "II/III", "trial.", "<tag2>", "On", "October", "24,", "2011,", "we", "initiated", "dosing", "of", "patients", "in", "a", "Phase", "II/III", "clinical", "trial", "of", "plecanatide", "to", "treat", "CC.", "<tag3>"], "wordsA": ["The", "next", "clinical", "trial", "of", "plecanatide", "to", "treat", "chronic", "idiopathic", "constipation", "patients", "is", "planned", "to", "begin", "in", "the", "second", "half", "of", "2011", "and", "is", "being", "designed", "as", "a", "Phase", "II/III", "trial."], "wordsB": ["On", "October", "24,", "2011,", "we", "initiated", "dosing", "of", "patients", "in", "a", "Phase", "II/III", "clinical", "trial", "of", "plecanatide", "to", "treat", "CC."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_12_item1_p6_s0", "idA": "1347613_11_item1_p11_s1", "sentA": "The trial, a 90-day repeat oral dose ranging, randomized, double-blind, placebo-controlled study, will utilize approximately 800 chronic constipation patients, and will have as its primary objective the measure of CSBMs using a responder analysis.", "sentB": "The study s primary objective is the measure of CSBMs using a responder analysis.", "type": 2, "words": ["<tag1>", "The", "trial,", "a", "90-day", "repeat", "oral", "dose", "ranging,", "randomized,", "double-blind,", "placebo-controlled", "study,", "will", "utilize", "approximately", "800", "chronic", "constipation", "patients,", "and", "will", "have", "as", "its", "primary", "objective", "the", "measure", "of", "CSBMs", "using", "a", "responder", "analysis.", "<tag2>", "The", "study", "s", "primary", "objective", "is", "the", "measure", "of", "CSBMs", "using", "a", "responder", "analysis.", "<tag3>"], "wordsA": ["The", "trial,", "a", "90-day", "repeat", "oral", "dose", "ranging,", "randomized,", "double-blind,", "placebo-controlled", "study,", "will", "utilize", "approximately", "800", "chronic", "constipation", "patients,", "and", "will", "have", "as", "its", "primary", "objective", "the", "measure", "of", "CSBMs", "using", "a", "responder", "analysis."], "wordsB": ["The", "study", "s", "primary", "objective", "is", "the", "measure", "of", "CSBMs", "using", "a", "responder", "analysis."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_12_item1_p6_s1", "idA": "1347613_11_item1_p11_s2", "sentA": "The trial will also evaluate SBMs and daily constipation symptoms including straining, stool consistency, abdominal discomfort, plus impact of plecanatide on disease specific quality of life measures.", "sentB": "The trial will also evaluate SBMs and daily constipation symptoms, as well as the impact of plecanatide on disease-specific quality of life measures.", "type": 2, "words": ["<tag1>", "The", "trial", "will", "also", "evaluate", "SBMs", "and", "daily", "constipation", "symptoms", "including", "straining,", "stool", "consistency,", "abdominal", "discomfort,", "plus", "impact", "of", "plecanatide", "on", "disease", "specific", "quality", "of", "life", "measures.", "<tag2>", "The", "trial", "will", "also", "evaluate", "SBMs", "and", "daily", "constipation", "symptoms,", "as", "well", "as", "the", "impact", "of", "plecanatide", "on", "disease-specific", "quality", "of", "life", "measures.", "<tag3>"], "wordsA": ["The", "trial", "will", "also", "evaluate", "SBMs", "and", "daily", "constipation", "symptoms", "including", "straining,", "stool", "consistency,", "abdominal", "discomfort,", "plus", "impact", "of", "plecanatide", "on", "disease", "specific", "quality", "of", "life", "measures."], "wordsB": ["The", "trial", "will", "also", "evaluate", "SBMs", "and", "daily", "constipation", "symptoms,", "as", "well", "as", "the", "impact", "of", "plecanatide", "on", "disease-specific", "quality", "of", "life", "measures."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_12_item1_p53_s3", "idA": "1347613_11_item1_p12_s0", "sentA": "We are also preparing to initiate a Phase 2b clinical trial of plecanatide for the treatment of IBS-C in patients during 2012.", "sentB": "In addition, we are aware that another pharmaceutical company has been issued a patent for the use of plecanatide for treatment of constipation or constipation predominant irritable bowel syndrome.", "type": 2, "words": ["<tag1>", "We", "are", "also", "preparing", "to", "initiate", "a", "Phase", "2b", "clinical", "trial", "of", "plecanatide", "for", "the", "treatment", "of", "IBS-C", "in", "patients", "during", "2012.", "<tag2>", "In", "addition,", "we", "are", "aware", "that", "another", "pharmaceutical", "company", "has", "been", "issued", "a", "patent", "for", "the", "use", "of", "plecanatide", "for", "treatment", "of", "constipation", "or", "constipation", "predominant", "irritable", "bowel", "syndrome.", "<tag3>"], "wordsA": ["We", "are", "also", "preparing", "to", "initiate", "a", "Phase", "2b", "clinical", "trial", "of", "plecanatide", "for", "the", "treatment", "of", "IBS-C", "in", "patients", "during", "2012."], "wordsB": ["In", "addition,", "we", "are", "aware", "that", "another", "pharmaceutical", "company", "has", "been", "issued", "a", "patent", "for", "the", "use", "of", "plecanatide", "for", "treatment", "of", "constipation", "or", "constipation", "predominant", "irritable", "bowel", "syndrome."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_12_item1_p16_s1", "idA": "1347613_11_item1_p14_s0", "sentA": "synthetic analog of uroguanylin, a natriuretic hormone which is normally produced in the body's intestinal tract.", "sentB": "SP-333 is a synthetic analog of uroguanylin, a natriuretic hormone which is normally produced in the body s intestinal tract.", "type": 2, "words": ["<tag1>", "synthetic", "analog", "of", "uroguanylin,", "a", "natriuretic", "hormone", "which", "is", "normally", "produced", "in", "the", "body's", "intestinal", "tract.", "<tag2>", "SP-333", "is", "a", "synthetic", "analog", "of", "uroguanylin,", "a", "natriuretic", "hormone", "which", "is", "normally", "produced", "in", "the", "body", "s", "intestinal", "tract.", "<tag3>"], "wordsA": ["synthetic", "analog", "of", "uroguanylin,", "a", "natriuretic", "hormone", "which", "is", "normally", "produced", "in", "the", "body's", "intestinal", "tract."], "wordsB": ["SP-333", "is", "a", "synthetic", "analog", "of", "uroguanylin,", "a", "natriuretic", "hormone", "which", "is", "normally", "produced", "in", "the", "body", "s", "intestinal", "tract."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_12_item1_p16_s2", "idA": "1347613_11_item1_p14_s1", "sentA": "Deficiency of this hormone is predicted to be one of the primary reasons for the formation of polyps that can lead to colon cancer, as well as debilitating and difficult-to-treat GI inflammatory disorders such as ulcerative colitis and Crohn's disease.", "sentB": "Deficiency of this hormone is predicted to be one of the primary reasons for the formation of polyps that can lead to colon cancer, as well as debilitating and difficult-to-treat GI inflammatory disorders such as UC and Crohn s disease.", "type": 2, "words": ["<tag1>", "Deficiency", "of", "this", "hormone", "is", "predicted", "to", "be", "one", "of", "the", "primary", "reasons", "for", "the", "formation", "of", "polyps", "that", "can", "lead", "to", "colon", "cancer,", "as", "well", "as", "debilitating", "and", "difficult-to-treat", "GI", "inflammatory", "disorders", "such", "as", "ulcerative", "colitis", "and", "Crohn's", "disease.", "<tag2>", "Deficiency", "of", "this", "hormone", "is", "predicted", "to", "be", "one", "of", "the", "primary", "reasons", "for", "the", "formation", "of", "polyps", "that", "can", "lead", "to", "colon", "cancer,", "as", "well", "as", "debilitating", "and", "difficult-to-treat", "GI", "inflammatory", "disorders", "such", "as", "UC", "and", "Crohn", "s", "disease.", "<tag3>"], "wordsA": ["Deficiency", "of", "this", "hormone", "is", "predicted", "to", "be", "one", "of", "the", "primary", "reasons", "for", "the", "formation", "of", "polyps", "that", "can", "lead", "to", "colon", "cancer,", "as", "well", "as", "debilitating", "and", "difficult-to-treat", "GI", "inflammatory", "disorders", "such", "as", "ulcerative", "colitis", "and", "Crohn's", "disease."], "wordsB": ["Deficiency", "of", "this", "hormone", "is", "predicted", "to", "be", "one", "of", "the", "primary", "reasons", "for", "the", "formation", "of", "polyps", "that", "can", "lead", "to", "colon", "cancer,", "as", "well", "as", "debilitating", "and", "difficult-to-treat", "GI", "inflammatory", "disorders", "such", "as", "UC", "and", "Crohn", "s", "disease."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_12_item1_p17_s0", "idA": "1347613_11_item1_p16_s0", "sentA": "More than 500,000 Americans are afflicted with ulcerative colitis, a type of IBD that causes chronic inflammation of the colon.", "sentB": "More than 500,000 Americans are afflicted with UC, a type of IBD that causes chronic inflammation of the colon.", "type": 2, "words": ["<tag1>", "More", "than", "500,000", "Americans", "are", "afflicted", "with", "ulcerative", "colitis,", "a", "type", "of", "IBD", "that", "causes", "chronic", "inflammation", "of", "the", "colon.", "<tag2>", "More", "than", "500,000", "Americans", "are", "afflicted", "with", "UC,", "a", "type", "of", "IBD", "that", "causes", "chronic", "inflammation", "of", "the", "colon.", "<tag3>"], "wordsA": ["More", "than", "500,000", "Americans", "are", "afflicted", "with", "ulcerative", "colitis,", "a", "type", "of", "IBD", "that", "causes", "chronic", "inflammation", "of", "the", "colon."], "wordsB": ["More", "than", "500,000", "Americans", "are", "afflicted", "with", "UC,", "a", "type", "of", "IBD", "that", "causes", "chronic", "inflammation", "of", "the", "colon."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_12_item1_p17_s1", "idA": "1347613_11_item1_p16_s1", "sentA": "Along with Crohn's disease, the other major form of IBD, ulcerative colitis is painful and debilitating, and can lead to other serious and life-threatening complications such as increased incidence of colon cancer.", "sentB": "Along with Crohn s disease, the other major form of IBD, UC is painful and debilitating, and can lead to other serious and life-threatening complications such as increased incidence of colon cancer.", "type": 2, "words": ["<tag1>", "Along", "with", "Crohn's", "disease,", "the", "other", "major", "form", "of", "IBD,", "ulcerative", "colitis", "is", "painful", "and", "debilitating,", "and", "can", "lead", "to", "other", "serious", "and", "life-threatening", "complications", "such", "as", "increased", "incidence", "of", "colon", "cancer.", "<tag2>", "Along", "with", "Crohn", "s", "disease,", "the", "other", "major", "form", "of", "IBD,", "UC", "is", "painful", "and", "debilitating,", "and", "can", "lead", "to", "other", "serious", "and", "life-threatening", "complications", "such", "as", "increased", "incidence", "of", "colon", "cancer.", "<tag3>"], "wordsA": ["Along", "with", "Crohn's", "disease,", "the", "other", "major", "form", "of", "IBD,", "ulcerative", "colitis", "is", "painful", "and", "debilitating,", "and", "can", "lead", "to", "other", "serious", "and", "life-threatening", "complications", "such", "as", "increased", "incidence", "of", "colon", "cancer."], "wordsB": ["Along", "with", "Crohn", "s", "disease,", "the", "other", "major", "form", "of", "IBD,", "UC", "is", "painful", "and", "debilitating,", "and", "can", "lead", "to", "other", "serious", "and", "life-threatening", "complications", "such", "as", "increased", "incidence", "of", "colon", "cancer."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_12_item1_p18_s0", "idA": "1347613_11_item1_p17_s0", "sentA": "There is currently no medical cure for ulcerative colitis.", "sentB": "There is currently no medical cure for UC.", "type": 2, "words": ["<tag1>", "There", "is", "currently", "no", "medical", "cure", "for", "ulcerative", "colitis.", "<tag2>", "There", "is", "currently", "no", "medical", "cure", "for", "UC.", "<tag3>"], "wordsA": ["There", "is", "currently", "no", "medical", "cure", "for", "ulcerative", "colitis."], "wordsB": ["There", "is", "currently", "no", "medical", "cure", "for", "UC."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_12_item1_p18_s1", "idA": "1347613_11_item1_p18_s0", "sentA": "A considerable medical need exists for the control and treatment of ulcerative colitis.", "sentB": "A considerable medical need exists for the control and treatment of UC.", "type": 2, "words": ["<tag1>", "A", "considerable", "medical", "need", "exists", "for", "the", "control", "and", "treatment", "of", "ulcerative", "colitis.", "<tag2>", "A", "considerable", "medical", "need", "exists", "for", "the", "control", "and", "treatment", "of", "UC.", "<tag3>"], "wordsA": ["A", "considerable", "medical", "need", "exists", "for", "the", "control", "and", "treatment", "of", "ulcerative", "colitis."], "wordsB": ["A", "considerable", "medical", "need", "exists", "for", "the", "control", "and", "treatment", "of", "UC."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_12_item1_p19_s1", "idA": "1347613_11_item1_p19_s1", "sentA": "SP-333 is a second-generation guanylate cyclase C (GC-C) agonist with the potential to treat gastro-intestinal diseases such as ulcerative colitis.", "sentB": "SP-333 is a second-generation guanylate cyclase C (GC-C) agonist with the potential to treat gastro-intestinal diseases such as UC.", "type": 2, "words": ["<tag1>", "SP-333", "is", "a", "second-generation", "guanylate", "cyclase", "C", "(GC-C)", "agonist", "with", "the", "potential", "to", "treat", "gastro-intestinal", "diseases", "such", "as", "ulcerative", "colitis.", "<tag2>", "SP-333", "is", "a", "second-generation", "guanylate", "cyclase", "C", "(GC-C)", "agonist", "with", "the", "potential", "to", "treat", "gastro-intestinal", "diseases", "such", "as", "UC.", "<tag3>"], "wordsA": ["SP-333", "is", "a", "second-generation", "guanylate", "cyclase", "C", "(GC-C)", "agonist", "with", "the", "potential", "to", "treat", "gastro-intestinal", "diseases", "such", "as", "ulcerative", "colitis."], "wordsB": ["SP-333", "is", "a", "second-generation", "guanylate", "cyclase", "C", "(GC-C)", "agonist", "with", "the", "potential", "to", "treat", "gastro-intestinal", "diseases", "such", "as", "UC."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_12_item1_p19_s2", "idA": "1347613_11_item1_p19_s2", "sentA": "The patent entitled \"Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders\" specifically claims composition of matter of SP-333 and use in the treatment of human diseases.", "sentB": "The patent entitled Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders specifically claims composition of matter of SP-333 and use in the treatment of human diseases.", "type": 2, "words": ["<tag1>", "The", "patent", "entitled", "\"Agonists", "of", "Guanylate", "Cyclase", "Useful", "for", "the", "Treatment", "of", "Gastrointestinal", "Disorders,", "Inflammation,", "Cancer", "and", "Other", "Disorders\"", "specifically", "claims", "composition", "of", "matter", "of", "SP-333", "and", "use", "in", "the", "treatment", "of", "human", "diseases.", "<tag2>", "The", "patent", "entitled", "Agonists", "of", "Guanylate", "Cyclase", "Useful", "for", "the", "Treatment", "of", "Gastrointestinal", "Disorders,", "Inflammation,", "Cancer", "and", "Other", "Disorders", "specifically", "claims", "composition", "of", "matter", "of", "SP-333", "and", "use", "in", "the", "treatment", "of", "human", "diseases.", "<tag3>"], "wordsA": ["The", "patent", "entitled", "\"Agonists", "of", "Guanylate", "Cyclase", "Useful", "for", "the", "Treatment", "of", "Gastrointestinal", "Disorders,", "Inflammation,", "Cancer", "and", "Other", "Disorders\"", "specifically", "claims", "composition", "of", "matter", "of", "SP-333", "and", "use", "in", "the", "treatment", "of", "human", "diseases."], "wordsB": ["The", "patent", "entitled", "Agonists", "of", "Guanylate", "Cyclase", "Useful", "for", "the", "Treatment", "of", "Gastrointestinal", "Disorders,", "Inflammation,", "Cancer", "and", "Other", "Disorders", "specifically", "claims", "composition", "of", "matter", "of", "SP-333", "and", "use", "in", "the", "treatment", "of", "human", "diseases."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_12_item1_p16_s3", "idA": "1347613_11_item1_p20_s0", "sentA": "We plan to submit an Investigational New Drug application, or IND, to the U.S. Food and Drug Administration, or FDA, to treat Ulcerative Colitis, or UC with SP-333 in 2011 and intend to initiate a Phase 1 clinical trial of SP-333 in UC volunteers during 2012.", "sentB": "We plan to submit by mid-2012 an Investigational New Drug application, or IND, to the U.S. Food and Drug Administration, or FDA, to treat UC, and intend to initiate a Phase 1 clinical trial of SP-333 in volunteers during the second half of 2012.", "type": 2, "words": ["<tag1>", "We", "plan", "to", "submit", "an", "Investigational", "New", "Drug", "application,", "or", "IND,", "to", "the", "U.S.", "Food", "and", "Drug", "Administration,", "or", "FDA,", "to", "treat", "Ulcerative", "Colitis,", "or", "UC", "with", "SP-333", "in", "2011", "and", "intend", "to", "initiate", "a", "Phase", "1", "clinical", "trial", "of", "SP-333", "in", "UC", "volunteers", "during", "2012.", "<tag2>", "We", "plan", "to", "submit", "by", "mid-2012", "an", "Investigational", "New", "Drug", "application,", "or", "IND,", "to", "the", "U.S.", "Food", "and", "Drug", "Administration,", "or", "FDA,", "to", "treat", "UC,", "and", "intend", "to", "initiate", "a", "Phase", "1", "clinical", "trial", "of", "SP-333", "in", "volunteers", "during", "the", "second", "half", "of", "2012.", "<tag3>"], "wordsA": ["We", "plan", "to", "submit", "an", "Investigational", "New", "Drug", "application,", "or", "IND,", "to", "the", "U.S.", "Food", "and", "Drug", "Administration,", "or", "FDA,", "to", "treat", "Ulcerative", "Colitis,", "or", "UC", "with", "SP-333", "in", "2011", "and", "intend", "to", "initiate", "a", "Phase", "1", "clinical", "trial", "of", "SP-333", "in", "UC", "volunteers", "during", "2012."], "wordsB": ["We", "plan", "to", "submit", "by", "mid-2012", "an", "Investigational", "New", "Drug", "application,", "or", "IND,", "to", "the", "U.S.", "Food", "and", "Drug", "Administration,", "or", "FDA,", "to", "treat", "UC,", "and", "intend", "to", "initiate", "a", "Phase", "1", "clinical", "trial", "of", "SP-333", "in", "volunteers", "during", "the", "second", "half", "of", "2012."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_12_item1_p20_s0", "idA": "1347613_11_item1_p21_s0", "sentA": "We do not have manufacturing capabilities.", "sentB": "We do not have any in-house manufacturing capabilities.", "type": 2, "words": ["<tag1>", "We", "do", "not", "have", "manufacturing", "capabilities.", "<tag2>", "We", "do", "not", "have", "any", "in-house", "manufacturing", "capabilities.", "<tag3>"], "wordsA": ["We", "do", "not", "have", "manufacturing", "capabilities."], "wordsB": ["We", "do", "not", "have", "any", "in-house", "manufacturing", "capabilities."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_12_item1_p20_s2", "idA": "1347613_11_item1_p21_s2", "sentA": "Accordingly, unless or until we develop or acquire sufficient manufacturing capabilities, we will depend on third parties to manufacture plecanatide, SP-333 and any future products that we may develop or acquire.", "sentB": "Accordingly, unless or until we develop or acquire sufficient manufacturing capabilities, we will depend on third parties to manufacture plecanatide, SP-333 and any future APIs that we may develop or acquire.", "type": 2, "words": ["<tag1>", "Accordingly,", "unless", "or", "until", "we", "develop", "or", "acquire", "sufficient", "manufacturing", "capabilities,", "we", "will", "depend", "on", "third", "parties", "to", "manufacture", "plecanatide,", "SP-333", "and", "any", "future", "products", "that", "we", "may", "develop", "or", "acquire.", "<tag2>", "Accordingly,", "unless", "or", "until", "we", "develop", "or", "acquire", "sufficient", "manufacturing", "capabilities,", "we", "will", "depend", "on", "third", "parties", "to", "manufacture", "plecanatide,", "SP-333", "and", "any", "future", "APIs", "that", "we", "may", "develop", "or", "acquire.", "<tag3>"], "wordsA": ["Accordingly,", "unless", "or", "until", "we", "develop", "or", "acquire", "sufficient", "manufacturing", "capabilities,", "we", "will", "depend", "on", "third", "parties", "to", "manufacture", "plecanatide,", "SP-333", "and", "any", "future", "products", "that", "we", "may", "develop", "or", "acquire."], "wordsB": ["Accordingly,", "unless", "or", "until", "we", "develop", "or", "acquire", "sufficient", "manufacturing", "capabilities,", "we", "will", "depend", "on", "third", "parties", "to", "manufacture", "plecanatide,", "SP-333", "and", "any", "future", "APIs", "that", "we", "may", "develop", "or", "acquire."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_12_item1_p21_s1", "idA": "1347613_11_item1_p21_s4", "sentA": "We are in the process of working with third-party manufacturers to develop the ability to produce plecanatide in accordance with current good manufacturing practices, or GMP, on a sufficient scale to meet our future commercial needs.", "sentB": "We are in the process of selecting at least one more manufacturer to produce our APIs in accordance with current good manufacturing practices, or cGMP, on a commercial scale to meet our future needs.", "type": 2, "words": ["<tag1>", "We", "are", "in", "the", "process", "of", "working", "with", "third-party", "manufacturers", "to", "develop", "the", "ability", "to", "produce", "plecanatide", "in", "accordance", "with", "current", "good", "manufacturing", "practices,", "or", "GMP,", "on", "a", "sufficient", "scale", "to", "meet", "our", "future", "commercial", "needs.", "<tag2>", "We", "are", "in", "the", "process", "of", "selecting", "at", "least", "one", "more", "manufacturer", "to", "produce", "our", "APIs", "in", "accordance", "with", "current", "good", "manufacturing", "practices,", "or", "cGMP,", "on", "a", "commercial", "scale", "to", "meet", "our", "future", "needs.", "<tag3>"], "wordsA": ["We", "are", "in", "the", "process", "of", "working", "with", "third-party", "manufacturers", "to", "develop", "the", "ability", "to", "produce", "plecanatide", "in", "accordance", "with", "current", "good", "manufacturing", "practices,", "or", "GMP,", "on", "a", "sufficient", "scale", "to", "meet", "our", "future", "commercial", "needs."], "wordsB": ["We", "are", "in", "the", "process", "of", "selecting", "at", "least", "one", "more", "manufacturer", "to", "produce", "our", "APIs", "in", "accordance", "with", "current", "good", "manufacturing", "practices,", "or", "cGMP,", "on", "a", "commercial", "scale", "to", "meet", "our", "future", "needs."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_12_item1_p29_s0", "idA": "1347613_11_item1_p28_s0", "sentA": "evaluate preliminarily the efficacy of the drug for specific, targeted conditions; determine dosage tolerance and appropriate dosage as well as other important information about how to design larger Phase 3 trials; and identify possible adverse effects and safety risks.", "sentB": "identify possible adverse effects and safety risks.", "type": 2, "words": ["<tag1>", "evaluate", "preliminarily", "the", "efficacy", "of", "the", "drug", "for", "specific,", "targeted", "conditions;", "determine", "dosage", "tolerance", "and", "appropriate", "dosage", "as", "well", "as", "other", "important", "information", "about", "how", "to", "design", "larger", "Phase", "3", "trials;", "and", "identify", "possible", "adverse", "effects", "and", "safety", "risks.", "<tag2>", "identify", "possible", "adverse", "effects", "and", "safety", "risks.", "<tag3>"], "wordsA": ["evaluate", "preliminarily", "the", "efficacy", "of", "the", "drug", "for", "specific,", "targeted", "conditions;", "determine", "dosage", "tolerance", "and", "appropriate", "dosage", "as", "well", "as", "other", "important", "information", "about", "how", "to", "design", "larger", "Phase", "3", "trials;", "and", "identify", "possible", "adverse", "effects", "and", "safety", "risks."], "wordsB": ["identify", "possible", "adverse", "effects", "and", "safety", "risks."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_12_item1_p32_s0", "idA": "1347613_11_item1_p31_s0", "sentA": "FDA requirements or presents an unacceptable risk to the clinical trial patients.", "sentB": "The FDA may order the temporary or permanent discontinuation of a clinical trial at any time or impose other sanctions if it believes that the clinical trial is not being conducted in accordance with FDA requirements or presents an unacceptable risk to the clinical trial patients.", "type": 2, "words": ["<tag1>", "FDA", "requirements", "or", "presents", "an", "unacceptable", "risk", "to", "the", "clinical", "trial", "patients.", "<tag2>", "The", "FDA", "may", "order", "the", "temporary", "or", "permanent", "discontinuation", "of", "a", "clinical", "trial", "at", "any", "time", "or", "impose", "other", "sanctions", "if", "it", "believes", "that", "the", "clinical", "trial", "is", "not", "being", "conducted", "in", "accordance", "with", "FDA", "requirements", "or", "presents", "an", "unacceptable", "risk", "to", "the", "clinical", "trial", "patients.", "<tag3>"], "wordsA": ["FDA", "requirements", "or", "presents", "an", "unacceptable", "risk", "to", "the", "clinical", "trial", "patients."], "wordsB": ["The", "FDA", "may", "order", "the", "temporary", "or", "permanent", "discontinuation", "of", "a", "clinical", "trial", "at", "any", "time", "or", "impose", "other", "sanctions", "if", "it", "believes", "that", "the", "clinical", "trial", "is", "not", "being", "conducted", "in", "accordance", "with", "FDA", "requirements", "or", "presents", "an", "unacceptable", "risk", "to", "the", "clinical", "trial", "patients."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_12_item1_p25_s0", "idA": "1347613_11_item1_p32_s1", "sentA": "FDA approval of the NDA is required before marketing of the product may begin in the U.S.", "sentB": "FDA review and approval of the NDA.", "type": 2, "words": ["<tag1>", "FDA", "approval", "of", "the", "NDA", "is", "required", "before", "marketing", "of", "the", "product", "may", "begin", "in", "the", "U.S.", "<tag2>", "FDA", "review", "and", "approval", "of", "the", "NDA.", "<tag3>"], "wordsA": ["FDA", "approval", "of", "the", "NDA", "is", "required", "before", "marketing", "of", "the", "product", "may", "begin", "in", "the", "U.S."], "wordsB": ["FDA", "review", "and", "approval", "of", "the", "NDA."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_12_item1_p33_s2", "idA": "1347613_11_item1_p32_s2", "sentA": "If the NDA contains all pertinent information and data, the FDA will \"file\" the application and begin review.", "sentB": "If the NDA contains all pertinent information and data, the FDA will file the application and begin review.", "type": 2, "words": ["<tag1>", "If", "the", "NDA", "contains", "all", "pertinent", "information", "and", "data,", "the", "FDA", "will", "\"file\"", "the", "application", "and", "begin", "review.", "<tag2>", "If", "the", "NDA", "contains", "all", "pertinent", "information", "and", "data,", "the", "FDA", "will", "file", "the", "application", "and", "begin", "review.", "<tag3>"], "wordsA": ["If", "the", "NDA", "contains", "all", "pertinent", "information", "and", "data,", "the", "FDA", "will", "\"file\"", "the", "application", "and", "begin", "review."], "wordsB": ["If", "the", "NDA", "contains", "all", "pertinent", "information", "and", "data,", "the", "FDA", "will", "file", "the", "application", "and", "begin", "review."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_12_item1_p33_s3", "idA": "1347613_11_item1_p32_s3", "sentA": "The FDA may \"refuse to file\" the NDA if it does not contain all pertinent information and data.", "sentB": "The FDA may refuse to file the NDA if it does not contain all pertinent information and data.", "type": 2, "words": ["<tag1>", "The", "FDA", "may", "\"refuse", "to", "file\"", "the", "NDA", "if", "it", "does", "not", "contain", "all", "pertinent", "information", "and", "data.", "<tag2>", "The", "FDA", "may", "refuse", "to", "file", "the", "NDA", "if", "it", "does", "not", "contain", "all", "pertinent", "information", "and", "data.", "<tag3>"], "wordsA": ["The", "FDA", "may", "\"refuse", "to", "file\"", "the", "NDA", "if", "it", "does", "not", "contain", "all", "pertinent", "information", "and", "data."], "wordsB": ["The", "FDA", "may", "refuse", "to", "file", "the", "NDA", "if", "it", "does", "not", "contain", "all", "pertinent", "information", "and", "data."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_12_item1_p20_s1", "idA": "1347613_11_item1_p34_s1", "sentA": "Most such applications for non-priority drug products are reviewed within 10 months.", "sentB": "Our active pharmaceutical ingredients, or APIs, and the final formulated drug products are manufactured for us by third party contractors.", "type": 2, "words": ["<tag1>", "Most", "such", "applications", "for", "non-priority", "drug", "products", "are", "reviewed", "within", "10", "months.", "<tag2>", "Our", "active", "pharmaceutical", "ingredients,", "or", "APIs,", "and", "the", "final", "formulated", "drug", "products", "are", "manufactured", "for", "us", "by", "third", "party", "contractors.", "<tag3>"], "wordsA": ["Most", "such", "applications", "for", "non-priority", "drug", "products", "are", "reviewed", "within", "10", "months."], "wordsB": ["Our", "active", "pharmaceutical", "ingredients,", "or", "APIs,", "and", "the", "final", "formulated", "drug", "products", "are", "manufactured", "for", "us", "by", "third", "party", "contractors."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_12_item1_p39_s1", "idA": "1347613_11_item1_p35_s3", "sentA": "FDA also typically inspects facilities responsible for performing animal testing, as well as clinical investigators who participate in clinical trials.", "sentB": "GMP regulations require among other things, quality control and quality assurance as well as the corresponding maintenance of records and documentation.", "type": 2, "words": ["<tag1>", "FDA", "also", "typically", "inspects", "facilities", "responsible", "for", "performing", "animal", "testing,", "as", "well", "as", "clinical", "investigators", "who", "participate", "in", "clinical", "trials.", "<tag2>", "GMP", "regulations", "require", "among", "other", "things,", "quality", "control", "and", "quality", "assurance", "as", "well", "as", "the", "corresponding", "maintenance", "of", "records", "and", "documentation.", "<tag3>"], "wordsA": ["FDA", "also", "typically", "inspects", "facilities", "responsible", "for", "performing", "animal", "testing,", "as", "well", "as", "clinical", "investigators", "who", "participate", "in", "clinical", "trials."], "wordsB": ["GMP", "regulations", "require", "among", "other", "things,", "quality", "control", "and", "quality", "assurance", "as", "well", "as", "the", "corresponding", "maintenance", "of", "records", "and", "documentation."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_12_item1_p38_s0", "idA": "1347613_11_item1_p37_s0", "sentA": "After approval, drug products are subject to extensive continuing regulation by the FDA, which include company obligations to manufacture products in accordance with GMP, maintain and provide to the FDA updated safety and efficacy information, report adverse experiences with the product, keep certain records and submit periodic reports, obtain FDA approval of certain manufacturing or labeling changes, and comply with FDA promotion and advertising requirements and restrictions.", "sentB": "After approval, drug products are subject to extensive continuing regulation by the FDA, which include company obligations to manufacture products in accordance with Good Manufacturing Practice, or GMP, maintain and provide to the FDA updated safety and efficacy information, report adverse experiences with the product, keep certain records and submit periodic reports, obtain FDA approval of certain manufacturing or labeling changes, and comply with FDA promotion and advertising requirements and restrictions.", "type": 2, "words": ["<tag1>", "After", "approval,", "drug", "products", "are", "subject", "to", "extensive", "continuing", "regulation", "by", "the", "FDA,", "which", "include", "company", "obligations", "to", "manufacture", "products", "in", "accordance", "with", "GMP,", "maintain", "and", "provide", "to", "the", "FDA", "updated", "safety", "and", "efficacy", "information,", "report", "adverse", "experiences", "with", "the", "product,", "keep", "certain", "records", "and", "submit", "periodic", "reports,", "obtain", "FDA", "approval", "of", "certain", "manufacturing", "or", "labeling", "changes,", "and", "comply", "with", "FDA", "promotion", "and", "advertising", "requirements", "and", "restrictions.", "<tag2>", "After", "approval,", "drug", "products", "are", "subject", "to", "extensive", "continuing", "regulation", "by", "the", "FDA,", "which", "include", "company", "obligations", "to", "manufacture", "products", "in", "accordance", "with", "Good", "Manufacturing", "Practice,", "or", "GMP,", "maintain", "and", "provide", "to", "the", "FDA", "updated", "safety", "and", "efficacy", "information,", "report", "adverse", "experiences", "with", "the", "product,", "keep", "certain", "records", "and", "submit", "periodic", "reports,", "obtain", "FDA", "approval", "of", "certain", "manufacturing", "or", "labeling", "changes,", "and", "comply", "with", "FDA", "promotion", "and", "advertising", "requirements", "and", "restrictions.", "<tag3>"], "wordsA": ["After", "approval,", "drug", "products", "are", "subject", "to", "extensive", "continuing", "regulation", "by", "the", "FDA,", "which", "include", "company", "obligations", "to", "manufacture", "products", "in", "accordance", "with", "GMP,", "maintain", "and", "provide", "to", "the", "FDA", "updated", "safety", "and", "efficacy", "information,", "report", "adverse", "experiences", "with", "the", "product,", "keep", "certain", "records", "and", "submit", "periodic", "reports,", "obtain", "FDA", "approval", "of", "certain", "manufacturing", "or", "labeling", "changes,", "and", "comply", "with", "FDA", "promotion", "and", "advertising", "requirements", "and", "restrictions."], "wordsB": ["After", "approval,", "drug", "products", "are", "subject", "to", "extensive", "continuing", "regulation", "by", "the", "FDA,", "which", "include", "company", "obligations", "to", "manufacture", "products", "in", "accordance", "with", "Good", "Manufacturing", "Practice,", "or", "GMP,", "maintain", "and", "provide", "to", "the", "FDA", "updated", "safety", "and", "efficacy", "information,", "report", "adverse", "experiences", "with", "the", "product,", "keep", "certain", "records", "and", "submit", "periodic", "reports,", "obtain", "FDA", "approval", "of", "certain", "manufacturing", "or", "labeling", "changes,", "and", "comply", "with", "FDA", "promotion", "and", "advertising", "requirements", "and", "restrictions."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_12_item1_p40_s0", "idA": "1347613_11_item1_p40_s0", "sentA": "With respect to post-market product advertising and promotion, the FDA imposes a number of complex regulations on entities that advertise and promote pharmaceuticals, which include, among others, standards for direct-to-consumer advertising, promoting drugs for uses or in patient populations that are not described in the drug's approved labeling (known as \"off-label use\"), industry-sponsored scientific and educational activities, and promotional activities involving the internet.", "sentB": "With respect to post-market product advertising and promotion, the FDA imposes a number of complex regulations on entities that advertise and promote pharmaceuticals, which include, among others, standards for direct-to-consumer advertising, promoting drugs for uses or in patient populations that are not described in the drug s approved labeling (known as off-label use ), industry-sponsored scientific and educational activities, and promotional activities involving the internet.", "type": 2, "words": ["<tag1>", "With", "respect", "to", "post-market", "product", "advertising", "and", "promotion,", "the", "FDA", "imposes", "a", "number", "of", "complex", "regulations", "on", "entities", "that", "advertise", "and", "promote", "pharmaceuticals,", "which", "include,", "among", "others,", "standards", "for", "direct-to-consumer", "advertising,", "promoting", "drugs", "for", "uses", "or", "in", "patient", "populations", "that", "are", "not", "described", "in", "the", "drug's", "approved", "labeling", "(known", "as", "\"off-label", "use\"),", "industry-sponsored", "scientific", "and", "educational", "activities,", "and", "promotional", "activities", "involving", "the", "internet.", "<tag2>", "With", "respect", "to", "post-market", "product", "advertising", "and", "promotion,", "the", "FDA", "imposes", "a", "number", "of", "complex", "regulations", "on", "entities", "that", "advertise", "and", "promote", "pharmaceuticals,", "which", "include,", "among", "others,", "standards", "for", "direct-to-consumer", "advertising,", "promoting", "drugs", "for", "uses", "or", "in", "patient", "populations", "that", "are", "not", "described", "in", "the", "drug", "s", "approved", "labeling", "(known", "as", "off-label", "use", "),", "industry-sponsored", "scientific", "and", "educational", "activities,", "and", "promotional", "activities", "involving", "the", "internet.", "<tag3>"], "wordsA": ["With", "respect", "to", "post-market", "product", "advertising", "and", "promotion,", "the", "FDA", "imposes", "a", "number", "of", "complex", "regulations", "on", "entities", "that", "advertise", "and", "promote", "pharmaceuticals,", "which", "include,", "among", "others,", "standards", "for", "direct-to-consumer", "advertising,", "promoting", "drugs", "for", "uses", "or", "in", "patient", "populations", "that", "are", "not", "described", "in", "the", "drug's", "approved", "labeling", "(known", "as", "\"off-label", "use\"),", "industry-sponsored", "scientific", "and", "educational", "activities,", "and", "promotional", "activities", "involving", "the", "internet."], "wordsB": ["With", "respect", "to", "post-market", "product", "advertising", "and", "promotion,", "the", "FDA", "imposes", "a", "number", "of", "complex", "regulations", "on", "entities", "that", "advertise", "and", "promote", "pharmaceuticals,", "which", "include,", "among", "others,", "standards", "for", "direct-to-consumer", "advertising,", "promoting", "drugs", "for", "uses", "or", "in", "patient", "populations", "that", "are", "not", "described", "in", "the", "drug", "s", "approved", "labeling", "(known", "as", "off-label", "use", "),", "industry-sponsored", "scientific", "and", "educational", "activities,", "and", "promotional", "activities", "involving", "the", "internet."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_12_item1_p41_s0", "idA": "1347613_11_item1_p40_s1", "sentA": "Failure to comply with FDA requirements can have negative consequences, including adverse publicity, enforcement letters from the FDA, mandated corrective advertising or communications with doctors, and civil or criminal penalties.", "sentB": "doctors, and civil or criminal penalties.", "type": 2, "words": ["<tag1>", "Failure", "to", "comply", "with", "FDA", "requirements", "can", "have", "negative", "consequences,", "including", "adverse", "publicity,", "enforcement", "letters", "from", "the", "FDA,", "mandated", "corrective", "advertising", "or", "communications", "with", "doctors,", "and", "civil", "or", "criminal", "penalties.", "<tag2>", "doctors,", "and", "civil", "or", "criminal", "penalties.", "<tag3>"], "wordsA": ["Failure", "to", "comply", "with", "FDA", "requirements", "can", "have", "negative", "consequences,", "including", "adverse", "publicity,", "enforcement", "letters", "from", "the", "FDA,", "mandated", "corrective", "advertising", "or", "communications", "with", "doctors,", "and", "civil", "or", "criminal", "penalties."], "wordsB": ["doctors,", "and", "civil", "or", "criminal", "penalties."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_12_item1_p47_s1", "idA": "1347613_11_item1_p46_s1", "sentA": "Our competitors include major pharmaceutical and biotechnology companies focusing on GI such as Ironwood Pharmaceuticals, Inc., Forest Laboratories, Inc., Takeda Pharmaceuticals America, Inc., Sucampo Pharmaceuticals, Inc., Salix Pharmaceuticals, Inc. and Movetis NV.", "sentB": "Our competitors include major pharmaceutical and biotechnology companies focusing on GI such as Ironwood Pharmaceuticals, Inc., Forest Laboratories, Inc., Takeda Pharmaceuticals America, Inc., Sucampo Pharmaceuticals, Inc., Salix Pharmaceuticals, Inc. and Shire Plc.", "type": 2, "words": ["<tag1>", "Our", "competitors", "include", "major", "pharmaceutical", "and", "biotechnology", "companies", "focusing", "on", "GI", "such", "as", "Ironwood", "Pharmaceuticals,", "Inc.,", "Forest", "Laboratories,", "Inc.,", "Takeda", "Pharmaceuticals", "America,", "Inc.,", "Sucampo", "Pharmaceuticals,", "Inc.,", "Salix", "Pharmaceuticals,", "Inc.", "and", "Movetis", "NV.", "<tag2>", "Our", "competitors", "include", "major", "pharmaceutical", "and", "biotechnology", "companies", "focusing", "on", "GI", "such", "as", "Ironwood", "Pharmaceuticals,", "Inc.,", "Forest", "Laboratories,", "Inc.,", "Takeda", "Pharmaceuticals", "America,", "Inc.,", "Sucampo", "Pharmaceuticals,", "Inc.,", "Salix", "Pharmaceuticals,", "Inc.", "and", "Shire", "Plc.", "<tag3>"], "wordsA": ["Our", "competitors", "include", "major", "pharmaceutical", "and", "biotechnology", "companies", "focusing", "on", "GI", "such", "as", "Ironwood", "Pharmaceuticals,", "Inc.,", "Forest", "Laboratories,", "Inc.,", "Takeda", "Pharmaceuticals", "America,", "Inc.,", "Sucampo", "Pharmaceuticals,", "Inc.,", "Salix", "Pharmaceuticals,", "Inc.", "and", "Movetis", "NV."], "wordsB": ["Our", "competitors", "include", "major", "pharmaceutical", "and", "biotechnology", "companies", "focusing", "on", "GI", "such", "as", "Ironwood", "Pharmaceuticals,", "Inc.,", "Forest", "Laboratories,", "Inc.,", "Takeda", "Pharmaceuticals", "America,", "Inc.,", "Sucampo", "Pharmaceuticals,", "Inc.,", "Salix", "Pharmaceuticals,", "Inc.", "and", "Shire", "Plc."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_12_item1_p49_s0", "idA": "1347613_11_item1_p48_s0", "sentA": "Research and development costs include expenditures in connection with an in-house research and development laboratory, salaries and staff costs, purchased in-process research and development, regulatory and scientific consulting fees, as well as contract research, patient costs, drug formulation and tableting, data collection, monitoring, insurance and FDA consultants.", "sentB": "Research and development costs include expenditures for an in-house research and development laboratory, salaries and staff costs, application and filing for regulatory approval of proposed products, purchased in-process research and development, regulatory and scientific consulting fees, as well as contract services, including clinical trial related patient costs, drug formulation and tableting, data collection, monitoring, insurance and FDA consultants.", "type": 2, "words": ["<tag1>", "Research", "and", "development", "costs", "include", "expenditures", "in", "connection", "with", "an", "in-house", "research", "and", "development", "laboratory,", "salaries", "and", "staff", "costs,", "purchased", "in-process", "research", "and", "development,", "regulatory", "and", "scientific", "consulting", "fees,", "as", "well", "as", "contract", "research,", "patient", "costs,", "drug", "formulation", "and", "tableting,", "data", "collection,", "monitoring,", "insurance", "and", "FDA", "consultants.", "<tag2>", "Research", "and", "development", "costs", "include", "expenditures", "for", "an", "in-house", "research", "and", "development", "laboratory,", "salaries", "and", "staff", "costs,", "application", "and", "filing", "for", "regulatory", "approval", "of", "proposed", "products,", "purchased", "in-process", "research", "and", "development,", "regulatory", "and", "scientific", "consulting", "fees,", "as", "well", "as", "contract", "services,", "including", "clinical", "trial", "related", "patient", "costs,", "drug", "formulation", "and", "tableting,", "data", "collection,", "monitoring,", "insurance", "and", "FDA", "consultants.", "<tag3>"], "wordsA": ["Research", "and", "development", "costs", "include", "expenditures", "in", "connection", "with", "an", "in-house", "research", "and", "development", "laboratory,", "salaries", "and", "staff", "costs,", "purchased", "in-process", "research", "and", "development,", "regulatory", "and", "scientific", "consulting", "fees,", "as", "well", "as", "contract", "research,", "patient", "costs,", "drug", "formulation", "and", "tableting,", "data", "collection,", "monitoring,", "insurance", "and", "FDA", "consultants."], "wordsB": ["Research", "and", "development", "costs", "include", "expenditures", "for", "an", "in-house", "research", "and", "development", "laboratory,", "salaries", "and", "staff", "costs,", "application", "and", "filing", "for", "regulatory", "approval", "of", "proposed", "products,", "purchased", "in-process", "research", "and", "development,", "regulatory", "and", "scientific", "consulting", "fees,", "as", "well", "as", "contract", "services,", "including", "clinical", "trial", "related", "patient", "costs,", "drug", "formulation", "and", "tableting,", "data", "collection,", "monitoring,", "insurance", "and", "FDA", "consultants."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_12_item1_p49_s1", "idA": "1347613_11_item1_p49_s0", "sentA": "expenses were $9,558,608 for the twelve months ended December 31, 2010, as compared to $3,732,734 and $1,773,494 for the twelve months ended December 31, 2009 and 2008, respectively.", "sentB": "Research and development expenses were $13,418,754 for the twelve months ended December 31, 2011, as compared to $9,558,608 and $3,732,734 for the twelve months ended December 31, 2010 and 2009, respectively.", "type": 2, "words": ["<tag1>", "expenses", "were", "$9,558,608", "for", "the", "twelve", "months", "ended", "December", "31,", "2010,", "as", "compared", "to", "$3,732,734", "and", "$1,773,494", "for", "the", "twelve", "months", "ended", "December", "31,", "2009", "and", "2008,", "respectively.", "<tag2>", "Research", "and", "development", "expenses", "were", "$13,418,754", "for", "the", "twelve", "months", "ended", "December", "31,", "2011,", "as", "compared", "to", "$9,558,608", "and", "$3,732,734", "for", "the", "twelve", "months", "ended", "December", "31,", "2010", "and", "2009,", "respectively.", "<tag3>"], "wordsA": ["expenses", "were", "$9,558,608", "for", "the", "twelve", "months", "ended", "December", "31,", "2010,", "as", "compared", "to", "$3,732,734", "and", "$1,773,494", "for", "the", "twelve", "months", "ended", "December", "31,", "2009", "and", "2008,", "respectively."], "wordsB": ["Research", "and", "development", "expenses", "were", "$13,418,754", "for", "the", "twelve", "months", "ended", "December", "31,", "2011,", "as", "compared", "to", "$9,558,608", "and", "$3,732,734", "for", "the", "twelve", "months", "ended", "December", "31,", "2010", "and", "2009,", "respectively."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_12_item1_p7_s0", "idA": "1347613_11_item1_p4_s0", "sentA": "We recently completed a Phase 2a randomized, double-blind, placebo-controlled, 14-day repeat, oral, dose-ranging clinical trial of plecanatide in patients with CC.", "sentB": "In September, 2010 we completed a Phase 2a randomized, double-blind, placebo-controlled, 14-day repeat, oral, dose-ranging clinical trial of plecanatide in patients with CC.", "type": 2, "words": ["<tag1>", "We", "recently", "completed", "a", "Phase", "2a", "randomized,", "double-blind,", "placebo-controlled,", "14-day", "repeat,", "oral,", "dose-ranging", "clinical", "trial", "of", "plecanatide", "in", "patients", "with", "CC.", "<tag2>", "In", "September,", "2010", "we", "completed", "a", "Phase", "2a", "randomized,", "double-blind,", "placebo-controlled,", "14-day", "repeat,", "oral,", "dose-ranging", "clinical", "trial", "of", "plecanatide", "in", "patients", "with", "CC.", "<tag3>"], "wordsA": ["We", "recently", "completed", "a", "Phase", "2a", "randomized,", "double-blind,", "placebo-controlled,", "14-day", "repeat,", "oral,", "dose-ranging", "clinical", "trial", "of", "plecanatide", "in", "patients", "with", "CC."], "wordsB": ["In", "September,", "2010", "we", "completed", "a", "Phase", "2a", "randomized,", "double-blind,", "placebo-controlled,", "14-day", "repeat,", "oral,", "dose-ranging", "clinical", "trial", "of", "plecanatide", "in", "patients", "with", "CC."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_12_item1_p4_s1", "idA": "1347613_11_item1_p4_s2", "sentA": "This clinical trial enrolled 78 evaluable patients at 14 sites in the United States.", "sentB": "This study is being conducted at 110 sites in the United States and is designed to enroll 880 patients with CC to insure we have 800 evaluable patients at the end of the study.", "type": 2, "words": ["<tag1>", "This", "clinical", "trial", "enrolled", "78", "evaluable", "patients", "at", "14", "sites", "in", "the", "United", "States.", "<tag2>", "This", "study", "is", "being", "conducted", "at", "110", "sites", "in", "the", "United", "States", "and", "is", "designed", "to", "enroll", "880", "patients", "with", "CC", "to", "insure", "we", "have", "800", "evaluable", "patients", "at", "the", "end", "of", "the", "study.", "<tag3>"], "wordsA": ["This", "clinical", "trial", "enrolled", "78", "evaluable", "patients", "at", "14", "sites", "in", "the", "United", "States."], "wordsB": ["This", "study", "is", "being", "conducted", "at", "110", "sites", "in", "the", "United", "States", "and", "is", "designed", "to", "enroll", "880", "patients", "with", "CC", "to", "insure", "we", "have", "800", "evaluable", "patients", "at", "the", "end", "of", "the", "study."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_12_item1_p7_s2", "idA": "1347613_11_item1_p4_s2", "sentA": "This clinical trial enrolled 78 evaluable patients at 14 sites in the United States.", "sentB": "The trial utilized 78 evaluable patients at 14 sites in the United States.", "type": 2, "words": ["<tag1>", "This", "clinical", "trial", "enrolled", "78", "evaluable", "patients", "at", "14", "sites", "in", "the", "United", "States.", "<tag2>", "The", "trial", "utilized", "78", "evaluable", "patients", "at", "14", "sites", "in", "the", "United", "States.", "<tag3>"], "wordsA": ["This", "clinical", "trial", "enrolled", "78", "evaluable", "patients", "at", "14", "sites", "in", "the", "United", "States."], "wordsB": ["The", "trial", "utilized", "78", "evaluable", "patients", "at", "14", "sites", "in", "the", "United", "States."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_12_item1_p20_s3", "idA": "1347613_11_item1_p4_s3", "sentA": "The primary objective of this clinical trial was to evaluate the safety of plecanatide in patients with CC.", "sentB": "We have executed manufacturing supply agreements for API manufacturing of plecanatide with two suppliers, sufficient to meet our foreseeable clinical trial requirements.", "type": 2, "words": ["<tag1>", "The", "primary", "objective", "of", "this", "clinical", "trial", "was", "to", "evaluate", "the", "safety", "of", "plecanatide", "in", "patients", "with", "CC.", "<tag2>", "We", "have", "executed", "manufacturing", "supply", "agreements", "for", "API", "manufacturing", "of", "plecanatide", "with", "two", "suppliers,", "sufficient", "to", "meet", "our", "foreseeable", "clinical", "trial", "requirements.", "<tag3>"], "wordsA": ["The", "primary", "objective", "of", "this", "clinical", "trial", "was", "to", "evaluate", "the", "safety", "of", "plecanatide", "in", "patients", "with", "CC."], "wordsB": ["We", "have", "executed", "manufacturing", "supply", "agreements", "for", "API", "manufacturing", "of", "plecanatide", "with", "two", "suppliers,", "sufficient", "to", "meet", "our", "foreseeable", "clinical", "trial", "requirements."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_12_item1_p7_s3", "idA": "1347613_11_item1_p4_s3", "sentA": "The primary objective of this clinical trial was to evaluate the safety of plecanatide in patients with CC.", "sentB": "The primary objective of the trial was to evaluate the safety of plecanatide in patients with CC.", "type": 2, "words": ["<tag1>", "The", "primary", "objective", "of", "this", "clinical", "trial", "was", "to", "evaluate", "the", "safety", "of", "plecanatide", "in", "patients", "with", "CC.", "<tag2>", "The", "primary", "objective", "of", "the", "trial", "was", "to", "evaluate", "the", "safety", "of", "plecanatide", "in", "patients", "with", "CC.", "<tag3>"], "wordsA": ["The", "primary", "objective", "of", "this", "clinical", "trial", "was", "to", "evaluate", "the", "safety", "of", "plecanatide", "in", "patients", "with", "CC."], "wordsB": ["The", "primary", "objective", "of", "the", "trial", "was", "to", "evaluate", "the", "safety", "of", "plecanatide", "in", "patients", "with", "CC."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_12_item1_p51_s0", "idA": "1347613_11_item1_p51_s0", "sentA": "As of March 12, 2011 we have three issued United States patents.", "sentB": "As of March 14, 2012 we have five issued United States patents.", "type": 2, "words": ["<tag1>", "As", "of", "March", "12,", "2011", "we", "have", "three", "issued", "United", "States", "patents.", "<tag2>", "As", "of", "March", "14,", "2012", "we", "have", "five", "issued", "United", "States", "patents.", "<tag3>"], "wordsA": ["As", "of", "March", "12,", "2011", "we", "have", "three", "issued", "United", "States", "patents."], "wordsB": ["As", "of", "March", "14,", "2012", "we", "have", "five", "issued", "United", "States", "patents."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_12_item1_p51_s3", "idA": "1347613_11_item1_p51_s1", "sentA": "Two of these patents cover the composition-of-matter of plecanatide and were issued on May 9, 2006 and September 21, 2010; they will expire in 2023 and 2022, respectively.", "sentB": "A fourth patent granted October 11, 2011 covers composition-of-matter of analogs related to plecanatide and SP333 and will expire in 2028.", "type": 2, "words": ["<tag1>", "Two", "of", "these", "patents", "cover", "the", "composition-of-matter", "of", "plecanatide", "and", "were", "issued", "on", "May", "9,", "2006", "and", "September", "21,", "2010;", "they", "will", "expire", "in", "2023", "and", "2022,", "respectively.", "<tag2>", "A", "fourth", "patent", "granted", "October", "11,", "2011", "covers", "composition-of-matter", "of", "analogs", "related", "to", "plecanatide", "and", "SP333", "and", "will", "expire", "in", "2028.", "<tag3>"], "wordsA": ["Two", "of", "these", "patents", "cover", "the", "composition-of-matter", "of", "plecanatide", "and", "were", "issued", "on", "May", "9,", "2006", "and", "September", "21,", "2010;", "they", "will", "expire", "in", "2023", "and", "2022,", "respectively."], "wordsB": ["A", "fourth", "patent", "granted", "October", "11,", "2011", "covers", "composition-of-matter", "of", "analogs", "related", "to", "plecanatide", "and", "SP333", "and", "will", "expire", "in", "2028."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_12_item1_p51_s2", "idA": "1347613_11_item1_p51_s2", "sentA": "The third patent covers the composition-of-matter of SP333 issued on February 1, 2011 and expires in 2028.", "sentB": "A third patent covers the composition-of-matter of SP333 issued on February 1, 2011 and expires in 2028.", "type": 2, "words": ["<tag1>", "The", "third", "patent", "covers", "the", "composition-of-matter", "of", "SP333", "issued", "on", "February", "1,", "2011", "and", "expires", "in", "2028.", "<tag2>", "A", "third", "patent", "covers", "the", "composition-of-matter", "of", "SP333", "issued", "on", "February", "1,", "2011", "and", "expires", "in", "2028.", "<tag3>"], "wordsA": ["The", "third", "patent", "covers", "the", "composition-of-matter", "of", "SP333", "issued", "on", "February", "1,", "2011", "and", "expires", "in", "2028."], "wordsB": ["A", "third", "patent", "covers", "the", "composition-of-matter", "of", "SP333", "issued", "on", "February", "1,", "2011", "and", "expires", "in", "2028."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_12_item1_p51_s4", "idA": "1347613_11_item1_p51_s3", "sentA": "In addition, we have three granted foreign patents which cover composition-of-matter of plecanatide and expire in 2022.", "sentB": "A fifth patent granted February 14, 2012 covers a method of treating inflammatory bowel disease using plecanatide and will expire in 2022.", "type": 2, "words": ["<tag1>", "In", "addition,", "we", "have", "three", "granted", "foreign", "patents", "which", "cover", "composition-of-matter", "of", "plecanatide", "and", "expire", "in", "2022.", "<tag2>", "A", "fifth", "patent", "granted", "February", "14,", "2012", "covers", "a", "method", "of", "treating", "inflammatory", "bowel", "disease", "using", "plecanatide", "and", "will", "expire", "in", "2022.", "<tag3>"], "wordsA": ["In", "addition,", "we", "have", "three", "granted", "foreign", "patents", "which", "cover", "composition-of-matter", "of", "plecanatide", "and", "expire", "in", "2022."], "wordsB": ["A", "fifth", "patent", "granted", "February", "14,", "2012", "covers", "a", "method", "of", "treating", "inflammatory", "bowel", "disease", "using", "plecanatide", "and", "will", "expire", "in", "2022."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_12_item1_p52_s0", "idA": "1347613_11_item1_p52_s0", "sentA": "Additionally as of March 12, 2011, we have 11 pending United States patent applications (seven utility and four provisional) and 29 pending foreign patent applications covering plecanatide and SP-333 and various derivatives and analogs.", "sentB": "Additionally as of March 14, 2012, we have 7 pending United States patent applications and 39 pending foreign patent applications covering plecanatide and SP-333 and various derivatives and analogs.", "type": 2, "words": ["<tag1>", "Additionally", "as", "of", "March", "12,", "2011,", "we", "have", "11", "pending", "United", "States", "patent", "applications", "(seven", "utility", "and", "four", "provisional)", "and", "29", "pending", "foreign", "patent", "applications", "covering", "plecanatide", "and", "SP-333", "and", "various", "derivatives", "and", "analogs.", "<tag2>", "Additionally", "as", "of", "March", "14,", "2012,", "we", "have", "7", "pending", "United", "States", "patent", "applications", "and", "39", "pending", "foreign", "patent", "applications", "covering", "plecanatide", "and", "SP-333", "and", "various", "derivatives", "and", "analogs.", "<tag3>"], "wordsA": ["Additionally", "as", "of", "March", "12,", "2011,", "we", "have", "11", "pending", "United", "States", "patent", "applications", "(seven", "utility", "and", "four", "provisional)", "and", "29", "pending", "foreign", "patent", "applications", "covering", "plecanatide", "and", "SP-333", "and", "various", "derivatives", "and", "analogs."], "wordsB": ["Additionally", "as", "of", "March", "14,", "2012,", "we", "have", "7", "pending", "United", "States", "patent", "applications", "and", "39", "pending", "foreign", "patent", "applications", "covering", "plecanatide", "and", "SP-333", "and", "various", "derivatives", "and", "analogs."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_12_item1_p57_s0", "idA": "1347613_11_item1_p56_s0", "sentA": "As of March 12, 2011, we had 8 full-time and 2 part-time employees.", "sentB": "As of March 14, 2012, we had 9 full-time and 1 part-time employees.", "type": 2, "words": ["<tag1>", "As", "of", "March", "12,", "2011,", "we", "had", "8", "full-time", "and", "2", "part-time", "employees.", "<tag2>", "As", "of", "March", "14,", "2012,", "we", "had", "9", "full-time", "and", "1", "part-time", "employees.", "<tag3>"], "wordsA": ["As", "of", "March", "12,", "2011,", "we", "had", "8", "full-time", "and", "2", "part-time", "employees."], "wordsB": ["As", "of", "March", "14,", "2012,", "we", "had", "9", "full-time", "and", "1", "part-time", "employees."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_12_item1_p7_s4", "idA": "1347613_11_item1_p5_s0", "sentA": "profile of plecanatide and to assess bowel function, including time to first bowel movement, frequency, completeness of evacuation, stool consistency, straining and abdominal discomfort, after treatment with plecanatide.", "sentB": "The secondary objectives of this clinical trial were to assess the pharmacokinetic profile of plecanatide and to assess bowel function, including time to first bowel movement, frequency, completeness of evacuation, stool consistency, straining and abdominal discomfort, after treatment with plecanatide.", "type": 2, "words": ["<tag1>", "profile", "of", "plecanatide", "and", "to", "assess", "bowel", "function,", "including", "time", "to", "first", "bowel", "movement,", "frequency,", "completeness", "of", "evacuation,", "stool", "consistency,", "straining", "and", "abdominal", "discomfort,", "after", "treatment", "with", "plecanatide.", "<tag2>", "The", "secondary", "objectives", "of", "this", "clinical", "trial", "were", "to", "assess", "the", "pharmacokinetic", "profile", "of", "plecanatide", "and", "to", "assess", "bowel", "function,", "including", "time", "to", "first", "bowel", "movement,", "frequency,", "completeness", "of", "evacuation,", "stool", "consistency,", "straining", "and", "abdominal", "discomfort,", "after", "treatment", "with", "plecanatide.", "<tag3>"], "wordsA": ["profile", "of", "plecanatide", "and", "to", "assess", "bowel", "function,", "including", "time", "to", "first", "bowel", "movement,", "frequency,", "completeness", "of", "evacuation,", "stool", "consistency,", "straining", "and", "abdominal", "discomfort,", "after", "treatment", "with", "plecanatide."], "wordsB": ["The", "secondary", "objectives", "of", "this", "clinical", "trial", "were", "to", "assess", "the", "pharmacokinetic", "profile", "of", "plecanatide", "and", "to", "assess", "bowel", "function,", "including", "time", "to", "first", "bowel", "movement,", "frequency,", "completeness", "of", "evacuation,", "stool", "consistency,", "straining", "and", "abdominal", "discomfort,", "after", "treatment", "with", "plecanatide."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_12_item1_p9_s0", "idA": "1347613_11_item1_p6_s1", "sentA": "Patients also had to have had a colonoscopy within five years before enrollment with no significant findings, had to be in good health as determined by a physical examination and other standard assessments and had to have reported less than six simultaneous bowel movements, or SBMs, and less than three complete SBMs, or CSBMs, in each week during the 14-days before treatment with plecanatide or placebo.", "sentB": "reported less than six simultaneous bowel movements, or SBMs, and less than three complete SBMs, or CSBMs, in each week during the 14-days before treatment with plecanatide or placebo.", "type": 2, "words": ["<tag1>", "Patients", "also", "had", "to", "have", "had", "a", "colonoscopy", "within", "five", "years", "before", "enrollment", "with", "no", "significant", "findings,", "had", "to", "be", "in", "good", "health", "as", "determined", "by", "a", "physical", "examination", "and", "other", "standard", "assessments", "and", "had", "to", "have", "reported", "less", "than", "six", "simultaneous", "bowel", "movements,", "or", "SBMs,", "and", "less", "than", "three", "complete", "SBMs,", "or", "CSBMs,", "in", "each", "week", "during", "the", "14-days", "before", "treatment", "with", "plecanatide", "or", "placebo.", "<tag2>", "reported", "less", "than", "six", "simultaneous", "bowel", "movements,", "or", "SBMs,", "and", "less", "than", "three", "complete", "SBMs,", "or", "CSBMs,", "in", "each", "week", "during", "the", "14-days", "before", "treatment", "with", "plecanatide", "or", "placebo.", "<tag3>"], "wordsA": ["Patients", "also", "had", "to", "have", "had", "a", "colonoscopy", "within", "five", "years", "before", "enrollment", "with", "no", "significant", "findings,", "had", "to", "be", "in", "good", "health", "as", "determined", "by", "a", "physical", "examination", "and", "other", "standard", "assessments", "and", "had", "to", "have", "reported", "less", "than", "six", "simultaneous", "bowel", "movements,", "or", "SBMs,", "and", "less", "than", "three", "complete", "SBMs,", "or", "CSBMs,", "in", "each", "week", "during", "the", "14-days", "before", "treatment", "with", "plecanatide", "or", "placebo."], "wordsB": ["reported", "less", "than", "six", "simultaneous", "bowel", "movements,", "or", "SBMs,", "and", "less", "than", "three", "complete", "SBMs,", "or", "CSBMs,", "in", "each", "week", "during", "the", "14-days", "before", "treatment", "with", "plecanatide", "or", "placebo."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_12_item1_p5_s0", "idA": "1347613_11_item1_p7_s0", "sentA": "Patients in this clinical trial received placebo or plecanatide once-daily in the morning for 14 consecutive days at oral doses of 0.3 mg, 1.0 mg, 3.0 mg or 9.0 mg, respectively.", "sentB": "Patients will be treated with one of three doses of plecanatide (0.3, 1.0 or 3.0 mg) or placebo taken once daily over a period of 12 weeks.", "type": 2, "words": ["<tag1>", "Patients", "in", "this", "clinical", "trial", "received", "placebo", "or", "plecanatide", "once-daily", "in", "the", "morning", "for", "14", "consecutive", "days", "at", "oral", "doses", "of", "0.3", "mg,", "1.0", "mg,", "3.0", "mg", "or", "9.0", "mg,", "respectively.", "<tag2>", "Patients", "will", "be", "treated", "with", "one", "of", "three", "doses", "of", "plecanatide", "(0.3,", "1.0", "or", "3.0", "mg)", "or", "placebo", "taken", "once", "daily", "over", "a", "period", "of", "12", "weeks.", "<tag3>"], "wordsA": ["Patients", "in", "this", "clinical", "trial", "received", "placebo", "or", "plecanatide", "once-daily", "in", "the", "morning", "for", "14", "consecutive", "days", "at", "oral", "doses", "of", "0.3", "mg,", "1.0", "mg,", "3.0", "mg", "or", "9.0", "mg,", "respectively."], "wordsB": ["Patients", "will", "be", "treated", "with", "one", "of", "three", "doses", "of", "plecanatide", "(0.3,", "1.0", "or", "3.0", "mg)", "or", "placebo", "taken", "once", "daily", "over", "a", "period", "of", "12", "weeks."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_13_item1_p0_s1", "idA": "1347613_12_item1_p0_s1", "sentA": "Our lead product candidate is plecanatide (formerly called SP-304), a guanylyl cyclase C, or GC-C, receptor agonist, to treat GI disorders, primarily chronic constipation, or CC, and constipation-predominant-irritable bowel syndrome, or IBS-C. CC and IBS-C are functional gastrointestinal disorders that afflict millions of sufferers worldwide.", "sentB": "Our lead product candidate is plecanatide (formerly called SP-304), a guanylate cyclase C, or GC-C, receptor agonist, to treat GI disorders, primarily chronic idiopathic constipation, or CIC, and constipation-predominant irritable bowel syndrome, or IBS-C. CIC and IBS-C are functional gastrointestinal disorders that afflict millions of sufferers worldwide.", "type": 2, "words": ["<tag1>", "Our", "lead", "product", "candidate", "is", "plecanatide", "(formerly", "called", "SP-304),", "a", "guanylyl", "cyclase", "C,", "or", "GC-C,", "receptor", "agonist,", "to", "treat", "GI", "disorders,", "primarily", "chronic", "constipation,", "or", "CC,", "and", "constipation-predominant-irritable", "bowel", "syndrome,", "or", "IBS-C.", "CC", "and", "IBS-C", "are", "functional", "gastrointestinal", "disorders", "that", "afflict", "millions", "of", "sufferers", "worldwide.", "<tag2>", "Our", "lead", "product", "candidate", "is", "plecanatide", "(formerly", "called", "SP-304),", "a", "guanylate", "cyclase", "C,", "or", "GC-C,", "receptor", "agonist,", "to", "treat", "GI", "disorders,", "primarily", "chronic", "idiopathic", "constipation,", "or", "CIC,", "and", "constipation-predominant", "irritable", "bowel", "syndrome,", "or", "IBS-C.", "CIC", "and", "IBS-C", "are", "functional", "gastrointestinal", "disorders", "that", "afflict", "millions", "of", "sufferers", "worldwide.", "<tag3>"], "wordsA": ["Our", "lead", "product", "candidate", "is", "plecanatide", "(formerly", "called", "SP-304),", "a", "guanylyl", "cyclase", "C,", "or", "GC-C,", "receptor", "agonist,", "to", "treat", "GI", "disorders,", "primarily", "chronic", "constipation,", "or", "CC,", "and", "constipation-predominant-irritable", "bowel", "syndrome,", "or", "IBS-C.", "CC", "and", "IBS-C", "are", "functional", "gastrointestinal", "disorders", "that", "afflict", "millions", "of", "sufferers", "worldwide."], "wordsB": ["Our", "lead", "product", "candidate", "is", "plecanatide", "(formerly", "called", "SP-304),", "a", "guanylate", "cyclase", "C,", "or", "GC-C,", "receptor", "agonist,", "to", "treat", "GI", "disorders,", "primarily", "chronic", "idiopathic", "constipation,", "or", "CIC,", "and", "constipation-predominant", "irritable", "bowel", "syndrome,", "or", "IBS-C.", "CIC", "and", "IBS-C", "are", "functional", "gastrointestinal", "disorders", "that", "afflict", "millions", "of", "sufferers", "worldwide."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_13_item1_p1_s0", "idA": "1347613_12_item1_p0_s2", "sentA": "CC is primarily characterized by constipation symptoms but a majority of these patients report experiencing bloating and abdominal discomfort as among their most bothersome symptoms.", "sentB": "CIC is primarily characterized by constipation symptoms but a majority of these patients report experiencing straining, bloating and abdominal discomfort as among their most bothersome symptoms.", "type": 2, "words": ["<tag1>", "CC", "is", "primarily", "characterized", "by", "constipation", "symptoms", "but", "a", "majority", "of", "these", "patients", "report", "experiencing", "bloating", "and", "abdominal", "discomfort", "as", "among", "their", "most", "bothersome", "symptoms.", "<tag2>", "CIC", "is", "primarily", "characterized", "by", "constipation", "symptoms", "but", "a", "majority", "of", "these", "patients", "report", "experiencing", "straining,", "bloating", "and", "abdominal", "discomfort", "as", "among", "their", "most", "bothersome", "symptoms.", "<tag3>"], "wordsA": ["CC", "is", "primarily", "characterized", "by", "constipation", "symptoms", "but", "a", "majority", "of", "these", "patients", "report", "experiencing", "bloating", "and", "abdominal", "discomfort", "as", "among", "their", "most", "bothersome", "symptoms."], "wordsB": ["CIC", "is", "primarily", "characterized", "by", "constipation", "symptoms", "but", "a", "majority", "of", "these", "patients", "report", "experiencing", "straining,", "bloating", "and", "abdominal", "discomfort", "as", "among", "their", "most", "bothersome", "symptoms."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_13_item1_p35_s2", "idA": "1347613_12_item1_p12_s0", "sentA": "The majority of AEs were mild to moderate and transient in nature.", "sentB": "SP-333 has exhibited potent anti-inflammatory activity in animal studies of colitis, displaying a novel mechanism-of-action that we believe might provide a new way to treat UC patients with mild to moderate disease.", "type": 2, "words": ["<tag1>", "The", "majority", "of", "AEs", "were", "mild", "to", "moderate", "and", "transient", "in", "nature.", "<tag2>", "SP-333", "has", "exhibited", "potent", "anti-inflammatory", "activity", "in", "animal", "studies", "of", "colitis,", "displaying", "a", "novel", "mechanism-of-action", "that", "we", "believe", "might", "provide", "a", "new", "way", "to", "treat", "UC", "patients", "with", "mild", "to", "moderate", "disease.", "<tag3>"], "wordsA": ["The", "majority", "of", "AEs", "were", "mild", "to", "moderate", "and", "transient", "in", "nature."], "wordsB": ["SP-333", "has", "exhibited", "potent", "anti-inflammatory", "activity", "in", "animal", "studies", "of", "colitis,", "displaying", "a", "novel", "mechanism-of-action", "that", "we", "believe", "might", "provide", "a", "new", "way", "to", "treat", "UC", "patients", "with", "mild", "to", "moderate", "disease."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_13_item1_p26_s2", "idA": "1347613_12_item1_p12_s1", "sentA": "One patient on placebo discontinued from the clinical trial due to diarrhea.", "sentB": "About 13 million of them suffer from the IBS-C subtype.", "type": 2, "words": ["<tag1>", "One", "patient", "on", "placebo", "discontinued", "from", "the", "clinical", "trial", "due", "to", "diarrhea.", "<tag2>", "About", "13", "million", "of", "them", "suffer", "from", "the", "IBS-C", "subtype.", "<tag3>"], "wordsA": ["One", "patient", "on", "placebo", "discontinued", "from", "the", "clinical", "trial", "due", "to", "diarrhea."], "wordsB": ["About", "13", "million", "of", "them", "suffer", "from", "the", "IBS-C", "subtype."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_13_item1_p10_s0", "idA": "1347613_12_item1_p15_s0", "sentA": "We are also preparing to initiate a Phase 2b clinical trial of plecanatide for the treatment of IBS-C in patients during 2012.", "sentB": "On September 14, 2012, we entered into a binding letter of intent, or LOI, with Ironwood Pharmaceuticals, Inc., or Ironwood, pursuant to which we and Ironwood agreed to enter into a definitive license agreement giving us an exclusive worldwide license to Ironwood s method of use patents on plecanatide for the treatment of CIC and IBS-C.", "type": 2, "words": ["<tag1>", "We", "are", "also", "preparing", "to", "initiate", "a", "Phase", "2b", "clinical", "trial", "of", "plecanatide", "for", "the", "treatment", "of", "IBS-C", "in", "patients", "during", "2012.", "<tag2>", "On", "September", "14,", "2012,", "we", "entered", "into", "a", "binding", "letter", "of", "intent,", "or", "LOI,", "with", "Ironwood", "Pharmaceuticals,", "Inc.,", "or", "Ironwood,", "pursuant", "to", "which", "we", "and", "Ironwood", "agreed", "to", "enter", "into", "a", "definitive", "license", "agreement", "giving", "us", "an", "exclusive", "worldwide", "license", "to", "Ironwood", "s", "method", "of", "use", "patents", "on", "plecanatide", "for", "the", "treatment", "of", "CIC", "and", "IBS-C.", "<tag3>"], "wordsA": ["We", "are", "also", "preparing", "to", "initiate", "a", "Phase", "2b", "clinical", "trial", "of", "plecanatide", "for", "the", "treatment", "of", "IBS-C", "in", "patients", "during", "2012."], "wordsB": ["On", "September", "14,", "2012,", "we", "entered", "into", "a", "binding", "letter", "of", "intent,", "or", "LOI,", "with", "Ironwood", "Pharmaceuticals,", "Inc.,", "or", "Ironwood,", "pursuant", "to", "which", "we", "and", "Ironwood", "agreed", "to", "enter", "into", "a", "definitive", "license", "agreement", "giving", "us", "an", "exclusive", "worldwide", "license", "to", "Ironwood", "s", "method", "of", "use", "patents", "on", "plecanatide", "for", "the", "treatment", "of", "CIC", "and", "IBS-C."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_13_item1_p33_s0", "idA": "1347613_12_item1_p16_s0", "sentA": "We are also developing a second generation GC-C receptor analog, SP-333, which is currently in pre-clinical development for the treatment of gastrointestinal inflammatory diseases.", "sentB": "We are developing a second generation GC-C receptor analog, SP-333, for the treatment of inflammatory bowel diseases, or IBD.", "type": 2, "words": ["<tag1>", "We", "are", "also", "developing", "a", "second", "generation", "GC-C", "receptor", "analog,", "SP-333,", "which", "is", "currently", "in", "pre-clinical", "development", "for", "the", "treatment", "of", "gastrointestinal", "inflammatory", "diseases.", "<tag2>", "We", "are", "developing", "a", "second", "generation", "GC-C", "receptor", "analog,", "SP-333,", "for", "the", "treatment", "of", "inflammatory", "bowel", "diseases,", "or", "IBD.", "<tag3>"], "wordsA": ["We", "are", "also", "developing", "a", "second", "generation", "GC-C", "receptor", "analog,", "SP-333,", "which", "is", "currently", "in", "pre-clinical", "development", "for", "the", "treatment", "of", "gastrointestinal", "inflammatory", "diseases."], "wordsB": ["We", "are", "developing", "a", "second", "generation", "GC-C", "receptor", "analog,", "SP-333,", "for", "the", "treatment", "of", "inflammatory", "bowel", "diseases,", "or", "IBD."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_13_item1_p5_s1", "idA": "1347613_12_item1_p16_s1", "sentA": "SP-333 is a synthetic analog of uroguanylin, a natriuretic hormone which is normally produced in the body s intestinal tract.", "sentB": "Plecanatide is a synthetic analog of uroguanylin, a natural human hormone that regulates ion and fluid transport in the intestine.", "type": 2, "words": ["<tag1>", "SP-333", "is", "a", "synthetic", "analog", "of", "uroguanylin,", "a", "natriuretic", "hormone", "which", "is", "normally", "produced", "in", "the", "body", "s", "intestinal", "tract.", "<tag2>", "Plecanatide", "is", "a", "synthetic", "analog", "of", "uroguanylin,", "a", "natural", "human", "hormone", "that", "regulates", "ion", "and", "fluid", "transport", "in", "the", "intestine.", "<tag3>"], "wordsA": ["SP-333", "is", "a", "synthetic", "analog", "of", "uroguanylin,", "a", "natriuretic", "hormone", "which", "is", "normally", "produced", "in", "the", "body", "s", "intestinal", "tract."], "wordsB": ["Plecanatide", "is", "a", "synthetic", "analog", "of", "uroguanylin,", "a", "natural", "human", "hormone", "that", "regulates", "ion", "and", "fluid", "transport", "in", "the", "intestine."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_13_item1_p28_s0", "idA": "1347613_12_item1_p16_s2", "sentA": "Deficiency of this hormone is predicted to be one of the primary reasons for the formation of polyps that can lead to colon cancer, as well as debilitating and difficult-to-treat GI inflammatory disorders such as UC and Crohn s disease.", "sentB": "IBS is one of the most common reasons for work or school absenteeism, second only to the common cold.", "type": 2, "words": ["<tag1>", "Deficiency", "of", "this", "hormone", "is", "predicted", "to", "be", "one", "of", "the", "primary", "reasons", "for", "the", "formation", "of", "polyps", "that", "can", "lead", "to", "colon", "cancer,", "as", "well", "as", "debilitating", "and", "difficult-to-treat", "GI", "inflammatory", "disorders", "such", "as", "UC", "and", "Crohn", "s", "disease.", "<tag2>", "IBS", "is", "one", "of", "the", "most", "common", "reasons", "for", "work", "or", "school", "absenteeism,", "second", "only", "to", "the", "common", "cold.", "<tag3>"], "wordsA": ["Deficiency", "of", "this", "hormone", "is", "predicted", "to", "be", "one", "of", "the", "primary", "reasons", "for", "the", "formation", "of", "polyps", "that", "can", "lead", "to", "colon", "cancer,", "as", "well", "as", "debilitating", "and", "difficult-to-treat", "GI", "inflammatory", "disorders", "such", "as", "UC", "and", "Crohn", "s", "disease."], "wordsB": ["IBS", "is", "one", "of", "the", "most", "common", "reasons", "for", "work", "or", "school", "absenteeism,", "second", "only", "to", "the", "common", "cold."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_13_item1_p33_s2", "idA": "1347613_12_item1_p16_s2", "sentA": "Deficiency of this hormone is predicted to be one of the primary reasons for the formation of polyps that can lead to colon cancer, as well as debilitating and difficult-to-treat GI inflammatory disorders such as UC and Crohn s disease.", "sentB": "Deficiency of this hormone is thought to be one of the primary reasons for the formation of polyps that can lead to colon cancer, as well as debilitating and difficult-to-treat GI inflammatory disorders such as UC and Crohn s disease.", "type": 2, "words": ["<tag1>", "Deficiency", "of", "this", "hormone", "is", "predicted", "to", "be", "one", "of", "the", "primary", "reasons", "for", "the", "formation", "of", "polyps", "that", "can", "lead", "to", "colon", "cancer,", "as", "well", "as", "debilitating", "and", "difficult-to-treat", "GI", "inflammatory", "disorders", "such", "as", "UC", "and", "Crohn", "s", "disease.", "<tag2>", "Deficiency", "of", "this", "hormone", "is", "thought", "to", "be", "one", "of", "the", "primary", "reasons", "for", "the", "formation", "of", "polyps", "that", "can", "lead", "to", "colon", "cancer,", "as", "well", "as", "debilitating", "and", "difficult-to-treat", "GI", "inflammatory", "disorders", "such", "as", "UC", "and", "Crohn", "s", "disease.", "<tag3>"], "wordsA": ["Deficiency", "of", "this", "hormone", "is", "predicted", "to", "be", "one", "of", "the", "primary", "reasons", "for", "the", "formation", "of", "polyps", "that", "can", "lead", "to", "colon", "cancer,", "as", "well", "as", "debilitating", "and", "difficult-to-treat", "GI", "inflammatory", "disorders", "such", "as", "UC", "and", "Crohn", "s", "disease."], "wordsB": ["Deficiency", "of", "this", "hormone", "is", "thought", "to", "be", "one", "of", "the", "primary", "reasons", "for", "the", "formation", "of", "polyps", "that", "can", "lead", "to", "colon", "cancer,", "as", "well", "as", "debilitating", "and", "difficult-to-treat", "GI", "inflammatory", "disorders", "such", "as", "UC", "and", "Crohn", "s", "disease."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_13_item1_p36_s0", "idA": "1347613_12_item1_p16_s3", "sentA": "We plan to submit by mid-2012 an Investigational New Drug application, or IND, to the U.S. Food and Drug Administration, or FDA, to treat UC, and intend to initiate a Phase 1 clinical trial of SP-333 in volunteers during the second half of 2012.", "sentB": "On September 7, 2012, we submitted an Investigational New Drug (IND) application for clinical evaluation of SP-333 to treat IBD.", "type": 2, "words": ["<tag1>", "We", "plan", "to", "submit", "by", "mid-2012", "an", "Investigational", "New", "Drug", "application,", "or", "IND,", "to", "the", "U.S.", "Food", "and", "Drug", "Administration,", "or", "FDA,", "to", "treat", "UC,", "and", "intend", "to", "initiate", "a", "Phase", "1", "clinical", "trial", "of", "SP-333", "in", "volunteers", "during", "the", "second", "half", "of", "2012.", "<tag2>", "On", "September", "7,", "2012,", "we", "submitted", "an", "Investigational", "New", "Drug", "(IND)", "application", "for", "clinical", "evaluation", "of", "SP-333", "to", "treat", "IBD.", "<tag3>"], "wordsA": ["We", "plan", "to", "submit", "by", "mid-2012", "an", "Investigational", "New", "Drug", "application,", "or", "IND,", "to", "the", "U.S.", "Food", "and", "Drug", "Administration,", "or", "FDA,", "to", "treat", "UC,", "and", "intend", "to", "initiate", "a", "Phase", "1", "clinical", "trial", "of", "SP-333", "in", "volunteers", "during", "the", "second", "half", "of", "2012."], "wordsB": ["On", "September", "7,", "2012,", "we", "submitted", "an", "Investigational", "New", "Drug", "(IND)", "application", "for", "clinical", "evaluation", "of", "SP-333", "to", "treat", "IBD."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_13_item1_p37_s0", "idA": "1347613_12_item1_p19_s0", "sentA": "On February 1, 2011 the U.S. Patent and Trademark Office issued U.S. Patent No. 7,879,802, covering our novel drug candidate SP-333 to treat inflammatory bowel disease (IBD).", "sentB": "On February 1, 2011 the U.S. Patent and Trademark Office issued U.S. Patent No. 7,879,802, covering our novel drug candidate SP-333 to treat IBD.", "type": 2, "words": ["<tag1>", "On", "February", "1,", "2011", "the", "U.S.", "Patent", "and", "Trademark", "Office", "issued", "U.S.", "Patent", "No.", "7,879,802,", "covering", "our", "novel", "drug", "candidate", "SP-333", "to", "treat", "inflammatory", "bowel", "disease", "(IBD).", "<tag2>", "On", "February", "1,", "2011", "the", "U.S.", "Patent", "and", "Trademark", "Office", "issued", "U.S.", "Patent", "No.", "7,879,802,", "covering", "our", "novel", "drug", "candidate", "SP-333", "to", "treat", "IBD.", "<tag3>"], "wordsA": ["On", "February", "1,", "2011", "the", "U.S.", "Patent", "and", "Trademark", "Office", "issued", "U.S.", "Patent", "No.", "7,879,802,", "covering", "our", "novel", "drug", "candidate", "SP-333", "to", "treat", "inflammatory", "bowel", "disease", "(IBD)."], "wordsB": ["On", "February", "1,", "2011", "the", "U.S.", "Patent", "and", "Trademark", "Office", "issued", "U.S.", "Patent", "No.", "7,879,802,", "covering", "our", "novel", "drug", "candidate", "SP-333", "to", "treat", "IBD."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_13_item1_p5_s0", "idA": "1347613_12_item1_p19_s1", "sentA": "SP-333 is a second-generation guanylate cyclase C (GC-C) agonist with the potential to treat gastro-intestinal diseases such as UC.", "sentB": "Plecanatide, our lead investigational drug, is a member of a new class of non-systemic drugs, referred to as guanylate cyclase C (GC-C) agonists.", "type": 2, "words": ["<tag1>", "SP-333", "is", "a", "second-generation", "guanylate", "cyclase", "C", "(GC-C)", "agonist", "with", "the", "potential", "to", "treat", "gastro-intestinal", "diseases", "such", "as", "UC.", "<tag2>", "Plecanatide,", "our", "lead", "investigational", "drug,", "is", "a", "member", "of", "a", "new", "class", "of", "non-systemic", "drugs,", "referred", "to", "as", "guanylate", "cyclase", "C", "(GC-C)", "agonists.", "<tag3>"], "wordsA": ["SP-333", "is", "a", "second-generation", "guanylate", "cyclase", "C", "(GC-C)", "agonist", "with", "the", "potential", "to", "treat", "gastro-intestinal", "diseases", "such", "as", "UC."], "wordsB": ["Plecanatide,", "our", "lead", "investigational", "drug,", "is", "a", "member", "of", "a", "new", "class", "of", "non-systemic", "drugs,", "referred", "to", "as", "guanylate", "cyclase", "C", "(GC-C)", "agonists."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_13_item1_p25_s0", "idA": "1347613_12_item1_p1_s0", "sentA": "IBS-C is characterized by frequent and recurring abdominal pain and/or discomfort associated with chronic constipation.", "sentB": "Irritable bowel syndrome, or IBS, is characterized by symptoms of abdominal pain or discomfort such as cramping, bloating, gas, and constipation or diarrhea or both.", "type": 2, "words": ["<tag1>", "IBS-C", "is", "characterized", "by", "frequent", "and", "recurring", "abdominal", "pain", "and/or", "discomfort", "associated", "with", "chronic", "constipation.", "<tag2>", "Irritable", "bowel", "syndrome,", "or", "IBS,", "is", "characterized", "by", "symptoms", "of", "abdominal", "pain", "or", "discomfort", "such", "as", "cramping,", "bloating,", "gas,", "and", "constipation", "or", "diarrhea", "or", "both.", "<tag3>"], "wordsA": ["IBS-C", "is", "characterized", "by", "frequent", "and", "recurring", "abdominal", "pain", "and/or", "discomfort", "associated", "with", "chronic", "constipation."], "wordsB": ["Irritable", "bowel", "syndrome,", "or", "IBS,", "is", "characterized", "by", "symptoms", "of", "abdominal", "pain", "or", "discomfort", "such", "as", "cramping,", "bloating,", "gas,", "and", "constipation", "or", "diarrhea", "or", "both."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_13_item1_p2_s1", "idA": "1347613_12_item1_p1_s1", "sentA": "We are also developing SP-333, our second generation GC-C receptor agonist for the treatment of gastrointestinal inflammatory diseases, such as ulcerative colitis, or UC.", "sentB": "We are also developing SP-333, a second generation GC-C receptor agonist for the treatment of inflammatory bowel diseases, such as ulcerative colitis, or UC.", "type": 2, "words": ["<tag1>", "We", "are", "also", "developing", "SP-333,", "our", "second", "generation", "GC-C", "receptor", "agonist", "for", "the", "treatment", "of", "gastrointestinal", "inflammatory", "diseases,", "such", "as", "ulcerative", "colitis,", "or", "UC.", "<tag2>", "We", "are", "also", "developing", "SP-333,", "a", "second", "generation", "GC-C", "receptor", "agonist", "for", "the", "treatment", "of", "inflammatory", "bowel", "diseases,", "such", "as", "ulcerative", "colitis,", "or", "UC.", "<tag3>"], "wordsA": ["We", "are", "also", "developing", "SP-333,", "our", "second", "generation", "GC-C", "receptor", "agonist", "for", "the", "treatment", "of", "gastrointestinal", "inflammatory", "diseases,", "such", "as", "ulcerative", "colitis,", "or", "UC."], "wordsB": ["We", "are", "also", "developing", "SP-333,", "a", "second", "generation", "GC-C", "receptor", "agonist", "for", "the", "treatment", "of", "inflammatory", "bowel", "diseases,", "such", "as", "ulcerative", "colitis,", "or", "UC."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_13_item1_p39_s1", "idA": "1347613_12_item1_p20_s1", "sentA": "Our active pharmaceutical ingredients, or APIs, and the final formulated drug products are manufactured for us by third party contractors.", "sentB": "Our active pharmaceutical ingredients, or APIs, are manufactured for us by third party contractors.", "type": 2, "words": ["<tag1>", "Our", "active", "pharmaceutical", "ingredients,", "or", "APIs,", "and", "the", "final", "formulated", "drug", "products", "are", "manufactured", "for", "us", "by", "third", "party", "contractors.", "<tag2>", "Our", "active", "pharmaceutical", "ingredients,", "or", "APIs,", "are", "manufactured", "for", "us", "by", "third", "party", "contractors.", "<tag3>"], "wordsA": ["Our", "active", "pharmaceutical", "ingredients,", "or", "APIs,", "and", "the", "final", "formulated", "drug", "products", "are", "manufactured", "for", "us", "by", "third", "party", "contractors."], "wordsB": ["Our", "active", "pharmaceutical", "ingredients,", "or", "APIs,", "are", "manufactured", "for", "us", "by", "third", "party", "contractors."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_13_item1_p39_s2", "idA": "1347613_12_item1_p20_s2", "sentA": "Accordingly, unless or until we develop or acquire sufficient manufacturing capabilities, we will depend on third parties to manufacture plecanatide, SP-333 and any future APIs that we may develop or acquire.", "sentB": "Accordingly, unless or until we develop or acquire sufficient manufacturing capabilities, we will depend on third parties to manufacture plecanatide, SP-333, FV-100 and any future APIs that we may develop or acquire.", "type": 2, "words": ["<tag1>", "Accordingly,", "unless", "or", "until", "we", "develop", "or", "acquire", "sufficient", "manufacturing", "capabilities,", "we", "will", "depend", "on", "third", "parties", "to", "manufacture", "plecanatide,", "SP-333", "and", "any", "future", "APIs", "that", "we", "may", "develop", "or", "acquire.", "<tag2>", "Accordingly,", "unless", "or", "until", "we", "develop", "or", "acquire", "sufficient", "manufacturing", "capabilities,", "we", "will", "depend", "on", "third", "parties", "to", "manufacture", "plecanatide,", "SP-333,", "FV-100", "and", "any", "future", "APIs", "that", "we", "may", "develop", "or", "acquire.", "<tag3>"], "wordsA": ["Accordingly,", "unless", "or", "until", "we", "develop", "or", "acquire", "sufficient", "manufacturing", "capabilities,", "we", "will", "depend", "on", "third", "parties", "to", "manufacture", "plecanatide,", "SP-333", "and", "any", "future", "APIs", "that", "we", "may", "develop", "or", "acquire."], "wordsB": ["Accordingly,", "unless", "or", "until", "we", "develop", "or", "acquire", "sufficient", "manufacturing", "capabilities,", "we", "will", "depend", "on", "third", "parties", "to", "manufacture", "plecanatide,", "SP-333,", "FV-100", "and", "any", "future", "APIs", "that", "we", "may", "develop", "or", "acquire."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_13_item1_p40_s0", "idA": "1347613_12_item1_p21_s0", "sentA": "We continue to pursue additional API and drug product supply agreements with other manufacturers.", "sentB": "We continue to pursue additional API supply agreements with other manufacturers.", "type": 2, "words": ["<tag1>", "We", "continue", "to", "pursue", "additional", "API", "and", "drug", "product", "supply", "agreements", "with", "other", "manufacturers.", "<tag2>", "We", "continue", "to", "pursue", "additional", "API", "supply", "agreements", "with", "other", "manufacturers.", "<tag3>"], "wordsA": ["We", "continue", "to", "pursue", "additional", "API", "and", "drug", "product", "supply", "agreements", "with", "other", "manufacturers."], "wordsB": ["We", "continue", "to", "pursue", "additional", "API", "supply", "agreements", "with", "other", "manufacturers."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_13_item1_p41_s0", "idA": "1347613_12_item1_p22_s0", "sentA": "We believe, based on the ongoing studies to date, that our current formulations of capsules/tablets are both cost effective and meet the stability requirements for pharmaceutical drug products.", "sentB": "In addition we believe, based on the ongoing studies to date, that our current formulations of capsules/tablets, or drug products, are both cost effective and meet the stability requirements for pharmaceutical drug products.", "type": 2, "words": ["<tag1>", "We", "believe,", "based", "on", "the", "ongoing", "studies", "to", "date,", "that", "our", "current", "formulations", "of", "capsules/tablets", "are", "both", "cost", "effective", "and", "meet", "the", "stability", "requirements", "for", "pharmaceutical", "drug", "products.", "<tag2>", "In", "addition", "we", "believe,", "based", "on", "the", "ongoing", "studies", "to", "date,", "that", "our", "current", "formulations", "of", "capsules/tablets,", "or", "drug", "products,", "are", "both", "cost", "effective", "and", "meet", "the", "stability", "requirements", "for", "pharmaceutical", "drug", "products.", "<tag3>"], "wordsA": ["We", "believe,", "based", "on", "the", "ongoing", "studies", "to", "date,", "that", "our", "current", "formulations", "of", "capsules/tablets", "are", "both", "cost", "effective", "and", "meet", "the", "stability", "requirements", "for", "pharmaceutical", "drug", "products."], "wordsB": ["In", "addition", "we", "believe,", "based", "on", "the", "ongoing", "studies", "to", "date,", "that", "our", "current", "formulations", "of", "capsules/tablets,", "or", "drug", "products,", "are", "both", "cost", "effective", "and", "meet", "the", "stability", "requirements", "for", "pharmaceutical", "drug", "products."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_13_item1_p48_s1", "idA": "1347613_12_item1_p24_s1", "sentA": "No manufacturer may market a new drug until it has submitted an NDA to the FDA, and the FDA has approved it.", "sentB": "No manufacturer may market a new drug until it has submitted an New Drug Application, or NDA, to the FDA, and the FDA has approved it.", "type": 2, "words": ["<tag1>", "No", "manufacturer", "may", "market", "a", "new", "drug", "until", "it", "has", "submitted", "an", "NDA", "to", "the", "FDA,", "and", "the", "FDA", "has", "approved", "it.", "<tag2>", "No", "manufacturer", "may", "market", "a", "new", "drug", "until", "it", "has", "submitted", "an", "New", "Drug", "Application,", "or", "NDA,", "to", "the", "FDA,", "and", "the", "FDA", "has", "approved", "it.", "<tag3>"], "wordsA": ["No", "manufacturer", "may", "market", "a", "new", "drug", "until", "it", "has", "submitted", "an", "NDA", "to", "the", "FDA,", "and", "the", "FDA", "has", "approved", "it."], "wordsB": ["No", "manufacturer", "may", "market", "a", "new", "drug", "until", "it", "has", "submitted", "an", "New", "Drug", "Application,", "or", "NDA,", "to", "the", "FDA,", "and", "the", "FDA", "has", "approved", "it."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_13_item1_p38_s0", "idA": "1347613_12_item1_p2_s0", "sentA": "We are currently developing plecanatide, a synthetic hexadecapeptide designed to mimic the actions of the GI hormone uroguanylin, for the treatment of CC and IBS-C. Plecanatide is an agonist of GC-C receptor.", "sentB": "On August 17, 2012, we entered into an Asset Purchase Agreement with Bristol-Myers Squibb Company and acquired certain assets related to FV-100, an orally available nucleoside analog, for the treatment of shingles, a severe, painful skin rash caused by reactivation of the varicella zoster virus the virus that causes chickenpox.", "type": 2, "words": ["<tag1>", "We", "are", "currently", "developing", "plecanatide,", "a", "synthetic", "hexadecapeptide", "designed", "to", "mimic", "the", "actions", "of", "the", "GI", "hormone", "uroguanylin,", "for", "the", "treatment", "of", "CC", "and", "IBS-C.", "Plecanatide", "is", "an", "agonist", "of", "GC-C", "receptor.", "<tag2>", "On", "August", "17,", "2012,", "we", "entered", "into", "an", "Asset", "Purchase", "Agreement", "with", "Bristol-Myers", "Squibb", "Company", "and", "acquired", "certain", "assets", "related", "to", "FV-100,", "an", "orally", "available", "nucleoside", "analog,", "for", "the", "treatment", "of", "shingles,", "a", "severe,", "painful", "skin", "rash", "caused", "by", "reactivation", "of", "the", "varicella", "zoster", "virus", "the", "virus", "that", "causes", "chickenpox.", "<tag3>"], "wordsA": ["We", "are", "currently", "developing", "plecanatide,", "a", "synthetic", "hexadecapeptide", "designed", "to", "mimic", "the", "actions", "of", "the", "GI", "hormone", "uroguanylin,", "for", "the", "treatment", "of", "CC", "and", "IBS-C.", "Plecanatide", "is", "an", "agonist", "of", "GC-C", "receptor."], "wordsB": ["On", "August", "17,", "2012,", "we", "entered", "into", "an", "Asset", "Purchase", "Agreement", "with", "Bristol-Myers", "Squibb", "Company", "and", "acquired", "certain", "assets", "related", "to", "FV-100,", "an", "orally", "available", "nucleoside", "analog,", "for", "the", "treatment", "of", "shingles,", "a", "severe,", "painful", "skin", "rash", "caused", "by", "reactivation", "of", "the", "varicella", "zoster", "virus", "the", "virus", "that", "causes", "chickenpox."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_13_item1_p82_s0", "idA": "1347613_12_item1_p2_s0", "sentA": "We are currently developing plecanatide, a synthetic hexadecapeptide designed to mimic the actions of the GI hormone uroguanylin, for the treatment of CC and IBS-C. Plecanatide is an agonist of GC-C receptor.", "sentB": "On September 14, 2012, we entered into a binding LOI with Ironwood pursuant to which we and Ironwood agreed to enter into a definitive license agreement giving us an exclusive worldwide license to Ironwood s method of use patents on plecanatide for the treatment of CC and IBS-C.", "type": 2, "words": ["<tag1>", "We", "are", "currently", "developing", "plecanatide,", "a", "synthetic", "hexadecapeptide", "designed", "to", "mimic", "the", "actions", "of", "the", "GI", "hormone", "uroguanylin,", "for", "the", "treatment", "of", "CC", "and", "IBS-C.", "Plecanatide", "is", "an", "agonist", "of", "GC-C", "receptor.", "<tag2>", "On", "September", "14,", "2012,", "we", "entered", "into", "a", "binding", "LOI", "with", "Ironwood", "pursuant", "to", "which", "we", "and", "Ironwood", "agreed", "to", "enter", "into", "a", "definitive", "license", "agreement", "giving", "us", "an", "exclusive", "worldwide", "license", "to", "Ironwood", "s", "method", "of", "use", "patents", "on", "plecanatide", "for", "the", "treatment", "of", "CC", "and", "IBS-C.", "<tag3>"], "wordsA": ["We", "are", "currently", "developing", "plecanatide,", "a", "synthetic", "hexadecapeptide", "designed", "to", "mimic", "the", "actions", "of", "the", "GI", "hormone", "uroguanylin,", "for", "the", "treatment", "of", "CC", "and", "IBS-C.", "Plecanatide", "is", "an", "agonist", "of", "GC-C", "receptor."], "wordsB": ["On", "September", "14,", "2012,", "we", "entered", "into", "a", "binding", "LOI", "with", "Ironwood", "pursuant", "to", "which", "we", "and", "Ironwood", "agreed", "to", "enter", "into", "a", "definitive", "license", "agreement", "giving", "us", "an", "exclusive", "worldwide", "license", "to", "Ironwood", "s", "method", "of", "use", "patents", "on", "plecanatide", "for", "the", "treatment", "of", "CC", "and", "IBS-C."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_13_item1_p30_s1", "idA": "1347613_12_item1_p33_s1", "sentA": "FDA approval of the NDA is required before marketing of the product may begin in the U.S.", "sentB": "This study will be conducted at 70 sites in the U.S. and 350 patients will be enrolled.", "type": 2, "words": ["<tag1>", "FDA", "approval", "of", "the", "NDA", "is", "required", "before", "marketing", "of", "the", "product", "may", "begin", "in", "the", "U.S.", "<tag2>", "This", "study", "will", "be", "conducted", "at", "70", "sites", "in", "the", "U.S.", "and", "350", "patients", "will", "be", "enrolled.", "<tag3>"], "wordsA": ["FDA", "approval", "of", "the", "NDA", "is", "required", "before", "marketing", "of", "the", "product", "may", "begin", "in", "the", "U.S."], "wordsB": ["This", "study", "will", "be", "conducted", "at", "70", "sites", "in", "the", "U.S.", "and", "350", "patients", "will", "be", "enrolled."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_13_item1_p71_s0", "idA": "1347613_12_item1_p39_s3", "sentA": "We and any third-party manufacturers are also subject to periodic inspections of facilities by the FDA and other authorities, including procedures and operations used in the testing and manufacture of our products to assess our compliance with applicable regulations.", "sentB": "We are also subject to various environmental, health and safety regulations including those governing laboratory procedures and the handling, use, storage, treatment, and disposal of hazardous materials.", "type": 2, "words": ["<tag1>", "We", "and", "any", "third-party", "manufacturers", "are", "also", "subject", "to", "periodic", "inspections", "of", "facilities", "by", "the", "FDA", "and", "other", "authorities,", "including", "procedures", "and", "operations", "used", "in", "the", "testing", "and", "manufacture", "of", "our", "products", "to", "assess", "our", "compliance", "with", "applicable", "regulations.", "<tag2>", "We", "are", "also", "subject", "to", "various", "environmental,", "health", "and", "safety", "regulations", "including", "those", "governing", "laboratory", "procedures", "and", "the", "handling,", "use,", "storage,", "treatment,", "and", "disposal", "of", "hazardous", "materials.", "<tag3>"], "wordsA": ["We", "and", "any", "third-party", "manufacturers", "are", "also", "subject", "to", "periodic", "inspections", "of", "facilities", "by", "the", "FDA", "and", "other", "authorities,", "including", "procedures", "and", "operations", "used", "in", "the", "testing", "and", "manufacture", "of", "our", "products", "to", "assess", "our", "compliance", "with", "applicable", "regulations."], "wordsB": ["We", "are", "also", "subject", "to", "various", "environmental,", "health", "and", "safety", "regulations", "including", "those", "governing", "laboratory", "procedures", "and", "the", "handling,", "use,", "storage,", "treatment,", "and", "disposal", "of", "hazardous", "materials."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_13_item1_p74_s0", "idA": "1347613_12_item1_p49_s0", "sentA": "Research and development costs include expenditures for an in-house research and development laboratory, salaries and staff costs, application and filing for regulatory approval of proposed products, purchased in-process research and development, regulatory and scientific consulting fees, as well as contract services, including clinical trial related patient costs, drug formulation and tableting, data collection, monitoring, insurance and FDA consultants.", "sentB": "Research and development costs include expenditures in connection with operating an in-house research and development laboratory, salaries and staff costs, application and filing for regulatory approval of proposed products, purchased in-process research and development, regulatory and scientific consulting fees, as well as contract research, patient costs, drug formulation and tableting, data collection, monitoring, clinical trial insurance.", "type": 2, "words": ["<tag1>", "Research", "and", "development", "costs", "include", "expenditures", "for", "an", "in-house", "research", "and", "development", "laboratory,", "salaries", "and", "staff", "costs,", "application", "and", "filing", "for", "regulatory", "approval", "of", "proposed", "products,", "purchased", "in-process", "research", "and", "development,", "regulatory", "and", "scientific", "consulting", "fees,", "as", "well", "as", "contract", "services,", "including", "clinical", "trial", "related", "patient", "costs,", "drug", "formulation", "and", "tableting,", "data", "collection,", "monitoring,", "insurance", "and", "FDA", "consultants.", "<tag2>", "Research", "and", "development", "costs", "include", "expenditures", "in", "connection", "with", "operating", "an", "in-house", "research", "and", "development", "laboratory,", "salaries", "and", "staff", "costs,", "application", "and", "filing", "for", "regulatory", "approval", "of", "proposed", "products,", "purchased", "in-process", "research", "and", "development,", "regulatory", "and", "scientific", "consulting", "fees,", "as", "well", "as", "contract", "research,", "patient", "costs,", "drug", "formulation", "and", "tableting,", "data", "collection,", "monitoring,", "clinical", "trial", "insurance.", "<tag3>"], "wordsA": ["Research", "and", "development", "costs", "include", "expenditures", "for", "an", "in-house", "research", "and", "development", "laboratory,", "salaries", "and", "staff", "costs,", "application", "and", "filing", "for", "regulatory", "approval", "of", "proposed", "products,", "purchased", "in-process", "research", "and", "development,", "regulatory", "and", "scientific", "consulting", "fees,", "as", "well", "as", "contract", "services,", "including", "clinical", "trial", "related", "patient", "costs,", "drug", "formulation", "and", "tableting,", "data", "collection,", "monitoring,", "insurance", "and", "FDA", "consultants."], "wordsB": ["Research", "and", "development", "costs", "include", "expenditures", "in", "connection", "with", "operating", "an", "in-house", "research", "and", "development", "laboratory,", "salaries", "and", "staff", "costs,", "application", "and", "filing", "for", "regulatory", "approval", "of", "proposed", "products,", "purchased", "in-process", "research", "and", "development,", "regulatory", "and", "scientific", "consulting", "fees,", "as", "well", "as", "contract", "research,", "patient", "costs,", "drug", "formulation", "and", "tableting,", "data", "collection,", "monitoring,", "clinical", "trial", "insurance."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_13_item1_p74_s1", "idA": "1347613_12_item1_p49_s1", "sentA": "Research and development expenses were $13,418,754 for the twelve months ended December 31, 2011, as compared to $9,558,608 and $3,732,734 for the twelve months ended December 31, 2010 and 2009, respectively.", "sentB": "Research and development expenses for the twelve months ended December 31, 2012 were approximately $29 million, as compared to approximately $13 million and $10 million for the twelve months ended December 31, 2011 and 2010, respectively.", "type": 2, "words": ["<tag1>", "Research", "and", "development", "expenses", "were", "$13,418,754", "for", "the", "twelve", "months", "ended", "December", "31,", "2011,", "as", "compared", "to", "$9,558,608", "and", "$3,732,734", "for", "the", "twelve", "months", "ended", "December", "31,", "2010", "and", "2009,", "respectively.", "<tag2>", "Research", "and", "development", "expenses", "for", "the", "twelve", "months", "ended", "December", "31,", "2012", "were", "approximately", "$29", "million,", "as", "compared", "to", "approximately", "$13", "million", "and", "$10", "million", "for", "the", "twelve", "months", "ended", "December", "31,", "2011", "and", "2010,", "respectively.", "<tag3>"], "wordsA": ["Research", "and", "development", "expenses", "were", "$13,418,754", "for", "the", "twelve", "months", "ended", "December", "31,", "2011,", "as", "compared", "to", "$9,558,608", "and", "$3,732,734", "for", "the", "twelve", "months", "ended", "December", "31,", "2010", "and", "2009,", "respectively."], "wordsB": ["Research", "and", "development", "expenses", "for", "the", "twelve", "months", "ended", "December", "31,", "2012", "were", "approximately", "$29", "million,", "as", "compared", "to", "approximately", "$13", "million", "and", "$10", "million", "for", "the", "twelve", "months", "ended", "December", "31,", "2011", "and", "2010,", "respectively."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_13_item1_p75_s0", "idA": "1347613_12_item1_p49_s1", "sentA": "Research and development expenses were $13,418,754 for the twelve months ended December 31, 2011, as compared to $9,558,608 and $3,732,734 for the twelve months ended December 31, 2010 and 2009, respectively.", "sentB": "In accordance with FASB ASC Topic 730-10-55, Research and Development, we recorded prepaid research and development costs of approximately $926,000 as of December 31, 2012, as compared to approximately $577,000 as of December 31, 2011, for nonrefundable pre-payments for production of drug substance, analytical testing services for our drug candidates, and upcoming clinical trials of plecanatide and SP-333.", "type": 2, "words": ["<tag1>", "Research", "and", "development", "expenses", "were", "$13,418,754", "for", "the", "twelve", "months", "ended", "December", "31,", "2011,", "as", "compared", "to", "$9,558,608", "and", "$3,732,734", "for", "the", "twelve", "months", "ended", "December", "31,", "2010", "and", "2009,", "respectively.", "<tag2>", "In", "accordance", "with", "FASB", "ASC", "Topic", "730-10-55,", "Research", "and", "Development,", "we", "recorded", "prepaid", "research", "and", "development", "costs", "of", "approximately", "$926,000", "as", "of", "December", "31,", "2012,", "as", "compared", "to", "approximately", "$577,000", "as", "of", "December", "31,", "2011,", "for", "nonrefundable", "pre-payments", "for", "production", "of", "drug", "substance,", "analytical", "testing", "services", "for", "our", "drug", "candidates,", "and", "upcoming", "clinical", "trials", "of", "plecanatide", "and", "SP-333.", "<tag3>"], "wordsA": ["Research", "and", "development", "expenses", "were", "$13,418,754", "for", "the", "twelve", "months", "ended", "December", "31,", "2011,", "as", "compared", "to", "$9,558,608", "and", "$3,732,734", "for", "the", "twelve", "months", "ended", "December", "31,", "2010", "and", "2009,", "respectively."], "wordsB": ["In", "accordance", "with", "FASB", "ASC", "Topic", "730-10-55,", "Research", "and", "Development,", "we", "recorded", "prepaid", "research", "and", "development", "costs", "of", "approximately", "$926,000", "as", "of", "December", "31,", "2012,", "as", "compared", "to", "approximately", "$577,000", "as", "of", "December", "31,", "2011,", "for", "nonrefundable", "pre-payments", "for", "production", "of", "drug", "substance,", "analytical", "testing", "services", "for", "our", "drug", "candidates,", "and", "upcoming", "clinical", "trials", "of", "plecanatide", "and", "SP-333."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_13_item1_p30_s0", "idA": "1347613_12_item1_p4_s0", "sentA": "On October 24, 2011, we initiated dosing of patients in a Phase II/III clinical trial of plecanatide to treat CC.", "sentB": "On December 27, 2012, we commenced a Phase 2b clinical trial of plecanatide to treat patients with IBS-C.", "type": 2, "words": ["<tag1>", "On", "October", "24,", "2011,", "we", "initiated", "dosing", "of", "patients", "in", "a", "Phase", "II/III", "clinical", "trial", "of", "plecanatide", "to", "treat", "CC.", "<tag2>", "On", "December", "27,", "2012,", "we", "commenced", "a", "Phase", "2b", "clinical", "trial", "of", "plecanatide", "to", "treat", "patients", "with", "IBS-C.", "<tag3>"], "wordsA": ["On", "October", "24,", "2011,", "we", "initiated", "dosing", "of", "patients", "in", "a", "Phase", "II/III", "clinical", "trial", "of", "plecanatide", "to", "treat", "CC."], "wordsB": ["On", "December", "27,", "2012,", "we", "commenced", "a", "Phase", "2b", "clinical", "trial", "of", "plecanatide", "to", "treat", "patients", "with", "IBS-C."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_13_item1_p36_s2", "idA": "1347613_12_item1_p4_s0", "sentA": "On October 24, 2011, we initiated dosing of patients in a Phase II/III clinical trial of plecanatide to treat CC.", "sentB": "On January 28, 2013, we commenced a multiple ascending oral dosing study of healthy volunteers in a Phase 1 trial of SP-333.", "type": 2, "words": ["<tag1>", "On", "October", "24,", "2011,", "we", "initiated", "dosing", "of", "patients", "in", "a", "Phase", "II/III", "clinical", "trial", "of", "plecanatide", "to", "treat", "CC.", "<tag2>", "On", "January", "28,", "2013,", "we", "commenced", "a", "multiple", "ascending", "oral", "dosing", "study", "of", "healthy", "volunteers", "in", "a", "Phase", "1", "trial", "of", "SP-333.", "<tag3>"], "wordsA": ["On", "October", "24,", "2011,", "we", "initiated", "dosing", "of", "patients", "in", "a", "Phase", "II/III", "clinical", "trial", "of", "plecanatide", "to", "treat", "CC."], "wordsB": ["On", "January", "28,", "2013,", "we", "commenced", "a", "multiple", "ascending", "oral", "dosing", "study", "of", "healthy", "volunteers", "in", "a", "Phase", "1", "trial", "of", "SP-333."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_13_item1_p8_s2", "idA": "1347613_12_item1_p4_s0", "sentA": "On October 24, 2011, we initiated dosing of patients in a Phase II/III clinical trial of plecanatide to treat CC.", "sentB": "Plecanatide is also being developed to treat IBS-C. We initiated a Phase 2b trial in IBS-C patients in December 2012.", "type": 2, "words": ["<tag1>", "On", "October", "24,", "2011,", "we", "initiated", "dosing", "of", "patients", "in", "a", "Phase", "II/III", "clinical", "trial", "of", "plecanatide", "to", "treat", "CC.", "<tag2>", "Plecanatide", "is", "also", "being", "developed", "to", "treat", "IBS-C.", "We", "initiated", "a", "Phase", "2b", "trial", "in", "IBS-C", "patients", "in", "December", "2012.", "<tag3>"], "wordsA": ["On", "October", "24,", "2011,", "we", "initiated", "dosing", "of", "patients", "in", "a", "Phase", "II/III", "clinical", "trial", "of", "plecanatide", "to", "treat", "CC."], "wordsB": ["Plecanatide", "is", "also", "being", "developed", "to", "treat", "IBS-C.", "We", "initiated", "a", "Phase", "2b", "trial", "in", "IBS-C", "patients", "in", "December", "2012."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_13_item1_p20_s1", "idA": "1347613_12_item1_p4_s1", "sentA": "This study is being conducted at 110 sites in the United States and is designed to enroll 880 patients with CC to insure we have 800 evaluable patients at the end of the study.", "sentB": "At the end of the study the patients had a 2 week post treatment period without drug followed by an end of study visit.", "type": 2, "words": ["<tag1>", "This", "study", "is", "being", "conducted", "at", "110", "sites", "in", "the", "United", "States", "and", "is", "designed", "to", "enroll", "880", "patients", "with", "CC", "to", "insure", "we", "have", "800", "evaluable", "patients", "at", "the", "end", "of", "the", "study.", "<tag2>", "At", "the", "end", "of", "the", "study", "the", "patients", "had", "a", "2", "week", "post", "treatment", "period", "without", "drug", "followed", "by", "an", "end", "of", "study", "visit.", "<tag3>"], "wordsA": ["This", "study", "is", "being", "conducted", "at", "110", "sites", "in", "the", "United", "States", "and", "is", "designed", "to", "enroll", "880", "patients", "with", "CC", "to", "insure", "we", "have", "800", "evaluable", "patients", "at", "the", "end", "of", "the", "study."], "wordsB": ["At", "the", "end", "of", "the", "study", "the", "patients", "had", "a", "2", "week", "post", "treatment", "period", "without", "drug", "followed", "by", "an", "end", "of", "study", "visit."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_13_item1_p77_s0", "idA": "1347613_12_item1_p51_s0", "sentA": "As of March 14, 2012 we have five issued United States patents.", "sentB": "As of December 31, 2012 we had six issued United States patents related to guanylate cyclase agonists.", "type": 2, "words": ["<tag1>", "As", "of", "March", "14,", "2012", "we", "have", "five", "issued", "United", "States", "patents.", "<tag2>", "As", "of", "December", "31,", "2012", "we", "had", "six", "issued", "United", "States", "patents", "related", "to", "guanylate", "cyclase", "agonists.", "<tag3>"], "wordsA": ["As", "of", "March", "14,", "2012", "we", "have", "five", "issued", "United", "States", "patents."], "wordsB": ["As", "of", "December", "31,", "2012", "we", "had", "six", "issued", "United", "States", "patents", "related", "to", "guanylate", "cyclase", "agonists."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_13_item1_p81_s0", "idA": "1347613_12_item1_p51_s0", "sentA": "As of March 14, 2012 we have five issued United States patents.", "sentB": "As of March 15, 2013 we had three issued United States patents related to FV-100.", "type": 2, "words": ["<tag1>", "As", "of", "March", "14,", "2012", "we", "have", "five", "issued", "United", "States", "patents.", "<tag2>", "As", "of", "March", "15,", "2013", "we", "had", "three", "issued", "United", "States", "patents", "related", "to", "FV-100.", "<tag3>"], "wordsA": ["As", "of", "March", "14,", "2012", "we", "have", "five", "issued", "United", "States", "patents."], "wordsB": ["As", "of", "March", "15,", "2013", "we", "had", "three", "issued", "United", "States", "patents", "related", "to", "FV-100."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_13_item1_p77_s2", "idA": "1347613_12_item1_p51_s1", "sentA": "Two of these patents cover the composition-of-matter of plecanatide and were issued on May 9, 2006 and September 21, 2010; they will expire in 2023 and 2022, respectively.", "sentB": "The patent that issued on May 9, 2006 has claims directed to the species of plecanatide, whereas the patent that issued on September 21, 2010 has claims directed to a genus of peptides that are identical in length to plecanatide and is inclusive of plecanatide.", "type": 2, "words": ["<tag1>", "Two", "of", "these", "patents", "cover", "the", "composition-of-matter", "of", "plecanatide", "and", "were", "issued", "on", "May", "9,", "2006", "and", "September", "21,", "2010;", "they", "will", "expire", "in", "2023", "and", "2022,", "respectively.", "<tag2>", "The", "patent", "that", "issued", "on", "May", "9,", "2006", "has", "claims", "directed", "to", "the", "species", "of", "plecanatide,", "whereas", "the", "patent", "that", "issued", "on", "September", "21,", "2010", "has", "claims", "directed", "to", "a", "genus", "of", "peptides", "that", "are", "identical", "in", "length", "to", "plecanatide", "and", "is", "inclusive", "of", "plecanatide.", "<tag3>"], "wordsA": ["Two", "of", "these", "patents", "cover", "the", "composition-of-matter", "of", "plecanatide", "and", "were", "issued", "on", "May", "9,", "2006", "and", "September", "21,", "2010;", "they", "will", "expire", "in", "2023", "and", "2022,", "respectively."], "wordsB": ["The", "patent", "that", "issued", "on", "May", "9,", "2006", "has", "claims", "directed", "to", "the", "species", "of", "plecanatide,", "whereas", "the", "patent", "that", "issued", "on", "September", "21,", "2010", "has", "claims", "directed", "to", "a", "genus", "of", "peptides", "that", "are", "identical", "in", "length", "to", "plecanatide", "and", "is", "inclusive", "of", "plecanatide."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_13_item1_p81_s2", "idA": "1347613_12_item1_p51_s1", "sentA": "Two of these patents cover the composition-of-matter of plecanatide and were issued on May 9, 2006 and September 21, 2010; they will expire in 2023 and 2022, respectively.", "sentB": "The other two cover the precursor and close analogs of FV-100 and were issued on November 8, 2001 and June 3, 2003 and will both expire in 2018.", "type": 2, "words": ["<tag1>", "Two", "of", "these", "patents", "cover", "the", "composition-of-matter", "of", "plecanatide", "and", "were", "issued", "on", "May", "9,", "2006", "and", "September", "21,", "2010;", "they", "will", "expire", "in", "2023", "and", "2022,", "respectively.", "<tag2>", "The", "other", "two", "cover", "the", "precursor", "and", "close", "analogs", "of", "FV-100", "and", "were", "issued", "on", "November", "8,", "2001", "and", "June", "3,", "2003", "and", "will", "both", "expire", "in", "2018.", "<tag3>"], "wordsA": ["Two", "of", "these", "patents", "cover", "the", "composition-of-matter", "of", "plecanatide", "and", "were", "issued", "on", "May", "9,", "2006", "and", "September", "21,", "2010;", "they", "will", "expire", "in", "2023", "and", "2022,", "respectively."], "wordsB": ["The", "other", "two", "cover", "the", "precursor", "and", "close", "analogs", "of", "FV-100", "and", "were", "issued", "on", "November", "8,", "2001", "and", "June", "3,", "2003", "and", "will", "both", "expire", "in", "2018."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_13_item1_p78_s2", "idA": "1347613_12_item1_p51_s2", "sentA": "A third patent covers the composition-of-matter of SP333 issued on February 1, 2011 and expires in 2028.", "sentB": "We also have a granted foreign patent that covers composition of matter related to SP333 that expires in 2028.", "type": 2, "words": ["<tag1>", "A", "third", "patent", "covers", "the", "composition-of-matter", "of", "SP333", "issued", "on", "February", "1,", "2011", "and", "expires", "in", "2028.", "<tag2>", "We", "also", "have", "a", "granted", "foreign", "patent", "that", "covers", "composition", "of", "matter", "related", "to", "SP333", "that", "expires", "in", "2028.", "<tag3>"], "wordsA": ["A", "third", "patent", "covers", "the", "composition-of-matter", "of", "SP333", "issued", "on", "February", "1,", "2011", "and", "expires", "in", "2028."], "wordsB": ["We", "also", "have", "a", "granted", "foreign", "patent", "that", "covers", "composition", "of", "matter", "related", "to", "SP333", "that", "expires", "in", "2028."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_13_item1_p81_s1", "idA": "1347613_12_item1_p51_s2", "sentA": "A third patent covers the composition-of-matter of SP333 issued on February 1, 2011 and expires in 2028.", "sentB": "One of these patents covers the composition-of-matter of FV-100 and was issued on December 11, 2012 and will expire in 2028.", "type": 2, "words": ["<tag1>", "A", "third", "patent", "covers", "the", "composition-of-matter", "of", "SP333", "issued", "on", "February", "1,", "2011", "and", "expires", "in", "2028.", "<tag2>", "One", "of", "these", "patents", "covers", "the", "composition-of-matter", "of", "FV-100", "and", "was", "issued", "on", "December", "11,", "2012", "and", "will", "expire", "in", "2028.", "<tag3>"], "wordsA": ["A", "third", "patent", "covers", "the", "composition-of-matter", "of", "SP333", "issued", "on", "February", "1,", "2011", "and", "expires", "in", "2028."], "wordsB": ["One", "of", "these", "patents", "covers", "the", "composition-of-matter", "of", "FV-100", "and", "was", "issued", "on", "December", "11,", "2012", "and", "will", "expire", "in", "2028."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_13_item1_p77_s6", "idA": "1347613_12_item1_p51_s3", "sentA": "A fourth patent granted October 11, 2011 covers composition-of-matter of analogs related to plecanatide and SP333 and will expire in 2028.", "sentB": "A sixth patent granted June 26, 2012 covers additional compositions-of-matter related to plecanatide and SP333 and will expire in 2029.", "type": 2, "words": ["<tag1>", "A", "fourth", "patent", "granted", "October", "11,", "2011", "covers", "composition-of-matter", "of", "analogs", "related", "to", "plecanatide", "and", "SP333", "and", "will", "expire", "in", "2028.", "<tag2>", "A", "sixth", "patent", "granted", "June", "26,", "2012", "covers", "additional", "compositions-of-matter", "related", "to", "plecanatide", "and", "SP333", "and", "will", "expire", "in", "2029.", "<tag3>"], "wordsA": ["A", "fourth", "patent", "granted", "October", "11,", "2011", "covers", "composition-of-matter", "of", "analogs", "related", "to", "plecanatide", "and", "SP333", "and", "will", "expire", "in", "2028."], "wordsB": ["A", "sixth", "patent", "granted", "June", "26,", "2012", "covers", "additional", "compositions-of-matter", "related", "to", "plecanatide", "and", "SP333", "and", "will", "expire", "in", "2029."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_13_item1_p78_s0", "idA": "1347613_12_item1_p51_s5", "sentA": "In addition, we have three granted foreign patents which cover composition-of-matter of plecanatide and expire in 2022.", "sentB": "In addition, we have four granted foreign patents which cover composition-of-matter of plecanatide and expire in 2022.", "type": 2, "words": ["<tag1>", "In", "addition,", "we", "have", "three", "granted", "foreign", "patents", "which", "cover", "composition-of-matter", "of", "plecanatide", "and", "expire", "in", "2022.", "<tag2>", "In", "addition,", "we", "have", "four", "granted", "foreign", "patents", "which", "cover", "composition-of-matter", "of", "plecanatide", "and", "expire", "in", "2022.", "<tag3>"], "wordsA": ["In", "addition,", "we", "have", "three", "granted", "foreign", "patents", "which", "cover", "composition-of-matter", "of", "plecanatide", "and", "expire", "in", "2022."], "wordsB": ["In", "addition,", "we", "have", "four", "granted", "foreign", "patents", "which", "cover", "composition-of-matter", "of", "plecanatide", "and", "expire", "in", "2022."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_13_item1_p81_s3", "idA": "1347613_12_item1_p51_s5", "sentA": "In addition, we have three granted foreign patents which cover composition-of-matter of plecanatide and expire in 2022.", "sentB": "In addition we have 37 granted foreign patents which cover composition-of-matter of FV-100 and expire in 2027.", "type": 2, "words": ["<tag1>", "In", "addition,", "we", "have", "three", "granted", "foreign", "patents", "which", "cover", "composition-of-matter", "of", "plecanatide", "and", "expire", "in", "2022.", "<tag2>", "In", "addition", "we", "have", "37", "granted", "foreign", "patents", "which", "cover", "composition-of-matter", "of", "FV-100", "and", "expire", "in", "2027.", "<tag3>"], "wordsA": ["In", "addition,", "we", "have", "three", "granted", "foreign", "patents", "which", "cover", "composition-of-matter", "of", "plecanatide", "and", "expire", "in", "2022."], "wordsB": ["In", "addition", "we", "have", "37", "granted", "foreign", "patents", "which", "cover", "composition-of-matter", "of", "FV-100", "and", "expire", "in", "2027."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_13_item1_p78_s1", "idA": "1347613_12_item1_p51_s6", "sentA": "These foreign patents cover Austria, Belgium, Switzerland, Cyprus, Germany, Denmark, Spain, Finland, France, United Kingdom, Greece, Ireland, Italy, Liechtenstein, Luxembourg, Monaco, Netherlands, Portugal, Sweden, Turkey, Hong Kong, Armenia, Azerbaijan, Belarus, Kazakhstan, Kyrgyz Republic, Moldova, Russian Federation, Tajikistan, Turkmenistan, and Japan.", "sentB": "These foreign patents cover Austria, Belgium, Switzerland, Cyprus, Germany, Denmark, Spain, Finland, France, United Kingdom, Greece, Ireland, Italy, Liechtenstein, Luxembourg, Monaco, Netherlands, Portugal, Sweden, Turkey, Armenia, Azerbaijan, Belarus, Kazakhstan, Kyrgyz Republic, Moldova, Russian Federation, Tajikistan, Turkmenistan, Canada and Japan..", "type": 2, "words": ["<tag1>", "These", "foreign", "patents", "cover", "Austria,", "Belgium,", "Switzerland,", "Cyprus,", "Germany,", "Denmark,", "Spain,", "Finland,", "France,", "United", "Kingdom,", "Greece,", "Ireland,", "Italy,", "Liechtenstein,", "Luxembourg,", "Monaco,", "Netherlands,", "Portugal,", "Sweden,", "Turkey,", "Hong", "Kong,", "Armenia,", "Azerbaijan,", "Belarus,", "Kazakhstan,", "Kyrgyz", "Republic,", "Moldova,", "Russian", "Federation,", "Tajikistan,", "Turkmenistan,", "and", "Japan.", "<tag2>", "These", "foreign", "patents", "cover", "Austria,", "Belgium,", "Switzerland,", "Cyprus,", "Germany,", "Denmark,", "Spain,", "Finland,", "France,", "United", "Kingdom,", "Greece,", "Ireland,", "Italy,", "Liechtenstein,", "Luxembourg,", "Monaco,", "Netherlands,", "Portugal,", "Sweden,", "Turkey,", "Armenia,", "Azerbaijan,", "Belarus,", "Kazakhstan,", "Kyrgyz", "Republic,", "Moldova,", "Russian", "Federation,", "Tajikistan,", "Turkmenistan,", "Canada", "and", "Japan..", "<tag3>"], "wordsA": ["These", "foreign", "patents", "cover", "Austria,", "Belgium,", "Switzerland,", "Cyprus,", "Germany,", "Denmark,", "Spain,", "Finland,", "France,", "United", "Kingdom,", "Greece,", "Ireland,", "Italy,", "Liechtenstein,", "Luxembourg,", "Monaco,", "Netherlands,", "Portugal,", "Sweden,", "Turkey,", "Hong", "Kong,", "Armenia,", "Azerbaijan,", "Belarus,", "Kazakhstan,", "Kyrgyz", "Republic,", "Moldova,", "Russian", "Federation,", "Tajikistan,", "Turkmenistan,", "and", "Japan."], "wordsB": ["These", "foreign", "patents", "cover", "Austria,", "Belgium,", "Switzerland,", "Cyprus,", "Germany,", "Denmark,", "Spain,", "Finland,", "France,", "United", "Kingdom,", "Greece,", "Ireland,", "Italy,", "Liechtenstein,", "Luxembourg,", "Monaco,", "Netherlands,", "Portugal,", "Sweden,", "Turkey,", "Armenia,", "Azerbaijan,", "Belarus,", "Kazakhstan,", "Kyrgyz", "Republic,", "Moldova,", "Russian", "Federation,", "Tajikistan,", "Turkmenistan,", "Canada", "and", "Japan.."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_13_item1_p78_s3", "idA": "1347613_12_item1_p51_s6", "sentA": "These foreign patents cover Austria, Belgium, Switzerland, Cyprus, Germany, Denmark, Spain, Finland, France, United Kingdom, Greece, Ireland, Italy, Liechtenstein, Luxembourg, Monaco, Netherlands, Portugal, Sweden, Turkey, Hong Kong, Armenia, Azerbaijan, Belarus, Kazakhstan, Kyrgyz Republic, Moldova, Russian Federation, Tajikistan, Turkmenistan, and Japan.", "sentB": "This patent covers Switzerland, Germany, Denmark, Spain, France, United Kingdom, Ireland, Italy, and Netherlands.", "type": 2, "words": ["<tag1>", "These", "foreign", "patents", "cover", "Austria,", "Belgium,", "Switzerland,", "Cyprus,", "Germany,", "Denmark,", "Spain,", "Finland,", "France,", "United", "Kingdom,", "Greece,", "Ireland,", "Italy,", "Liechtenstein,", "Luxembourg,", "Monaco,", "Netherlands,", "Portugal,", "Sweden,", "Turkey,", "Hong", "Kong,", "Armenia,", "Azerbaijan,", "Belarus,", "Kazakhstan,", "Kyrgyz", "Republic,", "Moldova,", "Russian", "Federation,", "Tajikistan,", "Turkmenistan,", "and", "Japan.", "<tag2>", "This", "patent", "covers", "Switzerland,", "Germany,", "Denmark,", "Spain,", "France,", "United", "Kingdom,", "Ireland,", "Italy,", "and", "Netherlands.", "<tag3>"], "wordsA": ["These", "foreign", "patents", "cover", "Austria,", "Belgium,", "Switzerland,", "Cyprus,", "Germany,", "Denmark,", "Spain,", "Finland,", "France,", "United", "Kingdom,", "Greece,", "Ireland,", "Italy,", "Liechtenstein,", "Luxembourg,", "Monaco,", "Netherlands,", "Portugal,", "Sweden,", "Turkey,", "Hong", "Kong,", "Armenia,", "Azerbaijan,", "Belarus,", "Kazakhstan,", "Kyrgyz", "Republic,", "Moldova,", "Russian", "Federation,", "Tajikistan,", "Turkmenistan,", "and", "Japan."], "wordsB": ["This", "patent", "covers", "Switzerland,", "Germany,", "Denmark,", "Spain,", "France,", "United", "Kingdom,", "Ireland,", "Italy,", "and", "Netherlands."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_13_item1_p81_s4", "idA": "1347613_12_item1_p51_s6", "sentA": "These foreign patents cover Austria, Belgium, Switzerland, Cyprus, Germany, Denmark, Spain, Finland, France, United Kingdom, Greece, Ireland, Italy, Liechtenstein, Luxembourg, Monaco, Netherlands, Portugal, Sweden, Turkey, Hong Kong, Armenia, Azerbaijan, Belarus, Kazakhstan, Kyrgyz Republic, Moldova, Russian Federation, Tajikistan, Turkmenistan, and Japan.", "sentB": "These foreign patents cover Australia, Austria, Belgium, Brazil, Bulgaria, Canada, China, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, India, Ireland, Israel, Italy, Japan, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Monaco, Netherlands, New Zealand, Pakistan, Poland, Portugal, Romania, Slovakia, Slovenia, South Korea, Spain, Sweden, Switzerland, Taiwan, Turkey, United Kingdom and the Russian Federation.", "type": 2, "words": ["<tag1>", "These", "foreign", "patents", "cover", "Austria,", "Belgium,", "Switzerland,", "Cyprus,", "Germany,", "Denmark,", "Spain,", "Finland,", "France,", "United", "Kingdom,", "Greece,", "Ireland,", "Italy,", "Liechtenstein,", "Luxembourg,", "Monaco,", "Netherlands,", "Portugal,", "Sweden,", "Turkey,", "Hong", "Kong,", "Armenia,", "Azerbaijan,", "Belarus,", "Kazakhstan,", "Kyrgyz", "Republic,", "Moldova,", "Russian", "Federation,", "Tajikistan,", "Turkmenistan,", "and", "Japan.", "<tag2>", "These", "foreign", "patents", "cover", "Australia,", "Austria,", "Belgium,", "Brazil,", "Bulgaria,", "Canada,", "China,", "Cyprus,", "Czech", "Republic,", "Denmark,", "Estonia,", "Finland,", "France,", "Germany,", "Greece,", "Hungary,", "Iceland,", "India,", "Ireland,", "Israel,", "Italy,", "Japan,", "Latvia,", "Liechtenstein,", "Lithuania,", "Luxembourg,", "Malta,", "Monaco,", "Netherlands,", "New", "Zealand,", "Pakistan,", "Poland,", "Portugal,", "Romania,", "Slovakia,", "Slovenia,", "South", "Korea,", "Spain,", "Sweden,", "Switzerland,", "Taiwan,", "Turkey,", "United", "Kingdom", "and", "the", "Russian", "Federation.", "<tag3>"], "wordsA": ["These", "foreign", "patents", "cover", "Austria,", "Belgium,", "Switzerland,", "Cyprus,", "Germany,", "Denmark,", "Spain,", "Finland,", "France,", "United", "Kingdom,", "Greece,", "Ireland,", "Italy,", "Liechtenstein,", "Luxembourg,", "Monaco,", "Netherlands,", "Portugal,", "Sweden,", "Turkey,", "Hong", "Kong,", "Armenia,", "Azerbaijan,", "Belarus,", "Kazakhstan,", "Kyrgyz", "Republic,", "Moldova,", "Russian", "Federation,", "Tajikistan,", "Turkmenistan,", "and", "Japan."], "wordsB": ["These", "foreign", "patents", "cover", "Australia,", "Austria,", "Belgium,", "Brazil,", "Bulgaria,", "Canada,", "China,", "Cyprus,", "Czech", "Republic,", "Denmark,", "Estonia,", "Finland,", "France,", "Germany,", "Greece,", "Hungary,", "Iceland,", "India,", "Ireland,", "Israel,", "Italy,", "Japan,", "Latvia,", "Liechtenstein,", "Lithuania,", "Luxembourg,", "Malta,", "Monaco,", "Netherlands,", "New", "Zealand,", "Pakistan,", "Poland,", "Portugal,", "Romania,", "Slovakia,", "Slovenia,", "South", "Korea,", "Spain,", "Sweden,", "Switzerland,", "Taiwan,", "Turkey,", "United", "Kingdom", "and", "the", "Russian", "Federation."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_13_item1_p79_s0", "idA": "1347613_12_item1_p52_s0", "sentA": "Additionally as of March 14, 2012, we have 7 pending United States patent applications and 39 pending foreign patent applications covering plecanatide and SP-333 and various derivatives and analogs.", "sentB": "Additionally as of December 31, 2012, we had 11 pending United States patent applications and 47 pending foreign patent applications covering plecanatide and SP-333 and various derivatives and analogs.", "type": 2, "words": ["<tag1>", "Additionally", "as", "of", "March", "14,", "2012,", "we", "have", "7", "pending", "United", "States", "patent", "applications", "and", "39", "pending", "foreign", "patent", "applications", "covering", "plecanatide", "and", "SP-333", "and", "various", "derivatives", "and", "analogs.", "<tag2>", "Additionally", "as", "of", "December", "31,", "2012,", "we", "had", "11", "pending", "United", "States", "patent", "applications", "and", "47", "pending", "foreign", "patent", "applications", "covering", "plecanatide", "and", "SP-333", "and", "various", "derivatives", "and", "analogs.", "<tag3>"], "wordsA": ["Additionally", "as", "of", "March", "14,", "2012,", "we", "have", "7", "pending", "United", "States", "patent", "applications", "and", "39", "pending", "foreign", "patent", "applications", "covering", "plecanatide", "and", "SP-333", "and", "various", "derivatives", "and", "analogs."], "wordsB": ["Additionally", "as", "of", "December", "31,", "2012,", "we", "had", "11", "pending", "United", "States", "patent", "applications", "and", "47", "pending", "foreign", "patent", "applications", "covering", "plecanatide", "and", "SP-333", "and", "various", "derivatives", "and", "analogs."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_13_item1_p43_s1", "idA": "1347613_12_item1_p56_s3", "sentA": "As a result of such disputes, we may have to develop costly non-infringing technology or enter into licensing agreements.", "sentB": "As a result of the Merger, each outstanding share of Callisto common stock was converted into the right to receive 0.1799 of one share of our common stock and the 22,295,000 shares of our common stock held by Callisto were canceled.", "type": 2, "words": ["<tag1>", "As", "a", "result", "of", "such", "disputes,", "we", "may", "have", "to", "develop", "costly", "non-infringing", "technology", "or", "enter", "into", "licensing", "agreements.", "<tag2>", "As", "a", "result", "of", "the", "Merger,", "each", "outstanding", "share", "of", "Callisto", "common", "stock", "was", "converted", "into", "the", "right", "to", "receive", "0.1799", "of", "one", "share", "of", "our", "common", "stock", "and", "the", "22,295,000", "shares", "of", "our", "common", "stock", "held", "by", "Callisto", "were", "canceled.", "<tag3>"], "wordsA": ["As", "a", "result", "of", "such", "disputes,", "we", "may", "have", "to", "develop", "costly", "non-infringing", "technology", "or", "enter", "into", "licensing", "agreements."], "wordsB": ["As", "a", "result", "of", "the", "Merger,", "each", "outstanding", "share", "of", "Callisto", "common", "stock", "was", "converted", "into", "the", "right", "to", "receive", "0.1799", "of", "one", "share", "of", "our", "common", "stock", "and", "the", "22,295,000", "shares", "of", "our", "common", "stock", "held", "by", "Callisto", "were", "canceled."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_13_item1_p86_s0", "idA": "1347613_12_item1_p57_s0", "sentA": "As of March 14, 2012, we had 9 full-time and 1 part-time employees.", "sentB": "As of March 18, 2013, we had 18 full-time employees.", "type": 2, "words": ["<tag1>", "As", "of", "March", "14,", "2012,", "we", "had", "9", "full-time", "and", "1", "part-time", "employees.", "<tag2>", "As", "of", "March", "18,", "2013,", "we", "had", "18", "full-time", "employees.", "<tag3>"], "wordsA": ["As", "of", "March", "14,", "2012,", "we", "had", "9", "full-time", "and", "1", "part-time", "employees."], "wordsB": ["As", "of", "March", "18,", "2013,", "we", "had", "18", "full-time", "employees."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_13_item1_p19_s2", "idA": "1347613_12_item1_p5_s0", "sentA": "Patients will be treated with one of three doses of plecanatide (0.3, 1.0 or 3.0 mg) or placebo taken once daily over a period of 12 weeks.", "sentB": "Patients who successfully completed the pre-treatment period were randomized to 0.3, 1.0, or 3.0 mg plecanatide, or placebo for a 12 week treatment period during which time they were required to call in their bowel movement observations and ratings of their associated abdominal symptoms.", "type": 2, "words": ["<tag1>", "Patients", "will", "be", "treated", "with", "one", "of", "three", "doses", "of", "plecanatide", "(0.3,", "1.0", "or", "3.0", "mg)", "or", "placebo", "taken", "once", "daily", "over", "a", "period", "of", "12", "weeks.", "<tag2>", "Patients", "who", "successfully", "completed", "the", "pre-treatment", "period", "were", "randomized", "to", "0.3,", "1.0,", "or", "3.0", "mg", "plecanatide,", "or", "placebo", "for", "a", "12", "week", "treatment", "period", "during", "which", "time", "they", "were", "required", "to", "call", "in", "their", "bowel", "movement", "observations", "and", "ratings", "of", "their", "associated", "abdominal", "symptoms.", "<tag3>"], "wordsA": ["Patients", "will", "be", "treated", "with", "one", "of", "three", "doses", "of", "plecanatide", "(0.3,", "1.0", "or", "3.0", "mg)", "or", "placebo", "taken", "once", "daily", "over", "a", "period", "of", "12", "weeks."], "wordsB": ["Patients", "who", "successfully", "completed", "the", "pre-treatment", "period", "were", "randomized", "to", "0.3,", "1.0,", "or", "3.0", "mg", "plecanatide,", "or", "placebo", "for", "a", "12", "week", "treatment", "period", "during", "which", "time", "they", "were", "required", "to", "call", "in", "their", "bowel", "movement", "observations", "and", "ratings", "of", "their", "associated", "abdominal", "symptoms."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_13_item1_p31_s1", "idA": "1347613_12_item1_p5_s0", "sentA": "Patients will be treated with one of three doses of plecanatide (0.3, 1.0 or 3.0 mg) or placebo taken once daily over a period of 12 weeks.", "sentB": "Qualified patients will be randomized to receive 0.3, 1, 3 or 9 mg of plecanatide or placebo once daily for 12 weeks and will be seen at the clinical site once a month during the study.", "type": 2, "words": ["<tag1>", "Patients", "will", "be", "treated", "with", "one", "of", "three", "doses", "of", "plecanatide", "(0.3,", "1.0", "or", "3.0", "mg)", "or", "placebo", "taken", "once", "daily", "over", "a", "period", "of", "12", "weeks.", "<tag2>", "Qualified", "patients", "will", "be", "randomized", "to", "receive", "0.3,", "1,", "3", "or", "9", "mg", "of", "plecanatide", "or", "placebo", "once", "daily", "for", "12", "weeks", "and", "will", "be", "seen", "at", "the", "clinical", "site", "once", "a", "month", "during", "the", "study.", "<tag3>"], "wordsA": ["Patients", "will", "be", "treated", "with", "one", "of", "three", "doses", "of", "plecanatide", "(0.3,", "1.0", "or", "3.0", "mg)", "or", "placebo", "taken", "once", "daily", "over", "a", "period", "of", "12", "weeks."], "wordsB": ["Qualified", "patients", "will", "be", "randomized", "to", "receive", "0.3,", "1,", "3", "or", "9", "mg", "of", "plecanatide", "or", "placebo", "once", "daily", "for", "12", "weeks", "and", "will", "be", "seen", "at", "the", "clinical", "site", "once", "a", "month", "during", "the", "study."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_13_item1_p11_s0", "idA": "1347613_12_item1_p7_s0", "sentA": "In September, 2010 we completed a Phase 2a randomized, double-blind, placebo-controlled, 14-day repeat, oral, dose-ranging clinical trial of plecanatide in patients with CC.", "sentB": "In September, 2010 we completed a Phase 2a randomized, double-blind, placebo-controlled, 14-day repeat, oral, dose-ranging clinical trial of plecanatide in patients with CIC.", "type": 2, "words": ["<tag1>", "In", "September,", "2010", "we", "completed", "a", "Phase", "2a", "randomized,", "double-blind,", "placebo-controlled,", "14-day", "repeat,", "oral,", "dose-ranging", "clinical", "trial", "of", "plecanatide", "in", "patients", "with", "CC.", "<tag2>", "In", "September,", "2010", "we", "completed", "a", "Phase", "2a", "randomized,", "double-blind,", "placebo-controlled,", "14-day", "repeat,", "oral,", "dose-ranging", "clinical", "trial", "of", "plecanatide", "in", "patients", "with", "CIC.", "<tag3>"], "wordsA": ["In", "September,", "2010", "we", "completed", "a", "Phase", "2a", "randomized,", "double-blind,", "placebo-controlled,", "14-day", "repeat,", "oral,", "dose-ranging", "clinical", "trial", "of", "plecanatide", "in", "patients", "with", "CC."], "wordsB": ["In", "September,", "2010", "we", "completed", "a", "Phase", "2a", "randomized,", "double-blind,", "placebo-controlled,", "14-day", "repeat,", "oral,", "dose-ranging", "clinical", "trial", "of", "plecanatide", "in", "patients", "with", "CIC."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_13_item1_p18_s0", "idA": "1347613_12_item1_p7_s0", "sentA": "In September, 2010 we completed a Phase 2a randomized, double-blind, placebo-controlled, 14-day repeat, oral, dose-ranging clinical trial of plecanatide in patients with CC.", "sentB": "On January 2, 2013, we announced positive results from our large multicenter clinical trial of plecanatide in patients with CIC.", "type": 2, "words": ["<tag1>", "In", "September,", "2010", "we", "completed", "a", "Phase", "2a", "randomized,", "double-blind,", "placebo-controlled,", "14-day", "repeat,", "oral,", "dose-ranging", "clinical", "trial", "of", "plecanatide", "in", "patients", "with", "CC.", "<tag2>", "On", "January", "2,", "2013,", "we", "announced", "positive", "results", "from", "our", "large", "multicenter", "clinical", "trial", "of", "plecanatide", "in", "patients", "with", "CIC.", "<tag3>"], "wordsA": ["In", "September,", "2010", "we", "completed", "a", "Phase", "2a", "randomized,", "double-blind,", "placebo-controlled,", "14-day", "repeat,", "oral,", "dose-ranging", "clinical", "trial", "of", "plecanatide", "in", "patients", "with", "CC."], "wordsB": ["On", "January", "2,", "2013,", "we", "announced", "positive", "results", "from", "our", "large", "multicenter", "clinical", "trial", "of", "plecanatide", "in", "patients", "with", "CIC."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_13_item1_p36_s1", "idA": "1347613_12_item1_p7_s0", "sentA": "In September, 2010 we completed a Phase 2a randomized, double-blind, placebo-controlled, 14-day repeat, oral, dose-ranging clinical trial of plecanatide in patients with CC.", "sentB": "On December 28, 2012, we successfully completed a Phase 1 placebo-controlled, dose-escalating, single-dose study of 70 healthy adult volunteers.", "type": 2, "words": ["<tag1>", "In", "September,", "2010", "we", "completed", "a", "Phase", "2a", "randomized,", "double-blind,", "placebo-controlled,", "14-day", "repeat,", "oral,", "dose-ranging", "clinical", "trial", "of", "plecanatide", "in", "patients", "with", "CC.", "<tag2>", "On", "December", "28,", "2012,", "we", "successfully", "completed", "a", "Phase", "1", "placebo-controlled,", "dose-escalating,", "single-dose", "study", "of", "70", "healthy", "adult", "volunteers.", "<tag3>"], "wordsA": ["In", "September,", "2010", "we", "completed", "a", "Phase", "2a", "randomized,", "double-blind,", "placebo-controlled,", "14-day", "repeat,", "oral,", "dose-ranging", "clinical", "trial", "of", "plecanatide", "in", "patients", "with", "CC."], "wordsB": ["On", "December", "28,", "2012,", "we", "successfully", "completed", "a", "Phase", "1", "placebo-controlled,", "dose-escalating,", "single-dose", "study", "of", "70", "healthy", "adult", "volunteers."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_13_item1_p8_s0", "idA": "1347613_12_item1_p7_s0", "sentA": "In September, 2010 we completed a Phase 2a randomized, double-blind, placebo-controlled, 14-day repeat, oral, dose-ranging clinical trial of plecanatide in patients with CC.", "sentB": "We successfully completed a Phase 1 study of plecanatide in healthy volunteers and a Phase IIa clinical trial in patients with CIC.", "type": 2, "words": ["<tag1>", "In", "September,", "2010", "we", "completed", "a", "Phase", "2a", "randomized,", "double-blind,", "placebo-controlled,", "14-day", "repeat,", "oral,", "dose-ranging", "clinical", "trial", "of", "plecanatide", "in", "patients", "with", "CC.", "<tag2>", "We", "successfully", "completed", "a", "Phase", "1", "study", "of", "plecanatide", "in", "healthy", "volunteers", "and", "a", "Phase", "IIa", "clinical", "trial", "in", "patients", "with", "CIC.", "<tag3>"], "wordsA": ["In", "September,", "2010", "we", "completed", "a", "Phase", "2a", "randomized,", "double-blind,", "placebo-controlled,", "14-day", "repeat,", "oral,", "dose-ranging", "clinical", "trial", "of", "plecanatide", "in", "patients", "with", "CC."], "wordsB": ["We", "successfully", "completed", "a", "Phase", "1", "study", "of", "plecanatide", "in", "healthy", "volunteers", "and", "a", "Phase", "IIa", "clinical", "trial", "in", "patients", "with", "CIC."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_13_item1_p8_s1", "idA": "1347613_12_item1_p7_s0", "sentA": "In September, 2010 we completed a Phase 2a randomized, double-blind, placebo-controlled, 14-day repeat, oral, dose-ranging clinical trial of plecanatide in patients with CC.", "sentB": "In December 2012, we successfully completed a large multicenter 951-patient, 12 week repeated-oral-dose, placebo-controlled clinical trial of plecanatide in CIC patients.", "type": 2, "words": ["<tag1>", "In", "September,", "2010", "we", "completed", "a", "Phase", "2a", "randomized,", "double-blind,", "placebo-controlled,", "14-day", "repeat,", "oral,", "dose-ranging", "clinical", "trial", "of", "plecanatide", "in", "patients", "with", "CC.", "<tag2>", "In", "December", "2012,", "we", "successfully", "completed", "a", "large", "multicenter", "951-patient,", "12", "week", "repeated-oral-dose,", "placebo-controlled", "clinical", "trial", "of", "plecanatide", "in", "CIC", "patients.", "<tag3>"], "wordsA": ["In", "September,", "2010", "we", "completed", "a", "Phase", "2a", "randomized,", "double-blind,", "placebo-controlled,", "14-day", "repeat,", "oral,", "dose-ranging", "clinical", "trial", "of", "plecanatide", "in", "patients", "with", "CC."], "wordsB": ["In", "December", "2012,", "we", "successfully", "completed", "a", "large", "multicenter", "951-patient,", "12", "week", "repeated-oral-dose,", "placebo-controlled", "clinical", "trial", "of", "plecanatide", "in", "CIC", "patients."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_13_item1_p12_s0", "idA": "1347613_12_item1_p7_s1", "sentA": "On October 18, 2010, we presented the results of this clinical trial at the American College of Gastroenterology Annual Scientific Meeting in San Antonio, Texas.", "sentB": "American College of Gastroenterology Annual Scientific Meeting in San Antonio, Texas.", "type": 2, "words": ["<tag1>", "On", "October", "18,", "2010,", "we", "presented", "the", "results", "of", "this", "clinical", "trial", "at", "the", "American", "College", "of", "Gastroenterology", "Annual", "Scientific", "Meeting", "in", "San", "Antonio,", "Texas.", "<tag2>", "American", "College", "of", "Gastroenterology", "Annual", "Scientific", "Meeting", "in", "San", "Antonio,", "Texas.", "<tag3>"], "wordsA": ["On", "October", "18,", "2010,", "we", "presented", "the", "results", "of", "this", "clinical", "trial", "at", "the", "American", "College", "of", "Gastroenterology", "Annual", "Scientific", "Meeting", "in", "San", "Antonio,", "Texas."], "wordsB": ["American", "College", "of", "Gastroenterology", "Annual", "Scientific", "Meeting", "in", "San", "Antonio,", "Texas."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_13_item1_p22_s1", "idA": "1347613_12_item1_p7_s2", "sentA": "The trial utilized 78 evaluable patients at 14 sites in the United States.", "sentB": "This 12-week study included 951 CIC patients at 113 clinical sites in the United States.", "type": 2, "words": ["<tag1>", "The", "trial", "utilized", "78", "evaluable", "patients", "at", "14", "sites", "in", "the", "United", "States.", "<tag2>", "This", "12-week", "study", "included", "951", "CIC", "patients", "at", "113", "clinical", "sites", "in", "the", "United", "States.", "<tag3>"], "wordsA": ["The", "trial", "utilized", "78", "evaluable", "patients", "at", "14", "sites", "in", "the", "United", "States."], "wordsB": ["This", "12-week", "study", "included", "951", "CIC", "patients", "at", "113", "clinical", "sites", "in", "the", "United", "States."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_13_item1_p26_s0", "idA": "1347613_12_item1_p7_s2", "sentA": "The trial utilized 78 evaluable patients at 14 sites in the United States.", "sentB": "IBS is one of the most commonly diagnosed Gl illnesses in the United States.", "type": 2, "words": ["<tag1>", "The", "trial", "utilized", "78", "evaluable", "patients", "at", "14", "sites", "in", "the", "United", "States.", "<tag2>", "IBS", "is", "one", "of", "the", "most", "commonly", "diagnosed", "Gl", "illnesses", "in", "the", "United", "States.", "<tag3>"], "wordsA": ["The", "trial", "utilized", "78", "evaluable", "patients", "at", "14", "sites", "in", "the", "United", "States."], "wordsB": ["IBS", "is", "one", "of", "the", "most", "commonly", "diagnosed", "Gl", "illnesses", "in", "the", "United", "States."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_13_item1_p12_s2", "idA": "1347613_12_item1_p7_s3", "sentA": "The primary objective of the trial was to evaluate the safety of plecanatide in patients with CC.", "sentB": "The primary objective of the trial was to evaluate the safety of plecanatide in patients with CIC.", "type": 2, "words": ["<tag1>", "The", "primary", "objective", "of", "the", "trial", "was", "to", "evaluate", "the", "safety", "of", "plecanatide", "in", "patients", "with", "CC.", "<tag2>", "The", "primary", "objective", "of", "the", "trial", "was", "to", "evaluate", "the", "safety", "of", "plecanatide", "in", "patients", "with", "CIC.", "<tag3>"], "wordsA": ["The", "primary", "objective", "of", "the", "trial", "was", "to", "evaluate", "the", "safety", "of", "plecanatide", "in", "patients", "with", "CC."], "wordsB": ["The", "primary", "objective", "of", "the", "trial", "was", "to", "evaluate", "the", "safety", "of", "plecanatide", "in", "patients", "with", "CIC."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_13_item1_p22_s0", "idA": "1347613_12_item1_p7_s4", "sentA": "The secondary objectives of this clinical trial were to assess the pharmacokinetic profile of plecanatide and to assess bowel function, including time to first bowel movement, frequency, completeness of evacuation, stool consistency, straining and abdominal discomfort, after treatment with plecanatide.", "sentB": "This large multicenter study was designed to determine whether plecanatide could increase the number of CSBM s and impact other parameters such as stool consistency, straining and time to first bowel movement in patients with CIC.", "type": 2, "words": ["<tag1>", "The", "secondary", "objectives", "of", "this", "clinical", "trial", "were", "to", "assess", "the", "pharmacokinetic", "profile", "of", "plecanatide", "and", "to", "assess", "bowel", "function,", "including", "time", "to", "first", "bowel", "movement,", "frequency,", "completeness", "of", "evacuation,", "stool", "consistency,", "straining", "and", "abdominal", "discomfort,", "after", "treatment", "with", "plecanatide.", "<tag2>", "This", "large", "multicenter", "study", "was", "designed", "to", "determine", "whether", "plecanatide", "could", "increase", "the", "number", "of", "CSBM", "s", "and", "impact", "other", "parameters", "such", "as", "stool", "consistency,", "straining", "and", "time", "to", "first", "bowel", "movement", "in", "patients", "with", "CIC.", "<tag3>"], "wordsA": ["The", "secondary", "objectives", "of", "this", "clinical", "trial", "were", "to", "assess", "the", "pharmacokinetic", "profile", "of", "plecanatide", "and", "to", "assess", "bowel", "function,", "including", "time", "to", "first", "bowel", "movement,", "frequency,", "completeness", "of", "evacuation,", "stool", "consistency,", "straining", "and", "abdominal", "discomfort,", "after", "treatment", "with", "plecanatide."], "wordsB": ["This", "large", "multicenter", "study", "was", "designed", "to", "determine", "whether", "plecanatide", "could", "increase", "the", "number", "of", "CSBM", "s", "and", "impact", "other", "parameters", "such", "as", "stool", "consistency,", "straining", "and", "time", "to", "first", "bowel", "movement", "in", "patients", "with", "CIC."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_13_item1_p32_s0", "idA": "1347613_12_item1_p7_s4", "sentA": "The secondary objectives of this clinical trial were to assess the pharmacokinetic profile of plecanatide and to assess bowel function, including time to first bowel movement, frequency, completeness of evacuation, stool consistency, straining and abdominal discomfort, after treatment with plecanatide.", "sentB": "The primary objective of this study is to select doses for the Phase 3 studies based on safety and efficacy endpoints including bowel movements, stool consistency, time to first bowel movement, reduction of abdominal pain, and quality of life measures.", "type": 2, "words": ["<tag1>", "The", "secondary", "objectives", "of", "this", "clinical", "trial", "were", "to", "assess", "the", "pharmacokinetic", "profile", "of", "plecanatide", "and", "to", "assess", "bowel", "function,", "including", "time", "to", "first", "bowel", "movement,", "frequency,", "completeness", "of", "evacuation,", "stool", "consistency,", "straining", "and", "abdominal", "discomfort,", "after", "treatment", "with", "plecanatide.", "<tag2>", "The", "primary", "objective", "of", "this", "study", "is", "to", "select", "doses", "for", "the", "Phase", "3", "studies", "based", "on", "safety", "and", "efficacy", "endpoints", "including", "bowel", "movements,", "stool", "consistency,", "time", "to", "first", "bowel", "movement,", "reduction", "of", "abdominal", "pain,", "and", "quality", "of", "life", "measures.", "<tag3>"], "wordsA": ["The", "secondary", "objectives", "of", "this", "clinical", "trial", "were", "to", "assess", "the", "pharmacokinetic", "profile", "of", "plecanatide", "and", "to", "assess", "bowel", "function,", "including", "time", "to", "first", "bowel", "movement,", "frequency,", "completeness", "of", "evacuation,", "stool", "consistency,", "straining", "and", "abdominal", "discomfort,", "after", "treatment", "with", "plecanatide."], "wordsB": ["The", "primary", "objective", "of", "this", "study", "is", "to", "select", "doses", "for", "the", "Phase", "3", "studies", "based", "on", "safety", "and", "efficacy", "endpoints", "including", "bowel", "movements,", "stool", "consistency,", "time", "to", "first", "bowel", "movement,", "reduction", "of", "abdominal", "pain,", "and", "quality", "of", "life", "measures."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_13_item1_p13_s0", "idA": "1347613_12_item1_p8_s0", "sentA": "In this clinical trial we enrolled patients that met the modified Rome III criteria of CC, a standard patient assessment tool used in the diagnosis of patients with CC.", "sentB": "In this clinical trial we enrolled patients who met the modified Rome III criteria of CIC, a standard patient assessment tool used in the diagnosis of patients with CIC.", "type": 2, "words": ["<tag1>", "In", "this", "clinical", "trial", "we", "enrolled", "patients", "that", "met", "the", "modified", "Rome", "III", "criteria", "of", "CC,", "a", "standard", "patient", "assessment", "tool", "used", "in", "the", "diagnosis", "of", "patients", "with", "CC.", "<tag2>", "In", "this", "clinical", "trial", "we", "enrolled", "patients", "who", "met", "the", "modified", "Rome", "III", "criteria", "of", "CIC,", "a", "standard", "patient", "assessment", "tool", "used", "in", "the", "diagnosis", "of", "patients", "with", "CIC.", "<tag3>"], "wordsA": ["In", "this", "clinical", "trial", "we", "enrolled", "patients", "that", "met", "the", "modified", "Rome", "III", "criteria", "of", "CC,", "a", "standard", "patient", "assessment", "tool", "used", "in", "the", "diagnosis", "of", "patients", "with", "CC."], "wordsB": ["In", "this", "clinical", "trial", "we", "enrolled", "patients", "who", "met", "the", "modified", "Rome", "III", "criteria", "of", "CIC,", "a", "standard", "patient", "assessment", "tool", "used", "in", "the", "diagnosis", "of", "patients", "with", "CIC."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_13_item1_p13_s1", "idA": "1347613_12_item1_p9_s0", "sentA": "reported less than six simultaneous bowel movements, or SBMs, and less than three complete SBMs, or CSBMs, in each week during the 14-days before treatment with plecanatide or placebo.", "sentB": "Patients also had to have had a colonoscopy within five years before enrollment with no significant findings, had to be in good health as determined by a physical examination and other standard assessments and had to have reported less than six simultaneous bowel movements, or SBMs, and less than three complete SBMs, or CSBMs, in each week during the 14-days before treatment with plecanatide or placebo.", "type": 2, "words": ["<tag1>", "reported", "less", "than", "six", "simultaneous", "bowel", "movements,", "or", "SBMs,", "and", "less", "than", "three", "complete", "SBMs,", "or", "CSBMs,", "in", "each", "week", "during", "the", "14-days", "before", "treatment", "with", "plecanatide", "or", "placebo.", "<tag2>", "Patients", "also", "had", "to", "have", "had", "a", "colonoscopy", "within", "five", "years", "before", "enrollment", "with", "no", "significant", "findings,", "had", "to", "be", "in", "good", "health", "as", "determined", "by", "a", "physical", "examination", "and", "other", "standard", "assessments", "and", "had", "to", "have", "reported", "less", "than", "six", "simultaneous", "bowel", "movements,", "or", "SBMs,", "and", "less", "than", "three", "complete", "SBMs,", "or", "CSBMs,", "in", "each", "week", "during", "the", "14-days", "before", "treatment", "with", "plecanatide", "or", "placebo.", "<tag3>"], "wordsA": ["reported", "less", "than", "six", "simultaneous", "bowel", "movements,", "or", "SBMs,", "and", "less", "than", "three", "complete", "SBMs,", "or", "CSBMs,", "in", "each", "week", "during", "the", "14-days", "before", "treatment", "with", "plecanatide", "or", "placebo."], "wordsB": ["Patients", "also", "had", "to", "have", "had", "a", "colonoscopy", "within", "five", "years", "before", "enrollment", "with", "no", "significant", "findings,", "had", "to", "be", "in", "good", "health", "as", "determined", "by", "a", "physical", "examination", "and", "other", "standard", "assessments", "and", "had", "to", "have", "reported", "less", "than", "six", "simultaneous", "bowel", "movements,", "or", "SBMs,", "and", "less", "than", "three", "complete", "SBMs,", "or", "CSBMs,", "in", "each", "week", "during", "the", "14-days", "before", "treatment", "with", "plecanatide", "or", "placebo."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_13_item1_p7_s1", "idA": "1347613_12_item1_p9_s1", "sentA": "SBMs are bowel movements that occur without the use of a laxative, enema or suppository within the preceding 24 hours; and CSBMs are SBMs after which the patient reports a feeling of complete evacuation.", "sentB": "They suffer from very hard stool and abdominal symptoms such as bloating, discomfort, gas, and a feeling of incomplete evacuation.", "type": 2, "words": ["<tag1>", "SBMs", "are", "bowel", "movements", "that", "occur", "without", "the", "use", "of", "a", "laxative,", "enema", "or", "suppository", "within", "the", "preceding", "24", "hours;", "and", "CSBMs", "are", "SBMs", "after", "which", "the", "patient", "reports", "a", "feeling", "of", "complete", "evacuation.", "<tag2>", "They", "suffer", "from", "very", "hard", "stool", "and", "abdominal", "symptoms", "such", "as", "bloating,", "discomfort,", "gas,", "and", "a", "feeling", "of", "incomplete", "evacuation.", "<tag3>"], "wordsA": ["SBMs", "are", "bowel", "movements", "that", "occur", "without", "the", "use", "of", "a", "laxative,", "enema", "or", "suppository", "within", "the", "preceding", "24", "hours;", "and", "CSBMs", "are", "SBMs", "after", "which", "the", "patient", "reports", "a", "feeling", "of", "complete", "evacuation."], "wordsB": ["They", "suffer", "from", "very", "hard", "stool", "and", "abdominal", "symptoms", "such", "as", "bloating,", "discomfort,", "gas,", "and", "a", "feeling", "of", "incomplete", "evacuation."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_14_item1_p11_s0", "idA": "1347613_13_item1_p11_s0", "sentA": "In September, 2010 we completed a Phase 2a randomized, double-blind, placebo-controlled, 14-day repeat, oral, dose-ranging clinical trial of plecanatide in patients with CIC.", "sentB": "The pivotal phase 3 trial is a randomized, double-blind, clinical trial to compare a 12-week regimen of plecanatide (3.0 and 6.0mg) against placebo in adult patients with CIC.", "type": 2, "words": ["<tag1>", "In", "September,", "2010", "we", "completed", "a", "Phase", "2a", "randomized,", "double-blind,", "placebo-controlled,", "14-day", "repeat,", "oral,", "dose-ranging", "clinical", "trial", "of", "plecanatide", "in", "patients", "with", "CIC.", "<tag2>", "The", "pivotal", "phase", "3", "trial", "is", "a", "randomized,", "double-blind,", "clinical", "trial", "to", "compare", "a", "12-week", "regimen", "of", "plecanatide", "(3.0", "and", "6.0mg)", "against", "placebo", "in", "adult", "patients", "with", "CIC.", "<tag3>"], "wordsA": ["In", "September,", "2010", "we", "completed", "a", "Phase", "2a", "randomized,", "double-blind,", "placebo-controlled,", "14-day", "repeat,", "oral,", "dose-ranging", "clinical", "trial", "of", "plecanatide", "in", "patients", "with", "CIC."], "wordsB": ["The", "pivotal", "phase", "3", "trial", "is", "a", "randomized,", "double-blind,", "clinical", "trial", "to", "compare", "a", "12-week", "regimen", "of", "plecanatide", "(3.0", "and", "6.0mg)", "against", "placebo", "in", "adult", "patients", "with", "CIC."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_14_item1_p50_s1", "idA": "1347613_13_item1_p12_s1", "sentA": "The trial utilized 78 evaluable patients at 14 sites in the United States.", "sentB": "No consistent policy regarding the breadth of claims allowed in biotechnology patents has emerged to date in the United States.", "type": 2, "words": ["<tag1>", "The", "trial", "utilized", "78", "evaluable", "patients", "at", "14", "sites", "in", "the", "United", "States.", "<tag2>", "No", "consistent", "policy", "regarding", "the", "breadth", "of", "claims", "allowed", "in", "biotechnology", "patents", "has", "emerged", "to", "date", "in", "the", "United", "States.", "<tag3>"], "wordsA": ["The", "trial", "utilized", "78", "evaluable", "patients", "at", "14", "sites", "in", "the", "United", "States."], "wordsB": ["No", "consistent", "policy", "regarding", "the", "breadth", "of", "claims", "allowed", "in", "biotechnology", "patents", "has", "emerged", "to", "date", "in", "the", "United", "States."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_14_item1_p50_s2", "idA": "1347613_13_item1_p12_s1", "sentA": "The trial utilized 78 evaluable patients at 14 sites in the United States.", "sentB": "The biotechnology patent situation outside the United States is even more uncertain.", "type": 2, "words": ["<tag1>", "The", "trial", "utilized", "78", "evaluable", "patients", "at", "14", "sites", "in", "the", "United", "States.", "<tag2>", "The", "biotechnology", "patent", "situation", "outside", "the", "United", "States", "is", "even", "more", "uncertain.", "<tag3>"], "wordsA": ["The", "trial", "utilized", "78", "evaluable", "patients", "at", "14", "sites", "in", "the", "United", "States."], "wordsB": ["The", "biotechnology", "patent", "situation", "outside", "the", "United", "States", "is", "even", "more", "uncertain."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_14_item1_p50_s3", "idA": "1347613_13_item1_p12_s1", "sentA": "The trial utilized 78 evaluable patients at 14 sites in the United States.", "sentB": "Changes in either the patent laws or in interpretations of patent laws in the United States and other countries may diminish the value of our intellectual property.", "type": 2, "words": ["<tag1>", "The", "trial", "utilized", "78", "evaluable", "patients", "at", "14", "sites", "in", "the", "United", "States.", "<tag2>", "Changes", "in", "either", "the", "patent", "laws", "or", "in", "interpretations", "of", "patent", "laws", "in", "the", "United", "States", "and", "other", "countries", "may", "diminish", "the", "value", "of", "our", "intellectual", "property.", "<tag3>"], "wordsA": ["The", "trial", "utilized", "78", "evaluable", "patients", "at", "14", "sites", "in", "the", "United", "States."], "wordsB": ["Changes", "in", "either", "the", "patent", "laws", "or", "in", "interpretations", "of", "patent", "laws", "in", "the", "United", "States", "and", "other", "countries", "may", "diminish", "the", "value", "of", "our", "intellectual", "property."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_14_item1_p10_s0", "idA": "1347613_13_item1_p12_s2", "sentA": "The primary objective of the trial was to evaluate the safety of plecanatide in patients with CIC.", "sentB": "On November 13, 2013, we announced the start of the first of two planned pivotal phase 3 clinical trials to confirm the safety and efficacy of plecanatide in adult patients with CIC.", "type": 2, "words": ["<tag1>", "The", "primary", "objective", "of", "the", "trial", "was", "to", "evaluate", "the", "safety", "of", "plecanatide", "in", "patients", "with", "CIC.", "<tag2>", "On", "November", "13,", "2013,", "we", "announced", "the", "start", "of", "the", "first", "of", "two", "planned", "pivotal", "phase", "3", "clinical", "trials", "to", "confirm", "the", "safety", "and", "efficacy", "of", "plecanatide", "in", "adult", "patients", "with", "CIC.", "<tag3>"], "wordsA": ["The", "primary", "objective", "of", "the", "trial", "was", "to", "evaluate", "the", "safety", "of", "plecanatide", "in", "patients", "with", "CIC."], "wordsB": ["On", "November", "13,", "2013,", "we", "announced", "the", "start", "of", "the", "first", "of", "two", "planned", "pivotal", "phase", "3", "clinical", "trials", "to", "confirm", "the", "safety", "and", "efficacy", "of", "plecanatide", "in", "adult", "patients", "with", "CIC."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_14_item1_p23_s0", "idA": "1347613_13_item1_p12_s2", "sentA": "The primary objective of the trial was to evaluate the safety of plecanatide in patients with CIC.", "sentB": "On October 30, 2013 we announced the start of the phase 2 clinical trial to evaluate the safety and efficacy of SP-333 in adult patients with OIC.", "type": 2, "words": ["<tag1>", "The", "primary", "objective", "of", "the", "trial", "was", "to", "evaluate", "the", "safety", "of", "plecanatide", "in", "patients", "with", "CIC.", "<tag2>", "On", "October", "30,", "2013", "we", "announced", "the", "start", "of", "the", "phase", "2", "clinical", "trial", "to", "evaluate", "the", "safety", "and", "efficacy", "of", "SP-333", "in", "adult", "patients", "with", "OIC.", "<tag3>"], "wordsA": ["The", "primary", "objective", "of", "the", "trial", "was", "to", "evaluate", "the", "safety", "of", "plecanatide", "in", "patients", "with", "CIC."], "wordsB": ["On", "October", "30,", "2013", "we", "announced", "the", "start", "of", "the", "phase", "2", "clinical", "trial", "to", "evaluate", "the", "safety", "and", "efficacy", "of", "SP-333", "in", "adult", "patients", "with", "OIC."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_14_item1_p23_s3", "idA": "1347613_13_item1_p17_s1", "sentA": "Patients receiving plecanatide also reported increases in the number of SBMs and CSBMs per week, improved stool consistency and reduced straining during bowel movements as compared to pre-treatment levels for each of these measures of bowel function.", "sentB": "The primary endpoint of the study is mean change from baseline in the number of SBMs during the 4-week treatment period.", "type": 2, "words": ["<tag1>", "Patients", "receiving", "plecanatide", "also", "reported", "increases", "in", "the", "number", "of", "SBMs", "and", "CSBMs", "per", "week,", "improved", "stool", "consistency", "and", "reduced", "straining", "during", "bowel", "movements", "as", "compared", "to", "pre-treatment", "levels", "for", "each", "of", "these", "measures", "of", "bowel", "function.", "<tag2>", "The", "primary", "endpoint", "of", "the", "study", "is", "mean", "change", "from", "baseline", "in", "the", "number", "of", "SBMs", "during", "the", "4-week", "treatment", "period.", "<tag3>"], "wordsA": ["Patients", "receiving", "plecanatide", "also", "reported", "increases", "in", "the", "number", "of", "SBMs", "and", "CSBMs", "per", "week,", "improved", "stool", "consistency", "and", "reduced", "straining", "during", "bowel", "movements", "as", "compared", "to", "pre-treatment", "levels", "for", "each", "of", "these", "measures", "of", "bowel", "function."], "wordsB": ["The", "primary", "endpoint", "of", "the", "study", "is", "mean", "change", "from", "baseline", "in", "the", "number", "of", "SBMs", "during", "the", "4-week", "treatment", "period."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_14_item1_p8_s0", "idA": "1347613_13_item1_p18_s0", "sentA": "On January 2, 2013, we announced positive results from our large multicenter clinical trial of plecanatide in patients with CIC.", "sentB": "On January 2, 2013, we announced positive results from our large multicenter clinical trial of our lead investigational drug plecanatide in patients with CIC.", "type": 2, "words": ["<tag1>", "On", "January", "2,", "2013,", "we", "announced", "positive", "results", "from", "our", "large", "multicenter", "clinical", "trial", "of", "plecanatide", "in", "patients", "with", "CIC.", "<tag2>", "On", "January", "2,", "2013,", "we", "announced", "positive", "results", "from", "our", "large", "multicenter", "clinical", "trial", "of", "our", "lead", "investigational", "drug", "plecanatide", "in", "patients", "with", "CIC.", "<tag3>"], "wordsA": ["On", "January", "2,", "2013,", "we", "announced", "positive", "results", "from", "our", "large", "multicenter", "clinical", "trial", "of", "plecanatide", "in", "patients", "with", "CIC."], "wordsB": ["On", "January", "2,", "2013,", "we", "announced", "positive", "results", "from", "our", "large", "multicenter", "clinical", "trial", "of", "our", "lead", "investigational", "drug", "plecanatide", "in", "patients", "with", "CIC."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_14_item1_p19_s0", "idA": "1347613_13_item1_p18_s1", "sentA": "We intend to present full study results at a major scientific meeting in the second quarter of 2013.", "sentB": "On December 24, 2013, we announced that we had closed patient enrollment and expect to report top line data in the second quarter of 2014.", "type": 2, "words": ["<tag1>", "We", "intend", "to", "present", "full", "study", "results", "at", "a", "major", "scientific", "meeting", "in", "the", "second", "quarter", "of", "2013.", "<tag2>", "On", "December", "24,", "2013,", "we", "announced", "that", "we", "had", "closed", "patient", "enrollment", "and", "expect", "to", "report", "top", "line", "data", "in", "the", "second", "quarter", "of", "2014.", "<tag3>"], "wordsA": ["We", "intend", "to", "present", "full", "study", "results", "at", "a", "major", "scientific", "meeting", "in", "the", "second", "quarter", "of", "2013."], "wordsB": ["On", "December", "24,", "2013,", "we", "announced", "that", "we", "had", "closed", "patient", "enrollment", "and", "expect", "to", "report", "top", "line", "data", "in", "the", "second", "quarter", "of", "2014."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_14_item1_p11_s2", "idA": "1347613_13_item1_p20_s1", "sentA": "At the end of the study the patients had a 2 week post treatment period without drug followed by an end of study visit.", "sentB": "The primary endpoint of the study is the proportion of patients who are overall responders for the 12-week treatment period.", "type": 2, "words": ["<tag1>", "At", "the", "end", "of", "the", "study", "the", "patients", "had", "a", "2", "week", "post", "treatment", "period", "without", "drug", "followed", "by", "an", "end", "of", "study", "visit.", "<tag2>", "The", "primary", "endpoint", "of", "the", "study", "is", "the", "proportion", "of", "patients", "who", "are", "overall", "responders", "for", "the", "12-week", "treatment", "period.", "<tag3>"], "wordsA": ["At", "the", "end", "of", "the", "study", "the", "patients", "had", "a", "2", "week", "post", "treatment", "period", "without", "drug", "followed", "by", "an", "end", "of", "study", "visit."], "wordsB": ["The", "primary", "endpoint", "of", "the", "study", "is", "the", "proportion", "of", "patients", "who", "are", "overall", "responders", "for", "the", "12-week", "treatment", "period."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_14_item1_p12_s0", "idA": "1347613_13_item1_p25_s0", "sentA": "Irritable bowel syndrome, or IBS, is characterized by symptoms of abdominal pain or discomfort such as cramping, bloating, gas, and constipation or diarrhea or both.", "sentB": "In addition to CIC, plecanatide is also being developed to treat IBS-C. IBS, which is one of the most commonly diagnosed GI illnesses in the United States, is generally characterized by symptoms of abdominal pain or discomfort such as cramping, bloating, gas, and constipation or diarrhea or both.", "type": 2, "words": ["<tag1>", "Irritable", "bowel", "syndrome,", "or", "IBS,", "is", "characterized", "by", "symptoms", "of", "abdominal", "pain", "or", "discomfort", "such", "as", "cramping,", "bloating,", "gas,", "and", "constipation", "or", "diarrhea", "or", "both.", "<tag2>", "In", "addition", "to", "CIC,", "plecanatide", "is", "also", "being", "developed", "to", "treat", "IBS-C.", "IBS,", "which", "is", "one", "of", "the", "most", "commonly", "diagnosed", "GI", "illnesses", "in", "the", "United", "States,", "is", "generally", "characterized", "by", "symptoms", "of", "abdominal", "pain", "or", "discomfort", "such", "as", "cramping,", "bloating,", "gas,", "and", "constipation", "or", "diarrhea", "or", "both.", "<tag3>"], "wordsA": ["Irritable", "bowel", "syndrome,", "or", "IBS,", "is", "characterized", "by", "symptoms", "of", "abdominal", "pain", "or", "discomfort", "such", "as", "cramping,", "bloating,", "gas,", "and", "constipation", "or", "diarrhea", "or", "both."], "wordsB": ["In", "addition", "to", "CIC,", "plecanatide", "is", "also", "being", "developed", "to", "treat", "IBS-C.", "IBS,", "which", "is", "one", "of", "the", "most", "commonly", "diagnosed", "GI", "illnesses", "in", "the", "United", "States,", "is", "generally", "characterized", "by", "symptoms", "of", "abdominal", "pain", "or", "discomfort", "such", "as", "cramping,", "bloating,", "gas,", "and", "constipation", "or", "diarrhea", "or", "both."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_14_item1_p12_s1", "idA": "1347613_13_item1_p25_s1", "sentA": "IBS-C is the subtype plecanatide is being developed to treat.", "sentB": "IBS-C is the subtype of IBS that plecanatide is being developed to treat and is characterized by abdominal pain associated with infrequent bowel movement and hard or lumpy stool.", "type": 2, "words": ["<tag1>", "IBS-C", "is", "the", "subtype", "plecanatide", "is", "being", "developed", "to", "treat.", "<tag2>", "IBS-C", "is", "the", "subtype", "of", "IBS", "that", "plecanatide", "is", "being", "developed", "to", "treat", "and", "is", "characterized", "by", "abdominal", "pain", "associated", "with", "infrequent", "bowel", "movement", "and", "hard", "or", "lumpy", "stool.", "<tag3>"], "wordsA": ["IBS-C", "is", "the", "subtype", "plecanatide", "is", "being", "developed", "to", "treat."], "wordsB": ["IBS-C", "is", "the", "subtype", "of", "IBS", "that", "plecanatide", "is", "being", "developed", "to", "treat", "and", "is", "characterized", "by", "abdominal", "pain", "associated", "with", "infrequent", "bowel", "movement", "and", "hard", "or", "lumpy", "stool."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_14_item1_p14_s0", "idA": "1347613_13_item1_p27_s0", "sentA": "IBS profoundly impacts patients physical, social and working lives.", "sentB": "IBS-C profoundly impacts patients physical, social and working lives.", "type": 2, "words": ["<tag1>", "IBS", "profoundly", "impacts", "patients", "physical,", "social", "and", "working", "lives.", "<tag2>", "IBS-C", "profoundly", "impacts", "patients", "physical,", "social", "and", "working", "lives.", "<tag3>"], "wordsA": ["IBS", "profoundly", "impacts", "patients", "physical,", "social", "and", "working", "lives."], "wordsB": ["IBS-C", "profoundly", "impacts", "patients", "physical,", "social", "and", "working", "lives."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_14_item1_p14_s2", "idA": "1347613_13_item1_p28_s1", "sentA": "Fewer than 1 in 10 patients say they are satisfied with available IBS treatments.", "sentB": "Fewer than 1 in 10 patients say they are satisfied with available IBS-C treatments.", "type": 2, "words": ["<tag1>", "Fewer", "than", "1", "in", "10", "patients", "say", "they", "are", "satisfied", "with", "available", "IBS", "treatments.", "<tag2>", "Fewer", "than", "1", "in", "10", "patients", "say", "they", "are", "satisfied", "with", "available", "IBS-C", "treatments.", "<tag3>"], "wordsA": ["Fewer", "than", "1", "in", "10", "patients", "say", "they", "are", "satisfied", "with", "available", "IBS", "treatments."], "wordsB": ["Fewer", "than", "1", "in", "10", "patients", "say", "they", "are", "satisfied", "with", "available", "IBS-C", "treatments."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_14_item1_p11_s1", "idA": "1347613_13_item1_p30_s1", "sentA": "This study will be conducted at 70 sites in the U.S. and 350 patients will be enrolled.", "sentB": "The study will be conducted at approximately 180 sites in the United States and Canada and is expected to enroll approximately 1,350 patients with CIC.", "type": 2, "words": ["<tag1>", "This", "study", "will", "be", "conducted", "at", "70", "sites", "in", "the", "U.S.", "and", "350", "patients", "will", "be", "enrolled.", "<tag2>", "The", "study", "will", "be", "conducted", "at", "approximately", "180", "sites", "in", "the", "United", "States", "and", "Canada", "and", "is", "expected", "to", "enroll", "approximately", "1,350", "patients", "with", "CIC.", "<tag3>"], "wordsA": ["This", "study", "will", "be", "conducted", "at", "70", "sites", "in", "the", "U.S.", "and", "350", "patients", "will", "be", "enrolled."], "wordsB": ["The", "study", "will", "be", "conducted", "at", "approximately", "180", "sites", "in", "the", "United", "States", "and", "Canada", "and", "is", "expected", "to", "enroll", "approximately", "1,350", "patients", "with", "CIC."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_14_item1_p16_s1", "idA": "1347613_13_item1_p30_s1", "sentA": "This study will be conducted at 70 sites in the U.S. and 350 patients will be enrolled.", "sentB": "This study is currently being conducted at 70 sites in the U.S., and was planned to enroll 350 patients.", "type": 2, "words": ["<tag1>", "This", "study", "will", "be", "conducted", "at", "70", "sites", "in", "the", "U.S.", "and", "350", "patients", "will", "be", "enrolled.", "<tag2>", "This", "study", "is", "currently", "being", "conducted", "at", "70", "sites", "in", "the", "U.S.,", "and", "was", "planned", "to", "enroll", "350", "patients.", "<tag3>"], "wordsA": ["This", "study", "will", "be", "conducted", "at", "70", "sites", "in", "the", "U.S.", "and", "350", "patients", "will", "be", "enrolled."], "wordsB": ["This", "study", "is", "currently", "being", "conducted", "at", "70", "sites", "in", "the", "U.S.,", "and", "was", "planned", "to", "enroll", "350", "patients."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_14_item1_p16_s2", "idA": "1347613_13_item1_p30_s2", "sentA": "To qualify for enrollment patients must meet the Rome III criteria for IBS-C as modified for this study.", "sentB": "To qualify for enrollment, patients were required to meet the Rome III criteria for IBS-C as modified for this study.", "type": 2, "words": ["<tag1>", "To", "qualify", "for", "enrollment", "patients", "must", "meet", "the", "Rome", "III", "criteria", "for", "IBS-C", "as", "modified", "for", "this", "study.", "<tag2>", "To", "qualify", "for", "enrollment,", "patients", "were", "required", "to", "meet", "the", "Rome", "III", "criteria", "for", "IBS-C", "as", "modified", "for", "this", "study.", "<tag3>"], "wordsA": ["To", "qualify", "for", "enrollment", "patients", "must", "meet", "the", "Rome", "III", "criteria", "for", "IBS-C", "as", "modified", "for", "this", "study."], "wordsB": ["To", "qualify", "for", "enrollment,", "patients", "were", "required", "to", "meet", "the", "Rome", "III", "criteria", "for", "IBS-C", "as", "modified", "for", "this", "study."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_14_item1_p17_s0", "idA": "1347613_13_item1_p31_s0", "sentA": "Abdominal pain is a major part of this syndrome and patients need to have pain scores of 3 or more (on a scale of 1 to 10) for 3 days in each of the two pre-treatment weeks.", "sentB": "Abdominal pain is a major part of this syndrome and patients need to have pain scores of 3 or more (on a scale of 0 to 10) for 3 days in each of the two pre-treatment weeks to qualify for the trial.", "type": 2, "words": ["<tag1>", "Abdominal", "pain", "is", "a", "major", "part", "of", "this", "syndrome", "and", "patients", "need", "to", "have", "pain", "scores", "of", "3", "or", "more", "(on", "a", "scale", "of", "1", "to", "10)", "for", "3", "days", "in", "each", "of", "the", "two", "pre-treatment", "weeks.", "<tag2>", "Abdominal", "pain", "is", "a", "major", "part", "of", "this", "syndrome", "and", "patients", "need", "to", "have", "pain", "scores", "of", "3", "or", "more", "(on", "a", "scale", "of", "0", "to", "10)", "for", "3", "days", "in", "each", "of", "the", "two", "pre-treatment", "weeks", "to", "qualify", "for", "the", "trial.", "<tag3>"], "wordsA": ["Abdominal", "pain", "is", "a", "major", "part", "of", "this", "syndrome", "and", "patients", "need", "to", "have", "pain", "scores", "of", "3", "or", "more", "(on", "a", "scale", "of", "1", "to", "10)", "for", "3", "days", "in", "each", "of", "the", "two", "pre-treatment", "weeks."], "wordsB": ["Abdominal", "pain", "is", "a", "major", "part", "of", "this", "syndrome", "and", "patients", "need", "to", "have", "pain", "scores", "of", "3", "or", "more", "(on", "a", "scale", "of", "0", "to", "10)", "for", "3", "days", "in", "each", "of", "the", "two", "pre-treatment", "weeks", "to", "qualify", "for", "the", "trial."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_14_item1_p17_s1", "idA": "1347613_13_item1_p31_s1", "sentA": "Qualified patients will be randomized to receive 0.3, 1, 3 or 9 mg of plecanatide or placebo once daily for 12 weeks and will be seen at the clinical site once a month during the study.", "sentB": "Qualified patients were being randomized to receive 0.3, 1, 3 or 9 mg of plecanatide or placebo once daily for 12 weeks, and are seen at the clinical site once a month during the study.", "type": 2, "words": ["<tag1>", "Qualified", "patients", "will", "be", "randomized", "to", "receive", "0.3,", "1,", "3", "or", "9", "mg", "of", "plecanatide", "or", "placebo", "once", "daily", "for", "12", "weeks", "and", "will", "be", "seen", "at", "the", "clinical", "site", "once", "a", "month", "during", "the", "study.", "<tag2>", "Qualified", "patients", "were", "being", "randomized", "to", "receive", "0.3,", "1,", "3", "or", "9", "mg", "of", "plecanatide", "or", "placebo", "once", "daily", "for", "12", "weeks,", "and", "are", "seen", "at", "the", "clinical", "site", "once", "a", "month", "during", "the", "study.", "<tag3>"], "wordsA": ["Qualified", "patients", "will", "be", "randomized", "to", "receive", "0.3,", "1,", "3", "or", "9", "mg", "of", "plecanatide", "or", "placebo", "once", "daily", "for", "12", "weeks", "and", "will", "be", "seen", "at", "the", "clinical", "site", "once", "a", "month", "during", "the", "study."], "wordsB": ["Qualified", "patients", "were", "being", "randomized", "to", "receive", "0.3,", "1,", "3", "or", "9", "mg", "of", "plecanatide", "or", "placebo", "once", "daily", "for", "12", "weeks,", "and", "are", "seen", "at", "the", "clinical", "site", "once", "a", "month", "during", "the", "study."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_14_item1_p17_s2", "idA": "1347613_13_item1_p31_s2", "sentA": "At the end of treatment patients are followed for two weeks and return for an end of study visit.", "sentB": "At the end of treatment, patients are followed for two weeks, and return for an end of study visit.", "type": 2, "words": ["<tag1>", "At", "the", "end", "of", "treatment", "patients", "are", "followed", "for", "two", "weeks", "and", "return", "for", "an", "end", "of", "study", "visit.", "<tag2>", "At", "the", "end", "of", "treatment,", "patients", "are", "followed", "for", "two", "weeks,", "and", "return", "for", "an", "end", "of", "study", "visit.", "<tag3>"], "wordsA": ["At", "the", "end", "of", "treatment", "patients", "are", "followed", "for", "two", "weeks", "and", "return", "for", "an", "end", "of", "study", "visit."], "wordsB": ["At", "the", "end", "of", "treatment,", "patients", "are", "followed", "for", "two", "weeks,", "and", "return", "for", "an", "end", "of", "study", "visit."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_14_item1_p18_s0", "idA": "1347613_13_item1_p32_s0", "sentA": "The primary objective of this study is to select doses for the Phase 3 studies based on safety and efficacy endpoints including bowel movements, stool consistency, time to first bowel movement, reduction of abdominal pain, and quality of life measures.", "sentB": "The primary objective of this study is to select doses for the following Phase 3 studies, based on safety and efficacy endpoints including bowel movement frequency, stool consistency, time to first bowel movement, reduction of abdominal pain, and quality of life measures.", "type": 2, "words": ["<tag1>", "The", "primary", "objective", "of", "this", "study", "is", "to", "select", "doses", "for", "the", "Phase", "3", "studies", "based", "on", "safety", "and", "efficacy", "endpoints", "including", "bowel", "movements,", "stool", "consistency,", "time", "to", "first", "bowel", "movement,", "reduction", "of", "abdominal", "pain,", "and", "quality", "of", "life", "measures.", "<tag2>", "The", "primary", "objective", "of", "this", "study", "is", "to", "select", "doses", "for", "the", "following", "Phase", "3", "studies,", "based", "on", "safety", "and", "efficacy", "endpoints", "including", "bowel", "movement", "frequency,", "stool", "consistency,", "time", "to", "first", "bowel", "movement,", "reduction", "of", "abdominal", "pain,", "and", "quality", "of", "life", "measures.", "<tag3>"], "wordsA": ["The", "primary", "objective", "of", "this", "study", "is", "to", "select", "doses", "for", "the", "Phase", "3", "studies", "based", "on", "safety", "and", "efficacy", "endpoints", "including", "bowel", "movements,", "stool", "consistency,", "time", "to", "first", "bowel", "movement,", "reduction", "of", "abdominal", "pain,", "and", "quality", "of", "life", "measures."], "wordsB": ["The", "primary", "objective", "of", "this", "study", "is", "to", "select", "doses", "for", "the", "following", "Phase", "3", "studies,", "based", "on", "safety", "and", "efficacy", "endpoints", "including", "bowel", "movement", "frequency,", "stool", "consistency,", "time", "to", "first", "bowel", "movement,", "reduction", "of", "abdominal", "pain,", "and", "quality", "of", "life", "measures."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_14_item1_p20_s0", "idA": "1347613_13_item1_p33_s0", "sentA": "We are developing a second generation GC-C receptor analog, SP-333, for the treatment of inflammatory bowel diseases, or IBD.", "sentB": "We are developing a second-generation GC-C receptor agonist, SP-333, for the treatment of opioid induced constipation, or OIC, and for ulcerative colitis, or UC, an inflammatory bowel disease.", "type": 2, "words": ["<tag1>", "We", "are", "developing", "a", "second", "generation", "GC-C", "receptor", "analog,", "SP-333,", "for", "the", "treatment", "of", "inflammatory", "bowel", "diseases,", "or", "IBD.", "<tag2>", "We", "are", "developing", "a", "second-generation", "GC-C", "receptor", "agonist,", "SP-333,", "for", "the", "treatment", "of", "opioid", "induced", "constipation,", "or", "OIC,", "and", "for", "ulcerative", "colitis,", "or", "UC,", "an", "inflammatory", "bowel", "disease.", "<tag3>"], "wordsA": ["We", "are", "developing", "a", "second", "generation", "GC-C", "receptor", "analog,", "SP-333,", "for", "the", "treatment", "of", "inflammatory", "bowel", "diseases,", "or", "IBD."], "wordsB": ["We", "are", "developing", "a", "second-generation", "GC-C", "receptor", "agonist,", "SP-333,", "for", "the", "treatment", "of", "opioid", "induced", "constipation,", "or", "OIC,", "and", "for", "ulcerative", "colitis,", "or", "UC,", "an", "inflammatory", "bowel", "disease."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_14_item1_p22_s0", "idA": "1347613_13_item1_p33_s0", "sentA": "We are developing a second generation GC-C receptor analog, SP-333, for the treatment of inflammatory bowel diseases, or IBD.", "sentB": "On October 2, 2013 we announced plans to move forward with SP-333 in a phase 2 study for the treatment of OIC.", "type": 2, "words": ["<tag1>", "We", "are", "developing", "a", "second", "generation", "GC-C", "receptor", "analog,", "SP-333,", "for", "the", "treatment", "of", "inflammatory", "bowel", "diseases,", "or", "IBD.", "<tag2>", "On", "October", "2,", "2013", "we", "announced", "plans", "to", "move", "forward", "with", "SP-333", "in", "a", "phase", "2", "study", "for", "the", "treatment", "of", "OIC.", "<tag3>"], "wordsA": ["We", "are", "developing", "a", "second", "generation", "GC-C", "receptor", "analog,", "SP-333,", "for", "the", "treatment", "of", "inflammatory", "bowel", "diseases,", "or", "IBD."], "wordsB": ["On", "October", "2,", "2013", "we", "announced", "plans", "to", "move", "forward", "with", "SP-333", "in", "a", "phase", "2", "study", "for", "the", "treatment", "of", "OIC."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_14_item1_p9_s0", "idA": "1347613_13_item1_p33_s0", "sentA": "We are developing a second generation GC-C receptor analog, SP-333, for the treatment of inflammatory bowel diseases, or IBD.", "sentB": "On August 5, 2013, we announced that we had completed an End-of-Phase 2 meeting with the U.S. Food and Drug Administration (FDA) regarding plecanatide for the treatment of CIC.", "type": 2, "words": ["<tag1>", "We", "are", "developing", "a", "second", "generation", "GC-C", "receptor", "analog,", "SP-333,", "for", "the", "treatment", "of", "inflammatory", "bowel", "diseases,", "or", "IBD.", "<tag2>", "On", "August", "5,", "2013,", "we", "announced", "that", "we", "had", "completed", "an", "End-of-Phase", "2", "meeting", "with", "the", "U.S.", "Food", "and", "Drug", "Administration", "(FDA)", "regarding", "plecanatide", "for", "the", "treatment", "of", "CIC.", "<tag3>"], "wordsA": ["We", "are", "developing", "a", "second", "generation", "GC-C", "receptor", "analog,", "SP-333,", "for", "the", "treatment", "of", "inflammatory", "bowel", "diseases,", "or", "IBD."], "wordsB": ["On", "August", "5,", "2013,", "we", "announced", "that", "we", "had", "completed", "an", "End-of-Phase", "2", "meeting", "with", "the", "U.S.", "Food", "and", "Drug", "Administration", "(FDA)", "regarding", "plecanatide", "for", "the", "treatment", "of", "CIC."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_14_item1_p21_s0", "idA": "1347613_13_item1_p36_s0", "sentA": "On September 7, 2012, we submitted an Investigational New Drug (IND) application for clinical evaluation of SP-333 to treat IBD.", "sentB": "On September 7, 2012, we submitted an Investigational New Drug, or IND, application for clinical evaluation of SP-333 to treat inflammatory bowel disease, or IBD.", "type": 2, "words": ["<tag1>", "On", "September", "7,", "2012,", "we", "submitted", "an", "Investigational", "New", "Drug", "(IND)", "application", "for", "clinical", "evaluation", "of", "SP-333", "to", "treat", "IBD.", "<tag2>", "On", "September", "7,", "2012,", "we", "submitted", "an", "Investigational", "New", "Drug,", "or", "IND,", "application", "for", "clinical", "evaluation", "of", "SP-333", "to", "treat", "inflammatory", "bowel", "disease,", "or", "IBD.", "<tag3>"], "wordsA": ["On", "September", "7,", "2012,", "we", "submitted", "an", "Investigational", "New", "Drug", "(IND)", "application", "for", "clinical", "evaluation", "of", "SP-333", "to", "treat", "IBD."], "wordsB": ["On", "September", "7,", "2012,", "we", "submitted", "an", "Investigational", "New", "Drug,", "or", "IND,", "application", "for", "clinical", "evaluation", "of", "SP-333", "to", "treat", "inflammatory", "bowel", "disease,", "or", "IBD."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_14_item1_p21_s1", "idA": "1347613_13_item1_p36_s1", "sentA": "On December 28, 2012, we successfully completed a Phase 1 placebo-controlled, dose-escalating, single-dose study of 70 healthy adult volunteers.", "sentB": "On December 28, 2012, we successfully completed a Phase 1 placebo-controlled, dose escalating, single-dose study of 71 healthy adult volunteers.", "type": 2, "words": ["<tag1>", "On", "December", "28,", "2012,", "we", "successfully", "completed", "a", "Phase", "1", "placebo-controlled,", "dose-escalating,", "single-dose", "study", "of", "70", "healthy", "adult", "volunteers.", "<tag2>", "On", "December", "28,", "2012,", "we", "successfully", "completed", "a", "Phase", "1", "placebo-controlled,", "dose", "escalating,", "single-dose", "study", "of", "71", "healthy", "adult", "volunteers.", "<tag3>"], "wordsA": ["On", "December", "28,", "2012,", "we", "successfully", "completed", "a", "Phase", "1", "placebo-controlled,", "dose-escalating,", "single-dose", "study", "of", "70", "healthy", "adult", "volunteers."], "wordsB": ["On", "December", "28,", "2012,", "we", "successfully", "completed", "a", "Phase", "1", "placebo-controlled,", "dose", "escalating,", "single-dose", "study", "of", "71", "healthy", "adult", "volunteers."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_14_item1_p21_s2", "idA": "1347613_13_item1_p36_s2", "sentA": "On January 28, 2013, we commenced a multiple ascending oral dosing study of healthy volunteers in a Phase 1 trial of SP-333.", "sentB": "On January 28, 2013, we commenced a multiple ascending oral dosing study of healthy volunteers in a Phase 1 trial of SP-333 which was completed during the quarter ended June 30, 2013.", "type": 2, "words": ["<tag1>", "On", "January", "28,", "2013,", "we", "commenced", "a", "multiple", "ascending", "oral", "dosing", "study", "of", "healthy", "volunteers", "in", "a", "Phase", "1", "trial", "of", "SP-333.", "<tag2>", "On", "January", "28,", "2013,", "we", "commenced", "a", "multiple", "ascending", "oral", "dosing", "study", "of", "healthy", "volunteers", "in", "a", "Phase", "1", "trial", "of", "SP-333", "which", "was", "completed", "during", "the", "quarter", "ended", "June", "30,", "2013.", "<tag3>"], "wordsA": ["On", "January", "28,", "2013,", "we", "commenced", "a", "multiple", "ascending", "oral", "dosing", "study", "of", "healthy", "volunteers", "in", "a", "Phase", "1", "trial", "of", "SP-333."], "wordsB": ["On", "January", "28,", "2013,", "we", "commenced", "a", "multiple", "ascending", "oral", "dosing", "study", "of", "healthy", "volunteers", "in", "a", "Phase", "1", "trial", "of", "SP-333", "which", "was", "completed", "during", "the", "quarter", "ended", "June", "30,", "2013."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_14_item1_p24_s1", "idA": "1347613_13_item1_p38_s1", "sentA": "The terms of the agreement provide for an initial base payment of $1 million, subsequent milestone payments covering (i) marketing (FDA) approval and (ii) achieving the milestone of aggregate net sales equal to or greater than $125 million, as well as a single digit royalty based on net sales.", "sentB": "The terms of the agreement provide for an initial base payment of $1 million, subsequent milestone payments covering (i)FDA approval and (ii) aggregate net sales equal to or greater than $125 million, as well as a single digit royalty based on net sales.", "type": 2, "words": ["<tag1>", "The", "terms", "of", "the", "agreement", "provide", "for", "an", "initial", "base", "payment", "of", "$1", "million,", "subsequent", "milestone", "payments", "covering", "(i)", "marketing", "(FDA)", "approval", "and", "(ii)", "achieving", "the", "milestone", "of", "aggregate", "net", "sales", "equal", "to", "or", "greater", "than", "$125", "million,", "as", "well", "as", "a", "single", "digit", "royalty", "based", "on", "net", "sales.", "<tag2>", "The", "terms", "of", "the", "agreement", "provide", "for", "an", "initial", "base", "payment", "of", "$1", "million,", "subsequent", "milestone", "payments", "covering", "(i)FDA", "approval", "and", "(ii)", "aggregate", "net", "sales", "equal", "to", "or", "greater", "than", "$125", "million,", "as", "well", "as", "a", "single", "digit", "royalty", "based", "on", "net", "sales.", "<tag3>"], "wordsA": ["The", "terms", "of", "the", "agreement", "provide", "for", "an", "initial", "base", "payment", "of", "$1", "million,", "subsequent", "milestone", "payments", "covering", "(i)", "marketing", "(FDA)", "approval", "and", "(ii)", "achieving", "the", "milestone", "of", "aggregate", "net", "sales", "equal", "to", "or", "greater", "than", "$125", "million,", "as", "well", "as", "a", "single", "digit", "royalty", "based", "on", "net", "sales."], "wordsB": ["The", "terms", "of", "the", "agreement", "provide", "for", "an", "initial", "base", "payment", "of", "$1", "million,", "subsequent", "milestone", "payments", "covering", "(i)FDA", "approval", "and", "(ii)", "aggregate", "net", "sales", "equal", "to", "or", "greater", "than", "$125", "million,", "as", "well", "as", "a", "single", "digit", "royalty", "based", "on", "net", "sales."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_14_item1_p27_s1", "idA": "1347613_13_item1_p43_s0", "sentA": "On January 17, 2013, we completed our acquisition of Callisto, pursuant to the Merger Agreement, as amended.", "sentB": "Pursuant to the Loan Agreement, as of December 31, 2013, we made advances to ContraVir totaling $350,000 under a promissory note, or Note.", "type": 2, "words": ["<tag1>", "On", "January", "17,", "2013,", "we", "completed", "our", "acquisition", "of", "Callisto,", "pursuant", "to", "the", "Merger", "Agreement,", "as", "amended.", "<tag2>", "Pursuant", "to", "the", "Loan", "Agreement,", "as", "of", "December", "31,", "2013,", "we", "made", "advances", "to", "ContraVir", "totaling", "$350,000", "under", "a", "promissory", "note,", "or", "Note.", "<tag3>"], "wordsA": ["On", "January", "17,", "2013,", "we", "completed", "our", "acquisition", "of", "Callisto,", "pursuant", "to", "the", "Merger", "Agreement,", "as", "amended."], "wordsB": ["Pursuant", "to", "the", "Loan", "Agreement,", "as", "of", "December", "31,", "2013,", "we", "made", "advances", "to", "ContraVir", "totaling", "$350,000", "under", "a", "promissory", "note,", "or", "Note."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_14_item1_p29_s1", "idA": "1347613_13_item1_p43_s1", "sentA": "As a result of the Merger, each outstanding share of Callisto common stock was converted into the right to receive 0.1799 of one share of our common stock and the 22,295,000 shares of our common stock held by Callisto were canceled.", "sentB": "The separation contemplates a 100% distribution of the ContraVir shares of common stock, now held by us, to our stockholders on a pro-rata basis.", "type": 2, "words": ["<tag1>", "As", "a", "result", "of", "the", "Merger,", "each", "outstanding", "share", "of", "Callisto", "common", "stock", "was", "converted", "into", "the", "right", "to", "receive", "0.1799", "of", "one", "share", "of", "our", "common", "stock", "and", "the", "22,295,000", "shares", "of", "our", "common", "stock", "held", "by", "Callisto", "were", "canceled.", "<tag2>", "The", "separation", "contemplates", "a", "100%", "distribution", "of", "the", "ContraVir", "shares", "of", "common", "stock,", "now", "held", "by", "us,", "to", "our", "stockholders", "on", "a", "pro-rata", "basis.", "<tag3>"], "wordsA": ["As", "a", "result", "of", "the", "Merger,", "each", "outstanding", "share", "of", "Callisto", "common", "stock", "was", "converted", "into", "the", "right", "to", "receive", "0.1799", "of", "one", "share", "of", "our", "common", "stock", "and", "the", "22,295,000", "shares", "of", "our", "common", "stock", "held", "by", "Callisto", "were", "canceled."], "wordsB": ["The", "separation", "contemplates", "a", "100%", "distribution", "of", "the", "ContraVir", "shares", "of", "common", "stock,", "now", "held", "by", "us,", "to", "our", "stockholders", "on", "a", "pro-rata", "basis."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_14_item1_p29_s2", "idA": "1347613_13_item1_p43_s1", "sentA": "As a result of the Merger, each outstanding share of Callisto common stock was converted into the right to receive 0.1799 of one share of our common stock and the 22,295,000 shares of our common stock held by Callisto were canceled.", "sentB": "On January 28, 2014, our Board of Directors declared a stock dividend of .0986 ContraVir shares for each share of our common stock held as of the record date of February 6, 2014, which was distributed on February 18, 2014.", "type": 2, "words": ["<tag1>", "As", "a", "result", "of", "the", "Merger,", "each", "outstanding", "share", "of", "Callisto", "common", "stock", "was", "converted", "into", "the", "right", "to", "receive", "0.1799", "of", "one", "share", "of", "our", "common", "stock", "and", "the", "22,295,000", "shares", "of", "our", "common", "stock", "held", "by", "Callisto", "were", "canceled.", "<tag2>", "On", "January", "28,", "2014,", "our", "Board", "of", "Directors", "declared", "a", "stock", "dividend", "of", ".0986", "ContraVir", "shares", "for", "each", "share", "of", "our", "common", "stock", "held", "as", "of", "the", "record", "date", "of", "February", "6,", "2014,", "which", "was", "distributed", "on", "February", "18,", "2014.", "<tag3>"], "wordsA": ["As", "a", "result", "of", "the", "Merger,", "each", "outstanding", "share", "of", "Callisto", "common", "stock", "was", "converted", "into", "the", "right", "to", "receive", "0.1799", "of", "one", "share", "of", "our", "common", "stock", "and", "the", "22,295,000", "shares", "of", "our", "common", "stock", "held", "by", "Callisto", "were", "canceled."], "wordsB": ["On", "January", "28,", "2014,", "our", "Board", "of", "Directors", "declared", "a", "stock", "dividend", "of", ".0986", "ContraVir", "shares", "for", "each", "share", "of", "our", "common", "stock", "held", "as", "of", "the", "record", "date", "of", "February", "6,", "2014,", "which", "was", "distributed", "on", "February", "18,", "2014."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_14_item1_p30_s0", "idA": "1347613_13_item1_p43_s1", "sentA": "As a result of the Merger, each outstanding share of Callisto common stock was converted into the right to receive 0.1799 of one share of our common stock and the 22,295,000 shares of our common stock held by Callisto were canceled.", "sentB": "As a result of the Distribution, an adjustment was made to the exercise price of all outstanding warrants in accordance with their terms and accordingly the exercise price decreased approximately $0.011 per share on the record date.", "type": 2, "words": ["<tag1>", "As", "a", "result", "of", "the", "Merger,", "each", "outstanding", "share", "of", "Callisto", "common", "stock", "was", "converted", "into", "the", "right", "to", "receive", "0.1799", "of", "one", "share", "of", "our", "common", "stock", "and", "the", "22,295,000", "shares", "of", "our", "common", "stock", "held", "by", "Callisto", "were", "canceled.", "<tag2>", "As", "a", "result", "of", "the", "Distribution,", "an", "adjustment", "was", "made", "to", "the", "exercise", "price", "of", "all", "outstanding", "warrants", "in", "accordance", "with", "their", "terms", "and", "accordingly", "the", "exercise", "price", "decreased", "approximately", "$0.011", "per", "share", "on", "the", "record", "date.", "<tag3>"], "wordsA": ["As", "a", "result", "of", "the", "Merger,", "each", "outstanding", "share", "of", "Callisto", "common", "stock", "was", "converted", "into", "the", "right", "to", "receive", "0.1799", "of", "one", "share", "of", "our", "common", "stock", "and", "the", "22,295,000", "shares", "of", "our", "common", "stock", "held", "by", "Callisto", "were", "canceled."], "wordsB": ["As", "a", "result", "of", "the", "Distribution,", "an", "adjustment", "was", "made", "to", "the", "exercise", "price", "of", "all", "outstanding", "warrants", "in", "accordance", "with", "their", "terms", "and", "accordingly", "the", "exercise", "price", "decreased", "approximately", "$0.011", "per", "share", "on", "the", "record", "date."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_14_item1_p49_s0", "idA": "1347613_13_item1_p43_s1", "sentA": "As a result of the Merger, each outstanding share of Callisto common stock was converted into the right to receive 0.1799 of one share of our common stock and the 22,295,000 shares of our common stock held by Callisto were canceled.", "sentB": "On January 28, 2014, our Board of Directors declared a stock dividend of .0986 ContraVir shares for each share of our common stock held as of the record date of February 6, 2014, which was distributed on February 18, 2014.", "type": 2, "words": ["<tag1>", "As", "a", "result", "of", "the", "Merger,", "each", "outstanding", "share", "of", "Callisto", "common", "stock", "was", "converted", "into", "the", "right", "to", "receive", "0.1799", "of", "one", "share", "of", "our", "common", "stock", "and", "the", "22,295,000", "shares", "of", "our", "common", "stock", "held", "by", "Callisto", "were", "canceled.", "<tag2>", "On", "January", "28,", "2014,", "our", "Board", "of", "Directors", "declared", "a", "stock", "dividend", "of", ".0986", "ContraVir", "shares", "for", "each", "share", "of", "our", "common", "stock", "held", "as", "of", "the", "record", "date", "of", "February", "6,", "2014,", "which", "was", "distributed", "on", "February", "18,", "2014.", "<tag3>"], "wordsA": ["As", "a", "result", "of", "the", "Merger,", "each", "outstanding", "share", "of", "Callisto", "common", "stock", "was", "converted", "into", "the", "right", "to", "receive", "0.1799", "of", "one", "share", "of", "our", "common", "stock", "and", "the", "22,295,000", "shares", "of", "our", "common", "stock", "held", "by", "Callisto", "were", "canceled."], "wordsB": ["On", "January", "28,", "2014,", "our", "Board", "of", "Directors", "declared", "a", "stock", "dividend", "of", ".0986", "ContraVir", "shares", "for", "each", "share", "of", "our", "common", "stock", "held", "as", "of", "the", "record", "date", "of", "February", "6,", "2014,", "which", "was", "distributed", "on", "February", "18,", "2014."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_14_item1_p26_s0", "idA": "1347613_13_item1_p44_s0", "sentA": "approximately 28,605,354 shares of our common stock to former Callisto stockholders in exchange for their shares of Callisto common stock.", "sentB": "We entered into a Contribution Agreement with ContraVir (the Contribution Agreement ), transferring the FV-100 Product to ContraVir, in exchange for the issuance to us of 9,000,000 shares of ContraVir common stock, par value $0.0001 per share , representing 100% of the outstanding shares of common stock as of immediately following such issuance.", "type": 2, "words": ["<tag1>", "approximately", "28,605,354", "shares", "of", "our", "common", "stock", "to", "former", "Callisto", "stockholders", "in", "exchange", "for", "their", "shares", "of", "Callisto", "common", "stock.", "<tag2>", "We", "entered", "into", "a", "Contribution", "Agreement", "with", "ContraVir", "(the", "Contribution", "Agreement", "),", "transferring", "the", "FV-100", "Product", "to", "ContraVir,", "in", "exchange", "for", "the", "issuance", "to", "us", "of", "9,000,000", "shares", "of", "ContraVir", "common", "stock,", "par", "value", "$0.0001", "per", "share", ",", "representing", "100%", "of", "the", "outstanding", "shares", "of", "common", "stock", "as", "of", "immediately", "following", "such", "issuance.", "<tag3>"], "wordsA": ["approximately", "28,605,354", "shares", "of", "our", "common", "stock", "to", "former", "Callisto", "stockholders", "in", "exchange", "for", "their", "shares", "of", "Callisto", "common", "stock."], "wordsB": ["We", "entered", "into", "a", "Contribution", "Agreement", "with", "ContraVir", "(the", "Contribution", "Agreement", "),", "transferring", "the", "FV-100", "Product", "to", "ContraVir,", "in", "exchange", "for", "the", "issuance", "to", "us", "of", "9,000,000", "shares", "of", "ContraVir", "common", "stock,", "par", "value", "$0.0001", "per", "share", ",", "representing", "100%", "of", "the", "outstanding", "shares", "of", "common", "stock", "as", "of", "immediately", "following", "such", "issuance."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_14_item1_p29_s3", "idA": "1347613_13_item1_p44_s0", "sentA": "approximately 28,605,354 shares of our common stock to former Callisto stockholders in exchange for their shares of Callisto common stock.", "sentB": "We believe the distribution of the ContraVir shares of common stock to our stockholders was not material to us.", "type": 2, "words": ["<tag1>", "approximately", "28,605,354", "shares", "of", "our", "common", "stock", "to", "former", "Callisto", "stockholders", "in", "exchange", "for", "their", "shares", "of", "Callisto", "common", "stock.", "<tag2>", "We", "believe", "the", "distribution", "of", "the", "ContraVir", "shares", "of", "common", "stock", "to", "our", "stockholders", "was", "not", "material", "to", "us.", "<tag3>"], "wordsA": ["approximately", "28,605,354", "shares", "of", "our", "common", "stock", "to", "former", "Callisto", "stockholders", "in", "exchange", "for", "their", "shares", "of", "Callisto", "common", "stock."], "wordsB": ["We", "believe", "the", "distribution", "of", "the", "ContraVir", "shares", "of", "common", "stock", "to", "our", "stockholders", "was", "not", "material", "to", "us."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_14_item1_p32_s5", "idA": "1347613_13_item1_p44_s0", "sentA": "approximately 28,605,354 shares of our common stock to former Callisto stockholders in exchange for their shares of Callisto common stock.", "sentB": "In connection with the consummation of the merger, we issued a total of approximately 28,605,354 shares of our common stock to former Callisto stockholders in exchange for their shares of Callisto common stock.", "type": 2, "words": ["<tag1>", "approximately", "28,605,354", "shares", "of", "our", "common", "stock", "to", "former", "Callisto", "stockholders", "in", "exchange", "for", "their", "shares", "of", "Callisto", "common", "stock.", "<tag2>", "In", "connection", "with", "the", "consummation", "of", "the", "merger,", "we", "issued", "a", "total", "of", "approximately", "28,605,354", "shares", "of", "our", "common", "stock", "to", "former", "Callisto", "stockholders", "in", "exchange", "for", "their", "shares", "of", "Callisto", "common", "stock.", "<tag3>"], "wordsA": ["approximately", "28,605,354", "shares", "of", "our", "common", "stock", "to", "former", "Callisto", "stockholders", "in", "exchange", "for", "their", "shares", "of", "Callisto", "common", "stock."], "wordsB": ["In", "connection", "with", "the", "consummation", "of", "the", "merger,", "we", "issued", "a", "total", "of", "approximately", "28,605,354", "shares", "of", "our", "common", "stock", "to", "former", "Callisto", "stockholders", "in", "exchange", "for", "their", "shares", "of", "Callisto", "common", "stock."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_14_item1_p26_s1", "idA": "1347613_13_item1_p45_s0", "sentA": "As Callisto did not have the required inputs, process or outputs, it does not meet the definition of a business under ASC 805, the merger will not be accounted for as a business combination.", "sentB": "During the period August 17, 2012 through September 30, 2013, we made no expenditures related to the research and development of FV-100, thus, we determined that the contributed asset did not meet the definition of a business, as defined in ASC 805, Business Combinations and was accounted for under ASC 350, Intangibles Goodwill and Other as a contribution of assets.", "type": 2, "words": ["<tag1>", "As", "Callisto", "did", "not", "have", "the", "required", "inputs,", "process", "or", "outputs,", "it", "does", "not", "meet", "the", "definition", "of", "a", "business", "under", "ASC", "805,", "the", "merger", "will", "not", "be", "accounted", "for", "as", "a", "business", "combination.", "<tag2>", "During", "the", "period", "August", "17,", "2012", "through", "September", "30,", "2013,", "we", "made", "no", "expenditures", "related", "to", "the", "research", "and", "development", "of", "FV-100,", "thus,", "we", "determined", "that", "the", "contributed", "asset", "did", "not", "meet", "the", "definition", "of", "a", "business,", "as", "defined", "in", "ASC", "805,", "Business", "Combinations", "and", "was", "accounted", "for", "under", "ASC", "350,", "Intangibles", "Goodwill", "and", "Other", "as", "a", "contribution", "of", "assets.", "<tag3>"], "wordsA": ["As", "Callisto", "did", "not", "have", "the", "required", "inputs,", "process", "or", "outputs,", "it", "does", "not", "meet", "the", "definition", "of", "a", "business", "under", "ASC", "805,", "the", "merger", "will", "not", "be", "accounted", "for", "as", "a", "business", "combination."], "wordsB": ["During", "the", "period", "August", "17,", "2012", "through", "September", "30,", "2013,", "we", "made", "no", "expenditures", "related", "to", "the", "research", "and", "development", "of", "FV-100,", "thus,", "we", "determined", "that", "the", "contributed", "asset", "did", "not", "meet", "the", "definition", "of", "a", "business,", "as", "defined", "in", "ASC", "805,", "Business", "Combinations", "and", "was", "accounted", "for", "under", "ASC", "350,", "Intangibles", "Goodwill", "and", "Other", "as", "a", "contribution", "of", "assets."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_14_item1_p33_s0", "idA": "1347613_13_item1_p45_s0", "sentA": "As Callisto did not have the required inputs, process or outputs, it does not meet the definition of a business under ASC 805, the merger will not be accounted for as a business combination.", "sentB": "As Callisto did not have the required inputs, process or outputs, it did not meet the definition of a business under ASC 805, thus the merger was not accounted for as a business combination.", "type": 2, "words": ["<tag1>", "As", "Callisto", "did", "not", "have", "the", "required", "inputs,", "process", "or", "outputs,", "it", "does", "not", "meet", "the", "definition", "of", "a", "business", "under", "ASC", "805,", "the", "merger", "will", "not", "be", "accounted", "for", "as", "a", "business", "combination.", "<tag2>", "As", "Callisto", "did", "not", "have", "the", "required", "inputs,", "process", "or", "outputs,", "it", "did", "not", "meet", "the", "definition", "of", "a", "business", "under", "ASC", "805,", "thus", "the", "merger", "was", "not", "accounted", "for", "as", "a", "business", "combination.", "<tag3>"], "wordsA": ["As", "Callisto", "did", "not", "have", "the", "required", "inputs,", "process", "or", "outputs,", "it", "does", "not", "meet", "the", "definition", "of", "a", "business", "under", "ASC", "805,", "the", "merger", "will", "not", "be", "accounted", "for", "as", "a", "business", "combination."], "wordsB": ["As", "Callisto", "did", "not", "have", "the", "required", "inputs,", "process", "or", "outputs,", "it", "did", "not", "meet", "the", "definition", "of", "a", "business", "under", "ASC", "805,", "thus", "the", "merger", "was", "not", "accounted", "for", "as", "a", "business", "combination."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_14_item1_p33_s1", "idA": "1347613_13_item1_p45_s1", "sentA": "The merger is expected to be accounted for as a recapitalization of us, effected through exchange of Callisto shares for our shares, and the cancellation of our shares held by Callisto.", "sentB": "The merger was accounted for as a recapitalization of us, effected through exchange of Callisto shares for our shares, and the cancellation of our shares held by Callisto.", "type": 2, "words": ["<tag1>", "The", "merger", "is", "expected", "to", "be", "accounted", "for", "as", "a", "recapitalization", "of", "us,", "effected", "through", "exchange", "of", "Callisto", "shares", "for", "our", "shares,", "and", "the", "cancellation", "of", "our", "shares", "held", "by", "Callisto.", "<tag2>", "The", "merger", "was", "accounted", "for", "as", "a", "recapitalization", "of", "us,", "effected", "through", "exchange", "of", "Callisto", "shares", "for", "our", "shares,", "and", "the", "cancellation", "of", "our", "shares", "held", "by", "Callisto.", "<tag3>"], "wordsA": ["The", "merger", "is", "expected", "to", "be", "accounted", "for", "as", "a", "recapitalization", "of", "us,", "effected", "through", "exchange", "of", "Callisto", "shares", "for", "our", "shares,", "and", "the", "cancellation", "of", "our", "shares", "held", "by", "Callisto."], "wordsB": ["The", "merger", "was", "accounted", "for", "as", "a", "recapitalization", "of", "us,", "effected", "through", "exchange", "of", "Callisto", "shares", "for", "our", "shares,", "and", "the", "cancellation", "of", "our", "shares", "held", "by", "Callisto."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_14_item1_p33_s2", "idA": "1347613_13_item1_p45_s2", "sentA": "The excess of our shares issued to Callisto shareholders over our shares held by Callisto is the result of a discount associated with the restricted nature of our shares to be received by Callisto shareholders.", "sentB": "The excess of our shares issued to Callisto shareholders over our shares held by Callisto was the result of a discount associated with the restricted nature of our shares received by Callisto shareholders.", "type": 2, "words": ["<tag1>", "The", "excess", "of", "our", "shares", "issued", "to", "Callisto", "shareholders", "over", "our", "shares", "held", "by", "Callisto", "is", "the", "result", "of", "a", "discount", "associated", "with", "the", "restricted", "nature", "of", "our", "shares", "to", "be", "received", "by", "Callisto", "shareholders.", "<tag2>", "The", "excess", "of", "our", "shares", "issued", "to", "Callisto", "shareholders", "over", "our", "shares", "held", "by", "Callisto", "was", "the", "result", "of", "a", "discount", "associated", "with", "the", "restricted", "nature", "of", "our", "shares", "received", "by", "Callisto", "shareholders.", "<tag3>"], "wordsA": ["The", "excess", "of", "our", "shares", "issued", "to", "Callisto", "shareholders", "over", "our", "shares", "held", "by", "Callisto", "is", "the", "result", "of", "a", "discount", "associated", "with", "the", "restricted", "nature", "of", "our", "shares", "to", "be", "received", "by", "Callisto", "shareholders."], "wordsB": ["The", "excess", "of", "our", "shares", "issued", "to", "Callisto", "shareholders", "over", "our", "shares", "held", "by", "Callisto", "was", "the", "result", "of", "a", "discount", "associated", "with", "the", "restricted", "nature", "of", "our", "shares", "received", "by", "Callisto", "shareholders."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_14_item1_p33_s3", "idA": "1347613_13_item1_p45_s3", "sentA": "Therefore, considering this discount, the share exchange has been determined to be equal from a fair value stand point.", "sentB": "Therefore, considering this discount, the share exchange was determined to be equal from a fair value stand point.", "type": 2, "words": ["<tag1>", "Therefore,", "considering", "this", "discount,", "the", "share", "exchange", "has", "been", "determined", "to", "be", "equal", "from", "a", "fair", "value", "stand", "point.", "<tag2>", "Therefore,", "considering", "this", "discount,", "the", "share", "exchange", "was", "determined", "to", "be", "equal", "from", "a", "fair", "value", "stand", "point.", "<tag3>"], "wordsA": ["Therefore,", "considering", "this", "discount,", "the", "share", "exchange", "has", "been", "determined", "to", "be", "equal", "from", "a", "fair", "value", "stand", "point."], "wordsB": ["Therefore,", "considering", "this", "discount,", "the", "share", "exchange", "was", "determined", "to", "be", "equal", "from", "a", "fair", "value", "stand", "point."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_14_item1_p34_s1", "idA": "1347613_13_item1_p46_s1", "sentA": "Our financial statements will not be restated retroactively to reflect the historical financial position or results of operations of Callisto.", "sentB": "In accordance with ASC 805, our financial statements were not restated retroactively to reflect the historical financial position or results of operations of Callisto.", "type": 2, "words": ["<tag1>", "Our", "financial", "statements", "will", "not", "be", "restated", "retroactively", "to", "reflect", "the", "historical", "financial", "position", "or", "results", "of", "operations", "of", "Callisto.", "<tag2>", "In", "accordance", "with", "ASC", "805,", "our", "financial", "statements", "were", "not", "restated", "retroactively", "to", "reflect", "the", "historical", "financial", "position", "or", "results", "of", "operations", "of", "Callisto.", "<tag3>"], "wordsA": ["Our", "financial", "statements", "will", "not", "be", "restated", "retroactively", "to", "reflect", "the", "historical", "financial", "position", "or", "results", "of", "operations", "of", "Callisto."], "wordsB": ["In", "accordance", "with", "ASC", "805,", "our", "financial", "statements", "were", "not", "restated", "retroactively", "to", "reflect", "the", "historical", "financial", "position", "or", "results", "of", "operations", "of", "Callisto."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_14_item1_p54_s1", "idA": "1347613_13_item1_p47_s1", "sentA": "The Federal Food, Drug, and Cosmetic Act and other federal and state statutes and regulations, govern, among other things, the research, development, testing, manufacture, storage, recordkeeping, approval, labeling, promotion and marketing, distribution, post-approval monitoring and reporting, sampling, and import and export of pharmaceutical products.", "sentB": "The Federal Food and Drug Administration, and Cosmetic Act and other federal and state statutes and regulations, govern, among other things, the research, development, testing, manufacture, storage, recordkeeping, approval, labeling, promotion and marketing, distribution, post-approval monitoring and reporting, sampling, and import and export of pharmaceutical products.", "type": 2, "words": ["<tag1>", "The", "Federal", "Food,", "Drug,", "and", "Cosmetic", "Act", "and", "other", "federal", "and", "state", "statutes", "and", "regulations,", "govern,", "among", "other", "things,", "the", "research,", "development,", "testing,", "manufacture,", "storage,", "recordkeeping,", "approval,", "labeling,", "promotion", "and", "marketing,", "distribution,", "post-approval", "monitoring", "and", "reporting,", "sampling,", "and", "import", "and", "export", "of", "pharmaceutical", "products.", "<tag2>", "The", "Federal", "Food", "and", "Drug", "Administration,", "and", "Cosmetic", "Act", "and", "other", "federal", "and", "state", "statutes", "and", "regulations,", "govern,", "among", "other", "things,", "the", "research,", "development,", "testing,", "manufacture,", "storage,", "recordkeeping,", "approval,", "labeling,", "promotion", "and", "marketing,", "distribution,", "post-approval", "monitoring", "and", "reporting,", "sampling,", "and", "import", "and", "export", "of", "pharmaceutical", "products.", "<tag3>"], "wordsA": ["The", "Federal", "Food,", "Drug,", "and", "Cosmetic", "Act", "and", "other", "federal", "and", "state", "statutes", "and", "regulations,", "govern,", "among", "other", "things,", "the", "research,", "development,", "testing,", "manufacture,", "storage,", "recordkeeping,", "approval,", "labeling,", "promotion", "and", "marketing,", "distribution,", "post-approval", "monitoring", "and", "reporting,", "sampling,", "and", "import", "and", "export", "of", "pharmaceutical", "products."], "wordsB": ["The", "Federal", "Food", "and", "Drug", "Administration,", "and", "Cosmetic", "Act", "and", "other", "federal", "and", "state", "statutes", "and", "regulations,", "govern,", "among", "other", "things,", "the", "research,", "development,", "testing,", "manufacture,", "storage,", "recordkeeping,", "approval,", "labeling,", "promotion", "and", "marketing,", "distribution,", "post-approval", "monitoring", "and", "reporting,", "sampling,", "and", "import", "and", "export", "of", "pharmaceutical", "products."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_14_item1_p9_s1", "idA": "1347613_13_item1_p50_s4", "sentA": "In such a case, we must work with the FDA to resolve any outstanding concerns before clinical trials can proceed.", "sentB": "Agreement was reached with the FDA on design, duration, size and primary and secondary efficacy endpoints for pivotal phase 3 studies.", "type": 2, "words": ["<tag1>", "In", "such", "a", "case,", "we", "must", "work", "with", "the", "FDA", "to", "resolve", "any", "outstanding", "concerns", "before", "clinical", "trials", "can", "proceed.", "<tag2>", "Agreement", "was", "reached", "with", "the", "FDA", "on", "design,", "duration,", "size", "and", "primary", "and", "secondary", "efficacy", "endpoints", "for", "pivotal", "phase", "3", "studies.", "<tag3>"], "wordsA": ["In", "such", "a", "case,", "we", "must", "work", "with", "the", "FDA", "to", "resolve", "any", "outstanding", "concerns", "before", "clinical", "trials", "can", "proceed."], "wordsB": ["Agreement", "was", "reached", "with", "the", "FDA", "on", "design,", "duration,", "size", "and", "primary", "and", "secondary", "efficacy", "endpoints", "for", "pivotal", "phase", "3", "studies."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_14_item1_p45_s1", "idA": "1347613_13_item1_p63_s2", "sentA": "The manufacturing facilities for our products must meet GMP requirements to the satisfaction of the FDA pursuant to a pre-approval inspection before we can use them to manufacture our products.", "sentB": "The FV-100 assets acquired by ContraVir from us are licensed from Cardiff pursuant to the terms of the Cardiff Agreement which ContraVir assumed from us.", "type": 2, "words": ["<tag1>", "The", "manufacturing", "facilities", "for", "our", "products", "must", "meet", "GMP", "requirements", "to", "the", "satisfaction", "of", "the", "FDA", "pursuant", "to", "a", "pre-approval", "inspection", "before", "we", "can", "use", "them", "to", "manufacture", "our", "products.", "<tag2>", "The", "FV-100", "assets", "acquired", "by", "ContraVir", "from", "us", "are", "licensed", "from", "Cardiff", "pursuant", "to", "the", "terms", "of", "the", "Cardiff", "Agreement", "which", "ContraVir", "assumed", "from", "us.", "<tag3>"], "wordsA": ["The", "manufacturing", "facilities", "for", "our", "products", "must", "meet", "GMP", "requirements", "to", "the", "satisfaction", "of", "the", "FDA", "pursuant", "to", "a", "pre-approval", "inspection", "before", "we", "can", "use", "them", "to", "manufacture", "our", "products."], "wordsB": ["The", "FV-100", "assets", "acquired", "by", "ContraVir", "from", "us", "are", "licensed", "from", "Cardiff", "pursuant", "to", "the", "terms", "of", "the", "Cardiff", "Agreement", "which", "ContraVir", "assumed", "from", "us."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_14_item1_p46_s2", "idA": "1347613_13_item1_p63_s2", "sentA": "The manufacturing facilities for our products must meet GMP requirements to the satisfaction of the FDA pursuant to a pre-approval inspection before we can use them to manufacture our products.", "sentB": "Synergy assumed the obligations under the Cardiff Agreement from BMS pursuant to the terms of the BMS Agreement.", "type": 2, "words": ["<tag1>", "The", "manufacturing", "facilities", "for", "our", "products", "must", "meet", "GMP", "requirements", "to", "the", "satisfaction", "of", "the", "FDA", "pursuant", "to", "a", "pre-approval", "inspection", "before", "we", "can", "use", "them", "to", "manufacture", "our", "products.", "<tag2>", "Synergy", "assumed", "the", "obligations", "under", "the", "Cardiff", "Agreement", "from", "BMS", "pursuant", "to", "the", "terms", "of", "the", "BMS", "Agreement.", "<tag3>"], "wordsA": ["The", "manufacturing", "facilities", "for", "our", "products", "must", "meet", "GMP", "requirements", "to", "the", "satisfaction", "of", "the", "FDA", "pursuant", "to", "a", "pre-approval", "inspection", "before", "we", "can", "use", "them", "to", "manufacture", "our", "products."], "wordsB": ["Synergy", "assumed", "the", "obligations", "under", "the", "Cardiff", "Agreement", "from", "BMS", "pursuant", "to", "the", "terms", "of", "the", "BMS", "Agreement."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_14_item1_p71_s1", "idA": "1347613_13_item1_p65_s0", "sentA": "doctors, and civil or criminal penalties.", "sentB": "Failure to comply with FDA requirements can have negative consequences, including adverse publicity, enforcement letters from the FDA, mandated corrective advertising or communications with doctors, and civil or criminal penalties.", "type": 2, "words": ["<tag1>", "doctors,", "and", "civil", "or", "criminal", "penalties.", "<tag2>", "Failure", "to", "comply", "with", "FDA", "requirements", "can", "have", "negative", "consequences,", "including", "adverse", "publicity,", "enforcement", "letters", "from", "the", "FDA,", "mandated", "corrective", "advertising", "or", "communications", "with", "doctors,", "and", "civil", "or", "criminal", "penalties.", "<tag3>"], "wordsA": ["doctors,", "and", "civil", "or", "criminal", "penalties."], "wordsB": ["Failure", "to", "comply", "with", "FDA", "requirements", "can", "have", "negative", "consequences,", "including", "adverse", "publicity,", "enforcement", "letters", "from", "the", "FDA,", "mandated", "corrective", "advertising", "or", "communications", "with", "doctors,", "and", "civil", "or", "criminal", "penalties."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_14_item1_p5_s0", "idA": "1347613_13_item1_p6_s0", "sentA": "There are a multitude of causes of constipation including other disease states and certain drug therapies (e.g., narcotics).", "sentB": "Constipation can be the by-product of other disease states, as well as due to certain drug therapies (e.g., narcotics) or anatomic anomalies.", "type": 2, "words": ["<tag1>", "There", "are", "a", "multitude", "of", "causes", "of", "constipation", "including", "other", "disease", "states", "and", "certain", "drug", "therapies", "(e.g.,", "narcotics).", "<tag2>", "Constipation", "can", "be", "the", "by-product", "of", "other", "disease", "states,", "as", "well", "as", "due", "to", "certain", "drug", "therapies", "(e.g.,", "narcotics)", "or", "anatomic", "anomalies.", "<tag3>"], "wordsA": ["There", "are", "a", "multitude", "of", "causes", "of", "constipation", "including", "other", "disease", "states", "and", "certain", "drug", "therapies", "(e.g.,", "narcotics)."], "wordsB": ["Constipation", "can", "be", "the", "by-product", "of", "other", "disease", "states,", "as", "well", "as", "due", "to", "certain", "drug", "therapies", "(e.g.,", "narcotics)", "or", "anatomic", "anomalies."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_14_item1_p5_s1", "idA": "1347613_13_item1_p6_s1", "sentA": "CIC has no identifiable causes such as these diseases or drugs or physical anomalies.", "sentB": "CIC, in contrast, has no identifiable causes.", "type": 2, "words": ["<tag1>", "CIC", "has", "no", "identifiable", "causes", "such", "as", "these", "diseases", "or", "drugs", "or", "physical", "anomalies.", "<tag2>", "CIC,", "in", "contrast,", "has", "no", "identifiable", "causes.", "<tag3>"], "wordsA": ["CIC", "has", "no", "identifiable", "causes", "such", "as", "these", "diseases", "or", "drugs", "or", "physical", "anomalies."], "wordsB": ["CIC,", "in", "contrast,", "has", "no", "identifiable", "causes."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_14_item1_p36_s0", "idA": "1347613_13_item1_p72_s1", "sentA": "Our competitors include major pharmaceutical and biotechnology companies focusing on GI such as Ironwood Pharmaceuticals, Inc., Forest Laboratories, Inc., Takeda Pharmaceuticals America, Inc., Sucampo Pharmaceuticals, Inc., Salix Pharmaceuticals, Inc. and Shire Plc.", "sentB": "Pharmaceuticals America, Inc., Sucampo Pharmaceuticals, Inc., Salix Pharmaceuticals, Inc. and Shire Plc.", "type": 2, "words": ["<tag1>", "Our", "competitors", "include", "major", "pharmaceutical", "and", "biotechnology", "companies", "focusing", "on", "GI", "such", "as", "Ironwood", "Pharmaceuticals,", "Inc.,", "Forest", "Laboratories,", "Inc.,", "Takeda", "Pharmaceuticals", "America,", "Inc.,", "Sucampo", "Pharmaceuticals,", "Inc.,", "Salix", "Pharmaceuticals,", "Inc.", "and", "Shire", "Plc.", "<tag2>", "Pharmaceuticals", "America,", "Inc.,", "Sucampo", "Pharmaceuticals,", "Inc.,", "Salix", "Pharmaceuticals,", "Inc.", "and", "Shire", "Plc.", "<tag3>"], "wordsA": ["Our", "competitors", "include", "major", "pharmaceutical", "and", "biotechnology", "companies", "focusing", "on", "GI", "such", "as", "Ironwood", "Pharmaceuticals,", "Inc.,", "Forest", "Laboratories,", "Inc.,", "Takeda", "Pharmaceuticals", "America,", "Inc.,", "Sucampo", "Pharmaceuticals,", "Inc.,", "Salix", "Pharmaceuticals,", "Inc.", "and", "Shire", "Plc."], "wordsB": ["Pharmaceuticals", "America,", "Inc.,", "Sucampo", "Pharmaceuticals,", "Inc.,", "Salix", "Pharmaceuticals,", "Inc.", "and", "Shire", "Plc."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_14_item1_p50_s0", "idA": "1347613_13_item1_p72_s1", "sentA": "Our competitors include major pharmaceutical and biotechnology companies focusing on GI such as Ironwood Pharmaceuticals, Inc., Forest Laboratories, Inc., Takeda Pharmaceuticals America, Inc., Sucampo Pharmaceuticals, Inc., Salix Pharmaceuticals, Inc. and Shire Plc.", "sentB": "The patent positions of pharmaceutical and biotechnology companies can be highly uncertain and involve complex legal and factual questions for which important legal principles remain unresolved.", "type": 2, "words": ["<tag1>", "Our", "competitors", "include", "major", "pharmaceutical", "and", "biotechnology", "companies", "focusing", "on", "GI", "such", "as", "Ironwood", "Pharmaceuticals,", "Inc.,", "Forest", "Laboratories,", "Inc.,", "Takeda", "Pharmaceuticals", "America,", "Inc.,", "Sucampo", "Pharmaceuticals,", "Inc.,", "Salix", "Pharmaceuticals,", "Inc.", "and", "Shire", "Plc.", "<tag2>", "The", "patent", "positions", "of", "pharmaceutical", "and", "biotechnology", "companies", "can", "be", "highly", "uncertain", "and", "involve", "complex", "legal", "and", "factual", "questions", "for", "which", "important", "legal", "principles", "remain", "unresolved.", "<tag3>"], "wordsA": ["Our", "competitors", "include", "major", "pharmaceutical", "and", "biotechnology", "companies", "focusing", "on", "GI", "such", "as", "Ironwood", "Pharmaceuticals,", "Inc.,", "Forest", "Laboratories,", "Inc.,", "Takeda", "Pharmaceuticals", "America,", "Inc.,", "Sucampo", "Pharmaceuticals,", "Inc.,", "Salix", "Pharmaceuticals,", "Inc.", "and", "Shire", "Plc."], "wordsB": ["The", "patent", "positions", "of", "pharmaceutical", "and", "biotechnology", "companies", "can", "be", "highly", "uncertain", "and", "involve", "complex", "legal", "and", "factual", "questions", "for", "which", "important", "legal", "principles", "remain", "unresolved."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_14_item1_p39_s1", "idA": "1347613_13_item1_p74_s1", "sentA": "Research and development expenses for the twelve months ended December 31, 2012 were approximately $29 million, as compared to approximately $13 million and $10 million for the twelve months ended December 31, 2011 and 2010, respectively.", "sentB": "Research and development expenses for the twelve months ended December 31, 2013 were approximately $50 million, as compared to approximately $29 million and $13 million for the twelve months ended December 31, 2012 and 2011, respectively.", "type": 2, "words": ["<tag1>", "Research", "and", "development", "expenses", "for", "the", "twelve", "months", "ended", "December", "31,", "2012", "were", "approximately", "$29", "million,", "as", "compared", "to", "approximately", "$13", "million", "and", "$10", "million", "for", "the", "twelve", "months", "ended", "December", "31,", "2011", "and", "2010,", "respectively.", "<tag2>", "Research", "and", "development", "expenses", "for", "the", "twelve", "months", "ended", "December", "31,", "2013", "were", "approximately", "$50", "million,", "as", "compared", "to", "approximately", "$29", "million", "and", "$13", "million", "for", "the", "twelve", "months", "ended", "December", "31,", "2012", "and", "2011,", "respectively.", "<tag3>"], "wordsA": ["Research", "and", "development", "expenses", "for", "the", "twelve", "months", "ended", "December", "31,", "2012", "were", "approximately", "$29", "million,", "as", "compared", "to", "approximately", "$13", "million", "and", "$10", "million", "for", "the", "twelve", "months", "ended", "December", "31,", "2011", "and", "2010,", "respectively."], "wordsB": ["Research", "and", "development", "expenses", "for", "the", "twelve", "months", "ended", "December", "31,", "2013", "were", "approximately", "$50", "million,", "as", "compared", "to", "approximately", "$29", "million", "and", "$13", "million", "for", "the", "twelve", "months", "ended", "December", "31,", "2012", "and", "2011,", "respectively."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_14_item1_p40_s0", "idA": "1347613_13_item1_p75_s0", "sentA": "In accordance with FASB ASC Topic 730-10-55, Research and Development, we recorded prepaid research and development costs of approximately $926,000 as of December 31, 2012, as compared to approximately $577,000 as of December 31, 2011, for nonrefundable pre-payments for production of drug substance, analytical testing services for our drug candidates, and upcoming clinical trials of plecanatide and SP-333.", "sentB": "In accordance with FASB ASC Topic 730-10-55, Research and Development, we recorded prepaid research and development costs of approximately $3.6 million as of December 31, 2013, as compared to approximately $0.9 million as of December 31, 2012, for nonrefundable pre-payments for production of drug substance, analytical testing services for our drug candidates, and upcoming clinical trials of plecanatide and SP-333.", "type": 2, "words": ["<tag1>", "In", "accordance", "with", "FASB", "ASC", "Topic", "730-10-55,", "Research", "and", "Development,", "we", "recorded", "prepaid", "research", "and", "development", "costs", "of", "approximately", "$926,000", "as", "of", "December", "31,", "2012,", "as", "compared", "to", "approximately", "$577,000", "as", "of", "December", "31,", "2011,", "for", "nonrefundable", "pre-payments", "for", "production", "of", "drug", "substance,", "analytical", "testing", "services", "for", "our", "drug", "candidates,", "and", "upcoming", "clinical", "trials", "of", "plecanatide", "and", "SP-333.", "<tag2>", "In", "accordance", "with", "FASB", "ASC", "Topic", "730-10-55,", "Research", "and", "Development,", "we", "recorded", "prepaid", "research", "and", "development", "costs", "of", "approximately", "$3.6", "million", "as", "of", "December", "31,", "2013,", "as", "compared", "to", "approximately", "$0.9", "million", "as", "of", "December", "31,", "2012,", "for", "nonrefundable", "pre-payments", "for", "production", "of", "drug", "substance,", "analytical", "testing", "services", "for", "our", "drug", "candidates,", "and", "upcoming", "clinical", "trials", "of", "plecanatide", "and", "SP-333.", "<tag3>"], "wordsA": ["In", "accordance", "with", "FASB", "ASC", "Topic", "730-10-55,", "Research", "and", "Development,", "we", "recorded", "prepaid", "research", "and", "development", "costs", "of", "approximately", "$926,000", "as", "of", "December", "31,", "2012,", "as", "compared", "to", "approximately", "$577,000", "as", "of", "December", "31,", "2011,", "for", "nonrefundable", "pre-payments", "for", "production", "of", "drug", "substance,", "analytical", "testing", "services", "for", "our", "drug", "candidates,", "and", "upcoming", "clinical", "trials", "of", "plecanatide", "and", "SP-333."], "wordsB": ["In", "accordance", "with", "FASB", "ASC", "Topic", "730-10-55,", "Research", "and", "Development,", "we", "recorded", "prepaid", "research", "and", "development", "costs", "of", "approximately", "$3.6", "million", "as", "of", "December", "31,", "2013,", "as", "compared", "to", "approximately", "$0.9", "million", "as", "of", "December", "31,", "2012,", "for", "nonrefundable", "pre-payments", "for", "production", "of", "drug", "substance,", "analytical", "testing", "services", "for", "our", "drug", "candidates,", "and", "upcoming", "clinical", "trials", "of", "plecanatide", "and", "SP-333."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_14_item1_p30_s1", "idA": "1347613_13_item1_p77_s0", "sentA": "As of December 31, 2012 we had six issued United States patents related to guanylate cyclase agonists.", "sentB": "As of December 31, 2013 there were 5,647,203 warrants outstanding with a weighted average exercise price of $5.37 per share pre-Distribution and $5.359 per share as adjusted.", "type": 2, "words": ["<tag1>", "As", "of", "December", "31,", "2012", "we", "had", "six", "issued", "United", "States", "patents", "related", "to", "guanylate", "cyclase", "agonists.", "<tag2>", "As", "of", "December", "31,", "2013", "there", "were", "5,647,203", "warrants", "outstanding", "with", "a", "weighted", "average", "exercise", "price", "of", "$5.37", "per", "share", "pre-Distribution", "and", "$5.359", "per", "share", "as", "adjusted.", "<tag3>"], "wordsA": ["As", "of", "December", "31,", "2012", "we", "had", "six", "issued", "United", "States", "patents", "related", "to", "guanylate", "cyclase", "agonists."], "wordsB": ["As", "of", "December", "31,", "2013", "there", "were", "5,647,203", "warrants", "outstanding", "with", "a", "weighted", "average", "exercise", "price", "of", "$5.37", "per", "share", "pre-Distribution", "and", "$5.359", "per", "share", "as", "adjusted."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_14_item1_p42_s0", "idA": "1347613_13_item1_p77_s0", "sentA": "As of December 31, 2012 we had six issued United States patents related to guanylate cyclase agonists.", "sentB": "As of December 31, 2013, we have eleven issued United States patents related to guanylate cyclase agonists.", "type": 2, "words": ["<tag1>", "As", "of", "December", "31,", "2012", "we", "had", "six", "issued", "United", "States", "patents", "related", "to", "guanylate", "cyclase", "agonists.", "<tag2>", "As", "of", "December", "31,", "2013,", "we", "have", "eleven", "issued", "United", "States", "patents", "related", "to", "guanylate", "cyclase", "agonists.", "<tag3>"], "wordsA": ["As", "of", "December", "31,", "2012", "we", "had", "six", "issued", "United", "States", "patents", "related", "to", "guanylate", "cyclase", "agonists."], "wordsB": ["As", "of", "December", "31,", "2013,", "we", "have", "eleven", "issued", "United", "States", "patents", "related", "to", "guanylate", "cyclase", "agonists."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_14_item1_p42_s3", "idA": "1347613_13_item1_p77_s3", "sentA": "A third patent covers the composition-of-matter of SP333 issued on February 1, 2011 and expires in 2028.", "sentB": "A third patent covers the composition-of-matter of SP-333 issued on February 1, 2011 and expires in 2028.", "type": 2, "words": ["<tag1>", "A", "third", "patent", "covers", "the", "composition-of-matter", "of", "SP333", "issued", "on", "February", "1,", "2011", "and", "expires", "in", "2028.", "<tag2>", "A", "third", "patent", "covers", "the", "composition-of-matter", "of", "SP-333", "issued", "on", "February", "1,", "2011", "and", "expires", "in", "2028.", "<tag3>"], "wordsA": ["A", "third", "patent", "covers", "the", "composition-of-matter", "of", "SP333", "issued", "on", "February", "1,", "2011", "and", "expires", "in", "2028."], "wordsB": ["A", "third", "patent", "covers", "the", "composition-of-matter", "of", "SP-333", "issued", "on", "February", "1,", "2011", "and", "expires", "in", "2028."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_14_item1_p42_s4", "idA": "1347613_13_item1_p77_s4", "sentA": "A fourth patent granted October 11, 2011 covers composition-of-matter of analogs related to plecanatide and SP333 and will expire in 2028.", "sentB": "A fourth patent granted October 11, 2011 covers composition-of-matter of analogs related to plecanatide and SP-333 and will expire in 2029.", "type": 2, "words": ["<tag1>", "A", "fourth", "patent", "granted", "October", "11,", "2011", "covers", "composition-of-matter", "of", "analogs", "related", "to", "plecanatide", "and", "SP333", "and", "will", "expire", "in", "2028.", "<tag2>", "A", "fourth", "patent", "granted", "October", "11,", "2011", "covers", "composition-of-matter", "of", "analogs", "related", "to", "plecanatide", "and", "SP-333", "and", "will", "expire", "in", "2029.", "<tag3>"], "wordsA": ["A", "fourth", "patent", "granted", "October", "11,", "2011", "covers", "composition-of-matter", "of", "analogs", "related", "to", "plecanatide", "and", "SP333", "and", "will", "expire", "in", "2028."], "wordsB": ["A", "fourth", "patent", "granted", "October", "11,", "2011", "covers", "composition-of-matter", "of", "analogs", "related", "to", "plecanatide", "and", "SP-333", "and", "will", "expire", "in", "2029."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_14_item1_p42_s6", "idA": "1347613_13_item1_p77_s6", "sentA": "A sixth patent granted June 26, 2012 covers additional compositions-of-matter related to plecanatide and SP333 and will expire in 2029.", "sentB": "A sixth patent granted June 26, 2012 covers additional composition-of-matter related to plecanatide and SP-333 and will expire in 2029.", "type": 2, "words": ["<tag1>", "A", "sixth", "patent", "granted", "June", "26,", "2012", "covers", "additional", "compositions-of-matter", "related", "to", "plecanatide", "and", "SP333", "and", "will", "expire", "in", "2029.", "<tag2>", "A", "sixth", "patent", "granted", "June", "26,", "2012", "covers", "additional", "composition-of-matter", "related", "to", "plecanatide", "and", "SP-333", "and", "will", "expire", "in", "2029.", "<tag3>"], "wordsA": ["A", "sixth", "patent", "granted", "June", "26,", "2012", "covers", "additional", "compositions-of-matter", "related", "to", "plecanatide", "and", "SP333", "and", "will", "expire", "in", "2029."], "wordsB": ["A", "sixth", "patent", "granted", "June", "26,", "2012", "covers", "additional", "composition-of-matter", "related", "to", "plecanatide", "and", "SP-333", "and", "will", "expire", "in", "2029."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_14_item1_p42_s7", "idA": "1347613_13_item1_p77_s6", "sentA": "A sixth patent granted June 26, 2012 covers additional compositions-of-matter related to plecanatide and SP333 and will expire in 2029.", "sentB": "A seventh patent granted on January 22, 2013 convers another composition-of-matter related to analogs of plecanatide and will expire in 2029.", "type": 2, "words": ["<tag1>", "A", "sixth", "patent", "granted", "June", "26,", "2012", "covers", "additional", "compositions-of-matter", "related", "to", "plecanatide", "and", "SP333", "and", "will", "expire", "in", "2029.", "<tag2>", "A", "seventh", "patent", "granted", "on", "January", "22,", "2013", "convers", "another", "composition-of-matter", "related", "to", "analogs", "of", "plecanatide", "and", "will", "expire", "in", "2029.", "<tag3>"], "wordsA": ["A", "sixth", "patent", "granted", "June", "26,", "2012", "covers", "additional", "compositions-of-matter", "related", "to", "plecanatide", "and", "SP333", "and", "will", "expire", "in", "2029."], "wordsB": ["A", "seventh", "patent", "granted", "on", "January", "22,", "2013", "convers", "another", "composition-of-matter", "related", "to", "analogs", "of", "plecanatide", "and", "will", "expire", "in", "2029."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_14_item1_p42_s8", "idA": "1347613_13_item1_p77_s6", "sentA": "A sixth patent granted June 26, 2012 covers additional compositions-of-matter related to plecanatide and SP333 and will expire in 2029.", "sentB": "An eighth patent granted on July 30, 2013 convers another composition-of-matter related to analogs of plecanatide and will expire in 2029.", "type": 2, "words": ["<tag1>", "A", "sixth", "patent", "granted", "June", "26,", "2012", "covers", "additional", "compositions-of-matter", "related", "to", "plecanatide", "and", "SP333", "and", "will", "expire", "in", "2029.", "<tag2>", "An", "eighth", "patent", "granted", "on", "July", "30,", "2013", "convers", "another", "composition-of-matter", "related", "to", "analogs", "of", "plecanatide", "and", "will", "expire", "in", "2029.", "<tag3>"], "wordsA": ["A", "sixth", "patent", "granted", "June", "26,", "2012", "covers", "additional", "compositions-of-matter", "related", "to", "plecanatide", "and", "SP333", "and", "will", "expire", "in", "2029."], "wordsB": ["An", "eighth", "patent", "granted", "on", "July", "30,", "2013", "convers", "another", "composition-of-matter", "related", "to", "analogs", "of", "plecanatide", "and", "will", "expire", "in", "2029."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_14_item1_p42_s11", "idA": "1347613_13_item1_p78_s1", "sentA": "These foreign patents cover Austria, Belgium, Switzerland, Cyprus, Germany, Denmark, Spain, Finland, France, United Kingdom, Greece, Ireland, Italy, Liechtenstein, Luxembourg, Monaco, Netherlands, Portugal, Sweden, Turkey, Armenia, Azerbaijan, Belarus, Kazakhstan, Kyrgyz Republic, Moldova, Russian Federation, Tajikistan, Turkmenistan, Canada and Japan..", "sentB": "These foreign patents cover Austria, Belgium, Switzerland, Cyprus, Germany, Denmark, Spain, Finland, France, United Kingdom, Greece, Ireland, Italy, Liechtenstein, Luxembourg, Monaco, Netherlands, Portugal, Sweden, Turkey, Armenia, Azerbaijan, Belarus, Kazakhstan, Kyrgyz Republic, Moldova, Russian Federation, Tajikistan, Turkmenistan, Canada and Japan.", "type": 2, "words": ["<tag1>", "These", "foreign", "patents", "cover", "Austria,", "Belgium,", "Switzerland,", "Cyprus,", "Germany,", "Denmark,", "Spain,", "Finland,", "France,", "United", "Kingdom,", "Greece,", "Ireland,", "Italy,", "Liechtenstein,", "Luxembourg,", "Monaco,", "Netherlands,", "Portugal,", "Sweden,", "Turkey,", "Armenia,", "Azerbaijan,", "Belarus,", "Kazakhstan,", "Kyrgyz", "Republic,", "Moldova,", "Russian", "Federation,", "Tajikistan,", "Turkmenistan,", "Canada", "and", "Japan..", "<tag2>", "These", "foreign", "patents", "cover", "Austria,", "Belgium,", "Switzerland,", "Cyprus,", "Germany,", "Denmark,", "Spain,", "Finland,", "France,", "United", "Kingdom,", "Greece,", "Ireland,", "Italy,", "Liechtenstein,", "Luxembourg,", "Monaco,", "Netherlands,", "Portugal,", "Sweden,", "Turkey,", "Armenia,", "Azerbaijan,", "Belarus,", "Kazakhstan,", "Kyrgyz", "Republic,", "Moldova,", "Russian", "Federation,", "Tajikistan,", "Turkmenistan,", "Canada", "and", "Japan.", "<tag3>"], "wordsA": ["These", "foreign", "patents", "cover", "Austria,", "Belgium,", "Switzerland,", "Cyprus,", "Germany,", "Denmark,", "Spain,", "Finland,", "France,", "United", "Kingdom,", "Greece,", "Ireland,", "Italy,", "Liechtenstein,", "Luxembourg,", "Monaco,", "Netherlands,", "Portugal,", "Sweden,", "Turkey,", "Armenia,", "Azerbaijan,", "Belarus,", "Kazakhstan,", "Kyrgyz", "Republic,", "Moldova,", "Russian", "Federation,", "Tajikistan,", "Turkmenistan,", "Canada", "and", "Japan.."], "wordsB": ["These", "foreign", "patents", "cover", "Austria,", "Belgium,", "Switzerland,", "Cyprus,", "Germany,", "Denmark,", "Spain,", "Finland,", "France,", "United", "Kingdom,", "Greece,", "Ireland,", "Italy,", "Liechtenstein,", "Luxembourg,", "Monaco,", "Netherlands,", "Portugal,", "Sweden,", "Turkey,", "Armenia,", "Azerbaijan,", "Belarus,", "Kazakhstan,", "Kyrgyz", "Republic,", "Moldova,", "Russian", "Federation,", "Tajikistan,", "Turkmenistan,", "Canada", "and", "Japan."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_14_item1_p42_s12", "idA": "1347613_13_item1_p78_s2", "sentA": "We also have a granted foreign patent that covers composition of matter related to SP333 that expires in 2028.", "sentB": "We also have two granted foreign patents that cover composition of matter related to SP-333 that expire in 2028.", "type": 2, "words": ["<tag1>", "We", "also", "have", "a", "granted", "foreign", "patent", "that", "covers", "composition", "of", "matter", "related", "to", "SP333", "that", "expires", "in", "2028.", "<tag2>", "We", "also", "have", "two", "granted", "foreign", "patents", "that", "cover", "composition", "of", "matter", "related", "to", "SP-333", "that", "expire", "in", "2028.", "<tag3>"], "wordsA": ["We", "also", "have", "a", "granted", "foreign", "patent", "that", "covers", "composition", "of", "matter", "related", "to", "SP333", "that", "expires", "in", "2028."], "wordsB": ["We", "also", "have", "two", "granted", "foreign", "patents", "that", "cover", "composition", "of", "matter", "related", "to", "SP-333", "that", "expire", "in", "2028."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_14_item1_p42_s13", "idA": "1347613_13_item1_p78_s3", "sentA": "This patent covers Switzerland, Germany, Denmark, Spain, France, United Kingdom, Ireland, Italy, and Netherlands.", "sentB": "These patents cover Switzerland, Germany, Denmark, Spain, France, United Kingdom, Ireland, Italy, Netherlands, Hong Kong, and China.", "type": 2, "words": ["<tag1>", "This", "patent", "covers", "Switzerland,", "Germany,", "Denmark,", "Spain,", "France,", "United", "Kingdom,", "Ireland,", "Italy,", "and", "Netherlands.", "<tag2>", "These", "patents", "cover", "Switzerland,", "Germany,", "Denmark,", "Spain,", "France,", "United", "Kingdom,", "Ireland,", "Italy,", "Netherlands,", "Hong", "Kong,", "and", "China.", "<tag3>"], "wordsA": ["This", "patent", "covers", "Switzerland,", "Germany,", "Denmark,", "Spain,", "France,", "United", "Kingdom,", "Ireland,", "Italy,", "and", "Netherlands."], "wordsB": ["These", "patents", "cover", "Switzerland,", "Germany,", "Denmark,", "Spain,", "France,", "United", "Kingdom,", "Ireland,", "Italy,", "Netherlands,", "Hong", "Kong,", "and", "China."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_14_item1_p43_s0", "idA": "1347613_13_item1_p79_s0", "sentA": "Additionally as of December 31, 2012, we had 11 pending United States patent applications and 47 pending foreign patent applications covering plecanatide and SP-333 and various derivatives and analogs.", "sentB": "Additionally, as of December 31, 2013, we have 12 pending United States utility patent applications; 9 pending U.S. provisional applications; and 59 pending foreign patent applications covering plecanatide and SP-333, various derivatives and analogs of plecanatide and SP-333, and their uses and manufacture.", "type": 2, "words": ["<tag1>", "Additionally", "as", "of", "December", "31,", "2012,", "we", "had", "11", "pending", "United", "States", "patent", "applications", "and", "47", "pending", "foreign", "patent", "applications", "covering", "plecanatide", "and", "SP-333", "and", "various", "derivatives", "and", "analogs.", "<tag2>", "Additionally,", "as", "of", "December", "31,", "2013,", "we", "have", "12", "pending", "United", "States", "utility", "patent", "applications;", "9", "pending", "U.S.", "provisional", "applications;", "and", "59", "pending", "foreign", "patent", "applications", "covering", "plecanatide", "and", "SP-333,", "various", "derivatives", "and", "analogs", "of", "plecanatide", "and", "SP-333,", "and", "their", "uses", "and", "manufacture.", "<tag3>"], "wordsA": ["Additionally", "as", "of", "December", "31,", "2012,", "we", "had", "11", "pending", "United", "States", "patent", "applications", "and", "47", "pending", "foreign", "patent", "applications", "covering", "plecanatide", "and", "SP-333", "and", "various", "derivatives", "and", "analogs."], "wordsB": ["Additionally,", "as", "of", "December", "31,", "2013,", "we", "have", "12", "pending", "United", "States", "utility", "patent", "applications;", "9", "pending", "U.S.", "provisional", "applications;", "and", "59", "pending", "foreign", "patent", "applications", "covering", "plecanatide", "and", "SP-333,", "various", "derivatives", "and", "analogs", "of", "plecanatide", "and", "SP-333,", "and", "their", "uses", "and", "manufacture."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_14_item1_p23_s2", "idA": "1347613_13_item1_p7_s0", "sentA": "Patients with CIC have had symptoms for 6 months or more and commonly have less than 3 bowel movements a week and often less than one.", "sentB": "The study plans to enroll approximately 260 patients with OIC who have less than 3 spontaneous bowel movements (SBMs) per week and who experience constipation-related symptoms.", "type": 2, "words": ["<tag1>", "Patients", "with", "CIC", "have", "had", "symptoms", "for", "6", "months", "or", "more", "and", "commonly", "have", "less", "than", "3", "bowel", "movements", "a", "week", "and", "often", "less", "than", "one.", "<tag2>", "The", "study", "plans", "to", "enroll", "approximately", "260", "patients", "with", "OIC", "who", "have", "less", "than", "3", "spontaneous", "bowel", "movements", "(SBMs)", "per", "week", "and", "who", "experience", "constipation-related", "symptoms.", "<tag3>"], "wordsA": ["Patients", "with", "CIC", "have", "had", "symptoms", "for", "6", "months", "or", "more", "and", "commonly", "have", "less", "than", "3", "bowel", "movements", "a", "week", "and", "often", "less", "than", "one."], "wordsB": ["The", "study", "plans", "to", "enroll", "approximately", "260", "patients", "with", "OIC", "who", "have", "less", "than", "3", "spontaneous", "bowel", "movements", "(SBMs)", "per", "week", "and", "who", "experience", "constipation-related", "symptoms."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_14_item1_p6_s0", "idA": "1347613_13_item1_p7_s0", "sentA": "Patients with CIC have had symptoms for 6 months or more and commonly have less than 3 bowel movements a week and often less than one.", "sentB": "Patients diagnosed with CIC have had symptoms for 6 months or more, and commonly have less than 3 bowel movements a week and often less than one.", "type": 2, "words": ["<tag1>", "Patients", "with", "CIC", "have", "had", "symptoms", "for", "6", "months", "or", "more", "and", "commonly", "have", "less", "than", "3", "bowel", "movements", "a", "week", "and", "often", "less", "than", "one.", "<tag2>", "Patients", "diagnosed", "with", "CIC", "have", "had", "symptoms", "for", "6", "months", "or", "more,", "and", "commonly", "have", "less", "than", "3", "bowel", "movements", "a", "week", "and", "often", "less", "than", "one.", "<tag3>"], "wordsA": ["Patients", "with", "CIC", "have", "had", "symptoms", "for", "6", "months", "or", "more", "and", "commonly", "have", "less", "than", "3", "bowel", "movements", "a", "week", "and", "often", "less", "than", "one."], "wordsB": ["Patients", "diagnosed", "with", "CIC", "have", "had", "symptoms", "for", "6", "months", "or", "more,", "and", "commonly", "have", "less", "than", "3", "bowel", "movements", "a", "week", "and", "often", "less", "than", "one."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_14_item1_p7_s0", "idA": "1347613_13_item1_p7_s2", "sentA": "Over-the counter medications offer only short term relief and are not indicated for chronic treatment.", "sentB": "Over-the-counter medications offer only short-term relief and are not indicated for chronic treatment.", "type": 2, "words": ["<tag1>", "Over-the", "counter", "medications", "offer", "only", "short", "term", "relief", "and", "are", "not", "indicated", "for", "chronic", "treatment.", "<tag2>", "Over-the-counter", "medications", "offer", "only", "short-term", "relief", "and", "are", "not", "indicated", "for", "chronic", "treatment.", "<tag3>"], "wordsA": ["Over-the", "counter", "medications", "offer", "only", "short", "term", "relief", "and", "are", "not", "indicated", "for", "chronic", "treatment."], "wordsB": ["Over-the-counter", "medications", "offer", "only", "short-term", "relief", "and", "are", "not", "indicated", "for", "chronic", "treatment."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_14_item1_p29_s0", "idA": "1347613_13_item1_p80_s0", "sentA": "In April 2010, two parties filed an opposition to our granted patent with the European Patent Office.", "sentB": "On August 8, 2013, ContraVir Pharmaceuticals, Inc. filed an initial Form 10 Registration Statement with the U.S. Securities and Exchange Commission.", "type": 2, "words": ["<tag1>", "In", "April", "2010,", "two", "parties", "filed", "an", "opposition", "to", "our", "granted", "patent", "with", "the", "European", "Patent", "Office.", "<tag2>", "On", "August", "8,", "2013,", "ContraVir", "Pharmaceuticals,", "Inc.", "filed", "an", "initial", "Form", "10", "Registration", "Statement", "with", "the", "U.S.", "Securities", "and", "Exchange", "Commission.", "<tag3>"], "wordsA": ["In", "April", "2010,", "two", "parties", "filed", "an", "opposition", "to", "our", "granted", "patent", "with", "the", "European", "Patent", "Office."], "wordsB": ["On", "August", "8,", "2013,", "ContraVir", "Pharmaceuticals,", "Inc.", "filed", "an", "initial", "Form", "10", "Registration", "Statement", "with", "the", "U.S.", "Securities", "and", "Exchange", "Commission."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_14_item1_p48_s0", "idA": "1347613_13_item1_p81_s0", "sentA": "As of March 15, 2013 we had three issued United States patents related to FV-100.", "sentB": "As of March 16, 2014, ContraVir currently licenses from Cardiff the four issued United States patents related to FV-100 which ContraVir acquired from us pursuant to the Contribution Agreement.", "type": 2, "words": ["<tag1>", "As", "of", "March", "15,", "2013", "we", "had", "three", "issued", "United", "States", "patents", "related", "to", "FV-100.", "<tag2>", "As", "of", "March", "16,", "2014,", "ContraVir", "currently", "licenses", "from", "Cardiff", "the", "four", "issued", "United", "States", "patents", "related", "to", "FV-100", "which", "ContraVir", "acquired", "from", "us", "pursuant", "to", "the", "Contribution", "Agreement.", "<tag3>"], "wordsA": ["As", "of", "March", "15,", "2013", "we", "had", "three", "issued", "United", "States", "patents", "related", "to", "FV-100."], "wordsB": ["As", "of", "March", "16,", "2014,", "ContraVir", "currently", "licenses", "from", "Cardiff", "the", "four", "issued", "United", "States", "patents", "related", "to", "FV-100", "which", "ContraVir", "acquired", "from", "us", "pursuant", "to", "the", "Contribution", "Agreement."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_14_item1_p42_s9", "idA": "1347613_13_item1_p81_s2", "sentA": "The other two cover the precursor and close analogs of FV-100 and were issued on November 8, 2001 and June 3, 2003 and will both expire in 2018.", "sentB": "Another two patents that also cover composition-of-matter related to analogs of plecanatide were issued on February 5, 2013 and October 29, 2013; and will both expire in 2029.", "type": 2, "words": ["<tag1>", "The", "other", "two", "cover", "the", "precursor", "and", "close", "analogs", "of", "FV-100", "and", "were", "issued", "on", "November", "8,", "2001", "and", "June", "3,", "2003", "and", "will", "both", "expire", "in", "2018.", "<tag2>", "Another", "two", "patents", "that", "also", "cover", "composition-of-matter", "related", "to", "analogs", "of", "plecanatide", "were", "issued", "on", "February", "5,", "2013", "and", "October", "29,", "2013;", "and", "will", "both", "expire", "in", "2029.", "<tag3>"], "wordsA": ["The", "other", "two", "cover", "the", "precursor", "and", "close", "analogs", "of", "FV-100", "and", "were", "issued", "on", "November", "8,", "2001", "and", "June", "3,", "2003", "and", "will", "both", "expire", "in", "2018."], "wordsB": ["Another", "two", "patents", "that", "also", "cover", "composition-of-matter", "related", "to", "analogs", "of", "plecanatide", "were", "issued", "on", "February", "5,", "2013", "and", "October", "29,", "2013;", "and", "will", "both", "expire", "in", "2029."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_14_item1_p48_s2", "idA": "1347613_13_item1_p81_s2", "sentA": "The other two cover the precursor and close analogs of FV-100 and were issued on November 8, 2001 and June 3, 2003 and will both expire in 2018.", "sentB": "The other three cover the precursor and close analogs of FV-100 and were issued on June 3, 2002, October 26, 2010 and October 8, 2013 and will expire in 2018, 2021 and 2021, respectively.", "type": 2, "words": ["<tag1>", "The", "other", "two", "cover", "the", "precursor", "and", "close", "analogs", "of", "FV-100", "and", "were", "issued", "on", "November", "8,", "2001", "and", "June", "3,", "2003", "and", "will", "both", "expire", "in", "2018.", "<tag2>", "The", "other", "three", "cover", "the", "precursor", "and", "close", "analogs", "of", "FV-100", "and", "were", "issued", "on", "June", "3,", "2002,", "October", "26,", "2010", "and", "October", "8,", "2013", "and", "will", "expire", "in", "2018,", "2021", "and", "2021,", "respectively.", "<tag3>"], "wordsA": ["The", "other", "two", "cover", "the", "precursor", "and", "close", "analogs", "of", "FV-100", "and", "were", "issued", "on", "November", "8,", "2001", "and", "June", "3,", "2003", "and", "will", "both", "expire", "in", "2018."], "wordsB": ["The", "other", "three", "cover", "the", "precursor", "and", "close", "analogs", "of", "FV-100", "and", "were", "issued", "on", "June", "3,", "2002,", "October", "26,", "2010", "and", "October", "8,", "2013", "and", "will", "expire", "in", "2018,", "2021", "and", "2021,", "respectively."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_14_item1_p48_s3", "idA": "1347613_13_item1_p81_s3", "sentA": "In addition we have 37 granted foreign patents which cover composition-of-matter of FV-100 and expire in 2027.", "sentB": "In addition, as of March 16, 2014, ContraVir also licenses from Cardiff the 38 granted foreign patents which cover composition-of-matter of FV-100 and expire in 2027.", "type": 2, "words": ["<tag1>", "In", "addition", "we", "have", "37", "granted", "foreign", "patents", "which", "cover", "composition-of-matter", "of", "FV-100", "and", "expire", "in", "2027.", "<tag2>", "In", "addition,", "as", "of", "March", "16,", "2014,", "ContraVir", "also", "licenses", "from", "Cardiff", "the", "38", "granted", "foreign", "patents", "which", "cover", "composition-of-matter", "of", "FV-100", "and", "expire", "in", "2027.", "<tag3>"], "wordsA": ["In", "addition", "we", "have", "37", "granted", "foreign", "patents", "which", "cover", "composition-of-matter", "of", "FV-100", "and", "expire", "in", "2027."], "wordsB": ["In", "addition,", "as", "of", "March", "16,", "2014,", "ContraVir", "also", "licenses", "from", "Cardiff", "the", "38", "granted", "foreign", "patents", "which", "cover", "composition-of-matter", "of", "FV-100", "and", "expire", "in", "2027."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_14_item1_p48_s4", "idA": "1347613_13_item1_p81_s4", "sentA": "These foreign patents cover Australia, Austria, Belgium, Brazil, Bulgaria, Canada, China, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, India, Ireland, Israel, Italy, Japan, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Monaco, Netherlands, New Zealand, Pakistan, Poland, Portugal, Romania, Slovakia, Slovenia, South Korea, Spain, Sweden, Switzerland, Taiwan, Turkey, United Kingdom and the Russian Federation.", "sentB": "These foreign patents cover Australia, Austria, Belgium, Bulgaria, China, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Japan, Latvia, Lithuania, Luxembourg, Malta, Monaco, Netherlands, New Zealand, Pakistan, Poland, Portugal, Romania, Slovakia, Slovenia, Spain, Sweden, Switzerland, Taiwan, Turkey, United Kingdom and the Russian Federation.", "type": 2, "words": ["<tag1>", "These", "foreign", "patents", "cover", "Australia,", "Austria,", "Belgium,", "Brazil,", "Bulgaria,", "Canada,", "China,", "Cyprus,", "Czech", "Republic,", "Denmark,", "Estonia,", "Finland,", "France,", "Germany,", "Greece,", "Hungary,", "Iceland,", "India,", "Ireland,", "Israel,", "Italy,", "Japan,", "Latvia,", "Liechtenstein,", "Lithuania,", "Luxembourg,", "Malta,", "Monaco,", "Netherlands,", "New", "Zealand,", "Pakistan,", "Poland,", "Portugal,", "Romania,", "Slovakia,", "Slovenia,", "South", "Korea,", "Spain,", "Sweden,", "Switzerland,", "Taiwan,", "Turkey,", "United", "Kingdom", "and", "the", "Russian", "Federation.", "<tag2>", "These", "foreign", "patents", "cover", "Australia,", "Austria,", "Belgium,", "Bulgaria,", "China,", "Cyprus,", "Czech", "Republic,", "Denmark,", "Estonia,", "Finland,", "France,", "Germany,", "Greece,", "Hungary,", "Iceland,", "Ireland,", "Italy,", "Japan,", "Latvia,", "Lithuania,", "Luxembourg,", "Malta,", "Monaco,", "Netherlands,", "New", "Zealand,", "Pakistan,", "Poland,", "Portugal,", "Romania,", "Slovakia,", "Slovenia,", "Spain,", "Sweden,", "Switzerland,", "Taiwan,", "Turkey,", "United", "Kingdom", "and", "the", "Russian", "Federation.", "<tag3>"], "wordsA": ["These", "foreign", "patents", "cover", "Australia,", "Austria,", "Belgium,", "Brazil,", "Bulgaria,", "Canada,", "China,", "Cyprus,", "Czech", "Republic,", "Denmark,", "Estonia,", "Finland,", "France,", "Germany,", "Greece,", "Hungary,", "Iceland,", "India,", "Ireland,", "Israel,", "Italy,", "Japan,", "Latvia,", "Liechtenstein,", "Lithuania,", "Luxembourg,", "Malta,", "Monaco,", "Netherlands,", "New", "Zealand,", "Pakistan,", "Poland,", "Portugal,", "Romania,", "Slovakia,", "Slovenia,", "South", "Korea,", "Spain,", "Sweden,", "Switzerland,", "Taiwan,", "Turkey,", "United", "Kingdom", "and", "the", "Russian", "Federation."], "wordsB": ["These", "foreign", "patents", "cover", "Australia,", "Austria,", "Belgium,", "Bulgaria,", "China,", "Cyprus,", "Czech", "Republic,", "Denmark,", "Estonia,", "Finland,", "France,", "Germany,", "Greece,", "Hungary,", "Iceland,", "Ireland,", "Italy,", "Japan,", "Latvia,", "Lithuania,", "Luxembourg,", "Malta,", "Monaco,", "Netherlands,", "New", "Zealand,", "Pakistan,", "Poland,", "Portugal,", "Romania,", "Slovakia,", "Slovenia,", "Spain,", "Sweden,", "Switzerland,", "Taiwan,", "Turkey,", "United", "Kingdom", "and", "the", "Russian", "Federation."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_14_item1_p48_s5", "idA": "1347613_13_item1_p81_s5", "sentA": "We also have 44 additional foreign patents that cover the precursor and close analogs of FV-100 and there are also 2 FV-100 foreign patents pending.", "sentB": "ContraVir also licenses from Cardiff the 5 pending foreign applications which cover the composition of matter of FV-100 as well as the 45 additional foreign patents covering the precursor and close analogs of FV-100.", "type": 2, "words": ["<tag1>", "We", "also", "have", "44", "additional", "foreign", "patents", "that", "cover", "the", "precursor", "and", "close", "analogs", "of", "FV-100", "and", "there", "are", "also", "2", "FV-100", "foreign", "patents", "pending.", "<tag2>", "ContraVir", "also", "licenses", "from", "Cardiff", "the", "5", "pending", "foreign", "applications", "which", "cover", "the", "composition", "of", "matter", "of", "FV-100", "as", "well", "as", "the", "45", "additional", "foreign", "patents", "covering", "the", "precursor", "and", "close", "analogs", "of", "FV-100.", "<tag3>"], "wordsA": ["We", "also", "have", "44", "additional", "foreign", "patents", "that", "cover", "the", "precursor", "and", "close", "analogs", "of", "FV-100", "and", "there", "are", "also", "2", "FV-100", "foreign", "patents", "pending."], "wordsB": ["ContraVir", "also", "licenses", "from", "Cardiff", "the", "5", "pending", "foreign", "applications", "which", "cover", "the", "composition", "of", "matter", "of", "FV-100", "as", "well", "as", "the", "45", "additional", "foreign", "patents", "covering", "the", "precursor", "and", "close", "analogs", "of", "FV-100."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_14_item1_p27_s0", "idA": "1347613_13_item1_p82_s0", "sentA": "On September 14, 2012, we entered into a binding LOI with Ironwood pursuant to which we and Ironwood agreed to enter into a definitive license agreement giving us an exclusive worldwide license to Ironwood s method of use patents on plecanatide for the treatment of CC and IBS-C.", "sentB": "On June 5, 2013, we entered into a Loan and Security Agreement, or Loan Agreement, with ContraVir pursuant to which we agreed to lend ContraVir up to five hundred thousand dollars ($500,000) for working capital purposes.", "type": 2, "words": ["<tag1>", "On", "September", "14,", "2012,", "we", "entered", "into", "a", "binding", "LOI", "with", "Ironwood", "pursuant", "to", "which", "we", "and", "Ironwood", "agreed", "to", "enter", "into", "a", "definitive", "license", "agreement", "giving", "us", "an", "exclusive", "worldwide", "license", "to", "Ironwood", "s", "method", "of", "use", "patents", "on", "plecanatide", "for", "the", "treatment", "of", "CC", "and", "IBS-C.", "<tag2>", "On", "June", "5,", "2013,", "we", "entered", "into", "a", "Loan", "and", "Security", "Agreement,", "or", "Loan", "Agreement,", "with", "ContraVir", "pursuant", "to", "which", "we", "agreed", "to", "lend", "ContraVir", "up", "to", "five", "hundred", "thousand", "dollars", "($500,000)", "for", "working", "capital", "purposes.", "<tag3>"], "wordsA": ["On", "September", "14,", "2012,", "we", "entered", "into", "a", "binding", "LOI", "with", "Ironwood", "pursuant", "to", "which", "we", "and", "Ironwood", "agreed", "to", "enter", "into", "a", "definitive", "license", "agreement", "giving", "us", "an", "exclusive", "worldwide", "license", "to", "Ironwood", "s", "method", "of", "use", "patents", "on", "plecanatide", "for", "the", "treatment", "of", "CC", "and", "IBS-C."], "wordsB": ["On", "June", "5,", "2013,", "we", "entered", "into", "a", "Loan", "and", "Security", "Agreement,", "or", "Loan", "Agreement,", "with", "ContraVir", "pursuant", "to", "which", "we", "agreed", "to", "lend", "ContraVir", "up", "to", "five", "hundred", "thousand", "dollars", "($500,000)", "for", "working", "capital", "purposes."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_14_item1_p44_s0", "idA": "1347613_13_item1_p82_s0", "sentA": "On September 14, 2012, we entered into a binding LOI with Ironwood pursuant to which we and Ironwood agreed to enter into a definitive license agreement giving us an exclusive worldwide license to Ironwood s method of use patents on plecanatide for the treatment of CC and IBS-C.", "sentB": "On September 14, 2012 we entered into a binding LOI with Ironwood pursuant to which we and Ironwood agreed to enter into a definitive license agreement giving us an exclusive worldwide license to Ironwood s method of use patents on plecanatide for the treatment of CC.", "type": 2, "words": ["<tag1>", "On", "September", "14,", "2012,", "we", "entered", "into", "a", "binding", "LOI", "with", "Ironwood", "pursuant", "to", "which", "we", "and", "Ironwood", "agreed", "to", "enter", "into", "a", "definitive", "license", "agreement", "giving", "us", "an", "exclusive", "worldwide", "license", "to", "Ironwood", "s", "method", "of", "use", "patents", "on", "plecanatide", "for", "the", "treatment", "of", "CC", "and", "IBS-C.", "<tag2>", "On", "September", "14,", "2012", "we", "entered", "into", "a", "binding", "LOI", "with", "Ironwood", "pursuant", "to", "which", "we", "and", "Ironwood", "agreed", "to", "enter", "into", "a", "definitive", "license", "agreement", "giving", "us", "an", "exclusive", "worldwide", "license", "to", "Ironwood", "s", "method", "of", "use", "patents", "on", "plecanatide", "for", "the", "treatment", "of", "CC.", "<tag3>"], "wordsA": ["On", "September", "14,", "2012,", "we", "entered", "into", "a", "binding", "LOI", "with", "Ironwood", "pursuant", "to", "which", "we", "and", "Ironwood", "agreed", "to", "enter", "into", "a", "definitive", "license", "agreement", "giving", "us", "an", "exclusive", "worldwide", "license", "to", "Ironwood", "s", "method", "of", "use", "patents", "on", "plecanatide", "for", "the", "treatment", "of", "CC", "and", "IBS-C."], "wordsB": ["On", "September", "14,", "2012", "we", "entered", "into", "a", "binding", "LOI", "with", "Ironwood", "pursuant", "to", "which", "we", "and", "Ironwood", "agreed", "to", "enter", "into", "a", "definitive", "license", "agreement", "giving", "us", "an", "exclusive", "worldwide", "license", "to", "Ironwood", "s", "method", "of", "use", "patents", "on", "plecanatide", "for", "the", "treatment", "of", "CC."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_14_item1_p44_s1", "idA": "1347613_13_item1_p82_s1", "sentA": "The LOI contemplates a low single digit royalty on net sales of plecanatide and both parties agreed not to challenge each other s patents covering certain GC-C agonists, with the exception that we retain the right to challenge Ironwood s method of use patent on plecanatide.", "sentB": "The LOI contemplates a low single digit royalty on net sales of plecanatide and both parties agreed not to challenge each other s patents covering certain GC-C agonists, except that we retain the right to challenge Ironwood s method of use patents on plecanatide.", "type": 2, "words": ["<tag1>", "The", "LOI", "contemplates", "a", "low", "single", "digit", "royalty", "on", "net", "sales", "of", "plecanatide", "and", "both", "parties", "agreed", "not", "to", "challenge", "each", "other", "s", "patents", "covering", "certain", "GC-C", "agonists,", "with", "the", "exception", "that", "we", "retain", "the", "right", "to", "challenge", "Ironwood", "s", "method", "of", "use", "patent", "on", "plecanatide.", "<tag2>", "The", "LOI", "contemplates", "a", "low", "single", "digit", "royalty", "on", "net", "sales", "of", "plecanatide", "and", "both", "parties", "agreed", "not", "to", "challenge", "each", "other", "s", "patents", "covering", "certain", "GC-C", "agonists,", "except", "that", "we", "retain", "the", "right", "to", "challenge", "Ironwood", "s", "method", "of", "use", "patents", "on", "plecanatide.", "<tag3>"], "wordsA": ["The", "LOI", "contemplates", "a", "low", "single", "digit", "royalty", "on", "net", "sales", "of", "plecanatide", "and", "both", "parties", "agreed", "not", "to", "challenge", "each", "other", "s", "patents", "covering", "certain", "GC-C", "agonists,", "with", "the", "exception", "that", "we", "retain", "the", "right", "to", "challenge", "Ironwood", "s", "method", "of", "use", "patent", "on", "plecanatide."], "wordsB": ["The", "LOI", "contemplates", "a", "low", "single", "digit", "royalty", "on", "net", "sales", "of", "plecanatide", "and", "both", "parties", "agreed", "not", "to", "challenge", "each", "other", "s", "patents", "covering", "certain", "GC-C", "agonists,", "except", "that", "we", "retain", "the", "right", "to", "challenge", "Ironwood", "s", "method", "of", "use", "patents", "on", "plecanatide."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_14_item1_p50_s4", "idA": "1347613_13_item1_p84_s5", "sentA": "Accordingly, we cannot ensure that employees, consultants or third parties will not breach the confidentiality provisions in our contracts, infringe or misappropriate our trade secrets and other proprietary rights or that measures we are taking to protect our proprietary rights will be adequate.", "sentB": "Accordingly, we cannot predict the breadth of claims that may be allowed or enforced in our issued patents or in third-party patents.", "type": 2, "words": ["<tag1>", "Accordingly,", "we", "cannot", "ensure", "that", "employees,", "consultants", "or", "third", "parties", "will", "not", "breach", "the", "confidentiality", "provisions", "in", "our", "contracts,", "infringe", "or", "misappropriate", "our", "trade", "secrets", "and", "other", "proprietary", "rights", "or", "that", "measures", "we", "are", "taking", "to", "protect", "our", "proprietary", "rights", "will", "be", "adequate.", "<tag2>", "Accordingly,", "we", "cannot", "predict", "the", "breadth", "of", "claims", "that", "may", "be", "allowed", "or", "enforced", "in", "our", "issued", "patents", "or", "in", "third-party", "patents.", "<tag3>"], "wordsA": ["Accordingly,", "we", "cannot", "ensure", "that", "employees,", "consultants", "or", "third", "parties", "will", "not", "breach", "the", "confidentiality", "provisions", "in", "our", "contracts,", "infringe", "or", "misappropriate", "our", "trade", "secrets", "and", "other", "proprietary", "rights", "or", "that", "measures", "we", "are", "taking", "to", "protect", "our", "proprietary", "rights", "will", "be", "adequate."], "wordsB": ["Accordingly,", "we", "cannot", "predict", "the", "breadth", "of", "claims", "that", "may", "be", "allowed", "or", "enforced", "in", "our", "issued", "patents", "or", "in", "third-party", "patents."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_14_item1_p78_s0", "idA": "1347613_13_item1_p86_s0", "sentA": "As of March 18, 2013, we had 18 full-time employees.", "sentB": "As of March 16, 2014, we had 25 full-time employees.", "type": 2, "words": ["<tag1>", "As", "of", "March", "18,", "2013,", "we", "had", "18", "full-time", "employees.", "<tag2>", "As", "of", "March", "16,", "2014,", "we", "had", "25", "full-time", "employees.", "<tag3>"], "wordsA": ["As", "of", "March", "18,", "2013,", "we", "had", "18", "full-time", "employees."], "wordsB": ["As", "of", "March", "16,", "2014,", "we", "had", "25", "full-time", "employees."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_15_item1_p1_s1", "idA": "1347613_14_item1_p0_s1", "sentA": "Our lead product candidate is plecanatide (formerly called SP-304), a guanylate cyclase C, or GC-C, receptor agonist, to treat GI disorders, primarily chronic idiopathic constipation, or CIC, and constipation-predominant- irritable bowel syndrome, or IBS-C. CIC and IBS-C are functional gastrointestinal disorders that afflict millions of sufferers worldwide.", "sentB": "Our lead product candidate is plecanatide (formerly called SP-304), a phase 3 guanylate cyclase C, or GC-C, receptor agonist, designed to treat GI disorders, primarily chronic idiopathic constipation, or CIC, and constipation-predominant irritable bowel syndrome, or IBS-C. CIC and IBS-C are functional gastrointestinal disorders that afflict millions of individuals worldwide.", "type": 2, "words": ["<tag1>", "Our", "lead", "product", "candidate", "is", "plecanatide", "(formerly", "called", "SP-304),", "a", "guanylate", "cyclase", "C,", "or", "GC-C,", "receptor", "agonist,", "to", "treat", "GI", "disorders,", "primarily", "chronic", "idiopathic", "constipation,", "or", "CIC,", "and", "constipation-predominant-", "irritable", "bowel", "syndrome,", "or", "IBS-C.", "CIC", "and", "IBS-C", "are", "functional", "gastrointestinal", "disorders", "that", "afflict", "millions", "of", "sufferers", "worldwide.", "<tag2>", "Our", "lead", "product", "candidate", "is", "plecanatide", "(formerly", "called", "SP-304),", "a", "phase", "3", "guanylate", "cyclase", "C,", "or", "GC-C,", "receptor", "agonist,", "designed", "to", "treat", "GI", "disorders,", "primarily", "chronic", "idiopathic", "constipation,", "or", "CIC,", "and", "constipation-predominant", "irritable", "bowel", "syndrome,", "or", "IBS-C.", "CIC", "and", "IBS-C", "are", "functional", "gastrointestinal", "disorders", "that", "afflict", "millions", "of", "individuals", "worldwide.", "<tag3>"], "wordsA": ["Our", "lead", "product", "candidate", "is", "plecanatide", "(formerly", "called", "SP-304),", "a", "guanylate", "cyclase", "C,", "or", "GC-C,", "receptor", "agonist,", "to", "treat", "GI", "disorders,", "primarily", "chronic", "idiopathic", "constipation,", "or", "CIC,", "and", "constipation-predominant-", "irritable", "bowel", "syndrome,", "or", "IBS-C.", "CIC", "and", "IBS-C", "are", "functional", "gastrointestinal", "disorders", "that", "afflict", "millions", "of", "sufferers", "worldwide."], "wordsB": ["Our", "lead", "product", "candidate", "is", "plecanatide", "(formerly", "called", "SP-304),", "a", "phase", "3", "guanylate", "cyclase", "C,", "or", "GC-C,", "receptor", "agonist,", "designed", "to", "treat", "GI", "disorders,", "primarily", "chronic", "idiopathic", "constipation,", "or", "CIC,", "and", "constipation-predominant", "irritable", "bowel", "syndrome,", "or", "IBS-C.", "CIC", "and", "IBS-C", "are", "functional", "gastrointestinal", "disorders", "that", "afflict", "millions", "of", "individuals", "worldwide."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_15_item1_p2_s0", "idA": "1347613_14_item1_p0_s2", "sentA": "CIC is primarily characterized by constipation symptoms but a majority of these patients report experiencing straining, bloating and abdominal discomfort as among their most bothersome symptoms.", "sentB": "CIC is primarily characterized by constipation symptoms with straining, bloating and abdominal discomfort reported by a majority of such patients.", "type": 2, "words": ["<tag1>", "CIC", "is", "primarily", "characterized", "by", "constipation", "symptoms", "but", "a", "majority", "of", "these", "patients", "report", "experiencing", "straining,", "bloating", "and", "abdominal", "discomfort", "as", "among", "their", "most", "bothersome", "symptoms.", "<tag2>", "CIC", "is", "primarily", "characterized", "by", "constipation", "symptoms", "with", "straining,", "bloating", "and", "abdominal", "discomfort", "reported", "by", "a", "majority", "of", "such", "patients.", "<tag3>"], "wordsA": ["CIC", "is", "primarily", "characterized", "by", "constipation", "symptoms", "but", "a", "majority", "of", "these", "patients", "report", "experiencing", "straining,", "bloating", "and", "abdominal", "discomfort", "as", "among", "their", "most", "bothersome", "symptoms."], "wordsB": ["CIC", "is", "primarily", "characterized", "by", "constipation", "symptoms", "with", "straining,", "bloating", "and", "abdominal", "discomfort", "reported", "by", "a", "majority", "of", "such", "patients."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_15_item1_p19_s1", "idA": "1347613_14_item1_p10_s0", "sentA": "On November 13, 2013, we announced the start of the first of two planned pivotal phase 3 clinical trials to confirm the safety and efficacy of plecanatide in adult patients with CIC.", "sentB": "The primary objective of this trial is to confirm the safety and efficacy of plecanatide, a GC-C receptor agonist and once-daily oral treatment, in adult patients with CIC.", "type": 2, "words": ["<tag1>", "On", "November", "13,", "2013,", "we", "announced", "the", "start", "of", "the", "first", "of", "two", "planned", "pivotal", "phase", "3", "clinical", "trials", "to", "confirm", "the", "safety", "and", "efficacy", "of", "plecanatide", "in", "adult", "patients", "with", "CIC.", "<tag2>", "The", "primary", "objective", "of", "this", "trial", "is", "to", "confirm", "the", "safety", "and", "efficacy", "of", "plecanatide,", "a", "GC-C", "receptor", "agonist", "and", "once-daily", "oral", "treatment,", "in", "adult", "patients", "with", "CIC.", "<tag3>"], "wordsA": ["On", "November", "13,", "2013,", "we", "announced", "the", "start", "of", "the", "first", "of", "two", "planned", "pivotal", "phase", "3", "clinical", "trials", "to", "confirm", "the", "safety", "and", "efficacy", "of", "plecanatide", "in", "adult", "patients", "with", "CIC."], "wordsB": ["The", "primary", "objective", "of", "this", "trial", "is", "to", "confirm", "the", "safety", "and", "efficacy", "of", "plecanatide,", "a", "GC-C", "receptor", "agonist", "and", "once-daily", "oral", "treatment,", "in", "adult", "patients", "with", "CIC."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_15_item1_p21_s0", "idA": "1347613_14_item1_p10_s0", "sentA": "On November 13, 2013, we announced the start of the first of two planned pivotal phase 3 clinical trials to confirm the safety and efficacy of plecanatide in adult patients with CIC.", "sentB": "On January 8, 2015 and February 2, 2015 we announced that we had completed patient enrollment in the first and second of two pivotal phase 3 trials, respectively, which are evaluating the safety and efficacy of two plecanatide doses (3.0 and 6.0 mg) in patients with CIC.", "type": 2, "words": ["<tag1>", "On", "November", "13,", "2013,", "we", "announced", "the", "start", "of", "the", "first", "of", "two", "planned", "pivotal", "phase", "3", "clinical", "trials", "to", "confirm", "the", "safety", "and", "efficacy", "of", "plecanatide", "in", "adult", "patients", "with", "CIC.", "<tag2>", "On", "January", "8,", "2015", "and", "February", "2,", "2015", "we", "announced", "that", "we", "had", "completed", "patient", "enrollment", "in", "the", "first", "and", "second", "of", "two", "pivotal", "phase", "3", "trials,", "respectively,", "which", "are", "evaluating", "the", "safety", "and", "efficacy", "of", "two", "plecanatide", "doses", "(3.0", "and", "6.0", "mg)", "in", "patients", "with", "CIC.", "<tag3>"], "wordsA": ["On", "November", "13,", "2013,", "we", "announced", "the", "start", "of", "the", "first", "of", "two", "planned", "pivotal", "phase", "3", "clinical", "trials", "to", "confirm", "the", "safety", "and", "efficacy", "of", "plecanatide", "in", "adult", "patients", "with", "CIC."], "wordsB": ["On", "January", "8,", "2015", "and", "February", "2,", "2015", "we", "announced", "that", "we", "had", "completed", "patient", "enrollment", "in", "the", "first", "and", "second", "of", "two", "pivotal", "phase", "3", "trials,", "respectively,", "which", "are", "evaluating", "the", "safety", "and", "efficacy", "of", "two", "plecanatide", "doses", "(3.0", "and", "6.0", "mg)", "in", "patients", "with", "CIC."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_15_item1_p35_s0", "idA": "1347613_14_item1_p10_s0", "sentA": "On November 13, 2013, we announced the start of the first of two planned pivotal phase 3 clinical trials to confirm the safety and efficacy of plecanatide in adult patients with CIC.", "sentB": "On December 18, 2014 we announced the initiation of the first of two planned pivotal phase 3 clinical trials evaluating the safety and efficacy of 3.0 and 6.0 mg plecanatide, once-daily oral tablets, for the treatment of irritable bowel syndrome with constipation (IBS-C), consistent with the ongoing CIC registration trials.", "type": 2, "words": ["<tag1>", "On", "November", "13,", "2013,", "we", "announced", "the", "start", "of", "the", "first", "of", "two", "planned", "pivotal", "phase", "3", "clinical", "trials", "to", "confirm", "the", "safety", "and", "efficacy", "of", "plecanatide", "in", "adult", "patients", "with", "CIC.", "<tag2>", "On", "December", "18,", "2014", "we", "announced", "the", "initiation", "of", "the", "first", "of", "two", "planned", "pivotal", "phase", "3", "clinical", "trials", "evaluating", "the", "safety", "and", "efficacy", "of", "3.0", "and", "6.0", "mg", "plecanatide,", "once-daily", "oral", "tablets,", "for", "the", "treatment", "of", "irritable", "bowel", "syndrome", "with", "constipation", "(IBS-C),", "consistent", "with", "the", "ongoing", "CIC", "registration", "trials.", "<tag3>"], "wordsA": ["On", "November", "13,", "2013,", "we", "announced", "the", "start", "of", "the", "first", "of", "two", "planned", "pivotal", "phase", "3", "clinical", "trials", "to", "confirm", "the", "safety", "and", "efficacy", "of", "plecanatide", "in", "adult", "patients", "with", "CIC."], "wordsB": ["On", "December", "18,", "2014", "we", "announced", "the", "initiation", "of", "the", "first", "of", "two", "planned", "pivotal", "phase", "3", "clinical", "trials", "evaluating", "the", "safety", "and", "efficacy", "of", "3.0", "and", "6.0", "mg", "plecanatide,", "once-daily", "oral", "tablets,", "for", "the", "treatment", "of", "irritable", "bowel", "syndrome", "with", "constipation", "(IBS-C),", "consistent", "with", "the", "ongoing", "CIC", "registration", "trials."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_15_item1_p3_s1", "idA": "1347613_14_item1_p10_s0", "sentA": "On November 13, 2013, we announced the start of the first of two planned pivotal phase 3 clinical trials to confirm the safety and efficacy of plecanatide in adult patients with CIC.", "sentB": "Plecanatide is currently completing two phase 3 registration trials in CIC patients, and has begun the first of two phase 3 registration trials in IBS-C patients.", "type": 2, "words": ["<tag1>", "On", "November", "13,", "2013,", "we", "announced", "the", "start", "of", "the", "first", "of", "two", "planned", "pivotal", "phase", "3", "clinical", "trials", "to", "confirm", "the", "safety", "and", "efficacy", "of", "plecanatide", "in", "adult", "patients", "with", "CIC.", "<tag2>", "Plecanatide", "is", "currently", "completing", "two", "phase", "3", "registration", "trials", "in", "CIC", "patients,", "and", "has", "begun", "the", "first", "of", "two", "phase", "3", "registration", "trials", "in", "IBS-C", "patients.", "<tag3>"], "wordsA": ["On", "November", "13,", "2013,", "we", "announced", "the", "start", "of", "the", "first", "of", "two", "planned", "pivotal", "phase", "3", "clinical", "trials", "to", "confirm", "the", "safety", "and", "efficacy", "of", "plecanatide", "in", "adult", "patients", "with", "CIC."], "wordsB": ["Plecanatide", "is", "currently", "completing", "two", "phase", "3", "registration", "trials", "in", "CIC", "patients,", "and", "has", "begun", "the", "first", "of", "two", "phase", "3", "registration", "trials", "in", "IBS-C", "patients."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_15_item1_p5_s0", "idA": "1347613_14_item1_p10_s0", "sentA": "On November 13, 2013, we announced the start of the first of two planned pivotal phase 3 clinical trials to confirm the safety and efficacy of plecanatide in adult patients with CIC.", "sentB": "On January 8, 2015 and January 29, 2015 we announced that we had completed patient enrollment in the first and second of two pivotal phase 3 trials, respectively, which are evaluating the safety and efficacy of two plecanatide doses (3.0 and 6.0 mg) in patients with CIC.", "type": 2, "words": ["<tag1>", "On", "November", "13,", "2013,", "we", "announced", "the", "start", "of", "the", "first", "of", "two", "planned", "pivotal", "phase", "3", "clinical", "trials", "to", "confirm", "the", "safety", "and", "efficacy", "of", "plecanatide", "in", "adult", "patients", "with", "CIC.", "<tag2>", "On", "January", "8,", "2015", "and", "January", "29,", "2015", "we", "announced", "that", "we", "had", "completed", "patient", "enrollment", "in", "the", "first", "and", "second", "of", "two", "pivotal", "phase", "3", "trials,", "respectively,", "which", "are", "evaluating", "the", "safety", "and", "efficacy", "of", "two", "plecanatide", "doses", "(3.0", "and", "6.0", "mg)", "in", "patients", "with", "CIC.", "<tag3>"], "wordsA": ["On", "November", "13,", "2013,", "we", "announced", "the", "start", "of", "the", "first", "of", "two", "planned", "pivotal", "phase", "3", "clinical", "trials", "to", "confirm", "the", "safety", "and", "efficacy", "of", "plecanatide", "in", "adult", "patients", "with", "CIC."], "wordsB": ["On", "January", "8,", "2015", "and", "January", "29,", "2015", "we", "announced", "that", "we", "had", "completed", "patient", "enrollment", "in", "the", "first", "and", "second", "of", "two", "pivotal", "phase", "3", "trials,", "respectively,", "which", "are", "evaluating", "the", "safety", "and", "efficacy", "of", "two", "plecanatide", "doses", "(3.0", "and", "6.0", "mg)", "in", "patients", "with", "CIC."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_15_item1_p6_s0", "idA": "1347613_14_item1_p10_s0", "sentA": "On November 13, 2013, we announced the start of the first of two planned pivotal phase 3 clinical trials to confirm the safety and efficacy of plecanatide in adult patients with CIC.", "sentB": "On December 18, 2014 we announced the initiation of the first of two planned pivotal phase 3 clinical trials evaluating the safety and efficacy of 3.0 and 6.0 mg plecanatide, once-daily oral tablets, for the treatment of irritable bowel syndrome with constipation (IBS-C).", "type": 2, "words": ["<tag1>", "On", "November", "13,", "2013,", "we", "announced", "the", "start", "of", "the", "first", "of", "two", "planned", "pivotal", "phase", "3", "clinical", "trials", "to", "confirm", "the", "safety", "and", "efficacy", "of", "plecanatide", "in", "adult", "patients", "with", "CIC.", "<tag2>", "On", "December", "18,", "2014", "we", "announced", "the", "initiation", "of", "the", "first", "of", "two", "planned", "pivotal", "phase", "3", "clinical", "trials", "evaluating", "the", "safety", "and", "efficacy", "of", "3.0", "and", "6.0", "mg", "plecanatide,", "once-daily", "oral", "tablets,", "for", "the", "treatment", "of", "irritable", "bowel", "syndrome", "with", "constipation", "(IBS-C).", "<tag3>"], "wordsA": ["On", "November", "13,", "2013,", "we", "announced", "the", "start", "of", "the", "first", "of", "two", "planned", "pivotal", "phase", "3", "clinical", "trials", "to", "confirm", "the", "safety", "and", "efficacy", "of", "plecanatide", "in", "adult", "patients", "with", "CIC."], "wordsB": ["On", "December", "18,", "2014", "we", "announced", "the", "initiation", "of", "the", "first", "of", "two", "planned", "pivotal", "phase", "3", "clinical", "trials", "evaluating", "the", "safety", "and", "efficacy", "of", "3.0", "and", "6.0", "mg", "plecanatide,", "once-daily", "oral", "tablets,", "for", "the", "treatment", "of", "irritable", "bowel", "syndrome", "with", "constipation", "(IBS-C)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_15_item1_p9_s0", "idA": "1347613_14_item1_p10_s0", "sentA": "On November 13, 2013, we announced the start of the first of two planned pivotal phase 3 clinical trials to confirm the safety and efficacy of plecanatide in adult patients with CIC.", "sentB": "On November 3, 2014 we announced the closing of a private offering of $200 million aggregate principal amount of 7.50% Convertible Senior Notes due 2019 (including the full exercise of the over-allotment option granted to the initial purchasers to purchase an additional $25 million aggregate principal amount of 7.50% Convertible Senior Notes due 2019).", "type": 2, "words": ["<tag1>", "On", "November", "13,", "2013,", "we", "announced", "the", "start", "of", "the", "first", "of", "two", "planned", "pivotal", "phase", "3", "clinical", "trials", "to", "confirm", "the", "safety", "and", "efficacy", "of", "plecanatide", "in", "adult", "patients", "with", "CIC.", "<tag2>", "On", "November", "3,", "2014", "we", "announced", "the", "closing", "of", "a", "private", "offering", "of", "$200", "million", "aggregate", "principal", "amount", "of", "7.50%", "Convertible", "Senior", "Notes", "due", "2019", "(including", "the", "full", "exercise", "of", "the", "over-allotment", "option", "granted", "to", "the", "initial", "purchasers", "to", "purchase", "an", "additional", "$25", "million", "aggregate", "principal", "amount", "of", "7.50%", "Convertible", "Senior", "Notes", "due", "2019).", "<tag3>"], "wordsA": ["On", "November", "13,", "2013,", "we", "announced", "the", "start", "of", "the", "first", "of", "two", "planned", "pivotal", "phase", "3", "clinical", "trials", "to", "confirm", "the", "safety", "and", "efficacy", "of", "plecanatide", "in", "adult", "patients", "with", "CIC."], "wordsB": ["On", "November", "3,", "2014", "we", "announced", "the", "closing", "of", "a", "private", "offering", "of", "$200", "million", "aggregate", "principal", "amount", "of", "7.50%", "Convertible", "Senior", "Notes", "due", "2019", "(including", "the", "full", "exercise", "of", "the", "over-allotment", "option", "granted", "to", "the", "initial", "purchasers", "to", "purchase", "an", "additional", "$25", "million", "aggregate", "principal", "amount", "of", "7.50%", "Convertible", "Senior", "Notes", "due", "2019)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_15_item1_p18_s1", "idA": "1347613_14_item1_p11_s0", "sentA": "The pivotal phase 3 trial is a randomized, double-blind, clinical trial to compare a 12-week regimen of plecanatide (3.0 and 6.0mg) against placebo in adult patients with CIC.", "sentB": "The pivotal Phase 3 trial is a randomized, double-blind, clinical trial to compare a 12-week, dose-ranging regimen of plecanatide (3.0 and 6.0mg) against placebo in adult patients with CIC.", "type": 2, "words": ["<tag1>", "The", "pivotal", "phase", "3", "trial", "is", "a", "randomized,", "double-blind,", "clinical", "trial", "to", "compare", "a", "12-week", "regimen", "of", "plecanatide", "(3.0", "and", "6.0mg)", "against", "placebo", "in", "adult", "patients", "with", "CIC.", "<tag2>", "The", "pivotal", "Phase", "3", "trial", "is", "a", "randomized,", "double-blind,", "clinical", "trial", "to", "compare", "a", "12-week,", "dose-ranging", "regimen", "of", "plecanatide", "(3.0", "and", "6.0mg)", "against", "placebo", "in", "adult", "patients", "with", "CIC.", "<tag3>"], "wordsA": ["The", "pivotal", "phase", "3", "trial", "is", "a", "randomized,", "double-blind,", "clinical", "trial", "to", "compare", "a", "12-week", "regimen", "of", "plecanatide", "(3.0", "and", "6.0mg)", "against", "placebo", "in", "adult", "patients", "with", "CIC."], "wordsB": ["The", "pivotal", "Phase", "3", "trial", "is", "a", "randomized,", "double-blind,", "clinical", "trial", "to", "compare", "a", "12-week,", "dose-ranging", "regimen", "of", "plecanatide", "(3.0", "and", "6.0mg)", "against", "placebo", "in", "adult", "patients", "with", "CIC."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_15_item1_p20_s0", "idA": "1347613_14_item1_p11_s0", "sentA": "The pivotal phase 3 trial is a randomized, double-blind, clinical trial to compare a 12-week regimen of plecanatide (3.0 and 6.0mg) against placebo in adult patients with CIC.", "sentB": "This Phase 3 trial is a randomized, double-blind clinical trial to compare a 12-week, dose-ranging regimen of plecanatide (3.0 and 6.0mg) against placebo in adult patients with CIC.", "type": 2, "words": ["<tag1>", "The", "pivotal", "phase", "3", "trial", "is", "a", "randomized,", "double-blind,", "clinical", "trial", "to", "compare", "a", "12-week", "regimen", "of", "plecanatide", "(3.0", "and", "6.0mg)", "against", "placebo", "in", "adult", "patients", "with", "CIC.", "<tag2>", "This", "Phase", "3", "trial", "is", "a", "randomized,", "double-blind", "clinical", "trial", "to", "compare", "a", "12-week,", "dose-ranging", "regimen", "of", "plecanatide", "(3.0", "and", "6.0mg)", "against", "placebo", "in", "adult", "patients", "with", "CIC.", "<tag3>"], "wordsA": ["The", "pivotal", "phase", "3", "trial", "is", "a", "randomized,", "double-blind,", "clinical", "trial", "to", "compare", "a", "12-week", "regimen", "of", "plecanatide", "(3.0", "and", "6.0mg)", "against", "placebo", "in", "adult", "patients", "with", "CIC."], "wordsB": ["This", "Phase", "3", "trial", "is", "a", "randomized,", "double-blind", "clinical", "trial", "to", "compare", "a", "12-week,", "dose-ranging", "regimen", "of", "plecanatide", "(3.0", "and", "6.0mg)", "against", "placebo", "in", "adult", "patients", "with", "CIC."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_15_item1_p21_s1", "idA": "1347613_14_item1_p11_s0", "sentA": "The pivotal phase 3 trial is a randomized, double-blind, clinical trial to compare a 12-week regimen of plecanatide (3.0 and 6.0mg) against placebo in adult patients with CIC.", "sentB": "Each trial is a randomized, 12-week, double-blind, placebo-controlled phase 3 trial evaluating approximately 1350 adult patients with CIC.", "type": 2, "words": ["<tag1>", "The", "pivotal", "phase", "3", "trial", "is", "a", "randomized,", "double-blind,", "clinical", "trial", "to", "compare", "a", "12-week", "regimen", "of", "plecanatide", "(3.0", "and", "6.0mg)", "against", "placebo", "in", "adult", "patients", "with", "CIC.", "<tag2>", "Each", "trial", "is", "a", "randomized,", "12-week,", "double-blind,", "placebo-controlled", "phase", "3", "trial", "evaluating", "approximately", "1350", "adult", "patients", "with", "CIC.", "<tag3>"], "wordsA": ["The", "pivotal", "phase", "3", "trial", "is", "a", "randomized,", "double-blind,", "clinical", "trial", "to", "compare", "a", "12-week", "regimen", "of", "plecanatide", "(3.0", "and", "6.0mg)", "against", "placebo", "in", "adult", "patients", "with", "CIC."], "wordsB": ["Each", "trial", "is", "a", "randomized,", "12-week,", "double-blind,", "placebo-controlled", "phase", "3", "trial", "evaluating", "approximately", "1350", "adult", "patients", "with", "CIC."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_15_item1_p5_s1", "idA": "1347613_14_item1_p11_s0", "sentA": "The pivotal phase 3 trial is a randomized, double-blind, clinical trial to compare a 12-week regimen of plecanatide (3.0 and 6.0mg) against placebo in adult patients with CIC.", "sentB": "Each trial is a randomized, 12-week, double-blind, placebo-controlled phase 3 trial evaluating plecanatide, once-daily oral tablets, in approximately 1350 adult patients with CIC.", "type": 2, "words": ["<tag1>", "The", "pivotal", "phase", "3", "trial", "is", "a", "randomized,", "double-blind,", "clinical", "trial", "to", "compare", "a", "12-week", "regimen", "of", "plecanatide", "(3.0", "and", "6.0mg)", "against", "placebo", "in", "adult", "patients", "with", "CIC.", "<tag2>", "Each", "trial", "is", "a", "randomized,", "12-week,", "double-blind,", "placebo-controlled", "phase", "3", "trial", "evaluating", "plecanatide,", "once-daily", "oral", "tablets,", "in", "approximately", "1350", "adult", "patients", "with", "CIC.", "<tag3>"], "wordsA": ["The", "pivotal", "phase", "3", "trial", "is", "a", "randomized,", "double-blind,", "clinical", "trial", "to", "compare", "a", "12-week", "regimen", "of", "plecanatide", "(3.0", "and", "6.0mg)", "against", "placebo", "in", "adult", "patients", "with", "CIC."], "wordsB": ["Each", "trial", "is", "a", "randomized,", "12-week,", "double-blind,", "placebo-controlled", "phase", "3", "trial", "evaluating", "plecanatide,", "once-daily", "oral", "tablets,", "in", "approximately", "1350", "adult", "patients", "with", "CIC."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_15_item1_p18_s2", "idA": "1347613_14_item1_p11_s1", "sentA": "The study will be conducted at approximately 180 sites in the United States and Canada and is expected to enroll approximately 1,350 patients with CIC.", "sentB": "The study is expected to be conducted at approximately 180 sites in the United States and Canada and is expected to enroll approximately 1,350 patients with CIC.", "type": 2, "words": ["<tag1>", "The", "study", "will", "be", "conducted", "at", "approximately", "180", "sites", "in", "the", "United", "States", "and", "Canada", "and", "is", "expected", "to", "enroll", "approximately", "1,350", "patients", "with", "CIC.", "<tag2>", "The", "study", "is", "expected", "to", "be", "conducted", "at", "approximately", "180", "sites", "in", "the", "United", "States", "and", "Canada", "and", "is", "expected", "to", "enroll", "approximately", "1,350", "patients", "with", "CIC.", "<tag3>"], "wordsA": ["The", "study", "will", "be", "conducted", "at", "approximately", "180", "sites", "in", "the", "United", "States", "and", "Canada", "and", "is", "expected", "to", "enroll", "approximately", "1,350", "patients", "with", "CIC."], "wordsB": ["The", "study", "is", "expected", "to", "be", "conducted", "at", "approximately", "180", "sites", "in", "the", "United", "States", "and", "Canada", "and", "is", "expected", "to", "enroll", "approximately", "1,350", "patients", "with", "CIC."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_15_item1_p20_s1", "idA": "1347613_14_item1_p11_s1", "sentA": "The study will be conducted at approximately 180 sites in the United States and Canada and is expected to enroll approximately 1,350 patients with CIC.", "sentB": "The study is expected to be conducted at approximately 180 sites in the United States and is expected to enroll approximately 1,350 patients with CIC.", "type": 2, "words": ["<tag1>", "The", "study", "will", "be", "conducted", "at", "approximately", "180", "sites", "in", "the", "United", "States", "and", "Canada", "and", "is", "expected", "to", "enroll", "approximately", "1,350", "patients", "with", "CIC.", "<tag2>", "The", "study", "is", "expected", "to", "be", "conducted", "at", "approximately", "180", "sites", "in", "the", "United", "States", "and", "is", "expected", "to", "enroll", "approximately", "1,350", "patients", "with", "CIC.", "<tag3>"], "wordsA": ["The", "study", "will", "be", "conducted", "at", "approximately", "180", "sites", "in", "the", "United", "States", "and", "Canada", "and", "is", "expected", "to", "enroll", "approximately", "1,350", "patients", "with", "CIC."], "wordsB": ["The", "study", "is", "expected", "to", "be", "conducted", "at", "approximately", "180", "sites", "in", "the", "United", "States", "and", "is", "expected", "to", "enroll", "approximately", "1,350", "patients", "with", "CIC."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_15_item1_p35_s1", "idA": "1347613_14_item1_p11_s2", "sentA": "The primary endpoint of the study is the proportion of patients who are overall responders for the 12-week treatment period.", "sentB": "IBS-C patients successfully completing either of the 12-week placebo-controlled registration trials will be offered enrollment into a long-term safety trial in order to support the ongoing long-term safety database for the CIC indication.", "type": 2, "words": ["<tag1>", "The", "primary", "endpoint", "of", "the", "study", "is", "the", "proportion", "of", "patients", "who", "are", "overall", "responders", "for", "the", "12-week", "treatment", "period.", "<tag2>", "IBS-C", "patients", "successfully", "completing", "either", "of", "the", "12-week", "placebo-controlled", "registration", "trials", "will", "be", "offered", "enrollment", "into", "a", "long-term", "safety", "trial", "in", "order", "to", "support", "the", "ongoing", "long-term", "safety", "database", "for", "the", "CIC", "indication.", "<tag3>"], "wordsA": ["The", "primary", "endpoint", "of", "the", "study", "is", "the", "proportion", "of", "patients", "who", "are", "overall", "responders", "for", "the", "12-week", "treatment", "period."], "wordsB": ["IBS-C", "patients", "successfully", "completing", "either", "of", "the", "12-week", "placebo-controlled", "registration", "trials", "will", "be", "offered", "enrollment", "into", "a", "long-term", "safety", "trial", "in", "order", "to", "support", "the", "ongoing", "long-term", "safety", "database", "for", "the", "CIC", "indication."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_15_item1_p22_s0", "idA": "1347613_14_item1_p12_s0", "sentA": "In addition to CIC, plecanatide is also being developed to treat IBS-C. IBS, which is one of the most commonly diagnosed GI illnesses in the United States, is generally characterized by symptoms of abdominal pain or discomfort such as cramping, bloating, gas, and constipation or diarrhea or both.", "sentB": "In addition to CIC, plecanatide is also being developed to treat IBS-C. IBS is generally characterized by symptoms of abdominal pain or discomfort such as cramping, bloating, gas, and constipation or diarrhea or both.", "type": 2, "words": ["<tag1>", "In", "addition", "to", "CIC,", "plecanatide", "is", "also", "being", "developed", "to", "treat", "IBS-C.", "IBS,", "which", "is", "one", "of", "the", "most", "commonly", "diagnosed", "GI", "illnesses", "in", "the", "United", "States,", "is", "generally", "characterized", "by", "symptoms", "of", "abdominal", "pain", "or", "discomfort", "such", "as", "cramping,", "bloating,", "gas,", "and", "constipation", "or", "diarrhea", "or", "both.", "<tag2>", "In", "addition", "to", "CIC,", "plecanatide", "is", "also", "being", "developed", "to", "treat", "IBS-C.", "IBS", "is", "generally", "characterized", "by", "symptoms", "of", "abdominal", "pain", "or", "discomfort", "such", "as", "cramping,", "bloating,", "gas,", "and", "constipation", "or", "diarrhea", "or", "both.", "<tag3>"], "wordsA": ["In", "addition", "to", "CIC,", "plecanatide", "is", "also", "being", "developed", "to", "treat", "IBS-C.", "IBS,", "which", "is", "one", "of", "the", "most", "commonly", "diagnosed", "GI", "illnesses", "in", "the", "United", "States,", "is", "generally", "characterized", "by", "symptoms", "of", "abdominal", "pain", "or", "discomfort", "such", "as", "cramping,", "bloating,", "gas,", "and", "constipation", "or", "diarrhea", "or", "both."], "wordsB": ["In", "addition", "to", "CIC,", "plecanatide", "is", "also", "being", "developed", "to", "treat", "IBS-C.", "IBS", "is", "generally", "characterized", "by", "symptoms", "of", "abdominal", "pain", "or", "discomfort", "such", "as", "cramping,", "bloating,", "gas,", "and", "constipation", "or", "diarrhea", "or", "both."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_15_item1_p24_s0", "idA": "1347613_14_item1_p12_s0", "sentA": "In addition to CIC, plecanatide is also being developed to treat IBS-C. IBS, which is one of the most commonly diagnosed GI illnesses in the United States, is generally characterized by symptoms of abdominal pain or discomfort such as cramping, bloating, gas, and constipation or diarrhea or both.", "sentB": "IBS is one of the most commonly diagnosed GI illnesses in the United States.", "type": 2, "words": ["<tag1>", "In", "addition", "to", "CIC,", "plecanatide", "is", "also", "being", "developed", "to", "treat", "IBS-C.", "IBS,", "which", "is", "one", "of", "the", "most", "commonly", "diagnosed", "GI", "illnesses", "in", "the", "United", "States,", "is", "generally", "characterized", "by", "symptoms", "of", "abdominal", "pain", "or", "discomfort", "such", "as", "cramping,", "bloating,", "gas,", "and", "constipation", "or", "diarrhea", "or", "both.", "<tag2>", "IBS", "is", "one", "of", "the", "most", "commonly", "diagnosed", "GI", "illnesses", "in", "the", "United", "States.", "<tag3>"], "wordsA": ["In", "addition", "to", "CIC,", "plecanatide", "is", "also", "being", "developed", "to", "treat", "IBS-C.", "IBS,", "which", "is", "one", "of", "the", "most", "commonly", "diagnosed", "GI", "illnesses", "in", "the", "United", "States,", "is", "generally", "characterized", "by", "symptoms", "of", "abdominal", "pain", "or", "discomfort", "such", "as", "cramping,", "bloating,", "gas,", "and", "constipation", "or", "diarrhea", "or", "both."], "wordsB": ["IBS", "is", "one", "of", "the", "most", "commonly", "diagnosed", "GI", "illnesses", "in", "the", "United", "States."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_15_item1_p27_s0", "idA": "1347613_14_item1_p12_s0", "sentA": "In addition to CIC, plecanatide is also being developed to treat IBS-C. IBS, which is one of the most commonly diagnosed GI illnesses in the United States, is generally characterized by symptoms of abdominal pain or discomfort such as cramping, bloating, gas, and constipation or diarrhea or both.", "sentB": "IBS is one of the most common reasons for work or school absenteeism, second only to the common cold.", "type": 2, "words": ["<tag1>", "In", "addition", "to", "CIC,", "plecanatide", "is", "also", "being", "developed", "to", "treat", "IBS-C.", "IBS,", "which", "is", "one", "of", "the", "most", "commonly", "diagnosed", "GI", "illnesses", "in", "the", "United", "States,", "is", "generally", "characterized", "by", "symptoms", "of", "abdominal", "pain", "or", "discomfort", "such", "as", "cramping,", "bloating,", "gas,", "and", "constipation", "or", "diarrhea", "or", "both.", "<tag2>", "IBS", "is", "one", "of", "the", "most", "common", "reasons", "for", "work", "or", "school", "absenteeism,", "second", "only", "to", "the", "common", "cold.", "<tag3>"], "wordsA": ["In", "addition", "to", "CIC,", "plecanatide", "is", "also", "being", "developed", "to", "treat", "IBS-C.", "IBS,", "which", "is", "one", "of", "the", "most", "commonly", "diagnosed", "GI", "illnesses", "in", "the", "United", "States,", "is", "generally", "characterized", "by", "symptoms", "of", "abdominal", "pain", "or", "discomfort", "such", "as", "cramping,", "bloating,", "gas,", "and", "constipation", "or", "diarrhea", "or", "both."], "wordsB": ["IBS", "is", "one", "of", "the", "most", "common", "reasons", "for", "work", "or", "school", "absenteeism,", "second", "only", "to", "the", "common", "cold."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_15_item1_p23_s0", "idA": "1347613_14_item1_p12_s1", "sentA": "IBS-C is the subtype of IBS that plecanatide is being developed to treat and is characterized by abdominal pain associated with infrequent bowel movement and hard or lumpy stool.", "sentB": "IBS-C is the subtype of IBS that plecanatide is being developed to treat.", "type": 2, "words": ["<tag1>", "IBS-C", "is", "the", "subtype", "of", "IBS", "that", "plecanatide", "is", "being", "developed", "to", "treat", "and", "is", "characterized", "by", "abdominal", "pain", "associated", "with", "infrequent", "bowel", "movement", "and", "hard", "or", "lumpy", "stool.", "<tag2>", "IBS-C", "is", "the", "subtype", "of", "IBS", "that", "plecanatide", "is", "being", "developed", "to", "treat.", "<tag3>"], "wordsA": ["IBS-C", "is", "the", "subtype", "of", "IBS", "that", "plecanatide", "is", "being", "developed", "to", "treat", "and", "is", "characterized", "by", "abdominal", "pain", "associated", "with", "infrequent", "bowel", "movement", "and", "hard", "or", "lumpy", "stool."], "wordsB": ["IBS-C", "is", "the", "subtype", "of", "IBS", "that", "plecanatide", "is", "being", "developed", "to", "treat."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_15_item1_p25_s0", "idA": "1347613_14_item1_p13_s0", "sentA": "As many as 1 in 6 or up to 50 million adult Americans suffer from IBS.", "sentB": "As many as 14% of, or up to 42 million, adult Americans suffer from IBS.", "type": 2, "words": ["<tag1>", "As", "many", "as", "1", "in", "6", "or", "up", "to", "50", "million", "adult", "Americans", "suffer", "from", "IBS.", "<tag2>", "As", "many", "as", "14%", "of,", "or", "up", "to", "42", "million,", "adult", "Americans", "suffer", "from", "IBS.", "<tag3>"], "wordsA": ["As", "many", "as", "1", "in", "6", "or", "up", "to", "50", "million", "adult", "Americans", "suffer", "from", "IBS."], "wordsB": ["As", "many", "as", "14%", "of,", "or", "up", "to", "42", "million,", "adult", "Americans", "suffer", "from", "IBS."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_15_item1_p25_s1", "idA": "1347613_14_item1_p13_s1", "sentA": "About 13 million of them suffer from the IBS-C subtype.", "sentB": "Depending on the criteria used to define bowel habit predominance, it is estimated that 16% to 30% of IBS patients (approximately 7 to 13 million) experience symptoms consistent with the IBS-C subtype.", "type": 2, "words": ["<tag1>", "About", "13", "million", "of", "them", "suffer", "from", "the", "IBS-C", "subtype.", "<tag2>", "Depending", "on", "the", "criteria", "used", "to", "define", "bowel", "habit", "predominance,", "it", "is", "estimated", "that", "16%", "to", "30%", "of", "IBS", "patients", "(approximately", "7", "to", "13", "million)", "experience", "symptoms", "consistent", "with", "the", "IBS-C", "subtype.", "<tag3>"], "wordsA": ["About", "13", "million", "of", "them", "suffer", "from", "the", "IBS-C", "subtype."], "wordsB": ["Depending", "on", "the", "criteria", "used", "to", "define", "bowel", "habit", "predominance,", "it", "is", "estimated", "that", "16%", "to", "30%", "of", "IBS", "patients", "(approximately", "7", "to", "13", "million)", "experience", "symptoms", "consistent", "with", "the", "IBS-C", "subtype."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_15_item1_p26_s0", "idA": "1347613_14_item1_p14_s0", "sentA": "IBS-C profoundly impacts patients physical, social and working lives.", "sentB": "IBS profoundly impacts patients physical, social and working lives.", "type": 2, "words": ["<tag1>", "IBS-C", "profoundly", "impacts", "patients", "physical,", "social", "and", "working", "lives.", "<tag2>", "IBS", "profoundly", "impacts", "patients", "physical,", "social", "and", "working", "lives.", "<tag3>"], "wordsA": ["IBS-C", "profoundly", "impacts", "patients", "physical,", "social", "and", "working", "lives."], "wordsB": ["IBS", "profoundly", "impacts", "patients", "physical,", "social", "and", "working", "lives."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_15_item1_p29_s0", "idA": "1347613_14_item1_p16_s0", "sentA": "On December 27, 2012, we commenced a Phase2b clinical trial of plecanatide to treat patients with IBS-C.", "sentB": "On December 27, 2012, we commenced a Phase 2b dose-ranging trial of plecanatide to treat patients with IBS-C.", "type": 2, "words": ["<tag1>", "On", "December", "27,", "2012,", "we", "commenced", "a", "Phase2b", "clinical", "trial", "of", "plecanatide", "to", "treat", "patients", "with", "IBS-C.", "<tag2>", "On", "December", "27,", "2012,", "we", "commenced", "a", "Phase", "2b", "dose-ranging", "trial", "of", "plecanatide", "to", "treat", "patients", "with", "IBS-C.", "<tag3>"], "wordsA": ["On", "December", "27,", "2012,", "we", "commenced", "a", "Phase2b", "clinical", "trial", "of", "plecanatide", "to", "treat", "patients", "with", "IBS-C."], "wordsB": ["On", "December", "27,", "2012,", "we", "commenced", "a", "Phase", "2b", "dose-ranging", "trial", "of", "plecanatide", "to", "treat", "patients", "with", "IBS-C."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_15_item1_p5_s3", "idA": "1347613_14_item1_p16_s0", "sentA": "On December 27, 2012, we commenced a Phase2b clinical trial of plecanatide to treat patients with IBS-C.", "sentB": "In the fourth quarter of 2015, we plan to file our first new drug application (NDA) with FDA for plecanatide to treat CIC.", "type": 2, "words": ["<tag1>", "On", "December", "27,", "2012,", "we", "commenced", "a", "Phase2b", "clinical", "trial", "of", "plecanatide", "to", "treat", "patients", "with", "IBS-C.", "<tag2>", "In", "the", "fourth", "quarter", "of", "2015,", "we", "plan", "to", "file", "our", "first", "new", "drug", "application", "(NDA)", "with", "FDA", "for", "plecanatide", "to", "treat", "CIC.", "<tag3>"], "wordsA": ["On", "December", "27,", "2012,", "we", "commenced", "a", "Phase2b", "clinical", "trial", "of", "plecanatide", "to", "treat", "patients", "with", "IBS-C."], "wordsB": ["In", "the", "fourth", "quarter", "of", "2015,", "we", "plan", "to", "file", "our", "first", "new", "drug", "application", "(NDA)", "with", "FDA", "for", "plecanatide", "to", "treat", "CIC."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_15_item1_p28_s1", "idA": "1347613_14_item1_p16_s1", "sentA": "This study is currently being conducted at 70 sites in the U.S., and was planned to enroll 350 patients.", "sentB": "In the U.S., the annual cost of IBS treatment is estimated to be as much as $8 billion in direct medical costs, including doctor and hospital visits and diagnostic procedures.", "type": 2, "words": ["<tag1>", "This", "study", "is", "currently", "being", "conducted", "at", "70", "sites", "in", "the", "U.S.,", "and", "was", "planned", "to", "enroll", "350", "patients.", "<tag2>", "In", "the", "U.S.,", "the", "annual", "cost", "of", "IBS", "treatment", "is", "estimated", "to", "be", "as", "much", "as", "$8", "billion", "in", "direct", "medical", "costs,", "including", "doctor", "and", "hospital", "visits", "and", "diagnostic", "procedures.", "<tag3>"], "wordsA": ["This", "study", "is", "currently", "being", "conducted", "at", "70", "sites", "in", "the", "U.S.,", "and", "was", "planned", "to", "enroll", "350", "patients."], "wordsB": ["In", "the", "U.S.,", "the", "annual", "cost", "of", "IBS", "treatment", "is", "estimated", "to", "be", "as", "much", "as", "$8", "billion", "in", "direct", "medical", "costs,", "including", "doctor", "and", "hospital", "visits", "and", "diagnostic", "procedures."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_15_item1_p29_s1", "idA": "1347613_14_item1_p16_s2", "sentA": "To qualify for enrollment, patients were required to meet the Rome III criteria for IBS-C as modified for this study.", "sentB": "This study was conducted at 70 sites in the U.S. To qualify for enrollment, patients had to meet the Rome III criteria for IBS-C as modified for this study.", "type": 2, "words": ["<tag1>", "To", "qualify", "for", "enrollment,", "patients", "were", "required", "to", "meet", "the", "Rome", "III", "criteria", "for", "IBS-C", "as", "modified", "for", "this", "study.", "<tag2>", "This", "study", "was", "conducted", "at", "70", "sites", "in", "the", "U.S.", "To", "qualify", "for", "enrollment,", "patients", "had", "to", "meet", "the", "Rome", "III", "criteria", "for", "IBS-C", "as", "modified", "for", "this", "study.", "<tag3>"], "wordsA": ["To", "qualify", "for", "enrollment,", "patients", "were", "required", "to", "meet", "the", "Rome", "III", "criteria", "for", "IBS-C", "as", "modified", "for", "this", "study."], "wordsB": ["This", "study", "was", "conducted", "at", "70", "sites", "in", "the", "U.S.", "To", "qualify", "for", "enrollment,", "patients", "had", "to", "meet", "the", "Rome", "III", "criteria", "for", "IBS-C", "as", "modified", "for", "this", "study."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_15_item1_p30_s0", "idA": "1347613_14_item1_p17_s0", "sentA": "Abdominal pain is a major part of this syndrome and patients need to have pain scores of 3 or more (on a scale of 0 to 10) for 3 days in each of the two pre-treatment weeks to qualify for the trial.", "sentB": "Abdominal pain is a major part of this syndrome and patients need to have pain scores of 3 or more (on a scale of 1 to 10) for 3 days in each of the two pre-treatment weeks.", "type": 2, "words": ["<tag1>", "Abdominal", "pain", "is", "a", "major", "part", "of", "this", "syndrome", "and", "patients", "need", "to", "have", "pain", "scores", "of", "3", "or", "more", "(on", "a", "scale", "of", "0", "to", "10)", "for", "3", "days", "in", "each", "of", "the", "two", "pre-treatment", "weeks", "to", "qualify", "for", "the", "trial.", "<tag2>", "Abdominal", "pain", "is", "a", "major", "part", "of", "this", "syndrome", "and", "patients", "need", "to", "have", "pain", "scores", "of", "3", "or", "more", "(on", "a", "scale", "of", "1", "to", "10)", "for", "3", "days", "in", "each", "of", "the", "two", "pre-treatment", "weeks.", "<tag3>"], "wordsA": ["Abdominal", "pain", "is", "a", "major", "part", "of", "this", "syndrome", "and", "patients", "need", "to", "have", "pain", "scores", "of", "3", "or", "more", "(on", "a", "scale", "of", "0", "to", "10)", "for", "3", "days", "in", "each", "of", "the", "two", "pre-treatment", "weeks", "to", "qualify", "for", "the", "trial."], "wordsB": ["Abdominal", "pain", "is", "a", "major", "part", "of", "this", "syndrome", "and", "patients", "need", "to", "have", "pain", "scores", "of", "3", "or", "more", "(on", "a", "scale", "of", "1", "to", "10)", "for", "3", "days", "in", "each", "of", "the", "two", "pre-treatment", "weeks."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_15_item1_p31_s0", "idA": "1347613_14_item1_p17_s1", "sentA": "Qualified patients were being randomized to receive 0.3, 1, 3 or 9 mg of plecanatide or placebo once daily for 12 weeks, and are seen at the clinical site once a month during the study.", "sentB": "Qualified patients were randomized to receive 0.3, 1, 3 or 9 mg of plecanatide or placebo once daily for 12 weeks, and were seen at the clinical site once a month during the study.", "type": 2, "words": ["<tag1>", "Qualified", "patients", "were", "being", "randomized", "to", "receive", "0.3,", "1,", "3", "or", "9", "mg", "of", "plecanatide", "or", "placebo", "once", "daily", "for", "12", "weeks,", "and", "are", "seen", "at", "the", "clinical", "site", "once", "a", "month", "during", "the", "study.", "<tag2>", "Qualified", "patients", "were", "randomized", "to", "receive", "0.3,", "1,", "3", "or", "9", "mg", "of", "plecanatide", "or", "placebo", "once", "daily", "for", "12", "weeks,", "and", "were", "seen", "at", "the", "clinical", "site", "once", "a", "month", "during", "the", "study.", "<tag3>"], "wordsA": ["Qualified", "patients", "were", "being", "randomized", "to", "receive", "0.3,", "1,", "3", "or", "9", "mg", "of", "plecanatide", "or", "placebo", "once", "daily", "for", "12", "weeks,", "and", "are", "seen", "at", "the", "clinical", "site", "once", "a", "month", "during", "the", "study."], "wordsB": ["Qualified", "patients", "were", "randomized", "to", "receive", "0.3,", "1,", "3", "or", "9", "mg", "of", "plecanatide", "or", "placebo", "once", "daily", "for", "12", "weeks,", "and", "were", "seen", "at", "the", "clinical", "site", "once", "a", "month", "during", "the", "study."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_15_item1_p32_s0", "idA": "1347613_14_item1_p18_s0", "sentA": "The primary objective of this study is to select doses for the following Phase 3 studies, based on safety and efficacy endpoints including bowel movement frequency, stool consistency, time to first bowel movement, reduction of abdominal pain, and quality of life measures.", "sentB": "On April 30, 2014, we announced positive top-line results from our Phase 2b dose-ranging trial assessing plecanatide s safety and efficacy in 424 patients with IBS-C. The primary objective of this trial was to determine an effective, safe and well tolerated dose for plecanatide Phase 3 trials with IBS-C patients.", "type": 2, "words": ["<tag1>", "The", "primary", "objective", "of", "this", "study", "is", "to", "select", "doses", "for", "the", "following", "Phase", "3", "studies,", "based", "on", "safety", "and", "efficacy", "endpoints", "including", "bowel", "movement", "frequency,", "stool", "consistency,", "time", "to", "first", "bowel", "movement,", "reduction", "of", "abdominal", "pain,", "and", "quality", "of", "life", "measures.", "<tag2>", "On", "April", "30,", "2014,", "we", "announced", "positive", "top-line", "results", "from", "our", "Phase", "2b", "dose-ranging", "trial", "assessing", "plecanatide", "s", "safety", "and", "efficacy", "in", "424", "patients", "with", "IBS-C.", "The", "primary", "objective", "of", "this", "trial", "was", "to", "determine", "an", "effective,", "safe", "and", "well", "tolerated", "dose", "for", "plecanatide", "Phase", "3", "trials", "with", "IBS-C", "patients.", "<tag3>"], "wordsA": ["The", "primary", "objective", "of", "this", "study", "is", "to", "select", "doses", "for", "the", "following", "Phase", "3", "studies,", "based", "on", "safety", "and", "efficacy", "endpoints", "including", "bowel", "movement", "frequency,", "stool", "consistency,", "time", "to", "first", "bowel", "movement,", "reduction", "of", "abdominal", "pain,", "and", "quality", "of", "life", "measures."], "wordsB": ["On", "April", "30,", "2014,", "we", "announced", "positive", "top-line", "results", "from", "our", "Phase", "2b", "dose-ranging", "trial", "assessing", "plecanatide", "s", "safety", "and", "efficacy", "in", "424", "patients", "with", "IBS-C.", "The", "primary", "objective", "of", "this", "trial", "was", "to", "determine", "an", "effective,", "safe", "and", "well", "tolerated", "dose", "for", "plecanatide", "Phase", "3", "trials", "with", "IBS-C", "patients."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_15_item1_p21_s2", "idA": "1347613_14_item1_p19_s0", "sentA": "On December 24, 2013, we announced that we had closed patient enrollment and expect to report top line data in the second quarter of 2014.", "sentB": "We expect to announce top-line data results from the first phase 3 CIC trial in 2Q 2015, and top-line results from the second phase 3 CIC trial in the third quarter of 2015.", "type": 2, "words": ["<tag1>", "On", "December", "24,", "2013,", "we", "announced", "that", "we", "had", "closed", "patient", "enrollment", "and", "expect", "to", "report", "top", "line", "data", "in", "the", "second", "quarter", "of", "2014.", "<tag2>", "We", "expect", "to", "announce", "top-line", "data", "results", "from", "the", "first", "phase", "3", "CIC", "trial", "in", "2Q", "2015,", "and", "top-line", "results", "from", "the", "second", "phase", "3", "CIC", "trial", "in", "the", "third", "quarter", "of", "2015.", "<tag3>"], "wordsA": ["On", "December", "24,", "2013,", "we", "announced", "that", "we", "had", "closed", "patient", "enrollment", "and", "expect", "to", "report", "top", "line", "data", "in", "the", "second", "quarter", "of", "2014."], "wordsB": ["We", "expect", "to", "announce", "top-line", "data", "results", "from", "the", "first", "phase", "3", "CIC", "trial", "in", "2Q", "2015,", "and", "top-line", "results", "from", "the", "second", "phase", "3", "CIC", "trial", "in", "the", "third", "quarter", "of", "2015."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_15_item1_p5_s2", "idA": "1347613_14_item1_p19_s0", "sentA": "On December 24, 2013, we announced that we had closed patient enrollment and expect to report top line data in the second quarter of 2014.", "sentB": "We expect to release top-line data results from the first phase 3 CIC trial in second quarter of 2015, and top-line results from the second phase 3 CIC trial in the third quarter of 2015.", "type": 2, "words": ["<tag1>", "On", "December", "24,", "2013,", "we", "announced", "that", "we", "had", "closed", "patient", "enrollment", "and", "expect", "to", "report", "top", "line", "data", "in", "the", "second", "quarter", "of", "2014.", "<tag2>", "We", "expect", "to", "release", "top-line", "data", "results", "from", "the", "first", "phase", "3", "CIC", "trial", "in", "second", "quarter", "of", "2015,", "and", "top-line", "results", "from", "the", "second", "phase", "3", "CIC", "trial", "in", "the", "third", "quarter", "of", "2015.", "<tag3>"], "wordsA": ["On", "December", "24,", "2013,", "we", "announced", "that", "we", "had", "closed", "patient", "enrollment", "and", "expect", "to", "report", "top", "line", "data", "in", "the", "second", "quarter", "of", "2014."], "wordsB": ["We", "expect", "to", "release", "top-line", "data", "results", "from", "the", "first", "phase", "3", "CIC", "trial", "in", "second", "quarter", "of", "2015,", "and", "top-line", "results", "from", "the", "second", "phase", "3", "CIC", "trial", "in", "the", "third", "quarter", "of", "2015."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_15_item1_p36_s0", "idA": "1347613_14_item1_p20_s0", "sentA": "We are developing a second-generation GC-C receptor agonist, SP-333, for the treatment of opioid induced constipation, or OIC, and for ulcerative colitis, or UC, an inflammatory bowel disease.", "sentB": "We are developing a second-generation GC-C receptor analog, SP-333, for the treatment of opioid induced constipation, or OIC, and for inflammatory bowel disease, or IBD.", "type": 2, "words": ["<tag1>", "We", "are", "developing", "a", "second-generation", "GC-C", "receptor", "agonist,", "SP-333,", "for", "the", "treatment", "of", "opioid", "induced", "constipation,", "or", "OIC,", "and", "for", "ulcerative", "colitis,", "or", "UC,", "an", "inflammatory", "bowel", "disease.", "<tag2>", "We", "are", "developing", "a", "second-generation", "GC-C", "receptor", "analog,", "SP-333,", "for", "the", "treatment", "of", "opioid", "induced", "constipation,", "or", "OIC,", "and", "for", "inflammatory", "bowel", "disease,", "or", "IBD.", "<tag3>"], "wordsA": ["We", "are", "developing", "a", "second-generation", "GC-C", "receptor", "agonist,", "SP-333,", "for", "the", "treatment", "of", "opioid", "induced", "constipation,", "or", "OIC,", "and", "for", "ulcerative", "colitis,", "or", "UC,", "an", "inflammatory", "bowel", "disease."], "wordsB": ["We", "are", "developing", "a", "second-generation", "GC-C", "receptor", "analog,", "SP-333,", "for", "the", "treatment", "of", "opioid", "induced", "constipation,", "or", "OIC,", "and", "for", "inflammatory", "bowel", "disease,", "or", "IBD."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_15_item1_p4_s0", "idA": "1347613_14_item1_p20_s0", "sentA": "We are developing a second-generation GC-C receptor agonist, SP-333, for the treatment of opioid induced constipation, or OIC, and for ulcerative colitis, or UC, an inflammatory bowel disease.", "sentB": "Our second drug in the clinic, SP-333 is a next-generation uroguanylin analog in development for the treatment of opioid induced constipation, or OIC, and mild-to-moderate ulcerative colitis.", "type": 2, "words": ["<tag1>", "We", "are", "developing", "a", "second-generation", "GC-C", "receptor", "agonist,", "SP-333,", "for", "the", "treatment", "of", "opioid", "induced", "constipation,", "or", "OIC,", "and", "for", "ulcerative", "colitis,", "or", "UC,", "an", "inflammatory", "bowel", "disease.", "<tag2>", "Our", "second", "drug", "in", "the", "clinic,", "SP-333", "is", "a", "next-generation", "uroguanylin", "analog", "in", "development", "for", "the", "treatment", "of", "opioid", "induced", "constipation,", "or", "OIC,", "and", "mild-to-moderate", "ulcerative", "colitis.", "<tag3>"], "wordsA": ["We", "are", "developing", "a", "second-generation", "GC-C", "receptor", "agonist,", "SP-333,", "for", "the", "treatment", "of", "opioid", "induced", "constipation,", "or", "OIC,", "and", "for", "ulcerative", "colitis,", "or", "UC,", "an", "inflammatory", "bowel", "disease."], "wordsB": ["Our", "second", "drug", "in", "the", "clinic,", "SP-333", "is", "a", "next-generation", "uroguanylin", "analog", "in", "development", "for", "the", "treatment", "of", "opioid", "induced", "constipation,", "or", "OIC,", "and", "mild-to-moderate", "ulcerative", "colitis."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_15_item1_p36_s1", "idA": "1347613_14_item1_p20_s1", "sentA": "SP-333 is a synthetic analog of uroguanylin, a natriuretic hormone that is normally produced in the body s intestinal tract.", "sentB": "SP-333 is a synthetic analog of uroguanylin, a natriuretic peptide that is normally produced in the body s intestinal tract.", "type": 2, "words": ["<tag1>", "SP-333", "is", "a", "synthetic", "analog", "of", "uroguanylin,", "a", "natriuretic", "hormone", "that", "is", "normally", "produced", "in", "the", "body", "s", "intestinal", "tract.", "<tag2>", "SP-333", "is", "a", "synthetic", "analog", "of", "uroguanylin,", "a", "natriuretic", "peptide", "that", "is", "normally", "produced", "in", "the", "body", "s", "intestinal", "tract.", "<tag3>"], "wordsA": ["SP-333", "is", "a", "synthetic", "analog", "of", "uroguanylin,", "a", "natriuretic", "hormone", "that", "is", "normally", "produced", "in", "the", "body", "s", "intestinal", "tract."], "wordsB": ["SP-333", "is", "a", "synthetic", "analog", "of", "uroguanylin,", "a", "natriuretic", "peptide", "that", "is", "normally", "produced", "in", "the", "body", "s", "intestinal", "tract."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_15_item1_p36_s2", "idA": "1347613_14_item1_p20_s2", "sentA": "Deficiency of this hormone is thought to be one of the primary reasons for the formation of polyps that can lead to colon cancer, as well as debilitating and difficult-to-treat GI inflammatory disorders such as UC and Crohn s disease.", "sentB": "Deficiency of this peptide is thought to be one of the primary reasons for the formation of polyps that can lead to colon cancer, as well as debilitating and difficult- to-treat GI inflammatory disorders such as UC and Crohn s disease.", "type": 2, "words": ["<tag1>", "Deficiency", "of", "this", "hormone", "is", "thought", "to", "be", "one", "of", "the", "primary", "reasons", "for", "the", "formation", "of", "polyps", "that", "can", "lead", "to", "colon", "cancer,", "as", "well", "as", "debilitating", "and", "difficult-to-treat", "GI", "inflammatory", "disorders", "such", "as", "UC", "and", "Crohn", "s", "disease.", "<tag2>", "Deficiency", "of", "this", "peptide", "is", "thought", "to", "be", "one", "of", "the", "primary", "reasons", "for", "the", "formation", "of", "polyps", "that", "can", "lead", "to", "colon", "cancer,", "as", "well", "as", "debilitating", "and", "difficult-", "to-treat", "GI", "inflammatory", "disorders", "such", "as", "UC", "and", "Crohn", "s", "disease.", "<tag3>"], "wordsA": ["Deficiency", "of", "this", "hormone", "is", "thought", "to", "be", "one", "of", "the", "primary", "reasons", "for", "the", "formation", "of", "polyps", "that", "can", "lead", "to", "colon", "cancer,", "as", "well", "as", "debilitating", "and", "difficult-to-treat", "GI", "inflammatory", "disorders", "such", "as", "UC", "and", "Crohn", "s", "disease."], "wordsB": ["Deficiency", "of", "this", "peptide", "is", "thought", "to", "be", "one", "of", "the", "primary", "reasons", "for", "the", "formation", "of", "polyps", "that", "can", "lead", "to", "colon", "cancer,", "as", "well", "as", "debilitating", "and", "difficult-", "to-treat", "GI", "inflammatory", "disorders", "such", "as", "UC", "and", "Crohn", "s", "disease."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_15_item1_p37_s0", "idA": "1347613_14_item1_p21_s0", "sentA": "On September 7, 2012, we submitted an Investigational New Drug, or IND, application for clinical evaluation of SP-333 to treat inflammatory bowel disease, or IBD.", "sentB": "On September 7, 2012, we submitted an Investigational New Drug, or IND, application for clinical evaluation of SP-333 to treat IBD.", "type": 2, "words": ["<tag1>", "On", "September", "7,", "2012,", "we", "submitted", "an", "Investigational", "New", "Drug,", "or", "IND,", "application", "for", "clinical", "evaluation", "of", "SP-333", "to", "treat", "inflammatory", "bowel", "disease,", "or", "IBD.", "<tag2>", "On", "September", "7,", "2012,", "we", "submitted", "an", "Investigational", "New", "Drug,", "or", "IND,", "application", "for", "clinical", "evaluation", "of", "SP-333", "to", "treat", "IBD.", "<tag3>"], "wordsA": ["On", "September", "7,", "2012,", "we", "submitted", "an", "Investigational", "New", "Drug,", "or", "IND,", "application", "for", "clinical", "evaluation", "of", "SP-333", "to", "treat", "inflammatory", "bowel", "disease,", "or", "IBD."], "wordsB": ["On", "September", "7,", "2012,", "we", "submitted", "an", "Investigational", "New", "Drug,", "or", "IND,", "application", "for", "clinical", "evaluation", "of", "SP-333", "to", "treat", "IBD."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_15_item1_p4_s2", "idA": "1347613_14_item1_p23_s0", "sentA": "On October 30, 2013 we announced the start of the phase 2 clinical trial to evaluate the safety and efficacy of SP-333 in adult patients with OIC.", "sentB": "We completed phase 1 single- and multiple-ascending dose studies in healthy volunteers, as well as reporting positive data from a phase 2 clinical trial of SP-333 in OIC patients.", "type": 2, "words": ["<tag1>", "On", "October", "30,", "2013", "we", "announced", "the", "start", "of", "the", "phase", "2", "clinical", "trial", "to", "evaluate", "the", "safety", "and", "efficacy", "of", "SP-333", "in", "adult", "patients", "with", "OIC.", "<tag2>", "We", "completed", "phase", "1", "single-", "and", "multiple-ascending", "dose", "studies", "in", "healthy", "volunteers,", "as", "well", "as", "reporting", "positive", "data", "from", "a", "phase", "2", "clinical", "trial", "of", "SP-333", "in", "OIC", "patients.", "<tag3>"], "wordsA": ["On", "October", "30,", "2013", "we", "announced", "the", "start", "of", "the", "phase", "2", "clinical", "trial", "to", "evaluate", "the", "safety", "and", "efficacy", "of", "SP-333", "in", "adult", "patients", "with", "OIC."], "wordsB": ["We", "completed", "phase", "1", "single-", "and", "multiple-ascending", "dose", "studies", "in", "healthy", "volunteers,", "as", "well", "as", "reporting", "positive", "data", "from", "a", "phase", "2", "clinical", "trial", "of", "SP-333", "in", "OIC", "patients."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_15_item1_p4_s3", "idA": "1347613_14_item1_p23_s0", "sentA": "On October 30, 2013 we announced the start of the phase 2 clinical trial to evaluate the safety and efficacy of SP-333 in adult patients with OIC.", "sentB": "We have also announced the start of a phase 1b proof-of-concept trial of SP-333 in patients with ulcerative colitis.", "type": 2, "words": ["<tag1>", "On", "October", "30,", "2013", "we", "announced", "the", "start", "of", "the", "phase", "2", "clinical", "trial", "to", "evaluate", "the", "safety", "and", "efficacy", "of", "SP-333", "in", "adult", "patients", "with", "OIC.", "<tag2>", "We", "have", "also", "announced", "the", "start", "of", "a", "phase", "1b", "proof-of-concept", "trial", "of", "SP-333", "in", "patients", "with", "ulcerative", "colitis.", "<tag3>"], "wordsA": ["On", "October", "30,", "2013", "we", "announced", "the", "start", "of", "the", "phase", "2", "clinical", "trial", "to", "evaluate", "the", "safety", "and", "efficacy", "of", "SP-333", "in", "adult", "patients", "with", "OIC."], "wordsB": ["We", "have", "also", "announced", "the", "start", "of", "a", "phase", "1b", "proof-of-concept", "trial", "of", "SP-333", "in", "patients", "with", "ulcerative", "colitis."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_15_item1_p39_s0", "idA": "1347613_14_item1_p23_s1", "sentA": "The multi-center, randomized, double-blind clinical trial will compare a 4-week, dose-ranging regimen of SP-333 (1.0, 3.0 and 6.0mg) against placebo in adult patients taking opioid analgesics for chronic, non-cancer pain for at least three months.", "sentB": "On November 19, 2014 we announced positive top-line results from a phase 2 trial assessing safety, efficacy and dose-response of three different once-daily oral SP-333 tablets (1.0, 3.0 and 6.0 mg) compared with placebo in 289 patients with OIC.", "type": 2, "words": ["<tag1>", "The", "multi-center,", "randomized,", "double-blind", "clinical", "trial", "will", "compare", "a", "4-week,", "dose-ranging", "regimen", "of", "SP-333", "(1.0,", "3.0", "and", "6.0mg)", "against", "placebo", "in", "adult", "patients", "taking", "opioid", "analgesics", "for", "chronic,", "non-cancer", "pain", "for", "at", "least", "three", "months.", "<tag2>", "On", "November", "19,", "2014", "we", "announced", "positive", "top-line", "results", "from", "a", "phase", "2", "trial", "assessing", "safety,", "efficacy", "and", "dose-response", "of", "three", "different", "once-daily", "oral", "SP-333", "tablets", "(1.0,", "3.0", "and", "6.0", "mg)", "compared", "with", "placebo", "in", "289", "patients", "with", "OIC.", "<tag3>"], "wordsA": ["The", "multi-center,", "randomized,", "double-blind", "clinical", "trial", "will", "compare", "a", "4-week,", "dose-ranging", "regimen", "of", "SP-333", "(1.0,", "3.0", "and", "6.0mg)", "against", "placebo", "in", "adult", "patients", "taking", "opioid", "analgesics", "for", "chronic,", "non-cancer", "pain", "for", "at", "least", "three", "months."], "wordsB": ["On", "November", "19,", "2014", "we", "announced", "positive", "top-line", "results", "from", "a", "phase", "2", "trial", "assessing", "safety,", "efficacy", "and", "dose-response", "of", "three", "different", "once-daily", "oral", "SP-333", "tablets", "(1.0,", "3.0", "and", "6.0", "mg)", "compared", "with", "placebo", "in", "289", "patients", "with", "OIC."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_15_item1_p7_s0", "idA": "1347613_14_item1_p23_s1", "sentA": "The multi-center, randomized, double-blind clinical trial will compare a 4-week, dose-ranging regimen of SP-333 (1.0, 3.0 and 6.0mg) against placebo in adult patients taking opioid analgesics for chronic, non-cancer pain for at least three months.", "sentB": "On November 19, 2014 we announced positive top-line results from a phase 2 trial assessing safety, efficacy and dose-response of three different once-daily oral SP-333 tablets (1.0, 3.0 and 6.0 mg) compared with placebo in 289 patients with opioid-induced constipation (OIC).", "type": 2, "words": ["<tag1>", "The", "multi-center,", "randomized,", "double-blind", "clinical", "trial", "will", "compare", "a", "4-week,", "dose-ranging", "regimen", "of", "SP-333", "(1.0,", "3.0", "and", "6.0mg)", "against", "placebo", "in", "adult", "patients", "taking", "opioid", "analgesics", "for", "chronic,", "non-cancer", "pain", "for", "at", "least", "three", "months.", "<tag2>", "On", "November", "19,", "2014", "we", "announced", "positive", "top-line", "results", "from", "a", "phase", "2", "trial", "assessing", "safety,", "efficacy", "and", "dose-response", "of", "three", "different", "once-daily", "oral", "SP-333", "tablets", "(1.0,", "3.0", "and", "6.0", "mg)", "compared", "with", "placebo", "in", "289", "patients", "with", "opioid-induced", "constipation", "(OIC).", "<tag3>"], "wordsA": ["The", "multi-center,", "randomized,", "double-blind", "clinical", "trial", "will", "compare", "a", "4-week,", "dose-ranging", "regimen", "of", "SP-333", "(1.0,", "3.0", "and", "6.0mg)", "against", "placebo", "in", "adult", "patients", "taking", "opioid", "analgesics", "for", "chronic,", "non-cancer", "pain", "for", "at", "least", "three", "months."], "wordsB": ["On", "November", "19,", "2014", "we", "announced", "positive", "top-line", "results", "from", "a", "phase", "2", "trial", "assessing", "safety,", "efficacy", "and", "dose-response", "of", "three", "different", "once-daily", "oral", "SP-333", "tablets", "(1.0,", "3.0", "and", "6.0", "mg)", "compared", "with", "placebo", "in", "289", "patients", "with", "opioid-induced", "constipation", "(OIC)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_15_item1_p39_s1", "idA": "1347613_14_item1_p23_s3", "sentA": "The primary endpoint of the study is mean change from baseline in the number of SBMs during the 4-week treatment period.", "sentB": "Preliminary analysis of the data indicates SP-333 met the study s primary endpoint and demonstrated statistically significant improvement in mean change from baseline in the number of spontaneous bowel movements (SBMs) during Week 4 of the treatment period.", "type": 2, "words": ["<tag1>", "The", "primary", "endpoint", "of", "the", "study", "is", "mean", "change", "from", "baseline", "in", "the", "number", "of", "SBMs", "during", "the", "4-week", "treatment", "period.", "<tag2>", "Preliminary", "analysis", "of", "the", "data", "indicates", "SP-333", "met", "the", "study", "s", "primary", "endpoint", "and", "demonstrated", "statistically", "significant", "improvement", "in", "mean", "change", "from", "baseline", "in", "the", "number", "of", "spontaneous", "bowel", "movements", "(SBMs)", "during", "Week", "4", "of", "the", "treatment", "period.", "<tag3>"], "wordsA": ["The", "primary", "endpoint", "of", "the", "study", "is", "mean", "change", "from", "baseline", "in", "the", "number", "of", "SBMs", "during", "the", "4-week", "treatment", "period."], "wordsB": ["Preliminary", "analysis", "of", "the", "data", "indicates", "SP-333", "met", "the", "study", "s", "primary", "endpoint", "and", "demonstrated", "statistically", "significant", "improvement", "in", "mean", "change", "from", "baseline", "in", "the", "number", "of", "spontaneous", "bowel", "movements", "(SBMs)", "during", "Week", "4", "of", "the", "treatment", "period."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_15_item1_p7_s1", "idA": "1347613_14_item1_p23_s3", "sentA": "The primary endpoint of the study is mean change from baseline in the number of SBMs during the 4-week treatment period.", "sentB": "Preliminary analysis of the data indicates SP-333 met the study s primary endpoint and demonstrated statistically significant improvement in mean change from baseline in the number of spontaneous bowel movements (SBMs) during Week 4 of the treatment period.", "type": 2, "words": ["<tag1>", "The", "primary", "endpoint", "of", "the", "study", "is", "mean", "change", "from", "baseline", "in", "the", "number", "of", "SBMs", "during", "the", "4-week", "treatment", "period.", "<tag2>", "Preliminary", "analysis", "of", "the", "data", "indicates", "SP-333", "met", "the", "study", "s", "primary", "endpoint", "and", "demonstrated", "statistically", "significant", "improvement", "in", "mean", "change", "from", "baseline", "in", "the", "number", "of", "spontaneous", "bowel", "movements", "(SBMs)", "during", "Week", "4", "of", "the", "treatment", "period.", "<tag3>"], "wordsA": ["The", "primary", "endpoint", "of", "the", "study", "is", "mean", "change", "from", "baseline", "in", "the", "number", "of", "SBMs", "during", "the", "4-week", "treatment", "period."], "wordsB": ["Preliminary", "analysis", "of", "the", "data", "indicates", "SP-333", "met", "the", "study", "s", "primary", "endpoint", "and", "demonstrated", "statistically", "significant", "improvement", "in", "mean", "change", "from", "baseline", "in", "the", "number", "of", "spontaneous", "bowel", "movements", "(SBMs)", "during", "Week", "4", "of", "the", "treatment", "period."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_15_item1_p43_s0", "idA": "1347613_14_item1_p26_s0", "sentA": "We entered into a Contribution Agreement with ContraVir (the Contribution Agreement ), transferring the FV-100 Product to ContraVir, in exchange for the issuance to us of 9,000,000 shares of ContraVir common stock, par value $0.0001 per share , representing 100% of the outstanding shares of common stock as of immediately following such issuance.", "sentB": "On June 10, 2013 we entered into a Contribution Agreement with ContraVir (the Contribution Agreement ), transferring the FV-100 Product to ContraVir, in exchange for the issuance to us of 9,000,000 shares of ContraVir common stock, par value $0.0001 per share, representing 100% of the outstanding shares of common stock as of immediately following such issuance.", "type": 2, "words": ["<tag1>", "We", "entered", "into", "a", "Contribution", "Agreement", "with", "ContraVir", "(the", "Contribution", "Agreement", "),", "transferring", "the", "FV-100", "Product", "to", "ContraVir,", "in", "exchange", "for", "the", "issuance", "to", "us", "of", "9,000,000", "shares", "of", "ContraVir", "common", "stock,", "par", "value", "$0.0001", "per", "share", ",", "representing", "100%", "of", "the", "outstanding", "shares", "of", "common", "stock", "as", "of", "immediately", "following", "such", "issuance.", "<tag2>", "On", "June", "10,", "2013", "we", "entered", "into", "a", "Contribution", "Agreement", "with", "ContraVir", "(the", "Contribution", "Agreement", "),", "transferring", "the", "FV-100", "Product", "to", "ContraVir,", "in", "exchange", "for", "the", "issuance", "to", "us", "of", "9,000,000", "shares", "of", "ContraVir", "common", "stock,", "par", "value", "$0.0001", "per", "share,", "representing", "100%", "of", "the", "outstanding", "shares", "of", "common", "stock", "as", "of", "immediately", "following", "such", "issuance.", "<tag3>"], "wordsA": ["We", "entered", "into", "a", "Contribution", "Agreement", "with", "ContraVir", "(the", "Contribution", "Agreement", "),", "transferring", "the", "FV-100", "Product", "to", "ContraVir,", "in", "exchange", "for", "the", "issuance", "to", "us", "of", "9,000,000", "shares", "of", "ContraVir", "common", "stock,", "par", "value", "$0.0001", "per", "share", ",", "representing", "100%", "of", "the", "outstanding", "shares", "of", "common", "stock", "as", "of", "immediately", "following", "such", "issuance."], "wordsB": ["On", "June", "10,", "2013", "we", "entered", "into", "a", "Contribution", "Agreement", "with", "ContraVir", "(the", "Contribution", "Agreement", "),", "transferring", "the", "FV-100", "Product", "to", "ContraVir,", "in", "exchange", "for", "the", "issuance", "to", "us", "of", "9,000,000", "shares", "of", "ContraVir", "common", "stock,", "par", "value", "$0.0001", "per", "share,", "representing", "100%", "of", "the", "outstanding", "shares", "of", "common", "stock", "as", "of", "immediately", "following", "such", "issuance."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_15_item1_p43_s2", "idA": "1347613_14_item1_p26_s2", "sentA": "The contribution of this asset was accounted for at our net book value which was zero.", "sentB": "The contribution of this asset was accounted for at our net book value, which was zero.", "type": 2, "words": ["<tag1>", "The", "contribution", "of", "this", "asset", "was", "accounted", "for", "at", "our", "net", "book", "value", "which", "was", "zero.", "<tag2>", "The", "contribution", "of", "this", "asset", "was", "accounted", "for", "at", "our", "net", "book", "value,", "which", "was", "zero.", "<tag3>"], "wordsA": ["The", "contribution", "of", "this", "asset", "was", "accounted", "for", "at", "our", "net", "book", "value", "which", "was", "zero."], "wordsB": ["The", "contribution", "of", "this", "asset", "was", "accounted", "for", "at", "our", "net", "book", "value,", "which", "was", "zero."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_15_item1_p44_s0", "idA": "1347613_14_item1_p27_s0", "sentA": "On June 5, 2013, we entered into a Loan and Security Agreement, or Loan Agreement, with ContraVir pursuant to which we agreed to lend ContraVir up to five hundred thousand dollars ($500,000) for working capital purposes.", "sentB": "On June 5, 2013, ContraVir entered into a Loan and Security Agreement with us pursuant to which we agreed to lend ContraVir up to five hundred thousand dollars ($500,000) for working capital purposes (the Loan Agreement ).", "type": 2, "words": ["<tag1>", "On", "June", "5,", "2013,", "we", "entered", "into", "a", "Loan", "and", "Security", "Agreement,", "or", "Loan", "Agreement,", "with", "ContraVir", "pursuant", "to", "which", "we", "agreed", "to", "lend", "ContraVir", "up", "to", "five", "hundred", "thousand", "dollars", "($500,000)", "for", "working", "capital", "purposes.", "<tag2>", "On", "June", "5,", "2013,", "ContraVir", "entered", "into", "a", "Loan", "and", "Security", "Agreement", "with", "us", "pursuant", "to", "which", "we", "agreed", "to", "lend", "ContraVir", "up", "to", "five", "hundred", "thousand", "dollars", "($500,000)", "for", "working", "capital", "purposes", "(the", "Loan", "Agreement", ").", "<tag3>"], "wordsA": ["On", "June", "5,", "2013,", "we", "entered", "into", "a", "Loan", "and", "Security", "Agreement,", "or", "Loan", "Agreement,", "with", "ContraVir", "pursuant", "to", "which", "we", "agreed", "to", "lend", "ContraVir", "up", "to", "five", "hundred", "thousand", "dollars", "($500,000)", "for", "working", "capital", "purposes."], "wordsB": ["On", "June", "5,", "2013,", "ContraVir", "entered", "into", "a", "Loan", "and", "Security", "Agreement", "with", "us", "pursuant", "to", "which", "we", "agreed", "to", "lend", "ContraVir", "up", "to", "five", "hundred", "thousand", "dollars", "($500,000)", "for", "working", "capital", "purposes", "(the", "Loan", "Agreement", ")."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_15_item1_p44_s4", "idA": "1347613_14_item1_p27_s0", "sentA": "On June 5, 2013, we entered into a Loan and Security Agreement, or Loan Agreement, with ContraVir pursuant to which we agreed to lend ContraVir up to five hundred thousand dollars ($500,000) for working capital purposes.", "sentB": "On November 18, 2013, ContraVir entered into an amendment to the Loan Agreement with us pursuant to which we agreed to increase the aggregate amount available to ContraVir under the Loan Agreement from five hundred thousand dollars ($500,000) to one million dollars ($1,000,000).", "type": 2, "words": ["<tag1>", "On", "June", "5,", "2013,", "we", "entered", "into", "a", "Loan", "and", "Security", "Agreement,", "or", "Loan", "Agreement,", "with", "ContraVir", "pursuant", "to", "which", "we", "agreed", "to", "lend", "ContraVir", "up", "to", "five", "hundred", "thousand", "dollars", "($500,000)", "for", "working", "capital", "purposes.", "<tag2>", "On", "November", "18,", "2013,", "ContraVir", "entered", "into", "an", "amendment", "to", "the", "Loan", "Agreement", "with", "us", "pursuant", "to", "which", "we", "agreed", "to", "increase", "the", "aggregate", "amount", "available", "to", "ContraVir", "under", "the", "Loan", "Agreement", "from", "five", "hundred", "thousand", "dollars", "($500,000)", "to", "one", "million", "dollars", "($1,000,000).", "<tag3>"], "wordsA": ["On", "June", "5,", "2013,", "we", "entered", "into", "a", "Loan", "and", "Security", "Agreement,", "or", "Loan", "Agreement,", "with", "ContraVir", "pursuant", "to", "which", "we", "agreed", "to", "lend", "ContraVir", "up", "to", "five", "hundred", "thousand", "dollars", "($500,000)", "for", "working", "capital", "purposes."], "wordsB": ["On", "November", "18,", "2013,", "ContraVir", "entered", "into", "an", "amendment", "to", "the", "Loan", "Agreement", "with", "us", "pursuant", "to", "which", "we", "agreed", "to", "increase", "the", "aggregate", "amount", "available", "to", "ContraVir", "under", "the", "Loan", "Agreement", "from", "five", "hundred", "thousand", "dollars", "($500,000)", "to", "one", "million", "dollars", "($1,000,000)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_15_item1_p44_s1", "idA": "1347613_14_item1_p27_s1", "sentA": "Pursuant to the Loan Agreement, as of December 31, 2013, we made advances to ContraVir totaling $350,000 under a promissory note, or Note.", "sentB": "Also on June 5, 2013, August 29, 2013, October 18, 2013 and January 9, 2014, pursuant to the Loan Agreement, we made an advance to ContraVir of $100,000, $100,000, $150,000 and $100,000, respectively, under a Promissory Note (the Note ).", "type": 2, "words": ["<tag1>", "Pursuant", "to", "the", "Loan", "Agreement,", "as", "of", "December", "31,", "2013,", "we", "made", "advances", "to", "ContraVir", "totaling", "$350,000", "under", "a", "promissory", "note,", "or", "Note.", "<tag2>", "Also", "on", "June", "5,", "2013,", "August", "29,", "2013,", "October", "18,", "2013", "and", "January", "9,", "2014,", "pursuant", "to", "the", "Loan", "Agreement,", "we", "made", "an", "advance", "to", "ContraVir", "of", "$100,000,", "$100,000,", "$150,000", "and", "$100,000,", "respectively,", "under", "a", "Promissory", "Note", "(the", "Note", ").", "<tag3>"], "wordsA": ["Pursuant", "to", "the", "Loan", "Agreement,", "as", "of", "December", "31,", "2013,", "we", "made", "advances", "to", "ContraVir", "totaling", "$350,000", "under", "a", "promissory", "note,", "or", "Note."], "wordsB": ["Also", "on", "June", "5,", "2013,", "August", "29,", "2013,", "October", "18,", "2013", "and", "January", "9,", "2014,", "pursuant", "to", "the", "Loan", "Agreement,", "we", "made", "an", "advance", "to", "ContraVir", "of", "$100,000,", "$100,000,", "$150,000", "and", "$100,000,", "respectively,", "under", "a", "Promissory", "Note", "(the", "Note", ")."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_15_item1_p44_s2", "idA": "1347613_14_item1_p27_s2", "sentA": "The Note bears interest at six percent (6%) per annum.", "sentB": "The Note bore interest at six percent (6%) per annum.", "type": 2, "words": ["<tag1>", "The", "Note", "bears", "interest", "at", "six", "percent", "(6%)", "per", "annum.", "<tag2>", "The", "Note", "bore", "interest", "at", "six", "percent", "(6%)", "per", "annum.", "<tag3>"], "wordsA": ["The", "Note", "bears", "interest", "at", "six", "percent", "(6%)", "per", "annum."], "wordsB": ["The", "Note", "bore", "interest", "at", "six", "percent", "(6%)", "per", "annum."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_15_item1_p44_s3", "idA": "1347613_14_item1_p27_s4", "sentA": "In connection with the Loan Agreement, ContraVir granted us a security interest in all of its assets, including its intellectual property, until the Note is repaid in full.", "sentB": "In connection with the Loan Agreement ContraVir granted to us a security interest in all of its assets, including its intellectual property, until the Note is repaid in full.", "type": 2, "words": ["<tag1>", "In", "connection", "with", "the", "Loan", "Agreement,", "ContraVir", "granted", "us", "a", "security", "interest", "in", "all", "of", "its", "assets,", "including", "its", "intellectual", "property,", "until", "the", "Note", "is", "repaid", "in", "full.", "<tag2>", "In", "connection", "with", "the", "Loan", "Agreement", "ContraVir", "granted", "to", "us", "a", "security", "interest", "in", "all", "of", "its", "assets,", "including", "its", "intellectual", "property,", "until", "the", "Note", "is", "repaid", "in", "full.", "<tag3>"], "wordsA": ["In", "connection", "with", "the", "Loan", "Agreement,", "ContraVir", "granted", "us", "a", "security", "interest", "in", "all", "of", "its", "assets,", "including", "its", "intellectual", "property,", "until", "the", "Note", "is", "repaid", "in", "full."], "wordsB": ["In", "connection", "with", "the", "Loan", "Agreement", "ContraVir", "granted", "to", "us", "a", "security", "interest", "in", "all", "of", "its", "assets,", "including", "its", "intellectual", "property,", "until", "the", "Note", "is", "repaid", "in", "full."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_15_item1_p45_s0", "idA": "1347613_14_item1_p28_s0", "sentA": "On July 8, 2013, ContraVir entered into a Shared Services Agreement with us, effective May 16, 2013.", "sentB": "On July 8, 2013, ContraVir entered into a Shared Services Agreement, as amended and restated August 5, 2013, with us, effective May 16, 2013.", "type": 2, "words": ["<tag1>", "On", "July", "8,", "2013,", "ContraVir", "entered", "into", "a", "Shared", "Services", "Agreement", "with", "us,", "effective", "May", "16,", "2013.", "<tag2>", "On", "July", "8,", "2013,", "ContraVir", "entered", "into", "a", "Shared", "Services", "Agreement,", "as", "amended", "and", "restated", "August", "5,", "2013,", "with", "us,", "effective", "May", "16,", "2013.", "<tag3>"], "wordsA": ["On", "July", "8,", "2013,", "ContraVir", "entered", "into", "a", "Shared", "Services", "Agreement", "with", "us,", "effective", "May", "16,", "2013."], "wordsB": ["On", "July", "8,", "2013,", "ContraVir", "entered", "into", "a", "Shared", "Services", "Agreement,", "as", "amended", "and", "restated", "August", "5,", "2013,", "with", "us,", "effective", "May", "16,", "2013."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_15_item1_p45_s1", "idA": "1347613_14_item1_p28_s1", "sentA": "Under the Shared Services Agreement, we will provide and/or make available to ContraVir various administrative, financial (including payroll functions), legal, insurance, facility, information technology, laboratory, real estate and other services to be provided by, or on behalf of, us, together with such other services as reasonably requested by ContraVir.", "sentB": "Under the Shared Services Agreement, we provided and/or made available to ContraVir various administrative, financial (accounting), insurance, facility, information technology, and other services.", "type": 2, "words": ["<tag1>", "Under", "the", "Shared", "Services", "Agreement,", "we", "will", "provide", "and/or", "make", "available", "to", "ContraVir", "various", "administrative,", "financial", "(including", "payroll", "functions),", "legal,", "insurance,", "facility,", "information", "technology,", "laboratory,", "real", "estate", "and", "other", "services", "to", "be", "provided", "by,", "or", "on", "behalf", "of,", "us,", "together", "with", "such", "other", "services", "as", "reasonably", "requested", "by", "ContraVir.", "<tag2>", "Under", "the", "Shared", "Services", "Agreement,", "we", "provided", "and/or", "made", "available", "to", "ContraVir", "various", "administrative,", "financial", "(accounting),", "insurance,", "facility,", "information", "technology,", "and", "other", "services.", "<tag3>"], "wordsA": ["Under", "the", "Shared", "Services", "Agreement,", "we", "will", "provide", "and/or", "make", "available", "to", "ContraVir", "various", "administrative,", "financial", "(including", "payroll", "functions),", "legal,", "insurance,", "facility,", "information", "technology,", "laboratory,", "real", "estate", "and", "other", "services", "to", "be", "provided", "by,", "or", "on", "behalf", "of,", "us,", "together", "with", "such", "other", "services", "as", "reasonably", "requested", "by", "ContraVir."], "wordsB": ["Under", "the", "Shared", "Services", "Agreement,", "we", "provided", "and/or", "made", "available", "to", "ContraVir", "various", "administrative,", "financial", "(accounting),", "insurance,", "facility,", "information", "technology,", "and", "other", "services."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_15_item1_p61_s0", "idA": "1347613_14_item1_p29_s0", "sentA": "On August 8, 2013, ContraVir Pharmaceuticals, Inc. filed an initial Form 10 Registration Statement with the U.S. Securities and Exchange Commission.", "sentB": "In April 2010, two parties filed an opposition to one of our granted European patents with the European Patent Office.", "type": 2, "words": ["<tag1>", "On", "August", "8,", "2013,", "ContraVir", "Pharmaceuticals,", "Inc.", "filed", "an", "initial", "Form", "10", "Registration", "Statement", "with", "the", "U.S.", "Securities", "and", "Exchange", "Commission.", "<tag2>", "In", "April", "2010,", "two", "parties", "filed", "an", "opposition", "to", "one", "of", "our", "granted", "European", "patents", "with", "the", "European", "Patent", "Office.", "<tag3>"], "wordsA": ["On", "August", "8,", "2013,", "ContraVir", "Pharmaceuticals,", "Inc.", "filed", "an", "initial", "Form", "10", "Registration", "Statement", "with", "the", "U.S.", "Securities", "and", "Exchange", "Commission."], "wordsB": ["In", "April", "2010,", "two", "parties", "filed", "an", "opposition", "to", "one", "of", "our", "granted", "European", "patents", "with", "the", "European", "Patent", "Office."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_15_item1_p44_s5", "idA": "1347613_14_item1_p29_s3", "sentA": "We believe the distribution of the ContraVir shares of common stock to our stockholders was not material to us.", "sentB": "On March 27, 2014, ContraVir paid $461,236 to us in full repayment of the advance, including accrued but unpaid interest thereon.", "type": 2, "words": ["<tag1>", "We", "believe", "the", "distribution", "of", "the", "ContraVir", "shares", "of", "common", "stock", "to", "our", "stockholders", "was", "not", "material", "to", "us.", "<tag2>", "On", "March", "27,", "2014,", "ContraVir", "paid", "$461,236", "to", "us", "in", "full", "repayment", "of", "the", "advance,", "including", "accrued", "but", "unpaid", "interest", "thereon.", "<tag3>"], "wordsA": ["We", "believe", "the", "distribution", "of", "the", "ContraVir", "shares", "of", "common", "stock", "to", "our", "stockholders", "was", "not", "material", "to", "us."], "wordsB": ["On", "March", "27,", "2014,", "ContraVir", "paid", "$461,236", "to", "us", "in", "full", "repayment", "of", "the", "advance,", "including", "accrued", "but", "unpaid", "interest", "thereon."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_15_item1_p49_s0", "idA": "1347613_14_item1_p30_s0", "sentA": "As a result of the Distribution, an adjustment was made to the exercise price of all outstanding warrants in accordance with their terms and accordingly the exercise price decreased approximately $0.011 per share on the record date.", "sentB": "As a result of the ContraVir distribution, an adjustment was made to the exercise price of all our outstanding warrants in accordance with their terms.", "type": 2, "words": ["<tag1>", "As", "a", "result", "of", "the", "Distribution,", "an", "adjustment", "was", "made", "to", "the", "exercise", "price", "of", "all", "outstanding", "warrants", "in", "accordance", "with", "their", "terms", "and", "accordingly", "the", "exercise", "price", "decreased", "approximately", "$0.011", "per", "share", "on", "the", "record", "date.", "<tag2>", "As", "a", "result", "of", "the", "ContraVir", "distribution,", "an", "adjustment", "was", "made", "to", "the", "exercise", "price", "of", "all", "our", "outstanding", "warrants", "in", "accordance", "with", "their", "terms.", "<tag3>"], "wordsA": ["As", "a", "result", "of", "the", "Distribution,", "an", "adjustment", "was", "made", "to", "the", "exercise", "price", "of", "all", "outstanding", "warrants", "in", "accordance", "with", "their", "terms", "and", "accordingly", "the", "exercise", "price", "decreased", "approximately", "$0.011", "per", "share", "on", "the", "record", "date."], "wordsB": ["As", "a", "result", "of", "the", "ContraVir", "distribution,", "an", "adjustment", "was", "made", "to", "the", "exercise", "price", "of", "all", "our", "outstanding", "warrants", "in", "accordance", "with", "their", "terms."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_15_item1_p49_s1", "idA": "1347613_14_item1_p30_s0", "sentA": "As a result of the Distribution, an adjustment was made to the exercise price of all outstanding warrants in accordance with their terms and accordingly the exercise price decreased approximately $0.011 per share on the record date.", "sentB": "Accordingly the exercise price decreased approximately $0.011 per share on the record date.", "type": 2, "words": ["<tag1>", "As", "a", "result", "of", "the", "Distribution,", "an", "adjustment", "was", "made", "to", "the", "exercise", "price", "of", "all", "outstanding", "warrants", "in", "accordance", "with", "their", "terms", "and", "accordingly", "the", "exercise", "price", "decreased", "approximately", "$0.011", "per", "share", "on", "the", "record", "date.", "<tag2>", "Accordingly", "the", "exercise", "price", "decreased", "approximately", "$0.011", "per", "share", "on", "the", "record", "date.", "<tag3>"], "wordsA": ["As", "a", "result", "of", "the", "Distribution,", "an", "adjustment", "was", "made", "to", "the", "exercise", "price", "of", "all", "outstanding", "warrants", "in", "accordance", "with", "their", "terms", "and", "accordingly", "the", "exercise", "price", "decreased", "approximately", "$0.011", "per", "share", "on", "the", "record", "date."], "wordsB": ["Accordingly", "the", "exercise", "price", "decreased", "approximately", "$0.011", "per", "share", "on", "the", "record", "date."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_15_item1_p49_s2", "idA": "1347613_14_item1_p30_s1", "sentA": "As of December 31, 2013 there were 5,647,203 warrants outstanding with a weighted average exercise price of $5.37 per share pre-Distribution and $5.359 per share as adjusted.", "sentB": "As of December 31, 2014, there were 3,378,453 of our non-public warrants outstanding with a weighted average exercise price of $5.34 per share pre-distribution and $5.33 per share as adjusted.", "type": 2, "words": ["<tag1>", "As", "of", "December", "31,", "2013", "there", "were", "5,647,203", "warrants", "outstanding", "with", "a", "weighted", "average", "exercise", "price", "of", "$5.37", "per", "share", "pre-Distribution", "and", "$5.359", "per", "share", "as", "adjusted.", "<tag2>", "As", "of", "December", "31,", "2014,", "there", "were", "3,378,453", "of", "our", "non-public", "warrants", "outstanding", "with", "a", "weighted", "average", "exercise", "price", "of", "$5.34", "per", "share", "pre-distribution", "and", "$5.33", "per", "share", "as", "adjusted.", "<tag3>"], "wordsA": ["As", "of", "December", "31,", "2013", "there", "were", "5,647,203", "warrants", "outstanding", "with", "a", "weighted", "average", "exercise", "price", "of", "$5.37", "per", "share", "pre-Distribution", "and", "$5.359", "per", "share", "as", "adjusted."], "wordsB": ["As", "of", "December", "31,", "2014,", "there", "were", "3,378,453", "of", "our", "non-public", "warrants", "outstanding", "with", "a", "weighted", "average", "exercise", "price", "of", "$5.34", "per", "share", "pre-distribution", "and", "$5.33", "per", "share", "as", "adjusted."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_15_item1_p51_s1", "idA": "1347613_14_item1_p32_s1", "sentA": "As a result of the Merger, each outstanding share of Callisto common stock was converted into the right to receive 0.1799 of one share of our common stock and the 22,295,000 shares of our common stock held by Callisto were canceled.", "sentB": "Pursuant to the Merger Agreement, each outstanding share of Callisto common stock was converted into the right to receive 0.1799 ( the Exchange Ratio ) of one share of our common stock and the 22,295,000 shares of our common stock held by Callisto were canceled.", "type": 2, "words": ["<tag1>", "As", "a", "result", "of", "the", "Merger,", "each", "outstanding", "share", "of", "Callisto", "common", "stock", "was", "converted", "into", "the", "right", "to", "receive", "0.1799", "of", "one", "share", "of", "our", "common", "stock", "and", "the", "22,295,000", "shares", "of", "our", "common", "stock", "held", "by", "Callisto", "were", "canceled.", "<tag2>", "Pursuant", "to", "the", "Merger", "Agreement,", "each", "outstanding", "share", "of", "Callisto", "common", "stock", "was", "converted", "into", "the", "right", "to", "receive", "0.1799", "(", "the", "Exchange", "Ratio", ")", "of", "one", "share", "of", "our", "common", "stock", "and", "the", "22,295,000", "shares", "of", "our", "common", "stock", "held", "by", "Callisto", "were", "canceled.", "<tag3>"], "wordsA": ["As", "a", "result", "of", "the", "Merger,", "each", "outstanding", "share", "of", "Callisto", "common", "stock", "was", "converted", "into", "the", "right", "to", "receive", "0.1799", "of", "one", "share", "of", "our", "common", "stock", "and", "the", "22,295,000", "shares", "of", "our", "common", "stock", "held", "by", "Callisto", "were", "canceled."], "wordsB": ["Pursuant", "to", "the", "Merger", "Agreement,", "each", "outstanding", "share", "of", "Callisto", "common", "stock", "was", "converted", "into", "the", "right", "to", "receive", "0.1799", "(", "the", "Exchange", "Ratio", ")", "of", "one", "share", "of", "our", "common", "stock", "and", "the", "22,295,000", "shares", "of", "our", "common", "stock", "held", "by", "Callisto", "were", "canceled."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_15_item1_p12_s0", "idA": "1347613_14_item1_p32_s5", "sentA": "In connection with the consummation of the merger, we issued a total of approximately 28,605,354 shares of our common stock to former Callisto stockholders in exchange for their shares of Callisto common stock.", "sentB": "The notes are convertible, at any time, into shares of our common stock at an initial conversion rate of 321.5434 shares per $1,000 principal amount of notes, which is equivalent to an initial conversion price of $3.11 per share.", "type": 2, "words": ["<tag1>", "In", "connection", "with", "the", "consummation", "of", "the", "merger,", "we", "issued", "a", "total", "of", "approximately", "28,605,354", "shares", "of", "our", "common", "stock", "to", "former", "Callisto", "stockholders", "in", "exchange", "for", "their", "shares", "of", "Callisto", "common", "stock.", "<tag2>", "The", "notes", "are", "convertible,", "at", "any", "time,", "into", "shares", "of", "our", "common", "stock", "at", "an", "initial", "conversion", "rate", "of", "321.5434", "shares", "per", "$1,000", "principal", "amount", "of", "notes,", "which", "is", "equivalent", "to", "an", "initial", "conversion", "price", "of", "$3.11", "per", "share.", "<tag3>"], "wordsA": ["In", "connection", "with", "the", "consummation", "of", "the", "merger,", "we", "issued", "a", "total", "of", "approximately", "28,605,354", "shares", "of", "our", "common", "stock", "to", "former", "Callisto", "stockholders", "in", "exchange", "for", "their", "shares", "of", "Callisto", "common", "stock."], "wordsB": ["The", "notes", "are", "convertible,", "at", "any", "time,", "into", "shares", "of", "our", "common", "stock", "at", "an", "initial", "conversion", "rate", "of", "321.5434", "shares", "per", "$1,000", "principal", "amount", "of", "notes,", "which", "is", "equivalent", "to", "an", "initial", "conversion", "price", "of", "$3.11", "per", "share."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_15_item1_p52_s3", "idA": "1347613_14_item1_p33_s3", "sentA": "Therefore, considering this discount, the share exchange was determined to be equal from a fair value stand point.", "sentB": "Therefore, considering this discount, the share exchange was determined to be equal from a fair value standpoint.", "type": 2, "words": ["<tag1>", "Therefore,", "considering", "this", "discount,", "the", "share", "exchange", "was", "determined", "to", "be", "equal", "from", "a", "fair", "value", "stand", "point.", "<tag2>", "Therefore,", "considering", "this", "discount,", "the", "share", "exchange", "was", "determined", "to", "be", "equal", "from", "a", "fair", "value", "standpoint.", "<tag3>"], "wordsA": ["Therefore,", "considering", "this", "discount,", "the", "share", "exchange", "was", "determined", "to", "be", "equal", "from", "a", "fair", "value", "stand", "point."], "wordsB": ["Therefore,", "considering", "this", "discount,", "the", "share", "exchange", "was", "determined", "to", "be", "equal", "from", "a", "fair", "value", "standpoint."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_15_item1_p47_s0", "idA": "1347613_14_item1_p34_s0", "sentA": "On January 17, 2013, the effective date of the merger, we accounted for the merger by assuming Callisto s net liabilities, of approximately $1.7 million, principally trade payables.", "sentB": "We accounted for this distribution according to FASB ASC Topic 505-60, Spinoffs and reverse spinoffs by eliminating ContraVir s net assets of approximately $1.7 million, with a corresponding decrease in additional paid in capital and the non-controlling interest of $1.6 million.", "type": 2, "words": ["<tag1>", "On", "January", "17,", "2013,", "the", "effective", "date", "of", "the", "merger,", "we", "accounted", "for", "the", "merger", "by", "assuming", "Callisto", "s", "net", "liabilities,", "of", "approximately", "$1.7", "million,", "principally", "trade", "payables.", "<tag2>", "We", "accounted", "for", "this", "distribution", "according", "to", "FASB", "ASC", "Topic", "505-60,", "Spinoffs", "and", "reverse", "spinoffs", "by", "eliminating", "ContraVir", "s", "net", "assets", "of", "approximately", "$1.7", "million,", "with", "a", "corresponding", "decrease", "in", "additional", "paid", "in", "capital", "and", "the", "non-controlling", "interest", "of", "$1.6", "million.", "<tag3>"], "wordsA": ["On", "January", "17,", "2013,", "the", "effective", "date", "of", "the", "merger,", "we", "accounted", "for", "the", "merger", "by", "assuming", "Callisto", "s", "net", "liabilities,", "of", "approximately", "$1.7", "million,", "principally", "trade", "payables."], "wordsB": ["We", "accounted", "for", "this", "distribution", "according", "to", "FASB", "ASC", "Topic", "505-60,", "Spinoffs", "and", "reverse", "spinoffs", "by", "eliminating", "ContraVir", "s", "net", "assets", "of", "approximately", "$1.7", "million,", "with", "a", "corresponding", "decrease", "in", "additional", "paid", "in", "capital", "and", "the", "non-controlling", "interest", "of", "$1.6", "million."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_15_item1_p48_s0", "idA": "1347613_14_item1_p34_s1", "sentA": "In accordance with ASC 805, our financial statements were not restated retroactively to reflect the historical financial position or results of operations of Callisto.", "sentB": "The spin-off of ContraVir s operation had an immaterial effect on our financial statements.", "type": 2, "words": ["<tag1>", "In", "accordance", "with", "ASC", "805,", "our", "financial", "statements", "were", "not", "restated", "retroactively", "to", "reflect", "the", "historical", "financial", "position", "or", "results", "of", "operations", "of", "Callisto.", "<tag2>", "The", "spin-off", "of", "ContraVir", "s", "operation", "had", "an", "immaterial", "effect", "on", "our", "financial", "statements.", "<tag3>"], "wordsA": ["In", "accordance", "with", "ASC", "805,", "our", "financial", "statements", "were", "not", "restated", "retroactively", "to", "reflect", "the", "historical", "financial", "position", "or", "results", "of", "operations", "of", "Callisto."], "wordsB": ["The", "spin-off", "of", "ContraVir", "s", "operation", "had", "an", "immaterial", "effect", "on", "our", "financial", "statements."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_15_item1_p54_s1", "idA": "1347613_14_item1_p36_s0", "sentA": "Pharmaceuticals America, Inc., Sucampo Pharmaceuticals, Inc., Salix Pharmaceuticals, Inc. and Shire Plc.", "sentB": "Our competitors include major pharmaceutical and biotechnology companies focusing on GI such as Ironwood Pharmaceuticals, Inc., Actavis plc, Takeda Pharmaceuticals America, Inc., Sucampo Pharmaceuticals, Inc., AstraZeneca, Salix Pharmaceuticals, Inc. and Shire Plc.", "type": 2, "words": ["<tag1>", "Pharmaceuticals", "America,", "Inc.,", "Sucampo", "Pharmaceuticals,", "Inc.,", "Salix", "Pharmaceuticals,", "Inc.", "and", "Shire", "Plc.", "<tag2>", "Our", "competitors", "include", "major", "pharmaceutical", "and", "biotechnology", "companies", "focusing", "on", "GI", "such", "as", "Ironwood", "Pharmaceuticals,", "Inc.,", "Actavis", "plc,", "Takeda", "Pharmaceuticals", "America,", "Inc.,", "Sucampo", "Pharmaceuticals,", "Inc.,", "AstraZeneca,", "Salix", "Pharmaceuticals,", "Inc.", "and", "Shire", "Plc.", "<tag3>"], "wordsA": ["Pharmaceuticals", "America,", "Inc.,", "Sucampo", "Pharmaceuticals,", "Inc.,", "Salix", "Pharmaceuticals,", "Inc.", "and", "Shire", "Plc."], "wordsB": ["Our", "competitors", "include", "major", "pharmaceutical", "and", "biotechnology", "companies", "focusing", "on", "GI", "such", "as", "Ironwood", "Pharmaceuticals,", "Inc.,", "Actavis", "plc,", "Takeda", "Pharmaceuticals", "America,", "Inc.,", "Sucampo", "Pharmaceuticals,", "Inc.,", "AstraZeneca,", "Salix", "Pharmaceuticals,", "Inc.", "and", "Shire", "Plc."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_15_item1_p56_s1", "idA": "1347613_14_item1_p39_s1", "sentA": "Research and development expenses for the twelve months ended December 31, 2013 were approximately $50 million, as compared to approximately $29 million and $13 million for the twelve months ended December 31, 2012 and 2011, respectively.", "sentB": "Research and development expenses for the twelve months ended December 31, 2014 were approximately $83 million, as compared to approximately $51 million and $29 million for the twelve months ended December 31, 2013 and 2012, respectively.", "type": 2, "words": ["<tag1>", "Research", "and", "development", "expenses", "for", "the", "twelve", "months", "ended", "December", "31,", "2013", "were", "approximately", "$50", "million,", "as", "compared", "to", "approximately", "$29", "million", "and", "$13", "million", "for", "the", "twelve", "months", "ended", "December", "31,", "2012", "and", "2011,", "respectively.", "<tag2>", "Research", "and", "development", "expenses", "for", "the", "twelve", "months", "ended", "December", "31,", "2014", "were", "approximately", "$83", "million,", "as", "compared", "to", "approximately", "$51", "million", "and", "$29", "million", "for", "the", "twelve", "months", "ended", "December", "31,", "2013", "and", "2012,", "respectively.", "<tag3>"], "wordsA": ["Research", "and", "development", "expenses", "for", "the", "twelve", "months", "ended", "December", "31,", "2013", "were", "approximately", "$50", "million,", "as", "compared", "to", "approximately", "$29", "million", "and", "$13", "million", "for", "the", "twelve", "months", "ended", "December", "31,", "2012", "and", "2011,", "respectively."], "wordsB": ["Research", "and", "development", "expenses", "for", "the", "twelve", "months", "ended", "December", "31,", "2014", "were", "approximately", "$83", "million,", "as", "compared", "to", "approximately", "$51", "million", "and", "$29", "million", "for", "the", "twelve", "months", "ended", "December", "31,", "2013", "and", "2012,", "respectively."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_15_item1_p57_s0", "idA": "1347613_14_item1_p40_s0", "sentA": "In accordance with FASB ASC Topic 730-10-55, Research and Development, we recorded prepaid research and development costs of approximately $3.6 million as of December 31, 2013, as compared to approximately $0.9 million as of December 31, 2012, for nonrefundable pre-payments for production of drug substance, analytical testing services for our drug candidates, and upcoming clinical trials of plecanatide and SP-333.", "sentB": "In accordance with FASB ASC Topic 730-10-55, Research and Development, we recorded prepaid research and development costs of approximately $3.6 million as of December 31, 2014 and December 31, 2013, respectively, for nonrefundable pre-payments for production of drug substance, analytical testing services for our drug candidates, and upcoming clinical trials of plecanatide and SP-333.", "type": 2, "words": ["<tag1>", "In", "accordance", "with", "FASB", "ASC", "Topic", "730-10-55,", "Research", "and", "Development,", "we", "recorded", "prepaid", "research", "and", "development", "costs", "of", "approximately", "$3.6", "million", "as", "of", "December", "31,", "2013,", "as", "compared", "to", "approximately", "$0.9", "million", "as", "of", "December", "31,", "2012,", "for", "nonrefundable", "pre-payments", "for", "production", "of", "drug", "substance,", "analytical", "testing", "services", "for", "our", "drug", "candidates,", "and", "upcoming", "clinical", "trials", "of", "plecanatide", "and", "SP-333.", "<tag2>", "In", "accordance", "with", "FASB", "ASC", "Topic", "730-10-55,", "Research", "and", "Development,", "we", "recorded", "prepaid", "research", "and", "development", "costs", "of", "approximately", "$3.6", "million", "as", "of", "December", "31,", "2014", "and", "December", "31,", "2013,", "respectively,", "for", "nonrefundable", "pre-payments", "for", "production", "of", "drug", "substance,", "analytical", "testing", "services", "for", "our", "drug", "candidates,", "and", "upcoming", "clinical", "trials", "of", "plecanatide", "and", "SP-333.", "<tag3>"], "wordsA": ["In", "accordance", "with", "FASB", "ASC", "Topic", "730-10-55,", "Research", "and", "Development,", "we", "recorded", "prepaid", "research", "and", "development", "costs", "of", "approximately", "$3.6", "million", "as", "of", "December", "31,", "2013,", "as", "compared", "to", "approximately", "$0.9", "million", "as", "of", "December", "31,", "2012,", "for", "nonrefundable", "pre-payments", "for", "production", "of", "drug", "substance,", "analytical", "testing", "services", "for", "our", "drug", "candidates,", "and", "upcoming", "clinical", "trials", "of", "plecanatide", "and", "SP-333."], "wordsB": ["In", "accordance", "with", "FASB", "ASC", "Topic", "730-10-55,", "Research", "and", "Development,", "we", "recorded", "prepaid", "research", "and", "development", "costs", "of", "approximately", "$3.6", "million", "as", "of", "December", "31,", "2014", "and", "December", "31,", "2013,", "respectively,", "for", "nonrefundable", "pre-payments", "for", "production", "of", "drug", "substance,", "analytical", "testing", "services", "for", "our", "drug", "candidates,", "and", "upcoming", "clinical", "trials", "of", "plecanatide", "and", "SP-333."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_15_item1_p59_s0", "idA": "1347613_14_item1_p42_s0", "sentA": "As of December 31, 2013, we have eleven issued United States patents related to guanylate cyclase agonists.", "sentB": "As of March 6, 2015 we have 15 issued United States patents related to guanylate cyclase agonists.", "type": 2, "words": ["<tag1>", "As", "of", "December", "31,", "2013,", "we", "have", "eleven", "issued", "United", "States", "patents", "related", "to", "guanylate", "cyclase", "agonists.", "<tag2>", "As", "of", "March", "6,", "2015", "we", "have", "15", "issued", "United", "States", "patents", "related", "to", "guanylate", "cyclase", "agonists.", "<tag3>"], "wordsA": ["As", "of", "December", "31,", "2013,", "we", "have", "eleven", "issued", "United", "States", "patents", "related", "to", "guanylate", "cyclase", "agonists."], "wordsB": ["As", "of", "March", "6,", "2015", "we", "have", "15", "issued", "United", "States", "patents", "related", "to", "guanylate", "cyclase", "agonists."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_15_item1_p59_s14", "idA": "1347613_14_item1_p42_s10", "sentA": "In addition, we have four granted foreign patents which cover composition-of-matter of plecanatide and expire in 2022.", "sentB": "In addition, we have four granted foreign patents which cover the composition-of-matter of plecanatide and expire in 2022.", "type": 2, "words": ["<tag1>", "In", "addition,", "we", "have", "four", "granted", "foreign", "patents", "which", "cover", "composition-of-matter", "of", "plecanatide", "and", "expire", "in", "2022.", "<tag2>", "In", "addition,", "we", "have", "four", "granted", "foreign", "patents", "which", "cover", "the", "composition-of-matter", "of", "plecanatide", "and", "expire", "in", "2022.", "<tag3>"], "wordsA": ["In", "addition,", "we", "have", "four", "granted", "foreign", "patents", "which", "cover", "composition-of-matter", "of", "plecanatide", "and", "expire", "in", "2022."], "wordsB": ["In", "addition,", "we", "have", "four", "granted", "foreign", "patents", "which", "cover", "the", "composition-of-matter", "of", "plecanatide", "and", "expire", "in", "2022."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_15_item1_p59_s15", "idA": "1347613_14_item1_p42_s11", "sentA": "These foreign patents cover Austria, Belgium, Switzerland, Cyprus, Germany, Denmark, Spain, Finland, France, United Kingdom, Greece, Ireland, Italy, Liechtenstein, Luxembourg, Monaco, Netherlands, Portugal, Sweden, Turkey, Armenia, Azerbaijan, Belarus, Kazakhstan, Kyrgyz Republic, Moldova, Russian Federation, Tajikistan, Turkmenistan, Canada and Japan.", "sentB": "These foreign patents cover Austria, Belgium, Switzerland, Cyprus, Germany, Denmark, Spain, Finland, France, the United Kingdom, Greece, Ireland, Italy, Liechtenstein, Luxembourg, Monaco, the Netherlands, Portugal, Sweden, Turkey, Armenia, Azerbaijan, Belarus, Kazakhstan, the Kyrgyz Republic, Moldova, the Russian Federation, Tajikistan, Turkmenistan, Canada and Japan.", "type": 2, "words": ["<tag1>", "These", "foreign", "patents", "cover", "Austria,", "Belgium,", "Switzerland,", "Cyprus,", "Germany,", "Denmark,", "Spain,", "Finland,", "France,", "United", "Kingdom,", "Greece,", "Ireland,", "Italy,", "Liechtenstein,", "Luxembourg,", "Monaco,", "Netherlands,", "Portugal,", "Sweden,", "Turkey,", "Armenia,", "Azerbaijan,", "Belarus,", "Kazakhstan,", "Kyrgyz", "Republic,", "Moldova,", "Russian", "Federation,", "Tajikistan,", "Turkmenistan,", "Canada", "and", "Japan.", "<tag2>", "These", "foreign", "patents", "cover", "Austria,", "Belgium,", "Switzerland,", "Cyprus,", "Germany,", "Denmark,", "Spain,", "Finland,", "France,", "the", "United", "Kingdom,", "Greece,", "Ireland,", "Italy,", "Liechtenstein,", "Luxembourg,", "Monaco,", "the", "Netherlands,", "Portugal,", "Sweden,", "Turkey,", "Armenia,", "Azerbaijan,", "Belarus,", "Kazakhstan,", "the", "Kyrgyz", "Republic,", "Moldova,", "the", "Russian", "Federation,", "Tajikistan,", "Turkmenistan,", "Canada", "and", "Japan.", "<tag3>"], "wordsA": ["These", "foreign", "patents", "cover", "Austria,", "Belgium,", "Switzerland,", "Cyprus,", "Germany,", "Denmark,", "Spain,", "Finland,", "France,", "United", "Kingdom,", "Greece,", "Ireland,", "Italy,", "Liechtenstein,", "Luxembourg,", "Monaco,", "Netherlands,", "Portugal,", "Sweden,", "Turkey,", "Armenia,", "Azerbaijan,", "Belarus,", "Kazakhstan,", "Kyrgyz", "Republic,", "Moldova,", "Russian", "Federation,", "Tajikistan,", "Turkmenistan,", "Canada", "and", "Japan."], "wordsB": ["These", "foreign", "patents", "cover", "Austria,", "Belgium,", "Switzerland,", "Cyprus,", "Germany,", "Denmark,", "Spain,", "Finland,", "France,", "the", "United", "Kingdom,", "Greece,", "Ireland,", "Italy,", "Liechtenstein,", "Luxembourg,", "Monaco,", "the", "Netherlands,", "Portugal,", "Sweden,", "Turkey,", "Armenia,", "Azerbaijan,", "Belarus,", "Kazakhstan,", "the", "Kyrgyz", "Republic,", "Moldova,", "the", "Russian", "Federation,", "Tajikistan,", "Turkmenistan,", "Canada", "and", "Japan."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_15_item1_p59_s16", "idA": "1347613_14_item1_p42_s12", "sentA": "We also have two granted foreign patents that cover composition of matter related to SP-333 that expire in 2028.", "sentB": "We also have six granted foreign patents that cover the composition-of-matter related to SP-333 that expire in 2028.", "type": 2, "words": ["<tag1>", "We", "also", "have", "two", "granted", "foreign", "patents", "that", "cover", "composition", "of", "matter", "related", "to", "SP-333", "that", "expire", "in", "2028.", "<tag2>", "We", "also", "have", "six", "granted", "foreign", "patents", "that", "cover", "the", "composition-of-matter", "related", "to", "SP-333", "that", "expire", "in", "2028.", "<tag3>"], "wordsA": ["We", "also", "have", "two", "granted", "foreign", "patents", "that", "cover", "composition", "of", "matter", "related", "to", "SP-333", "that", "expire", "in", "2028."], "wordsB": ["We", "also", "have", "six", "granted", "foreign", "patents", "that", "cover", "the", "composition-of-matter", "related", "to", "SP-333", "that", "expire", "in", "2028."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_15_item1_p59_s18", "idA": "1347613_14_item1_p42_s12", "sentA": "We also have two granted foreign patents that cover composition of matter related to SP-333 that expire in 2028.", "sentB": "We also have two foreign patents that cover composition-of-matter of certain analogs related to plecanatide and expire in 2029.", "type": 2, "words": ["<tag1>", "We", "also", "have", "two", "granted", "foreign", "patents", "that", "cover", "composition", "of", "matter", "related", "to", "SP-333", "that", "expire", "in", "2028.", "<tag2>", "We", "also", "have", "two", "foreign", "patents", "that", "cover", "composition-of-matter", "of", "certain", "analogs", "related", "to", "plecanatide", "and", "expire", "in", "2029.", "<tag3>"], "wordsA": ["We", "also", "have", "two", "granted", "foreign", "patents", "that", "cover", "composition", "of", "matter", "related", "to", "SP-333", "that", "expire", "in", "2028."], "wordsB": ["We", "also", "have", "two", "foreign", "patents", "that", "cover", "composition-of-matter", "of", "certain", "analogs", "related", "to", "plecanatide", "and", "expire", "in", "2029."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_15_item1_p59_s17", "idA": "1347613_14_item1_p42_s13", "sentA": "These patents cover Switzerland, Germany, Denmark, Spain, France, United Kingdom, Ireland, Italy, Netherlands, Hong Kong, and China.", "sentB": "These patents cover Switzerland, Germany, Denmark, Spain, France, the United Kingdom, Ireland, Italy, the Netherlands, Hong Kong, Armenia, Azerbaijan, Belarus, Kazakhstan, the Kyrgyz Republic, Moldova, the Russian Federation, Tajikistan, Turkmenistan, China, Australia, Japan and Mexico.", "type": 2, "words": ["<tag1>", "These", "patents", "cover", "Switzerland,", "Germany,", "Denmark,", "Spain,", "France,", "United", "Kingdom,", "Ireland,", "Italy,", "Netherlands,", "Hong", "Kong,", "and", "China.", "<tag2>", "These", "patents", "cover", "Switzerland,", "Germany,", "Denmark,", "Spain,", "France,", "the", "United", "Kingdom,", "Ireland,", "Italy,", "the", "Netherlands,", "Hong", "Kong,", "Armenia,", "Azerbaijan,", "Belarus,", "Kazakhstan,", "the", "Kyrgyz", "Republic,", "Moldova,", "the", "Russian", "Federation,", "Tajikistan,", "Turkmenistan,", "China,", "Australia,", "Japan", "and", "Mexico.", "<tag3>"], "wordsA": ["These", "patents", "cover", "Switzerland,", "Germany,", "Denmark,", "Spain,", "France,", "United", "Kingdom,", "Ireland,", "Italy,", "Netherlands,", "Hong", "Kong,", "and", "China."], "wordsB": ["These", "patents", "cover", "Switzerland,", "Germany,", "Denmark,", "Spain,", "France,", "the", "United", "Kingdom,", "Ireland,", "Italy,", "the", "Netherlands,", "Hong", "Kong,", "Armenia,", "Azerbaijan,", "Belarus,", "Kazakhstan,", "the", "Kyrgyz", "Republic,", "Moldova,", "the", "Russian", "Federation,", "Tajikistan,", "Turkmenistan,", "China,", "Australia,", "Japan", "and", "Mexico."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_15_item1_p59_s12", "idA": "1347613_14_item1_p42_s3", "sentA": "A third patent covers the composition-of-matter of SP-333 issued on February 1, 2011 and expires in 2028.", "sentB": "A fourteenth patent granted December 2, 2014 and covers composition-of-matter of SP-333 and expires in 2028.", "type": 2, "words": ["<tag1>", "A", "third", "patent", "covers", "the", "composition-of-matter", "of", "SP-333", "issued", "on", "February", "1,", "2011", "and", "expires", "in", "2028.", "<tag2>", "A", "fourteenth", "patent", "granted", "December", "2,", "2014", "and", "covers", "composition-of-matter", "of", "SP-333", "and", "expires", "in", "2028.", "<tag3>"], "wordsA": ["A", "third", "patent", "covers", "the", "composition-of-matter", "of", "SP-333", "issued", "on", "February", "1,", "2011", "and", "expires", "in", "2028."], "wordsB": ["A", "fourteenth", "patent", "granted", "December", "2,", "2014", "and", "covers", "composition-of-matter", "of", "SP-333", "and", "expires", "in", "2028."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_15_item1_p59_s4", "idA": "1347613_14_item1_p42_s4", "sentA": "A fourth patent granted October 11, 2011 covers composition-of-matter of analogs related to plecanatide and SP-333 and will expire in 2029.", "sentB": "A fourth patent granted October 11, 2011 covers the composition-of-matter of certain analogs related to plecanatide and SP-333 and will expire in 2029.", "type": 2, "words": ["<tag1>", "A", "fourth", "patent", "granted", "October", "11,", "2011", "covers", "composition-of-matter", "of", "analogs", "related", "to", "plecanatide", "and", "SP-333", "and", "will", "expire", "in", "2029.", "<tag2>", "A", "fourth", "patent", "granted", "October", "11,", "2011", "covers", "the", "composition-of-matter", "of", "certain", "analogs", "related", "to", "plecanatide", "and", "SP-333", "and", "will", "expire", "in", "2029.", "<tag3>"], "wordsA": ["A", "fourth", "patent", "granted", "October", "11,", "2011", "covers", "composition-of-matter", "of", "analogs", "related", "to", "plecanatide", "and", "SP-333", "and", "will", "expire", "in", "2029."], "wordsB": ["A", "fourth", "patent", "granted", "October", "11,", "2011", "covers", "the", "composition-of-matter", "of", "certain", "analogs", "related", "to", "plecanatide", "and", "SP-333", "and", "will", "expire", "in", "2029."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_15_item1_p59_s6", "idA": "1347613_14_item1_p42_s5", "sentA": "A fifth patent granted February 14, 2012 covers a method of treating inflammatory bowel disease using plecanatide and will expire in 2022.", "sentB": "A sixth patent granted January 28, 2014 covers methods of stimulating water transport in the gastrointestinal tract using plecanatide and will expire in 2022.", "type": 2, "words": ["<tag1>", "A", "fifth", "patent", "granted", "February", "14,", "2012", "covers", "a", "method", "of", "treating", "inflammatory", "bowel", "disease", "using", "plecanatide", "and", "will", "expire", "in", "2022.", "<tag2>", "A", "sixth", "patent", "granted", "January", "28,", "2014", "covers", "methods", "of", "stimulating", "water", "transport", "in", "the", "gastrointestinal", "tract", "using", "plecanatide", "and", "will", "expire", "in", "2022.", "<tag3>"], "wordsA": ["A", "fifth", "patent", "granted", "February", "14,", "2012", "covers", "a", "method", "of", "treating", "inflammatory", "bowel", "disease", "using", "plecanatide", "and", "will", "expire", "in", "2022."], "wordsB": ["A", "sixth", "patent", "granted", "January", "28,", "2014", "covers", "methods", "of", "stimulating", "water", "transport", "in", "the", "gastrointestinal", "tract", "using", "plecanatide", "and", "will", "expire", "in", "2022."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_15_item1_p59_s11", "idA": "1347613_14_item1_p42_s6", "sentA": "A sixth patent granted June 26, 2012 covers additional composition-of-matter related to plecanatide and SP-333 and will expire in 2029.", "sentB": "A thirteenth patent granted May 6, 2014 covers certain methods of treating a variety of gastrointestinal and other disorders using SP-333 and will expire in 2029.", "type": 2, "words": ["<tag1>", "A", "sixth", "patent", "granted", "June", "26,", "2012", "covers", "additional", "composition-of-matter", "related", "to", "plecanatide", "and", "SP-333", "and", "will", "expire", "in", "2029.", "<tag2>", "A", "thirteenth", "patent", "granted", "May", "6,", "2014", "covers", "certain", "methods", "of", "treating", "a", "variety", "of", "gastrointestinal", "and", "other", "disorders", "using", "SP-333", "and", "will", "expire", "in", "2029.", "<tag3>"], "wordsA": ["A", "sixth", "patent", "granted", "June", "26,", "2012", "covers", "additional", "composition-of-matter", "related", "to", "plecanatide", "and", "SP-333", "and", "will", "expire", "in", "2029."], "wordsB": ["A", "thirteenth", "patent", "granted", "May", "6,", "2014", "covers", "certain", "methods", "of", "treating", "a", "variety", "of", "gastrointestinal", "and", "other", "disorders", "using", "SP-333", "and", "will", "expire", "in", "2029."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_15_item1_p59_s7", "idA": "1347613_14_item1_p42_s6", "sentA": "A sixth patent granted June 26, 2012 covers additional composition-of-matter related to plecanatide and SP-333 and will expire in 2029.", "sentB": "A seventh patent granted June 26, 2012 covers an additional composition-of-matter related to certain analogs of plecanatide and SP-333 and will expire in 2029.", "type": 2, "words": ["<tag1>", "A", "sixth", "patent", "granted", "June", "26,", "2012", "covers", "additional", "composition-of-matter", "related", "to", "plecanatide", "and", "SP-333", "and", "will", "expire", "in", "2029.", "<tag2>", "A", "seventh", "patent", "granted", "June", "26,", "2012", "covers", "an", "additional", "composition-of-matter", "related", "to", "certain", "analogs", "of", "plecanatide", "and", "SP-333", "and", "will", "expire", "in", "2029.", "<tag3>"], "wordsA": ["A", "sixth", "patent", "granted", "June", "26,", "2012", "covers", "additional", "composition-of-matter", "related", "to", "plecanatide", "and", "SP-333", "and", "will", "expire", "in", "2029."], "wordsB": ["A", "seventh", "patent", "granted", "June", "26,", "2012", "covers", "an", "additional", "composition-of-matter", "related", "to", "certain", "analogs", "of", "plecanatide", "and", "SP-333", "and", "will", "expire", "in", "2029."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_15_item1_p59_s13", "idA": "1347613_14_item1_p42_s7", "sentA": "A seventh patent granted on January 22, 2013 convers another composition-of-matter related to analogs of plecanatide and will expire in 2029.", "sentB": "A fifteenth patent granted on March 3, 2015 and covers methods of use of plecanatide and expires in 2031.", "type": 2, "words": ["<tag1>", "A", "seventh", "patent", "granted", "on", "January", "22,", "2013", "convers", "another", "composition-of-matter", "related", "to", "analogs", "of", "plecanatide", "and", "will", "expire", "in", "2029.", "<tag2>", "A", "fifteenth", "patent", "granted", "on", "March", "3,", "2015", "and", "covers", "methods", "of", "use", "of", "plecanatide", "and", "expires", "in", "2031.", "<tag3>"], "wordsA": ["A", "seventh", "patent", "granted", "on", "January", "22,", "2013", "convers", "another", "composition-of-matter", "related", "to", "analogs", "of", "plecanatide", "and", "will", "expire", "in", "2029."], "wordsB": ["A", "fifteenth", "patent", "granted", "on", "March", "3,", "2015", "and", "covers", "methods", "of", "use", "of", "plecanatide", "and", "expires", "in", "2031."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_15_item1_p59_s8", "idA": "1347613_14_item1_p42_s7", "sentA": "A seventh patent granted on January 22, 2013 convers another composition-of-matter related to analogs of plecanatide and will expire in 2029.", "sentB": "An eighth patent granted on January 22, 2013 covers another composition-of-matter related to certain analogs of plecanatide and will expire in 2029.", "type": 2, "words": ["<tag1>", "A", "seventh", "patent", "granted", "on", "January", "22,", "2013", "convers", "another", "composition-of-matter", "related", "to", "analogs", "of", "plecanatide", "and", "will", "expire", "in", "2029.", "<tag2>", "An", "eighth", "patent", "granted", "on", "January", "22,", "2013", "covers", "another", "composition-of-matter", "related", "to", "certain", "analogs", "of", "plecanatide", "and", "will", "expire", "in", "2029.", "<tag3>"], "wordsA": ["A", "seventh", "patent", "granted", "on", "January", "22,", "2013", "convers", "another", "composition-of-matter", "related", "to", "analogs", "of", "plecanatide", "and", "will", "expire", "in", "2029."], "wordsB": ["An", "eighth", "patent", "granted", "on", "January", "22,", "2013", "covers", "another", "composition-of-matter", "related", "to", "certain", "analogs", "of", "plecanatide", "and", "will", "expire", "in", "2029."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_15_item1_p59_s9", "idA": "1347613_14_item1_p42_s8", "sentA": "An eighth patent granted on July 30, 2013 convers another composition-of-matter related to analogs of plecanatide and will expire in 2029.", "sentB": "A ninth patent granted on July 30, 2013 covers another composition-of-matter related to certain analogs of plecanatide and will expire in 2029.", "type": 2, "words": ["<tag1>", "An", "eighth", "patent", "granted", "on", "July", "30,", "2013", "convers", "another", "composition-of-matter", "related", "to", "analogs", "of", "plecanatide", "and", "will", "expire", "in", "2029.", "<tag2>", "A", "ninth", "patent", "granted", "on", "July", "30,", "2013", "covers", "another", "composition-of-matter", "related", "to", "certain", "analogs", "of", "plecanatide", "and", "will", "expire", "in", "2029.", "<tag3>"], "wordsA": ["An", "eighth", "patent", "granted", "on", "July", "30,", "2013", "convers", "another", "composition-of-matter", "related", "to", "analogs", "of", "plecanatide", "and", "will", "expire", "in", "2029."], "wordsB": ["A", "ninth", "patent", "granted", "on", "July", "30,", "2013", "covers", "another", "composition-of-matter", "related", "to", "certain", "analogs", "of", "plecanatide", "and", "will", "expire", "in", "2029."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_15_item1_p59_s10", "idA": "1347613_14_item1_p42_s9", "sentA": "Another two patents that also cover composition-of-matter related to analogs of plecanatide were issued on February 5, 2013 and October 29, 2013; and will both expire in 2029.", "sentB": "Another three patents that also cover compositions-of-matter related to certain analogs of plecanatide were issued on February 5, 2013, October 29, 2013, and March 4, 2014 and will expire in 2029.", "type": 2, "words": ["<tag1>", "Another", "two", "patents", "that", "also", "cover", "composition-of-matter", "related", "to", "analogs", "of", "plecanatide", "were", "issued", "on", "February", "5,", "2013", "and", "October", "29,", "2013;", "and", "will", "both", "expire", "in", "2029.", "<tag2>", "Another", "three", "patents", "that", "also", "cover", "compositions-of-matter", "related", "to", "certain", "analogs", "of", "plecanatide", "were", "issued", "on", "February", "5,", "2013,", "October", "29,", "2013,", "and", "March", "4,", "2014", "and", "will", "expire", "in", "2029.", "<tag3>"], "wordsA": ["Another", "two", "patents", "that", "also", "cover", "composition-of-matter", "related", "to", "analogs", "of", "plecanatide", "were", "issued", "on", "February", "5,", "2013", "and", "October", "29,", "2013;", "and", "will", "both", "expire", "in", "2029."], "wordsB": ["Another", "three", "patents", "that", "also", "cover", "compositions-of-matter", "related", "to", "certain", "analogs", "of", "plecanatide", "were", "issued", "on", "February", "5,", "2013,", "October", "29,", "2013,", "and", "March", "4,", "2014", "and", "will", "expire", "in", "2029."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_15_item1_p60_s0", "idA": "1347613_14_item1_p43_s0", "sentA": "Additionally, as of December 31, 2013, we have 12 pending United States utility patent applications; 9 pending U.S. provisional applications; and 59 pending foreign patent applications covering plecanatide and SP-333, various derivatives and analogs of plecanatide and SP-333, and their uses and manufacture.", "sentB": "Additionally, as of the date of this report on Form 10-K, we have 13 pending United States utility patent applications; 2 pending U.S. provisional applications; and 66 pending foreign patent applications relating to plecanatide and SP-333, various derivatives and analogs of plecanatide and SP-333, and their uses and manufacture.", "type": 2, "words": ["<tag1>", "Additionally,", "as", "of", "December", "31,", "2013,", "we", "have", "12", "pending", "United", "States", "utility", "patent", "applications;", "9", "pending", "U.S.", "provisional", "applications;", "and", "59", "pending", "foreign", "patent", "applications", "covering", "plecanatide", "and", "SP-333,", "various", "derivatives", "and", "analogs", "of", "plecanatide", "and", "SP-333,", "and", "their", "uses", "and", "manufacture.", "<tag2>", "Additionally,", "as", "of", "the", "date", "of", "this", "report", "on", "Form", "10-K,", "we", "have", "13", "pending", "United", "States", "utility", "patent", "applications;", "2", "pending", "U.S.", "provisional", "applications;", "and", "66", "pending", "foreign", "patent", "applications", "relating", "to", "plecanatide", "and", "SP-333,", "various", "derivatives", "and", "analogs", "of", "plecanatide", "and", "SP-333,", "and", "their", "uses", "and", "manufacture.", "<tag3>"], "wordsA": ["Additionally,", "as", "of", "December", "31,", "2013,", "we", "have", "12", "pending", "United", "States", "utility", "patent", "applications;", "9", "pending", "U.S.", "provisional", "applications;", "and", "59", "pending", "foreign", "patent", "applications", "covering", "plecanatide", "and", "SP-333,", "various", "derivatives", "and", "analogs", "of", "plecanatide", "and", "SP-333,", "and", "their", "uses", "and", "manufacture."], "wordsB": ["Additionally,", "as", "of", "the", "date", "of", "this", "report", "on", "Form", "10-K,", "we", "have", "13", "pending", "United", "States", "utility", "patent", "applications;", "2", "pending", "U.S.", "provisional", "applications;", "and", "66", "pending", "foreign", "patent", "applications", "relating", "to", "plecanatide", "and", "SP-333,", "various", "derivatives", "and", "analogs", "of", "plecanatide", "and", "SP-333,", "and", "their", "uses", "and", "manufacture."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_15_item1_p62_s0", "idA": "1347613_14_item1_p44_s0", "sentA": "On September 14, 2012 we entered into a binding LOI with Ironwood pursuant to which we and Ironwood agreed to enter into a definitive license agreement giving us an exclusive worldwide license to Ironwood s method of use patents on plecanatide for the treatment of CC.", "sentB": "On September 14, 2012 we entered into a binding letter of intent with Ironwood Pharmaceuticals, Inc. ( Ironwood ), pursuant to which we and Ironwood agreed to enter into a definitive license agreement giving us an exclusive worldwide license to Ironwood s method of use patents on plecanatide for the treatment of chronic constipation, or CC.", "type": 2, "words": ["<tag1>", "On", "September", "14,", "2012", "we", "entered", "into", "a", "binding", "LOI", "with", "Ironwood", "pursuant", "to", "which", "we", "and", "Ironwood", "agreed", "to", "enter", "into", "a", "definitive", "license", "agreement", "giving", "us", "an", "exclusive", "worldwide", "license", "to", "Ironwood", "s", "method", "of", "use", "patents", "on", "plecanatide", "for", "the", "treatment", "of", "CC.", "<tag2>", "On", "September", "14,", "2012", "we", "entered", "into", "a", "binding", "letter", "of", "intent", "with", "Ironwood", "Pharmaceuticals,", "Inc.", "(", "Ironwood", "),", "pursuant", "to", "which", "we", "and", "Ironwood", "agreed", "to", "enter", "into", "a", "definitive", "license", "agreement", "giving", "us", "an", "exclusive", "worldwide", "license", "to", "Ironwood", "s", "method", "of", "use", "patents", "on", "plecanatide", "for", "the", "treatment", "of", "chronic", "constipation,", "or", "CC.", "<tag3>"], "wordsA": ["On", "September", "14,", "2012", "we", "entered", "into", "a", "binding", "LOI", "with", "Ironwood", "pursuant", "to", "which", "we", "and", "Ironwood", "agreed", "to", "enter", "into", "a", "definitive", "license", "agreement", "giving", "us", "an", "exclusive", "worldwide", "license", "to", "Ironwood", "s", "method", "of", "use", "patents", "on", "plecanatide", "for", "the", "treatment", "of", "CC."], "wordsB": ["On", "September", "14,", "2012", "we", "entered", "into", "a", "binding", "letter", "of", "intent", "with", "Ironwood", "Pharmaceuticals,", "Inc.", "(", "Ironwood", "),", "pursuant", "to", "which", "we", "and", "Ironwood", "agreed", "to", "enter", "into", "a", "definitive", "license", "agreement", "giving", "us", "an", "exclusive", "worldwide", "license", "to", "Ironwood", "s", "method", "of", "use", "patents", "on", "plecanatide", "for", "the", "treatment", "of", "chronic", "constipation,", "or", "CC."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_15_item1_p62_s1", "idA": "1347613_14_item1_p44_s1", "sentA": "The LOI contemplates a low single digit royalty on net sales of plecanatide and both parties agreed not to challenge each other s patents covering certain GC-C agonists, except that we retain the right to challenge Ironwood s method of use patents on plecanatide.", "sentB": "The letter of intent contemplates a low single digit royalty on net sales of plecanatide and both parties agreed not to challenge each other s patents covering certain GC-C agonists, except that we retain the right to challenge Ironwood s method of use patents on plecanatide.", "type": 2, "words": ["<tag1>", "The", "LOI", "contemplates", "a", "low", "single", "digit", "royalty", "on", "net", "sales", "of", "plecanatide", "and", "both", "parties", "agreed", "not", "to", "challenge", "each", "other", "s", "patents", "covering", "certain", "GC-C", "agonists,", "except", "that", "we", "retain", "the", "right", "to", "challenge", "Ironwood", "s", "method", "of", "use", "patents", "on", "plecanatide.", "<tag2>", "The", "letter", "of", "intent", "contemplates", "a", "low", "single", "digit", "royalty", "on", "net", "sales", "of", "plecanatide", "and", "both", "parties", "agreed", "not", "to", "challenge", "each", "other", "s", "patents", "covering", "certain", "GC-C", "agonists,", "except", "that", "we", "retain", "the", "right", "to", "challenge", "Ironwood", "s", "method", "of", "use", "patents", "on", "plecanatide.", "<tag3>"], "wordsA": ["The", "LOI", "contemplates", "a", "low", "single", "digit", "royalty", "on", "net", "sales", "of", "plecanatide", "and", "both", "parties", "agreed", "not", "to", "challenge", "each", "other", "s", "patents", "covering", "certain", "GC-C", "agonists,", "except", "that", "we", "retain", "the", "right", "to", "challenge", "Ironwood", "s", "method", "of", "use", "patents", "on", "plecanatide."], "wordsB": ["The", "letter", "of", "intent", "contemplates", "a", "low", "single", "digit", "royalty", "on", "net", "sales", "of", "plecanatide", "and", "both", "parties", "agreed", "not", "to", "challenge", "each", "other", "s", "patents", "covering", "certain", "GC-C", "agonists,", "except", "that", "we", "retain", "the", "right", "to", "challenge", "Ironwood", "s", "method", "of", "use", "patents", "on", "plecanatide."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_15_item1_p63_s0", "idA": "1347613_14_item1_p45_s0", "sentA": "During 2013, we transferred ownership of all FV-100 intellectual property rights we acquired from Bristol-Meyers Squibb Company ( BMS ) in August 2012, to a newly formed wholly owned subsidiary, ContraVir Pharmaceuticals, Inc.( ContraVir ).", "sentB": "During 2013, we transferred ownership of all FV-100 intellectual property rights we acquired from BristolMeyersSquib Company ( BMS ), in August 2012, to ContraVir, our former majority-owned subsidiary which we spun off to our shareholders on February 18, 2014.", "type": 2, "words": ["<tag1>", "During", "2013,", "we", "transferred", "ownership", "of", "all", "FV-100", "intellectual", "property", "rights", "we", "acquired", "from", "Bristol-Meyers", "Squibb", "Company", "(", "BMS", ")", "in", "August", "2012,", "to", "a", "newly", "formed", "wholly", "owned", "subsidiary,", "ContraVir", "Pharmaceuticals,", "Inc.(", "ContraVir", ").", "<tag2>", "During", "2013,", "we", "transferred", "ownership", "of", "all", "FV-100", "intellectual", "property", "rights", "we", "acquired", "from", "BristolMeyersSquib", "Company", "(", "BMS", "),", "in", "August", "2012,", "to", "ContraVir,", "our", "former", "majority-owned", "subsidiary", "which", "we", "spun", "off", "to", "our", "shareholders", "on", "February", "18,", "2014.", "<tag3>"], "wordsA": ["During", "2013,", "we", "transferred", "ownership", "of", "all", "FV-100", "intellectual", "property", "rights", "we", "acquired", "from", "Bristol-Meyers", "Squibb", "Company", "(", "BMS", ")", "in", "August", "2012,", "to", "a", "newly", "formed", "wholly", "owned", "subsidiary,", "ContraVir", "Pharmaceuticals,", "Inc.(", "ContraVir", ")."], "wordsB": ["During", "2013,", "we", "transferred", "ownership", "of", "all", "FV-100", "intellectual", "property", "rights", "we", "acquired", "from", "BristolMeyersSquib", "Company", "(", "BMS", "),", "in", "August", "2012,", "to", "ContraVir,", "our", "former", "majority-owned", "subsidiary", "which", "we", "spun", "off", "to", "our", "shareholders", "on", "February", "18,", "2014."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_15_item1_p63_s1", "idA": "1347613_14_item1_p45_s1", "sentA": "The FV-100 assets acquired by ContraVir from us are licensed from Cardiff pursuant to the terms of the Cardiff Agreement which ContraVir assumed from us.", "sentB": "The FV-100 assets acquired by ContraVir from us were licensed from University College Cardiff Consultants Limited ( Cardiff ) pursuant to the terms of that certain Patent and Technology License Agreement, dated as of February 2, 2005, between Cardiff and Contravir Research Incorporated, an entity with no prior relationship with the Company ( CRI ), as amended March 27, 2007, which ContraVir assumed from us (the Cardiff Agreement ).", "type": 2, "words": ["<tag1>", "The", "FV-100", "assets", "acquired", "by", "ContraVir", "from", "us", "are", "licensed", "from", "Cardiff", "pursuant", "to", "the", "terms", "of", "the", "Cardiff", "Agreement", "which", "ContraVir", "assumed", "from", "us.", "<tag2>", "The", "FV-100", "assets", "acquired", "by", "ContraVir", "from", "us", "were", "licensed", "from", "University", "College", "Cardiff", "Consultants", "Limited", "(", "Cardiff", ")", "pursuant", "to", "the", "terms", "of", "that", "certain", "Patent", "and", "Technology", "License", "Agreement,", "dated", "as", "of", "February", "2,", "2005,", "between", "Cardiff", "and", "Contravir", "Research", "Incorporated,", "an", "entity", "with", "no", "prior", "relationship", "with", "the", "Company", "(", "CRI", "),", "as", "amended", "March", "27,", "2007,", "which", "ContraVir", "assumed", "from", "us", "(the", "Cardiff", "Agreement", ").", "<tag3>"], "wordsA": ["The", "FV-100", "assets", "acquired", "by", "ContraVir", "from", "us", "are", "licensed", "from", "Cardiff", "pursuant", "to", "the", "terms", "of", "the", "Cardiff", "Agreement", "which", "ContraVir", "assumed", "from", "us."], "wordsB": ["The", "FV-100", "assets", "acquired", "by", "ContraVir", "from", "us", "were", "licensed", "from", "University", "College", "Cardiff", "Consultants", "Limited", "(", "Cardiff", ")", "pursuant", "to", "the", "terms", "of", "that", "certain", "Patent", "and", "Technology", "License", "Agreement,", "dated", "as", "of", "February", "2,", "2005,", "between", "Cardiff", "and", "Contravir", "Research", "Incorporated,", "an", "entity", "with", "no", "prior", "relationship", "with", "the", "Company", "(", "CRI", "),", "as", "amended", "March", "27,", "2007,", "which", "ContraVir", "assumed", "from", "us", "(the", "Cardiff", "Agreement", ")."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_15_item1_p65_s0", "idA": "1347613_14_item1_p46_s2", "sentA": "Synergy assumed the obligations under the Cardiff Agreement from BMS pursuant to the terms of the BMS Agreement.", "sentB": "We assumed the obligations under the Cardiff Agreement from BMS pursuant to the terms of the BMS Agreement.", "type": 2, "words": ["<tag1>", "Synergy", "assumed", "the", "obligations", "under", "the", "Cardiff", "Agreement", "from", "BMS", "pursuant", "to", "the", "terms", "of", "the", "BMS", "Agreement.", "<tag2>", "We", "assumed", "the", "obligations", "under", "the", "Cardiff", "Agreement", "from", "BMS", "pursuant", "to", "the", "terms", "of", "the", "BMS", "Agreement.", "<tag3>"], "wordsA": ["Synergy", "assumed", "the", "obligations", "under", "the", "Cardiff", "Agreement", "from", "BMS", "pursuant", "to", "the", "terms", "of", "the", "BMS", "Agreement."], "wordsB": ["We", "assumed", "the", "obligations", "under", "the", "Cardiff", "Agreement", "from", "BMS", "pursuant", "to", "the", "terms", "of", "the", "BMS", "Agreement."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_15_item1_p65_s1", "idA": "1347613_14_item1_p46_s2", "sentA": "Synergy assumed the obligations under the Cardiff Agreement from BMS pursuant to the terms of the BMS Agreement.", "sentB": "BMS assumed the obligations under the Cardiff Agreement from Inhibitex Inc.", "type": 2, "words": ["<tag1>", "Synergy", "assumed", "the", "obligations", "under", "the", "Cardiff", "Agreement", "from", "BMS", "pursuant", "to", "the", "terms", "of", "the", "BMS", "Agreement.", "<tag2>", "BMS", "assumed", "the", "obligations", "under", "the", "Cardiff", "Agreement", "from", "Inhibitex", "Inc.", "<tag3>"], "wordsA": ["Synergy", "assumed", "the", "obligations", "under", "the", "Cardiff", "Agreement", "from", "BMS", "pursuant", "to", "the", "terms", "of", "the", "BMS", "Agreement."], "wordsB": ["BMS", "assumed", "the", "obligations", "under", "the", "Cardiff", "Agreement", "from", "Inhibitex", "Inc."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_15_item1_p65_s2", "idA": "1347613_14_item1_p46_s3", "sentA": "BMS assumed the obligations under the Cardiff agreement from Inhibitex upon its acquisition of Inhibitex in January 2012.", "sentB": "( Inhibitex ) upon its acquisition of Inhibitex in January 2012.", "type": 2, "words": ["<tag1>", "BMS", "assumed", "the", "obligations", "under", "the", "Cardiff", "agreement", "from", "Inhibitex", "upon", "its", "acquisition", "of", "Inhibitex", "in", "January", "2012.", "<tag2>", "(", "Inhibitex", ")", "upon", "its", "acquisition", "of", "Inhibitex", "in", "January", "2012.", "<tag3>"], "wordsA": ["BMS", "assumed", "the", "obligations", "under", "the", "Cardiff", "agreement", "from", "Inhibitex", "upon", "its", "acquisition", "of", "Inhibitex", "in", "January", "2012."], "wordsB": ["(", "Inhibitex", ")", "upon", "its", "acquisition", "of", "Inhibitex", "in", "January", "2012."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_15_item1_p65_s3", "idA": "1347613_14_item1_p47_s0", "sentA": "Agreement upon its acquisition of FermaVir Pharmaceuticals, Inc. in September 2010.", "sentB": "Inhibitex assumed the obligations under the Cardiff Agreement upon its acquisition of FermaVir Pharmaceuticals, Inc. ( FermaVir ) in September 2010.", "type": 2, "words": ["<tag1>", "Agreement", "upon", "its", "acquisition", "of", "FermaVir", "Pharmaceuticals,", "Inc.", "in", "September", "2010.", "<tag2>", "Inhibitex", "assumed", "the", "obligations", "under", "the", "Cardiff", "Agreement", "upon", "its", "acquisition", "of", "FermaVir", "Pharmaceuticals,", "Inc.", "(", "FermaVir", ")", "in", "September", "2010.", "<tag3>"], "wordsA": ["Agreement", "upon", "its", "acquisition", "of", "FermaVir", "Pharmaceuticals,", "Inc.", "in", "September", "2010."], "wordsB": ["Inhibitex", "assumed", "the", "obligations", "under", "the", "Cardiff", "Agreement", "upon", "its", "acquisition", "of", "FermaVir", "Pharmaceuticals,", "Inc.", "(", "FermaVir", ")", "in", "September", "2010."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_15_item1_p59_s19", "idA": "1347613_14_item1_p48_s4", "sentA": "These foreign patents cover Australia, Austria, Belgium, Bulgaria, China, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Japan, Latvia, Lithuania, Luxembourg, Malta, Monaco, Netherlands, New Zealand, Pakistan, Poland, Portugal, Romania, Slovakia, Slovenia, Spain, Sweden, Switzerland, Taiwan, Turkey, United Kingdom and the Russian Federation.", "sentB": "This patent covers Australia, France, Germany, Italy, Spain and the United Kingdom.", "type": 2, "words": ["<tag1>", "These", "foreign", "patents", "cover", "Australia,", "Austria,", "Belgium,", "Bulgaria,", "China,", "Cyprus,", "Czech", "Republic,", "Denmark,", "Estonia,", "Finland,", "France,", "Germany,", "Greece,", "Hungary,", "Iceland,", "Ireland,", "Italy,", "Japan,", "Latvia,", "Lithuania,", "Luxembourg,", "Malta,", "Monaco,", "Netherlands,", "New", "Zealand,", "Pakistan,", "Poland,", "Portugal,", "Romania,", "Slovakia,", "Slovenia,", "Spain,", "Sweden,", "Switzerland,", "Taiwan,", "Turkey,", "United", "Kingdom", "and", "the", "Russian", "Federation.", "<tag2>", "This", "patent", "covers", "Australia,", "France,", "Germany,", "Italy,", "Spain", "and", "the", "United", "Kingdom.", "<tag3>"], "wordsA": ["These", "foreign", "patents", "cover", "Australia,", "Austria,", "Belgium,", "Bulgaria,", "China,", "Cyprus,", "Czech", "Republic,", "Denmark,", "Estonia,", "Finland,", "France,", "Germany,", "Greece,", "Hungary,", "Iceland,", "Ireland,", "Italy,", "Japan,", "Latvia,", "Lithuania,", "Luxembourg,", "Malta,", "Monaco,", "Netherlands,", "New", "Zealand,", "Pakistan,", "Poland,", "Portugal,", "Romania,", "Slovakia,", "Slovenia,", "Spain,", "Sweden,", "Switzerland,", "Taiwan,", "Turkey,", "United", "Kingdom", "and", "the", "Russian", "Federation."], "wordsB": ["This", "patent", "covers", "Australia,", "France,", "Germany,", "Italy,", "Spain", "and", "the", "United", "Kingdom."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_15_item1_p46_s0", "idA": "1347613_14_item1_p49_s0", "sentA": "On January 28, 2014, our Board of Directors declared a stock dividend of .0986 ContraVir shares for each share of our common stock held as of the record date of February 6, 2014, which was distributed on February 18, 2014.", "sentB": "On February 18, 2014, we completed the distribution of the ContraVir common stock (our previous wholly-owned subsidiary) to our stockholders on a pro rata basis with a stock dividend of .0986 ContraVir shares for each share of our common stock held as of the record date of February 6, 2014.", "type": 2, "words": ["<tag1>", "On", "January", "28,", "2014,", "our", "Board", "of", "Directors", "declared", "a", "stock", "dividend", "of", ".0986", "ContraVir", "shares", "for", "each", "share", "of", "our", "common", "stock", "held", "as", "of", "the", "record", "date", "of", "February", "6,", "2014,", "which", "was", "distributed", "on", "February", "18,", "2014.", "<tag2>", "On", "February", "18,", "2014,", "we", "completed", "the", "distribution", "of", "the", "ContraVir", "common", "stock", "(our", "previous", "wholly-owned", "subsidiary)", "to", "our", "stockholders", "on", "a", "pro", "rata", "basis", "with", "a", "stock", "dividend", "of", ".0986", "ContraVir", "shares", "for", "each", "share", "of", "our", "common", "stock", "held", "as", "of", "the", "record", "date", "of", "February", "6,", "2014.", "<tag3>"], "wordsA": ["On", "January", "28,", "2014,", "our", "Board", "of", "Directors", "declared", "a", "stock", "dividend", "of", ".0986", "ContraVir", "shares", "for", "each", "share", "of", "our", "common", "stock", "held", "as", "of", "the", "record", "date", "of", "February", "6,", "2014,", "which", "was", "distributed", "on", "February", "18,", "2014."], "wordsB": ["On", "February", "18,", "2014,", "we", "completed", "the", "distribution", "of", "the", "ContraVir", "common", "stock", "(our", "previous", "wholly-owned", "subsidiary)", "to", "our", "stockholders", "on", "a", "pro", "rata", "basis", "with", "a", "stock", "dividend", "of", ".0986", "ContraVir", "shares", "for", "each", "share", "of", "our", "common", "stock", "held", "as", "of", "the", "record", "date", "of", "February", "6,", "2014."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_15_item1_p14_s0", "idA": "1347613_14_item1_p4_s0", "sentA": "Plecanatide is a synthetic analog of uroguanylin, a natural human hormone that regulates ion and fluid transport in the intestine.", "sentB": "Plecanatide is a synthetic analog of uroguanylin, a natural human peptide that regulates ion and fluid transport in the intestine.", "type": 2, "words": ["<tag1>", "Plecanatide", "is", "a", "synthetic", "analog", "of", "uroguanylin,", "a", "natural", "human", "hormone", "that", "regulates", "ion", "and", "fluid", "transport", "in", "the", "intestine.", "<tag2>", "Plecanatide", "is", "a", "synthetic", "analog", "of", "uroguanylin,", "a", "natural", "human", "peptide", "that", "regulates", "ion", "and", "fluid", "transport", "in", "the", "intestine.", "<tag3>"], "wordsA": ["Plecanatide", "is", "a", "synthetic", "analog", "of", "uroguanylin,", "a", "natural", "human", "hormone", "that", "regulates", "ion", "and", "fluid", "transport", "in", "the", "intestine."], "wordsB": ["Plecanatide", "is", "a", "synthetic", "analog", "of", "uroguanylin,", "a", "natural", "human", "peptide", "that", "regulates", "ion", "and", "fluid", "transport", "in", "the", "intestine."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_15_item1_p11_s0", "idA": "1347613_14_item1_p68_s3", "sentA": "Failure by us to obtain, or any delay in obtaining, regulatory approvals or in complying with requirements could adversely affect the commercialization of product candidates and our ability to receive product or royalty revenues.", "sentB": "The holders of the notes have the ability to require us to repurchase the notes in whole or in part for cash in the event of a fundamental change, as defined in the indenture agreement.", "type": 2, "words": ["<tag1>", "Failure", "by", "us", "to", "obtain,", "or", "any", "delay", "in", "obtaining,", "regulatory", "approvals", "or", "in", "complying", "with", "requirements", "could", "adversely", "affect", "the", "commercialization", "of", "product", "candidates", "and", "our", "ability", "to", "receive", "product", "or", "royalty", "revenues.", "<tag2>", "The", "holders", "of", "the", "notes", "have", "the", "ability", "to", "require", "us", "to", "repurchase", "the", "notes", "in", "whole", "or", "in", "part", "for", "cash", "in", "the", "event", "of", "a", "fundamental", "change,", "as", "defined", "in", "the", "indenture", "agreement.", "<tag3>"], "wordsA": ["Failure", "by", "us", "to", "obtain,", "or", "any", "delay", "in", "obtaining,", "regulatory", "approvals", "or", "in", "complying", "with", "requirements", "could", "adversely", "affect", "the", "commercialization", "of", "product", "candidates", "and", "our", "ability", "to", "receive", "product", "or", "royalty", "revenues."], "wordsB": ["The", "holders", "of", "the", "notes", "have", "the", "ability", "to", "require", "us", "to", "repurchase", "the", "notes", "in", "whole", "or", "in", "part", "for", "cash", "in", "the", "event", "of", "a", "fundamental", "change,", "as", "defined", "in", "the", "indenture", "agreement."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_15_item1_p45_s3", "idA": "1347613_14_item1_p78_s0", "sentA": "As of March 16, 2014, we had 25 full-time employees.", "sentB": "Effective April 1, 2014, we terminated the shared services agreement with ContraVir.", "type": 2, "words": ["<tag1>", "As", "of", "March", "16,", "2014,", "we", "had", "25", "full-time", "employees.", "<tag2>", "Effective", "April", "1,", "2014,", "we", "terminated", "the", "shared", "services", "agreement", "with", "ContraVir.", "<tag3>"], "wordsA": ["As", "of", "March", "16,", "2014,", "we", "had", "25", "full-time", "employees."], "wordsB": ["Effective", "April", "1,", "2014,", "we", "terminated", "the", "shared", "services", "agreement", "with", "ContraVir."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_15_item1_p94_s0", "idA": "1347613_14_item1_p78_s0", "sentA": "As of March 16, 2014, we had 25 full-time employees.", "sentB": "As of March 16, 2015, we had 35 full-time employees.", "type": 2, "words": ["<tag1>", "As", "of", "March", "16,", "2014,", "we", "had", "25", "full-time", "employees.", "<tag2>", "As", "of", "March", "16,", "2015,", "we", "had", "35", "full-time", "employees.", "<tag3>"], "wordsA": ["As", "of", "March", "16,", "2014,", "we", "had", "25", "full-time", "employees."], "wordsB": ["As", "of", "March", "16,", "2015,", "we", "had", "35", "full-time", "employees."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_15_item1_p17_s0", "idA": "1347613_14_item1_p8_s0", "sentA": "On January 2, 2013, we announced positive results from our large multicenter clinical trial of our lead investigational drug plecanatide in patients with CIC.", "sentB": "On January 2, 2013, we announced positive results from our large phase 2 multicenter clinical trial of our lead investigational drug plecanatide in patients with CIC.", "type": 2, "words": ["<tag1>", "On", "January", "2,", "2013,", "we", "announced", "positive", "results", "from", "our", "large", "multicenter", "clinical", "trial", "of", "our", "lead", "investigational", "drug", "plecanatide", "in", "patients", "with", "CIC.", "<tag2>", "On", "January", "2,", "2013,", "we", "announced", "positive", "results", "from", "our", "large", "phase", "2", "multicenter", "clinical", "trial", "of", "our", "lead", "investigational", "drug", "plecanatide", "in", "patients", "with", "CIC.", "<tag3>"], "wordsA": ["On", "January", "2,", "2013,", "we", "announced", "positive", "results", "from", "our", "large", "multicenter", "clinical", "trial", "of", "our", "lead", "investigational", "drug", "plecanatide", "in", "patients", "with", "CIC."], "wordsB": ["On", "January", "2,", "2013,", "we", "announced", "positive", "results", "from", "our", "large", "phase", "2", "multicenter", "clinical", "trial", "of", "our", "lead", "investigational", "drug", "plecanatide", "in", "patients", "with", "CIC."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_15_item1_p19_s0", "idA": "1347613_14_item1_p8_s0", "sentA": "On January 2, 2013, we announced positive results from our large multicenter clinical trial of our lead investigational drug plecanatide in patients with CIC.", "sentB": "On April 28, 2014, we initiated our second pivotal Phase 3 clinical trial for plecanatide in CIC patients.", "type": 2, "words": ["<tag1>", "On", "January", "2,", "2013,", "we", "announced", "positive", "results", "from", "our", "large", "multicenter", "clinical", "trial", "of", "our", "lead", "investigational", "drug", "plecanatide", "in", "patients", "with", "CIC.", "<tag2>", "On", "April", "28,", "2014,", "we", "initiated", "our", "second", "pivotal", "Phase", "3", "clinical", "trial", "for", "plecanatide", "in", "CIC", "patients.", "<tag3>"], "wordsA": ["On", "January", "2,", "2013,", "we", "announced", "positive", "results", "from", "our", "large", "multicenter", "clinical", "trial", "of", "our", "lead", "investigational", "drug", "plecanatide", "in", "patients", "with", "CIC."], "wordsB": ["On", "April", "28,", "2014,", "we", "initiated", "our", "second", "pivotal", "Phase", "3", "clinical", "trial", "for", "plecanatide", "in", "CIC", "patients."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_15_item1_p33_s0", "idA": "1347613_14_item1_p8_s0", "sentA": "On January 2, 2013, we announced positive results from our large multicenter clinical trial of our lead investigational drug plecanatide in patients with CIC.", "sentB": "On October 20, 2014, we presented additional positive results from our phase 2b dose-ranging study assessing plecanatide s safety and efficacy in patients with IBS-C.", "type": 2, "words": ["<tag1>", "On", "January", "2,", "2013,", "we", "announced", "positive", "results", "from", "our", "large", "multicenter", "clinical", "trial", "of", "our", "lead", "investigational", "drug", "plecanatide", "in", "patients", "with", "CIC.", "<tag2>", "On", "October", "20,", "2014,", "we", "presented", "additional", "positive", "results", "from", "our", "phase", "2b", "dose-ranging", "study", "assessing", "plecanatide", "s", "safety", "and", "efficacy", "in", "patients", "with", "IBS-C.", "<tag3>"], "wordsA": ["On", "January", "2,", "2013,", "we", "announced", "positive", "results", "from", "our", "large", "multicenter", "clinical", "trial", "of", "our", "lead", "investigational", "drug", "plecanatide", "in", "patients", "with", "CIC."], "wordsB": ["On", "October", "20,", "2014,", "we", "presented", "additional", "positive", "results", "from", "our", "phase", "2b", "dose-ranging", "study", "assessing", "plecanatide", "s", "safety", "and", "efficacy", "in", "patients", "with", "IBS-C."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_15_item1_p4_s4", "idA": "1347613_14_item1_p8_s0", "sentA": "On January 2, 2013, we announced positive results from our large multicenter clinical trial of our lead investigational drug plecanatide in patients with CIC.", "sentB": "We have additionally been developing a unique formulation of SP-333 for use in patients with ulcerative colitis.", "type": 2, "words": ["<tag1>", "On", "January", "2,", "2013,", "we", "announced", "positive", "results", "from", "our", "large", "multicenter", "clinical", "trial", "of", "our", "lead", "investigational", "drug", "plecanatide", "in", "patients", "with", "CIC.", "<tag2>", "We", "have", "additionally", "been", "developing", "a", "unique", "formulation", "of", "SP-333", "for", "use", "in", "patients", "with", "ulcerative", "colitis.", "<tag3>"], "wordsA": ["On", "January", "2,", "2013,", "we", "announced", "positive", "results", "from", "our", "large", "multicenter", "clinical", "trial", "of", "our", "lead", "investigational", "drug", "plecanatide", "in", "patients", "with", "CIC."], "wordsB": ["We", "have", "additionally", "been", "developing", "a", "unique", "formulation", "of", "SP-333", "for", "use", "in", "patients", "with", "ulcerative", "colitis."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_16_item1_p3_s0", "idA": "1347613_15_item1_p14_s0", "sentA": "Plecanatide is a synthetic analog of uroguanylin, a natural human peptide that regulates ion and fluid transport in the intestine.", "sentB": "Plecanatide is a 16-amino acid peptide that is structurally identical to uroguanylin with the exception of a single amino acid change.", "type": 2, "words": ["<tag1>", "Plecanatide", "is", "a", "synthetic", "analog", "of", "uroguanylin,", "a", "natural", "human", "peptide", "that", "regulates", "ion", "and", "fluid", "transport", "in", "the", "intestine.", "<tag2>", "Plecanatide", "is", "a", "16-amino", "acid", "peptide", "that", "is", "structurally", "identical", "to", "uroguanylin", "with", "the", "exception", "of", "a", "single", "amino", "acid", "change.", "<tag3>"], "wordsA": ["Plecanatide", "is", "a", "synthetic", "analog", "of", "uroguanylin,", "a", "natural", "human", "peptide", "that", "regulates", "ion", "and", "fluid", "transport", "in", "the", "intestine."], "wordsB": ["Plecanatide", "is", "a", "16-amino", "acid", "peptide", "that", "is", "structurally", "identical", "to", "uroguanylin", "with", "the", "exception", "of", "a", "single", "amino", "acid", "change."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_16_item1_p19_s0", "idA": "1347613_15_item1_p18_s0", "sentA": "On November 13, 2013, we announced the start of the first of two planned pivotal Phase 3 clinical trials to confirm the safety and efficacy of plecanatide in adult patients with CIC.", "sentB": "On June 17, 2015 we announced positive top-line results from the first of two pivotal phase 3 clinical trials of plecanatide in 1,346 adult patients with CIC.", "type": 2, "words": ["<tag1>", "On", "November", "13,", "2013,", "we", "announced", "the", "start", "of", "the", "first", "of", "two", "planned", "pivotal", "Phase", "3", "clinical", "trials", "to", "confirm", "the", "safety", "and", "efficacy", "of", "plecanatide", "in", "adult", "patients", "with", "CIC.", "<tag2>", "On", "June", "17,", "2015", "we", "announced", "positive", "top-line", "results", "from", "the", "first", "of", "two", "pivotal", "phase", "3", "clinical", "trials", "of", "plecanatide", "in", "1,346", "adult", "patients", "with", "CIC.", "<tag3>"], "wordsA": ["On", "November", "13,", "2013,", "we", "announced", "the", "start", "of", "the", "first", "of", "two", "planned", "pivotal", "Phase", "3", "clinical", "trials", "to", "confirm", "the", "safety", "and", "efficacy", "of", "plecanatide", "in", "adult", "patients", "with", "CIC."], "wordsB": ["On", "June", "17,", "2015", "we", "announced", "positive", "top-line", "results", "from", "the", "first", "of", "two", "pivotal", "phase", "3", "clinical", "trials", "of", "plecanatide", "in", "1,346", "adult", "patients", "with", "CIC."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_16_item1_p23_s0", "idA": "1347613_15_item1_p18_s0", "sentA": "On November 13, 2013, we announced the start of the first of two planned pivotal Phase 3 clinical trials to confirm the safety and efficacy of plecanatide in adult patients with CIC.", "sentB": "On July 30, 2015 we announced positive top-line results from the second of two pivotal phase 3 clinical trials of plecanatide in 1,337 adult patients with CIC.", "type": 2, "words": ["<tag1>", "On", "November", "13,", "2013,", "we", "announced", "the", "start", "of", "the", "first", "of", "two", "planned", "pivotal", "Phase", "3", "clinical", "trials", "to", "confirm", "the", "safety", "and", "efficacy", "of", "plecanatide", "in", "adult", "patients", "with", "CIC.", "<tag2>", "On", "July", "30,", "2015", "we", "announced", "positive", "top-line", "results", "from", "the", "second", "of", "two", "pivotal", "phase", "3", "clinical", "trials", "of", "plecanatide", "in", "1,337", "adult", "patients", "with", "CIC.", "<tag3>"], "wordsA": ["On", "November", "13,", "2013,", "we", "announced", "the", "start", "of", "the", "first", "of", "two", "planned", "pivotal", "Phase", "3", "clinical", "trials", "to", "confirm", "the", "safety", "and", "efficacy", "of", "plecanatide", "in", "adult", "patients", "with", "CIC."], "wordsB": ["On", "July", "30,", "2015", "we", "announced", "positive", "top-line", "results", "from", "the", "second", "of", "two", "pivotal", "phase", "3", "clinical", "trials", "of", "plecanatide", "in", "1,337", "adult", "patients", "with", "CIC."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_16_item1_p32_s0", "idA": "1347613_15_item1_p18_s0", "sentA": "On November 13, 2013, we announced the start of the first of two planned pivotal Phase 3 clinical trials to confirm the safety and efficacy of plecanatide in adult patients with CIC.", "sentB": "We announced the start of the first phase 3 IBS-C trial with plecanatide in December 2014 and the second trial was initiated in June 2015.", "type": 2, "words": ["<tag1>", "On", "November", "13,", "2013,", "we", "announced", "the", "start", "of", "the", "first", "of", "two", "planned", "pivotal", "Phase", "3", "clinical", "trials", "to", "confirm", "the", "safety", "and", "efficacy", "of", "plecanatide", "in", "adult", "patients", "with", "CIC.", "<tag2>", "We", "announced", "the", "start", "of", "the", "first", "phase", "3", "IBS-C", "trial", "with", "plecanatide", "in", "December", "2014", "and", "the", "second", "trial", "was", "initiated", "in", "June", "2015.", "<tag3>"], "wordsA": ["On", "November", "13,", "2013,", "we", "announced", "the", "start", "of", "the", "first", "of", "two", "planned", "pivotal", "Phase", "3", "clinical", "trials", "to", "confirm", "the", "safety", "and", "efficacy", "of", "plecanatide", "in", "adult", "patients", "with", "CIC."], "wordsB": ["We", "announced", "the", "start", "of", "the", "first", "phase", "3", "IBS-C", "trial", "with", "plecanatide", "in", "December", "2014", "and", "the", "second", "trial", "was", "initiated", "in", "June", "2015."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_16_item1_p17_s0", "idA": "1347613_15_item1_p18_s3", "sentA": "The primary endpoint of the study is the proportion of patients who are overall responders for the 12-week treatment period.", "sentB": "The primary endpoint for both trials was the proportion of durable overall complete spontaneous bowl movement (CSBM) responders (%), which is the current regulatory endpoint required for U.S. approval in CIC.", "type": 2, "words": ["<tag1>", "The", "primary", "endpoint", "of", "the", "study", "is", "the", "proportion", "of", "patients", "who", "are", "overall", "responders", "for", "the", "12-week", "treatment", "period.", "<tag2>", "The", "primary", "endpoint", "for", "both", "trials", "was", "the", "proportion", "of", "durable", "overall", "complete", "spontaneous", "bowl", "movement", "(CSBM)", "responders", "(%),", "which", "is", "the", "current", "regulatory", "endpoint", "required", "for", "U.S.", "approval", "in", "CIC.", "<tag3>"], "wordsA": ["The", "primary", "endpoint", "of", "the", "study", "is", "the", "proportion", "of", "patients", "who", "are", "overall", "responders", "for", "the", "12-week", "treatment", "period."], "wordsB": ["The", "primary", "endpoint", "for", "both", "trials", "was", "the", "proportion", "of", "durable", "overall", "complete", "spontaneous", "bowl", "movement", "(CSBM)", "responders", "(%),", "which", "is", "the", "current", "regulatory", "endpoint", "required", "for", "U.S.", "approval", "in", "CIC."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_16_item1_p29_s0", "idA": "1347613_15_item1_p18_s3", "sentA": "The primary endpoint of the study is the proportion of patients who are overall responders for the 12-week treatment period.", "sentB": "The primary efficacy endpoint for both trials is the percentage of patients who are Overall Responders during the 12 week treatment period.", "type": 2, "words": ["<tag1>", "The", "primary", "endpoint", "of", "the", "study", "is", "the", "proportion", "of", "patients", "who", "are", "overall", "responders", "for", "the", "12-week", "treatment", "period.", "<tag2>", "The", "primary", "efficacy", "endpoint", "for", "both", "trials", "is", "the", "percentage", "of", "patients", "who", "are", "Overall", "Responders", "during", "the", "12", "week", "treatment", "period.", "<tag3>"], "wordsA": ["The", "primary", "endpoint", "of", "the", "study", "is", "the", "proportion", "of", "patients", "who", "are", "overall", "responders", "for", "the", "12-week", "treatment", "period."], "wordsB": ["The", "primary", "efficacy", "endpoint", "for", "both", "trials", "is", "the", "percentage", "of", "patients", "who", "are", "Overall", "Responders", "during", "the", "12", "week", "treatment", "period."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_16_item1_p10_s2", "idA": "1347613_15_item1_p19_s1", "sentA": "The primary objective of this trial is to confirm the safety and efficacy of plecanatide, a GC-C receptor agonist and once-daily oral treatment, in adult patients with CIC.", "sentB": "The objective of this trial is to evaluate the long-term safety and tolerability of plecanatide in patients with CIC.", "type": 2, "words": ["<tag1>", "The", "primary", "objective", "of", "this", "trial", "is", "to", "confirm", "the", "safety", "and", "efficacy", "of", "plecanatide,", "a", "GC-C", "receptor", "agonist", "and", "once-daily", "oral", "treatment,", "in", "adult", "patients", "with", "CIC.", "<tag2>", "The", "objective", "of", "this", "trial", "is", "to", "evaluate", "the", "long-term", "safety", "and", "tolerability", "of", "plecanatide", "in", "patients", "with", "CIC.", "<tag3>"], "wordsA": ["The", "primary", "objective", "of", "this", "trial", "is", "to", "confirm", "the", "safety", "and", "efficacy", "of", "plecanatide,", "a", "GC-C", "receptor", "agonist", "and", "once-daily", "oral", "treatment,", "in", "adult", "patients", "with", "CIC."], "wordsB": ["The", "objective", "of", "this", "trial", "is", "to", "evaluate", "the", "long-term", "safety", "and", "tolerability", "of", "plecanatide", "in", "patients", "with", "CIC."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_16_item1_p26_s2", "idA": "1347613_15_item1_p19_s1", "sentA": "The primary objective of this trial is to confirm the safety and efficacy of plecanatide, a GC-C receptor agonist and once-daily oral treatment, in adult patients with CIC.", "sentB": "The objective of this trial is to evaluate the long-term safety and tolerability of plecanatide in patients with CIC.", "type": 2, "words": ["<tag1>", "The", "primary", "objective", "of", "this", "trial", "is", "to", "confirm", "the", "safety", "and", "efficacy", "of", "plecanatide,", "a", "GC-C", "receptor", "agonist", "and", "once-daily", "oral", "treatment,", "in", "adult", "patients", "with", "CIC.", "<tag2>", "The", "objective", "of", "this", "trial", "is", "to", "evaluate", "the", "long-term", "safety", "and", "tolerability", "of", "plecanatide", "in", "patients", "with", "CIC.", "<tag3>"], "wordsA": ["The", "primary", "objective", "of", "this", "trial", "is", "to", "confirm", "the", "safety", "and", "efficacy", "of", "plecanatide,", "a", "GC-C", "receptor", "agonist", "and", "once-daily", "oral", "treatment,", "in", "adult", "patients", "with", "CIC."], "wordsB": ["The", "objective", "of", "this", "trial", "is", "to", "evaluate", "the", "long-term", "safety", "and", "tolerability", "of", "plecanatide", "in", "patients", "with", "CIC."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_16_item1_p1_s0", "idA": "1347613_15_item1_p1_s0", "sentA": "We are a biopharmaceutical company focused primarily on the development of drugs to treat gastrointestinal, or GI, disorders and diseases.", "sentB": "We are a biopharmaceutical company focused on the development and commercialization of novel gastrointestinal (GI) therapies.", "type": 2, "words": ["<tag1>", "We", "are", "a", "biopharmaceutical", "company", "focused", "primarily", "on", "the", "development", "of", "drugs", "to", "treat", "gastrointestinal,", "or", "GI,", "disorders", "and", "diseases.", "<tag2>", "We", "are", "a", "biopharmaceutical", "company", "focused", "on", "the", "development", "and", "commercialization", "of", "novel", "gastrointestinal", "(GI)", "therapies.", "<tag3>"], "wordsA": ["We", "are", "a", "biopharmaceutical", "company", "focused", "primarily", "on", "the", "development", "of", "drugs", "to", "treat", "gastrointestinal,", "or", "GI,", "disorders", "and", "diseases."], "wordsB": ["We", "are", "a", "biopharmaceutical", "company", "focused", "on", "the", "development", "and", "commercialization", "of", "novel", "gastrointestinal", "(GI)", "therapies."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_16_item1_p14_s1", "idA": "1347613_15_item1_p20_s2", "sentA": "The primary endpoint of the study is the proportion of patients who are overall responders for the 12-week treatment period.", "sentB": "Both trials included a two-week pre-treatment baseline period, a 12-week treatment period, and a two-week post-treatment period.", "type": 2, "words": ["<tag1>", "The", "primary", "endpoint", "of", "the", "study", "is", "the", "proportion", "of", "patients", "who", "are", "overall", "responders", "for", "the", "12-week", "treatment", "period.", "<tag2>", "Both", "trials", "included", "a", "two-week", "pre-treatment", "baseline", "period,", "a", "12-week", "treatment", "period,", "and", "a", "two-week", "post-treatment", "period.", "<tag3>"], "wordsA": ["The", "primary", "endpoint", "of", "the", "study", "is", "the", "proportion", "of", "patients", "who", "are", "overall", "responders", "for", "the", "12-week", "treatment", "period."], "wordsB": ["Both", "trials", "included", "a", "two-week", "pre-treatment", "baseline", "period,", "a", "12-week", "treatment", "period,", "and", "a", "two-week", "post-treatment", "period."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_16_item1_p10_s0", "idA": "1347613_15_item1_p21_s0", "sentA": "On January 8, 2015 and February 2, 2015 we announced that we had completed patient enrollment in the first and second of two pivotal phase 3 trials, respectively, which are evaluating the safety and efficacy of two plecanatide doses (3.0 and 6.0 mg) in patients with CIC.", "sentB": "We have completed patient enrollment in our ongoing open-label, long-term safety trial with plecanatide for CIC.", "type": 2, "words": ["<tag1>", "On", "January", "8,", "2015", "and", "February", "2,", "2015", "we", "announced", "that", "we", "had", "completed", "patient", "enrollment", "in", "the", "first", "and", "second", "of", "two", "pivotal", "phase", "3", "trials,", "respectively,", "which", "are", "evaluating", "the", "safety", "and", "efficacy", "of", "two", "plecanatide", "doses", "(3.0", "and", "6.0", "mg)", "in", "patients", "with", "CIC.", "<tag2>", "We", "have", "completed", "patient", "enrollment", "in", "our", "ongoing", "open-label,", "long-term", "safety", "trial", "with", "plecanatide", "for", "CIC.", "<tag3>"], "wordsA": ["On", "January", "8,", "2015", "and", "February", "2,", "2015", "we", "announced", "that", "we", "had", "completed", "patient", "enrollment", "in", "the", "first", "and", "second", "of", "two", "pivotal", "phase", "3", "trials,", "respectively,", "which", "are", "evaluating", "the", "safety", "and", "efficacy", "of", "two", "plecanatide", "doses", "(3.0", "and", "6.0", "mg)", "in", "patients", "with", "CIC."], "wordsB": ["We", "have", "completed", "patient", "enrollment", "in", "our", "ongoing", "open-label,", "long-term", "safety", "trial", "with", "plecanatide", "for", "CIC."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_16_item1_p14_s0", "idA": "1347613_15_item1_p21_s0", "sentA": "On January 8, 2015 and February 2, 2015 we announced that we had completed patient enrollment in the first and second of two pivotal phase 3 trials, respectively, which are evaluating the safety and efficacy of two plecanatide doses (3.0 and 6.0 mg) in patients with CIC.", "sentB": "The plecanatide phase 3 CIC program includes two randomized, 12-week, double-blind, placebo-controlled pivotal trials evaluating the efficacy and safety of two different plecanatide treatment doses (3.0 mg and 6.0 mg), taken as a tablet once-a-day, in patients with CIC.", "type": 2, "words": ["<tag1>", "On", "January", "8,", "2015", "and", "February", "2,", "2015", "we", "announced", "that", "we", "had", "completed", "patient", "enrollment", "in", "the", "first", "and", "second", "of", "two", "pivotal", "phase", "3", "trials,", "respectively,", "which", "are", "evaluating", "the", "safety", "and", "efficacy", "of", "two", "plecanatide", "doses", "(3.0", "and", "6.0", "mg)", "in", "patients", "with", "CIC.", "<tag2>", "The", "plecanatide", "phase", "3", "CIC", "program", "includes", "two", "randomized,", "12-week,", "double-blind,", "placebo-controlled", "pivotal", "trials", "evaluating", "the", "efficacy", "and", "safety", "of", "two", "different", "plecanatide", "treatment", "doses", "(3.0", "mg", "and", "6.0", "mg),", "taken", "as", "a", "tablet", "once-a-day,", "in", "patients", "with", "CIC.", "<tag3>"], "wordsA": ["On", "January", "8,", "2015", "and", "February", "2,", "2015", "we", "announced", "that", "we", "had", "completed", "patient", "enrollment", "in", "the", "first", "and", "second", "of", "two", "pivotal", "phase", "3", "trials,", "respectively,", "which", "are", "evaluating", "the", "safety", "and", "efficacy", "of", "two", "plecanatide", "doses", "(3.0", "and", "6.0", "mg)", "in", "patients", "with", "CIC."], "wordsB": ["The", "plecanatide", "phase", "3", "CIC", "program", "includes", "two", "randomized,", "12-week,", "double-blind,", "placebo-controlled", "pivotal", "trials", "evaluating", "the", "efficacy", "and", "safety", "of", "two", "different", "plecanatide", "treatment", "doses", "(3.0", "mg", "and", "6.0", "mg),", "taken", "as", "a", "tablet", "once-a-day,", "in", "patients", "with", "CIC."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_16_item1_p28_s0", "idA": "1347613_15_item1_p21_s1", "sentA": "Each trial is a randomized, 12-week, double-blind, placebo-controlled phase 3 trial evaluating approximately 1350 adult patients with CIC.", "sentB": "The plecanatide phase 3 IBS-C program includes two randomized, 12-week, double-blind, placebo-controlled pivotal trials evaluating the efficacy and safety of two different plecanatide treatment doses (3.0 mg and 6.0 mg), taken as a tablet once-a-day, in patients with IBS-C. Each phase 3 trial is expected to enroll approximately 1,050 patients with IBS-C and includes a two-week pre-treatment baseline period, a 12-week treatment period, and a two-week post-treatment period.", "type": 2, "words": ["<tag1>", "Each", "trial", "is", "a", "randomized,", "12-week,", "double-blind,", "placebo-controlled", "phase", "3", "trial", "evaluating", "approximately", "1350", "adult", "patients", "with", "CIC.", "<tag2>", "The", "plecanatide", "phase", "3", "IBS-C", "program", "includes", "two", "randomized,", "12-week,", "double-blind,", "placebo-controlled", "pivotal", "trials", "evaluating", "the", "efficacy", "and", "safety", "of", "two", "different", "plecanatide", "treatment", "doses", "(3.0", "mg", "and", "6.0", "mg),", "taken", "as", "a", "tablet", "once-a-day,", "in", "patients", "with", "IBS-C.", "Each", "phase", "3", "trial", "is", "expected", "to", "enroll", "approximately", "1,050", "patients", "with", "IBS-C", "and", "includes", "a", "two-week", "pre-treatment", "baseline", "period,", "a", "12-week", "treatment", "period,", "and", "a", "two-week", "post-treatment", "period.", "<tag3>"], "wordsA": ["Each", "trial", "is", "a", "randomized,", "12-week,", "double-blind,", "placebo-controlled", "phase", "3", "trial", "evaluating", "approximately", "1350", "adult", "patients", "with", "CIC."], "wordsB": ["The", "plecanatide", "phase", "3", "IBS-C", "program", "includes", "two", "randomized,", "12-week,", "double-blind,", "placebo-controlled", "pivotal", "trials", "evaluating", "the", "efficacy", "and", "safety", "of", "two", "different", "plecanatide", "treatment", "doses", "(3.0", "mg", "and", "6.0", "mg),", "taken", "as", "a", "tablet", "once-a-day,", "in", "patients", "with", "IBS-C.", "Each", "phase", "3", "trial", "is", "expected", "to", "enroll", "approximately", "1,050", "patients", "with", "IBS-C", "and", "includes", "a", "two-week", "pre-treatment", "baseline", "period,", "a", "12-week", "treatment", "period,", "and", "a", "two-week", "post-treatment", "period."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_16_item1_p15_s0", "idA": "1347613_15_item1_p21_s2", "sentA": "We expect to announce top-line data results from the first phase 3 CIC trial in 2Q 2015, and top-line results from the second phase 3 CIC trial in the third quarter of 2015.", "sentB": "The first phase 3 CIC trial was conducted in North America and assessed 1,346 adult patients (19.2% males and 80.8% females) that were randomly assigned to take 3.0 mg or 6.0 mg plecanatide or placebo once-a-day during the 12 week treatment period (453 patients in the 3 mg dose group, 441 patients in the 6.0 mg dose group and 452 patients in the placebo group).", "type": 2, "words": ["<tag1>", "We", "expect", "to", "announce", "top-line", "data", "results", "from", "the", "first", "phase", "3", "CIC", "trial", "in", "2Q", "2015,", "and", "top-line", "results", "from", "the", "second", "phase", "3", "CIC", "trial", "in", "the", "third", "quarter", "of", "2015.", "<tag2>", "The", "first", "phase", "3", "CIC", "trial", "was", "conducted", "in", "North", "America", "and", "assessed", "1,346", "adult", "patients", "(19.2%", "males", "and", "80.8%", "females)", "that", "were", "randomly", "assigned", "to", "take", "3.0", "mg", "or", "6.0", "mg", "plecanatide", "or", "placebo", "once-a-day", "during", "the", "12", "week", "treatment", "period", "(453", "patients", "in", "the", "3", "mg", "dose", "group,", "441", "patients", "in", "the", "6.0", "mg", "dose", "group", "and", "452", "patients", "in", "the", "placebo", "group).", "<tag3>"], "wordsA": ["We", "expect", "to", "announce", "top-line", "data", "results", "from", "the", "first", "phase", "3", "CIC", "trial", "in", "2Q", "2015,", "and", "top-line", "results", "from", "the", "second", "phase", "3", "CIC", "trial", "in", "the", "third", "quarter", "of", "2015."], "wordsB": ["The", "first", "phase", "3", "CIC", "trial", "was", "conducted", "in", "North", "America", "and", "assessed", "1,346", "adult", "patients", "(19.2%", "males", "and", "80.8%", "females)", "that", "were", "randomly", "assigned", "to", "take", "3.0", "mg", "or", "6.0", "mg", "plecanatide", "or", "placebo", "once-a-day", "during", "the", "12", "week", "treatment", "period", "(453", "patients", "in", "the", "3", "mg", "dose", "group,", "441", "patients", "in", "the", "6.0", "mg", "dose", "group", "and", "452", "patients", "in", "the", "placebo", "group)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_16_item1_p16_s0", "idA": "1347613_15_item1_p21_s2", "sentA": "We expect to announce top-line data results from the first phase 3 CIC trial in 2Q 2015, and top-line results from the second phase 3 CIC trial in the third quarter of 2015.", "sentB": "The second phase 3 CIC trial was conducted in the United States and assessed 1,337 adult patients (21.6% males and 78.4% females) that were randomly assigned to take 3.0 mg or 6.0 mg plecanatide or placebo once-a-day during the 12 week treatment period (443 patients in the 3.0 mg dose group, 449 patients in the 6.0 mg dose group and 445 patients in the placebo group).", "type": 2, "words": ["<tag1>", "We", "expect", "to", "announce", "top-line", "data", "results", "from", "the", "first", "phase", "3", "CIC", "trial", "in", "2Q", "2015,", "and", "top-line", "results", "from", "the", "second", "phase", "3", "CIC", "trial", "in", "the", "third", "quarter", "of", "2015.", "<tag2>", "The", "second", "phase", "3", "CIC", "trial", "was", "conducted", "in", "the", "United", "States", "and", "assessed", "1,337", "adult", "patients", "(21.6%", "males", "and", "78.4%", "females)", "that", "were", "randomly", "assigned", "to", "take", "3.0", "mg", "or", "6.0", "mg", "plecanatide", "or", "placebo", "once-a-day", "during", "the", "12", "week", "treatment", "period", "(443", "patients", "in", "the", "3.0", "mg", "dose", "group,", "449", "patients", "in", "the", "6.0", "mg", "dose", "group", "and", "445", "patients", "in", "the", "placebo", "group).", "<tag3>"], "wordsA": ["We", "expect", "to", "announce", "top-line", "data", "results", "from", "the", "first", "phase", "3", "CIC", "trial", "in", "2Q", "2015,", "and", "top-line", "results", "from", "the", "second", "phase", "3", "CIC", "trial", "in", "the", "third", "quarter", "of", "2015."], "wordsB": ["The", "second", "phase", "3", "CIC", "trial", "was", "conducted", "in", "the", "United", "States", "and", "assessed", "1,337", "adult", "patients", "(21.6%", "males", "and", "78.4%", "females)", "that", "were", "randomly", "assigned", "to", "take", "3.0", "mg", "or", "6.0", "mg", "plecanatide", "or", "placebo", "once-a-day", "during", "the", "12", "week", "treatment", "period", "(443", "patients", "in", "the", "3.0", "mg", "dose", "group,", "449", "patients", "in", "the", "6.0", "mg", "dose", "group", "and", "445", "patients", "in", "the", "placebo", "group)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_16_item1_p27_s0", "idA": "1347613_15_item1_p21_s2", "sentA": "We expect to announce top-line data results from the first phase 3 CIC trial in 2Q 2015, and top-line results from the second phase 3 CIC trial in the third quarter of 2015.", "sentB": "We plan to present additional data results from both phase 3 CIC trials at appropriate scientific conferences.", "type": 2, "words": ["<tag1>", "We", "expect", "to", "announce", "top-line", "data", "results", "from", "the", "first", "phase", "3", "CIC", "trial", "in", "2Q", "2015,", "and", "top-line", "results", "from", "the", "second", "phase", "3", "CIC", "trial", "in", "the", "third", "quarter", "of", "2015.", "<tag2>", "We", "plan", "to", "present", "additional", "data", "results", "from", "both", "phase", "3", "CIC", "trials", "at", "appropriate", "scientific", "conferences.", "<tag3>"], "wordsA": ["We", "expect", "to", "announce", "top-line", "data", "results", "from", "the", "first", "phase", "3", "CIC", "trial", "in", "2Q", "2015,", "and", "top-line", "results", "from", "the", "second", "phase", "3", "CIC", "trial", "in", "the", "third", "quarter", "of", "2015."], "wordsB": ["We", "plan", "to", "present", "additional", "data", "results", "from", "both", "phase", "3", "CIC", "trials", "at", "appropriate", "scientific", "conferences."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_16_item1_p3_s3", "idA": "1347613_15_item1_p21_s2", "sentA": "We expect to announce top-line data results from the first phase 3 CIC trial in 2Q 2015, and top-line results from the second phase 3 CIC trial in the third quarter of 2015.", "sentB": "We are continuing to progress two phase 3 clinical trials with plecanatide for IBS-C. We expect top-line results from the first phase 3 IBS-C trial in 1H 2016 and results from the second phase 3 IBS-C trial are expected in 2H 2016.", "type": 2, "words": ["<tag1>", "We", "expect", "to", "announce", "top-line", "data", "results", "from", "the", "first", "phase", "3", "CIC", "trial", "in", "2Q", "2015,", "and", "top-line", "results", "from", "the", "second", "phase", "3", "CIC", "trial", "in", "the", "third", "quarter", "of", "2015.", "<tag2>", "We", "are", "continuing", "to", "progress", "two", "phase", "3", "clinical", "trials", "with", "plecanatide", "for", "IBS-C.", "We", "expect", "top-line", "results", "from", "the", "first", "phase", "3", "IBS-C", "trial", "in", "1H", "2016", "and", "results", "from", "the", "second", "phase", "3", "IBS-C", "trial", "are", "expected", "in", "2H", "2016.", "<tag3>"], "wordsA": ["We", "expect", "to", "announce", "top-line", "data", "results", "from", "the", "first", "phase", "3", "CIC", "trial", "in", "2Q", "2015,", "and", "top-line", "results", "from", "the", "second", "phase", "3", "CIC", "trial", "in", "the", "third", "quarter", "of", "2015."], "wordsB": ["We", "are", "continuing", "to", "progress", "two", "phase", "3", "clinical", "trials", "with", "plecanatide", "for", "IBS-C.", "We", "expect", "top-line", "results", "from", "the", "first", "phase", "3", "IBS-C", "trial", "in", "1H", "2016", "and", "results", "from", "the", "second", "phase", "3", "IBS-C", "trial", "are", "expected", "in", "2H", "2016."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_16_item1_p7_s1", "idA": "1347613_15_item1_p21_s2", "sentA": "We expect to announce top-line data results from the first phase 3 CIC trial in 2Q 2015, and top-line results from the second phase 3 CIC trial in the third quarter of 2015.", "sentB": "The plecanatide NDA for CIC is supported by positive results from two phase 3 clinical trials which we completed in 2015.", "type": 2, "words": ["<tag1>", "We", "expect", "to", "announce", "top-line", "data", "results", "from", "the", "first", "phase", "3", "CIC", "trial", "in", "2Q", "2015,", "and", "top-line", "results", "from", "the", "second", "phase", "3", "CIC", "trial", "in", "the", "third", "quarter", "of", "2015.", "<tag2>", "The", "plecanatide", "NDA", "for", "CIC", "is", "supported", "by", "positive", "results", "from", "two", "phase", "3", "clinical", "trials", "which", "we", "completed", "in", "2015.", "<tag3>"], "wordsA": ["We", "expect", "to", "announce", "top-line", "data", "results", "from", "the", "first", "phase", "3", "CIC", "trial", "in", "2Q", "2015,", "and", "top-line", "results", "from", "the", "second", "phase", "3", "CIC", "trial", "in", "the", "third", "quarter", "of", "2015."], "wordsB": ["The", "plecanatide", "NDA", "for", "CIC", "is", "supported", "by", "positive", "results", "from", "two", "phase", "3", "clinical", "trials", "which", "we", "completed", "in", "2015."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_16_item1_p32_s1", "idA": "1347613_15_item1_p21_s3", "sentA": "In the fourth quarter of this year, we plan to file our first NDA with FDA for plecanatide in the CIC indication.", "sentB": "We intend to file our second NDA with plecanatide in the IBS-C indication by year-end 2016.", "type": 2, "words": ["<tag1>", "In", "the", "fourth", "quarter", "of", "this", "year,", "we", "plan", "to", "file", "our", "first", "NDA", "with", "FDA", "for", "plecanatide", "in", "the", "CIC", "indication.", "<tag2>", "We", "intend", "to", "file", "our", "second", "NDA", "with", "plecanatide", "in", "the", "IBS-C", "indication", "by", "year-end", "2016.", "<tag3>"], "wordsA": ["In", "the", "fourth", "quarter", "of", "this", "year,", "we", "plan", "to", "file", "our", "first", "NDA", "with", "FDA", "for", "plecanatide", "in", "the", "CIC", "indication."], "wordsB": ["We", "intend", "to", "file", "our", "second", "NDA", "with", "plecanatide", "in", "the", "IBS-C", "indication", "by", "year-end", "2016."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_16_item1_p3_s4", "idA": "1347613_15_item1_p21_s3", "sentA": "In the fourth quarter of this year, we plan to file our first NDA with FDA for plecanatide in the CIC indication.", "sentB": "We intend to file our second NDA with plecanatide for IBS-C by year-end 2016.", "type": 2, "words": ["<tag1>", "In", "the", "fourth", "quarter", "of", "this", "year,", "we", "plan", "to", "file", "our", "first", "NDA", "with", "FDA", "for", "plecanatide", "in", "the", "CIC", "indication.", "<tag2>", "We", "intend", "to", "file", "our", "second", "NDA", "with", "plecanatide", "for", "IBS-C", "by", "year-end", "2016.", "<tag3>"], "wordsA": ["In", "the", "fourth", "quarter", "of", "this", "year,", "we", "plan", "to", "file", "our", "first", "NDA", "with", "FDA", "for", "plecanatide", "in", "the", "CIC", "indication."], "wordsB": ["We", "intend", "to", "file", "our", "second", "NDA", "with", "plecanatide", "for", "IBS-C", "by", "year-end", "2016."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_16_item1_p7_s2", "idA": "1347613_15_item1_p21_s3", "sentA": "In the fourth quarter of this year, we plan to file our first NDA with FDA for plecanatide in the CIC indication.", "sentB": "If approved, we plan to launch plecanatide with the CIC indication in the first quarter of 2017.", "type": 2, "words": ["<tag1>", "In", "the", "fourth", "quarter", "of", "this", "year,", "we", "plan", "to", "file", "our", "first", "NDA", "with", "FDA", "for", "plecanatide", "in", "the", "CIC", "indication.", "<tag2>", "If", "approved,", "we", "plan", "to", "launch", "plecanatide", "with", "the", "CIC", "indication", "in", "the", "first", "quarter", "of", "2017.", "<tag3>"], "wordsA": ["In", "the", "fourth", "quarter", "of", "this", "year,", "we", "plan", "to", "file", "our", "first", "NDA", "with", "FDA", "for", "plecanatide", "in", "the", "CIC", "indication."], "wordsB": ["If", "approved,", "we", "plan", "to", "launch", "plecanatide", "with", "the", "CIC", "indication", "in", "the", "first", "quarter", "of", "2017."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_16_item1_p20_s1", "idA": "1347613_15_item1_p34_s0", "sentA": "Plecanatide 1.0, 3.0 and 9.0 mg doses demonstrated statistically significant improvement in complete spontaneous bowel movement (CSBM) frequency, the trial s primary endpoint, with the highest two doses showing the greatest response (increase from baseline of 2.12, 2.74, 2.44 and 1.27 for 1.0, 3.0, 9.0 mg and placebo dose groups, respectively).", "sentB": "Stool consistency was the key secondary endpoint reported with top-line analyses; both 3.0 mg and 6.0 mg plecanatide doses showed statistically significant improvement from baseline in Bristol Stool Form Scale (BSFS) scores compared to placebo (mean increase of 1.53 in 3.0 mg and 1.52 in 6.0 mg dose groups compared to a mean increase of 0.77 in placebo; p 0.001 for both doses).", "type": 2, "words": ["<tag1>", "Plecanatide", "1.0,", "3.0", "and", "9.0", "mg", "doses", "demonstrated", "statistically", "significant", "improvement", "in", "complete", "spontaneous", "bowel", "movement", "(CSBM)", "frequency,", "the", "trial", "s", "primary", "endpoint,", "with", "the", "highest", "two", "doses", "showing", "the", "greatest", "response", "(increase", "from", "baseline", "of", "2.12,", "2.74,", "2.44", "and", "1.27", "for", "1.0,", "3.0,", "9.0", "mg", "and", "placebo", "dose", "groups,", "respectively).", "<tag2>", "Stool", "consistency", "was", "the", "key", "secondary", "endpoint", "reported", "with", "top-line", "analyses;", "both", "3.0", "mg", "and", "6.0", "mg", "plecanatide", "doses", "showed", "statistically", "significant", "improvement", "from", "baseline", "in", "Bristol", "Stool", "Form", "Scale", "(BSFS)", "scores", "compared", "to", "placebo", "(mean", "increase", "of", "1.53", "in", "3.0", "mg", "and", "1.52", "in", "6.0", "mg", "dose", "groups", "compared", "to", "a", "mean", "increase", "of", "0.77", "in", "placebo;", "p", "0.001", "for", "both", "doses).", "<tag3>"], "wordsA": ["Plecanatide", "1.0,", "3.0", "and", "9.0", "mg", "doses", "demonstrated", "statistically", "significant", "improvement", "in", "complete", "spontaneous", "bowel", "movement", "(CSBM)", "frequency,", "the", "trial", "s", "primary", "endpoint,", "with", "the", "highest", "two", "doses", "showing", "the", "greatest", "response", "(increase", "from", "baseline", "of", "2.12,", "2.74,", "2.44", "and", "1.27", "for", "1.0,", "3.0,", "9.0", "mg", "and", "placebo", "dose", "groups,", "respectively)."], "wordsB": ["Stool", "consistency", "was", "the", "key", "secondary", "endpoint", "reported", "with", "top-line", "analyses;", "both", "3.0", "mg", "and", "6.0", "mg", "plecanatide", "doses", "showed", "statistically", "significant", "improvement", "from", "baseline", "in", "Bristol", "Stool", "Form", "Scale", "(BSFS)", "scores", "compared", "to", "placebo", "(mean", "increase", "of", "1.53", "in", "3.0", "mg", "and", "1.52", "in", "6.0", "mg", "dose", "groups", "compared", "to", "a", "mean", "increase", "of", "0.77", "in", "placebo;", "p", "0.001", "for", "both", "doses)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_16_item1_p23_s3", "idA": "1347613_15_item1_p34_s0", "sentA": "Plecanatide 1.0, 3.0 and 9.0 mg doses demonstrated statistically significant improvement in complete spontaneous bowel movement (CSBM) frequency, the trial s primary endpoint, with the highest two doses showing the greatest response (increase from baseline of 2.12, 2.74, 2.44 and 1.27 for 1.0, 3.0, 9.0 mg and placebo dose groups, respectively).", "sentB": "Stool consistency was the key secondary endpoint reported with top-line analyses; both 3.0 mg and 6.0 mg plecanatide doses showed statistically significant improvement from baseline in Bristol Stool Form Scale (BSFS) scores compared to placebo (mean increase of 1.49 in 3.0 mg and 1.50 in 6.0 mg dose groups compared to a mean increase of 0.87 in placebo; p 0.001 for both doses).", "type": 2, "words": ["<tag1>", "Plecanatide", "1.0,", "3.0", "and", "9.0", "mg", "doses", "demonstrated", "statistically", "significant", "improvement", "in", "complete", "spontaneous", "bowel", "movement", "(CSBM)", "frequency,", "the", "trial", "s", "primary", "endpoint,", "with", "the", "highest", "two", "doses", "showing", "the", "greatest", "response", "(increase", "from", "baseline", "of", "2.12,", "2.74,", "2.44", "and", "1.27", "for", "1.0,", "3.0,", "9.0", "mg", "and", "placebo", "dose", "groups,", "respectively).", "<tag2>", "Stool", "consistency", "was", "the", "key", "secondary", "endpoint", "reported", "with", "top-line", "analyses;", "both", "3.0", "mg", "and", "6.0", "mg", "plecanatide", "doses", "showed", "statistically", "significant", "improvement", "from", "baseline", "in", "Bristol", "Stool", "Form", "Scale", "(BSFS)", "scores", "compared", "to", "placebo", "(mean", "increase", "of", "1.49", "in", "3.0", "mg", "and", "1.50", "in", "6.0", "mg", "dose", "groups", "compared", "to", "a", "mean", "increase", "of", "0.87", "in", "placebo;", "p", "0.001", "for", "both", "doses).", "<tag3>"], "wordsA": ["Plecanatide", "1.0,", "3.0", "and", "9.0", "mg", "doses", "demonstrated", "statistically", "significant", "improvement", "in", "complete", "spontaneous", "bowel", "movement", "(CSBM)", "frequency,", "the", "trial", "s", "primary", "endpoint,", "with", "the", "highest", "two", "doses", "showing", "the", "greatest", "response", "(increase", "from", "baseline", "of", "2.12,", "2.74,", "2.44", "and", "1.27", "for", "1.0,", "3.0,", "9.0", "mg", "and", "placebo", "dose", "groups,", "respectively)."], "wordsB": ["Stool", "consistency", "was", "the", "key", "secondary", "endpoint", "reported", "with", "top-line", "analyses;", "both", "3.0", "mg", "and", "6.0", "mg", "plecanatide", "doses", "showed", "statistically", "significant", "improvement", "from", "baseline", "in", "Bristol", "Stool", "Form", "Scale", "(BSFS)", "scores", "compared", "to", "placebo", "(mean", "increase", "of", "1.49", "in", "3.0", "mg", "and", "1.50", "in", "6.0", "mg", "dose", "groups", "compared", "to", "a", "mean", "increase", "of", "0.87", "in", "placebo;", "p", "0.001", "for", "both", "doses)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_16_item1_p21_s0", "idA": "1347613_15_item1_p34_s2", "sentA": "All doses were safe and well tolerated with no treatment-related serious adverse events.", "sentB": "15 patients in the trial (1.1%) experienced serious adverse events but there was no imbalance across treatment groups in either incidences or individual serious adverse events.", "type": 2, "words": ["<tag1>", "All", "doses", "were", "safe", "and", "well", "tolerated", "with", "no", "treatment-related", "serious", "adverse", "events.", "<tag2>", "15", "patients", "in", "the", "trial", "(1.1%)", "experienced", "serious", "adverse", "events", "but", "there", "was", "no", "imbalance", "across", "treatment", "groups", "in", "either", "incidences", "or", "individual", "serious", "adverse", "events.", "<tag3>"], "wordsA": ["All", "doses", "were", "safe", "and", "well", "tolerated", "with", "no", "treatment-related", "serious", "adverse", "events."], "wordsB": ["15", "patients", "in", "the", "trial", "(1.1%)", "experienced", "serious", "adverse", "events", "but", "there", "was", "no", "imbalance", "across", "treatment", "groups", "in", "either", "incidences", "or", "individual", "serious", "adverse", "events."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_16_item1_p24_s0", "idA": "1347613_15_item1_p34_s2", "sentA": "All doses were safe and well tolerated with no treatment-related serious adverse events.", "sentB": "20 patients in the trial (1.4%) experienced serious adverse events but there was no imbalance across treatment groups in either incidences or individual serious adverse events.", "type": 2, "words": ["<tag1>", "All", "doses", "were", "safe", "and", "well", "tolerated", "with", "no", "treatment-related", "serious", "adverse", "events.", "<tag2>", "20", "patients", "in", "the", "trial", "(1.4%)", "experienced", "serious", "adverse", "events", "but", "there", "was", "no", "imbalance", "across", "treatment", "groups", "in", "either", "incidences", "or", "individual", "serious", "adverse", "events.", "<tag3>"], "wordsA": ["All", "doses", "were", "safe", "and", "well", "tolerated", "with", "no", "treatment-related", "serious", "adverse", "events."], "wordsB": ["20", "patients", "in", "the", "trial", "(1.4%)", "experienced", "serious", "adverse", "events", "but", "there", "was", "no", "imbalance", "across", "treatment", "groups", "in", "either", "incidences", "or", "individual", "serious", "adverse", "events."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_16_item1_p18_s0", "idA": "1347613_15_item1_p35_s0", "sentA": "On December 18, 2014 we announced the initiation of the first of two planned pivotal phase 3 clinical trials evaluating the safety and efficacy of 3.0 and 6.0 mg plecanatide, once-daily oral tablets, for the treatment of irritable bowel syndrome with constipation (IBS-C), consistent with the ongoing CIC registration trials.", "sentB": "Patients were selected using the modified Rome 3 criteria for CIC and had (1) fewer than 3 defecations per week, (2) loose stools occurring rarely without laxatives, (3) inadequate criteria for irritable bowel syndrome with constipation (IBS-C), and (4) at least two of the following applied to at least 25% of defecations: (a) straining during evacuation, (b) lumpy or hard stools, (c) sensation of anorectal obstruction or blockage.", "type": 2, "words": ["<tag1>", "On", "December", "18,", "2014", "we", "announced", "the", "initiation", "of", "the", "first", "of", "two", "planned", "pivotal", "phase", "3", "clinical", "trials", "evaluating", "the", "safety", "and", "efficacy", "of", "3.0", "and", "6.0", "mg", "plecanatide,", "once-daily", "oral", "tablets,", "for", "the", "treatment", "of", "irritable", "bowel", "syndrome", "with", "constipation", "(IBS-C),", "consistent", "with", "the", "ongoing", "CIC", "registration", "trials.", "<tag2>", "Patients", "were", "selected", "using", "the", "modified", "Rome", "3", "criteria", "for", "CIC", "and", "had", "(1)", "fewer", "than", "3", "defecations", "per", "week,", "(2)", "loose", "stools", "occurring", "rarely", "without", "laxatives,", "(3)", "inadequate", "criteria", "for", "irritable", "bowel", "syndrome", "with", "constipation", "(IBS-C),", "and", "(4)", "at", "least", "two", "of", "the", "following", "applied", "to", "at", "least", "25%", "of", "defecations:", "(a)", "straining", "during", "evacuation,", "(b)", "lumpy", "or", "hard", "stools,", "(c)", "sensation", "of", "anorectal", "obstruction", "or", "blockage.", "<tag3>"], "wordsA": ["On", "December", "18,", "2014", "we", "announced", "the", "initiation", "of", "the", "first", "of", "two", "planned", "pivotal", "phase", "3", "clinical", "trials", "evaluating", "the", "safety", "and", "efficacy", "of", "3.0", "and", "6.0", "mg", "plecanatide,", "once-daily", "oral", "tablets,", "for", "the", "treatment", "of", "irritable", "bowel", "syndrome", "with", "constipation", "(IBS-C),", "consistent", "with", "the", "ongoing", "CIC", "registration", "trials."], "wordsB": ["Patients", "were", "selected", "using", "the", "modified", "Rome", "3", "criteria", "for", "CIC", "and", "had", "(1)", "fewer", "than", "3", "defecations", "per", "week,", "(2)", "loose", "stools", "occurring", "rarely", "without", "laxatives,", "(3)", "inadequate", "criteria", "for", "irritable", "bowel", "syndrome", "with", "constipation", "(IBS-C),", "and", "(4)", "at", "least", "two", "of", "the", "following", "applied", "to", "at", "least", "25%", "of", "defecations:", "(a)", "straining", "during", "evacuation,", "(b)", "lumpy", "or", "hard", "stools,", "(c)", "sensation", "of", "anorectal", "obstruction", "or", "blockage."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_16_item1_p26_s0", "idA": "1347613_15_item1_p35_s1", "sentA": "IBS-C patients successfully completing either of the 12-week placebo-controlled registration trials will be offered enrollment into a long-term safety trial in order to support the ongoing long-term safety database for the CIC indication.", "sentB": "We have completed enrollment into our ongoing CIC open-label, long-term safety trial with plecanatide.", "type": 2, "words": ["<tag1>", "IBS-C", "patients", "successfully", "completing", "either", "of", "the", "12-week", "placebo-controlled", "registration", "trials", "will", "be", "offered", "enrollment", "into", "a", "long-term", "safety", "trial", "in", "order", "to", "support", "the", "ongoing", "long-term", "safety", "database", "for", "the", "CIC", "indication.", "<tag2>", "We", "have", "completed", "enrollment", "into", "our", "ongoing", "CIC", "open-label,", "long-term", "safety", "trial", "with", "plecanatide.", "<tag3>"], "wordsA": ["IBS-C", "patients", "successfully", "completing", "either", "of", "the", "12-week", "placebo-controlled", "registration", "trials", "will", "be", "offered", "enrollment", "into", "a", "long-term", "safety", "trial", "in", "order", "to", "support", "the", "ongoing", "long-term", "safety", "database", "for", "the", "CIC", "indication."], "wordsB": ["We", "have", "completed", "enrollment", "into", "our", "ongoing", "CIC", "open-label,", "long-term", "safety", "trial", "with", "plecanatide."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_16_item1_p2_s0", "idA": "1347613_15_item1_p36_s0", "sentA": "We are developing a second-generation GC-C receptor analog, SP-333, for the treatment of opioid induced constipation, or OIC, and for inflammatory bowel disease, or IBD.", "sentB": "Since the company s inception in 2008, we have pioneered discovery, research and development efforts involving uroguanylin analogs for the treatment of functional gastrointestinal (GI) disorders and inflammatory bowel disease.", "type": 2, "words": ["<tag1>", "We", "are", "developing", "a", "second-generation", "GC-C", "receptor", "analog,", "SP-333,", "for", "the", "treatment", "of", "opioid", "induced", "constipation,", "or", "OIC,", "and", "for", "inflammatory", "bowel", "disease,", "or", "IBD.", "<tag2>", "Since", "the", "company", "s", "inception", "in", "2008,", "we", "have", "pioneered", "discovery,", "research", "and", "development", "efforts", "involving", "uroguanylin", "analogs", "for", "the", "treatment", "of", "functional", "gastrointestinal", "(GI)", "disorders", "and", "inflammatory", "bowel", "disease.", "<tag3>"], "wordsA": ["We", "are", "developing", "a", "second-generation", "GC-C", "receptor", "analog,", "SP-333,", "for", "the", "treatment", "of", "opioid", "induced", "constipation,", "or", "OIC,", "and", "for", "inflammatory", "bowel", "disease,", "or", "IBD."], "wordsB": ["Since", "the", "company", "s", "inception", "in", "2008,", "we", "have", "pioneered", "discovery,", "research", "and", "development", "efforts", "involving", "uroguanylin", "analogs", "for", "the", "treatment", "of", "functional", "gastrointestinal", "(GI)", "disorders", "and", "inflammatory", "bowel", "disease."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_16_item1_p19_s1", "idA": "1347613_15_item1_p39_s1", "sentA": "Preliminary analysis of the data indicates SP-333 met the study s primary endpoint and demonstrated statistically significant improvement in mean change from baseline in the number of spontaneous bowel movements (SBMs) during Week 4 of the treatment period.", "sentB": "Preliminary analysis of the data indicates that both plecanatide 3.0 mg and 6.0 mg doses met the study s primary endpoint and demonstrated statistical significance in the proportion of patients in the intention-to-treat population who were durable overall CSBM responders compared to placebo during the 12-week treatment period (21.0% in 3.0 mg and 19.5% in 6.0 mg dose groups compared to 10.2% in placebo; p 0.001 for both doses).", "type": 2, "words": ["<tag1>", "Preliminary", "analysis", "of", "the", "data", "indicates", "SP-333", "met", "the", "study", "s", "primary", "endpoint", "and", "demonstrated", "statistically", "significant", "improvement", "in", "mean", "change", "from", "baseline", "in", "the", "number", "of", "spontaneous", "bowel", "movements", "(SBMs)", "during", "Week", "4", "of", "the", "treatment", "period.", "<tag2>", "Preliminary", "analysis", "of", "the", "data", "indicates", "that", "both", "plecanatide", "3.0", "mg", "and", "6.0", "mg", "doses", "met", "the", "study", "s", "primary", "endpoint", "and", "demonstrated", "statistical", "significance", "in", "the", "proportion", "of", "patients", "in", "the", "intention-to-treat", "population", "who", "were", "durable", "overall", "CSBM", "responders", "compared", "to", "placebo", "during", "the", "12-week", "treatment", "period", "(21.0%", "in", "3.0", "mg", "and", "19.5%", "in", "6.0", "mg", "dose", "groups", "compared", "to", "10.2%", "in", "placebo;", "p", "0.001", "for", "both", "doses).", "<tag3>"], "wordsA": ["Preliminary", "analysis", "of", "the", "data", "indicates", "SP-333", "met", "the", "study", "s", "primary", "endpoint", "and", "demonstrated", "statistically", "significant", "improvement", "in", "mean", "change", "from", "baseline", "in", "the", "number", "of", "spontaneous", "bowel", "movements", "(SBMs)", "during", "Week", "4", "of", "the", "treatment", "period."], "wordsB": ["Preliminary", "analysis", "of", "the", "data", "indicates", "that", "both", "plecanatide", "3.0", "mg", "and", "6.0", "mg", "doses", "met", "the", "study", "s", "primary", "endpoint", "and", "demonstrated", "statistical", "significance", "in", "the", "proportion", "of", "patients", "in", "the", "intention-to-treat", "population", "who", "were", "durable", "overall", "CSBM", "responders", "compared", "to", "placebo", "during", "the", "12-week", "treatment", "period", "(21.0%", "in", "3.0", "mg", "and", "19.5%", "in", "6.0", "mg", "dose", "groups", "compared", "to", "10.2%", "in", "placebo;", "p", "0.001", "for", "both", "doses)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_16_item1_p23_s1", "idA": "1347613_15_item1_p39_s1", "sentA": "Preliminary analysis of the data indicates SP-333 met the study s primary endpoint and demonstrated statistically significant improvement in mean change from baseline in the number of spontaneous bowel movements (SBMs) during Week 4 of the treatment period.", "sentB": "Preliminary analysis of the data indicates that both plecanatide 3.0 mg and 6.0 mg doses met the study s primary endpoint and demonstrated statistical significance in the proportion of patients in the intention-to-treat population who were durable overall CSBM responders compared to placebo during the 12-week treatment period (20.1% in 3.0 mg and 20.0% in 6.0 mg dose groups compared to 12.8% in placebo; p=0.004 for both doses).", "type": 2, "words": ["<tag1>", "Preliminary", "analysis", "of", "the", "data", "indicates", "SP-333", "met", "the", "study", "s", "primary", "endpoint", "and", "demonstrated", "statistically", "significant", "improvement", "in", "mean", "change", "from", "baseline", "in", "the", "number", "of", "spontaneous", "bowel", "movements", "(SBMs)", "during", "Week", "4", "of", "the", "treatment", "period.", "<tag2>", "Preliminary", "analysis", "of", "the", "data", "indicates", "that", "both", "plecanatide", "3.0", "mg", "and", "6.0", "mg", "doses", "met", "the", "study", "s", "primary", "endpoint", "and", "demonstrated", "statistical", "significance", "in", "the", "proportion", "of", "patients", "in", "the", "intention-to-treat", "population", "who", "were", "durable", "overall", "CSBM", "responders", "compared", "to", "placebo", "during", "the", "12-week", "treatment", "period", "(20.1%", "in", "3.0", "mg", "and", "20.0%", "in", "6.0", "mg", "dose", "groups", "compared", "to", "12.8%", "in", "placebo;", "p=0.004", "for", "both", "doses).", "<tag3>"], "wordsA": ["Preliminary", "analysis", "of", "the", "data", "indicates", "SP-333", "met", "the", "study", "s", "primary", "endpoint", "and", "demonstrated", "statistically", "significant", "improvement", "in", "mean", "change", "from", "baseline", "in", "the", "number", "of", "spontaneous", "bowel", "movements", "(SBMs)", "during", "Week", "4", "of", "the", "treatment", "period."], "wordsB": ["Preliminary", "analysis", "of", "the", "data", "indicates", "that", "both", "plecanatide", "3.0", "mg", "and", "6.0", "mg", "doses", "met", "the", "study", "s", "primary", "endpoint", "and", "demonstrated", "statistical", "significance", "in", "the", "proportion", "of", "patients", "in", "the", "intention-to-treat", "population", "who", "were", "durable", "overall", "CSBM", "responders", "compared", "to", "placebo", "during", "the", "12-week", "treatment", "period", "(20.1%", "in", "3.0", "mg", "and", "20.0%", "in", "6.0", "mg", "dose", "groups", "compared", "to", "12.8%", "in", "placebo;", "p=0.004", "for", "both", "doses)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_16_item1_p35_s1", "idA": "1347613_15_item1_p39_s1", "sentA": "Preliminary analysis of the data indicates SP-333 met the study s primary endpoint and demonstrated statistically significant improvement in mean change from baseline in the number of spontaneous bowel movements (SBMs) during Week 4 of the treatment period.", "sentB": "Analysis of the data indicates clear signals of improvement in dolcanatide-treated patients compared with placebo-treated patients.", "type": 2, "words": ["<tag1>", "Preliminary", "analysis", "of", "the", "data", "indicates", "SP-333", "met", "the", "study", "s", "primary", "endpoint", "and", "demonstrated", "statistically", "significant", "improvement", "in", "mean", "change", "from", "baseline", "in", "the", "number", "of", "spontaneous", "bowel", "movements", "(SBMs)", "during", "Week", "4", "of", "the", "treatment", "period.", "<tag2>", "Analysis", "of", "the", "data", "indicates", "clear", "signals", "of", "improvement", "in", "dolcanatide-treated", "patients", "compared", "with", "placebo-treated", "patients.", "<tag3>"], "wordsA": ["Preliminary", "analysis", "of", "the", "data", "indicates", "SP-333", "met", "the", "study", "s", "primary", "endpoint", "and", "demonstrated", "statistically", "significant", "improvement", "in", "mean", "change", "from", "baseline", "in", "the", "number", "of", "spontaneous", "bowel", "movements", "(SBMs)", "during", "Week", "4", "of", "the", "treatment", "period."], "wordsB": ["Analysis", "of", "the", "data", "indicates", "clear", "signals", "of", "improvement", "in", "dolcanatide-treated", "patients", "compared", "with", "placebo-treated", "patients."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_16_item1_p8_s1", "idA": "1347613_15_item1_p39_s1", "sentA": "Preliminary analysis of the data indicates SP-333 met the study s primary endpoint and demonstrated statistically significant improvement in mean change from baseline in the number of spontaneous bowel movements (SBMs) during Week 4 of the treatment period.", "sentB": "Analysis of the data indicates clear signals of improvement in dolcanatide-treated patients compared with placebo-treated patients.", "type": 2, "words": ["<tag1>", "Preliminary", "analysis", "of", "the", "data", "indicates", "SP-333", "met", "the", "study", "s", "primary", "endpoint", "and", "demonstrated", "statistically", "significant", "improvement", "in", "mean", "change", "from", "baseline", "in", "the", "number", "of", "spontaneous", "bowel", "movements", "(SBMs)", "during", "Week", "4", "of", "the", "treatment", "period.", "<tag2>", "Analysis", "of", "the", "data", "indicates", "clear", "signals", "of", "improvement", "in", "dolcanatide-treated", "patients", "compared", "with", "placebo-treated", "patients.", "<tag3>"], "wordsA": ["Preliminary", "analysis", "of", "the", "data", "indicates", "SP-333", "met", "the", "study", "s", "primary", "endpoint", "and", "demonstrated", "statistically", "significant", "improvement", "in", "mean", "change", "from", "baseline", "in", "the", "number", "of", "spontaneous", "bowel", "movements", "(SBMs)", "during", "Week", "4", "of", "the", "treatment", "period."], "wordsB": ["Analysis", "of", "the", "data", "indicates", "clear", "signals", "of", "improvement", "in", "dolcanatide-treated", "patients", "compared", "with", "placebo-treated", "patients."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_16_item1_p20_s0", "idA": "1347613_15_item1_p40_s0", "sentA": "SP-333 was safe and well tolerated at all doses.", "sentB": "Plecanatide was safe and well tolerated at both doses; the most common adverse event was diarrhea, which occurred in 5.9% of patients in 3.0 mg and 5.5% of patients in 6.0 mg dose groups compared to 1.3% of placebo-treated patients.", "type": 2, "words": ["<tag1>", "SP-333", "was", "safe", "and", "well", "tolerated", "at", "all", "doses.", "<tag2>", "Plecanatide", "was", "safe", "and", "well", "tolerated", "at", "both", "doses;", "the", "most", "common", "adverse", "event", "was", "diarrhea,", "which", "occurred", "in", "5.9%", "of", "patients", "in", "3.0", "mg", "and", "5.5%", "of", "patients", "in", "6.0", "mg", "dose", "groups", "compared", "to", "1.3%", "of", "placebo-treated", "patients.", "<tag3>"], "wordsA": ["SP-333", "was", "safe", "and", "well", "tolerated", "at", "all", "doses."], "wordsB": ["Plecanatide", "was", "safe", "and", "well", "tolerated", "at", "both", "doses;", "the", "most", "common", "adverse", "event", "was", "diarrhea,", "which", "occurred", "in", "5.9%", "of", "patients", "in", "3.0", "mg", "and", "5.5%", "of", "patients", "in", "6.0", "mg", "dose", "groups", "compared", "to", "1.3%", "of", "placebo-treated", "patients."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_16_item1_p38_s0", "idA": "1347613_15_item1_p40_s0", "sentA": "SP-333 was safe and well tolerated at all doses.", "sentB": "Dolcanatide was safe and well tolerated at all doses.", "type": 2, "words": ["<tag1>", "SP-333", "was", "safe", "and", "well", "tolerated", "at", "all", "doses.", "<tag2>", "Dolcanatide", "was", "safe", "and", "well", "tolerated", "at", "all", "doses.", "<tag3>"], "wordsA": ["SP-333", "was", "safe", "and", "well", "tolerated", "at", "all", "doses."], "wordsB": ["Dolcanatide", "was", "safe", "and", "well", "tolerated", "at", "all", "doses."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_16_item1_p17_s2", "idA": "1347613_15_item1_p4_s1", "sentA": "SP-333 is designed to be a highly potent and proteolytically stable analog of the naturally occurring GI peptide, uroguanylin, displaying significant resistance to proteolysis in gastric intestinal fluids.", "sentB": "In addition, the same patient must be a weekly responder for at least 3 of the last 4 treatment weeks in order to be considered a durable overall responder.", "type": 2, "words": ["<tag1>", "SP-333", "is", "designed", "to", "be", "a", "highly", "potent", "and", "proteolytically", "stable", "analog", "of", "the", "naturally", "occurring", "GI", "peptide,", "uroguanylin,", "displaying", "significant", "resistance", "to", "proteolysis", "in", "gastric", "intestinal", "fluids.", "<tag2>", "In", "addition,", "the", "same", "patient", "must", "be", "a", "weekly", "responder", "for", "at", "least", "3", "of", "the", "last", "4", "treatment", "weeks", "in", "order", "to", "be", "considered", "a", "durable", "overall", "responder.", "<tag3>"], "wordsA": ["SP-333", "is", "designed", "to", "be", "a", "highly", "potent", "and", "proteolytically", "stable", "analog", "of", "the", "naturally", "occurring", "GI", "peptide,", "uroguanylin,", "displaying", "significant", "resistance", "to", "proteolysis", "in", "gastric", "intestinal", "fluids."], "wordsB": ["In", "addition,", "the", "same", "patient", "must", "be", "a", "weekly", "responder", "for", "at", "least", "3", "of", "the", "last", "4", "treatment", "weeks", "in", "order", "to", "be", "considered", "a", "durable", "overall", "responder."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_16_item1_p34_s0", "idA": "1347613_15_item1_p4_s1", "sentA": "SP-333 is designed to be a highly potent and proteolytically stable analog of the naturally occurring GI peptide, uroguanylin, displaying significant resistance to proteolysis in gastric intestinal fluids.", "sentB": "Dolcanatide is designed to be an analog of uroguanylin with enhanced resistance to standard digestive breakdown by proteases in the intestine.", "type": 2, "words": ["<tag1>", "SP-333", "is", "designed", "to", "be", "a", "highly", "potent", "and", "proteolytically", "stable", "analog", "of", "the", "naturally", "occurring", "GI", "peptide,", "uroguanylin,", "displaying", "significant", "resistance", "to", "proteolysis", "in", "gastric", "intestinal", "fluids.", "<tag2>", "Dolcanatide", "is", "designed", "to", "be", "an", "analog", "of", "uroguanylin", "with", "enhanced", "resistance", "to", "standard", "digestive", "breakdown", "by", "proteases", "in", "the", "intestine.", "<tag3>"], "wordsA": ["SP-333", "is", "designed", "to", "be", "a", "highly", "potent", "and", "proteolytically", "stable", "analog", "of", "the", "naturally", "occurring", "GI", "peptide,", "uroguanylin,", "displaying", "significant", "resistance", "to", "proteolysis", "in", "gastric", "intestinal", "fluids."], "wordsB": ["Dolcanatide", "is", "designed", "to", "be", "an", "analog", "of", "uroguanylin", "with", "enhanced", "resistance", "to", "standard", "digestive", "breakdown", "by", "proteases", "in", "the", "intestine."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_16_item1_p5_s0", "idA": "1347613_15_item1_p4_s1", "sentA": "SP-333 is designed to be a highly potent and proteolytically stable analog of the naturally occurring GI peptide, uroguanylin, displaying significant resistance to proteolysis in gastric intestinal fluids.", "sentB": "Dolcanatide is designed to be an analog of uroguanylin with enhanced resistance to standard digestive breakdown by proteases in the intestine.", "type": 2, "words": ["<tag1>", "SP-333", "is", "designed", "to", "be", "a", "highly", "potent", "and", "proteolytically", "stable", "analog", "of", "the", "naturally", "occurring", "GI", "peptide,", "uroguanylin,", "displaying", "significant", "resistance", "to", "proteolysis", "in", "gastric", "intestinal", "fluids.", "<tag2>", "Dolcanatide", "is", "designed", "to", "be", "an", "analog", "of", "uroguanylin", "with", "enhanced", "resistance", "to", "standard", "digestive", "breakdown", "by", "proteases", "in", "the", "intestine.", "<tag3>"], "wordsA": ["SP-333", "is", "designed", "to", "be", "a", "highly", "potent", "and", "proteolytically", "stable", "analog", "of", "the", "naturally", "occurring", "GI", "peptide,", "uroguanylin,", "displaying", "significant", "resistance", "to", "proteolysis", "in", "gastric", "intestinal", "fluids."], "wordsB": ["Dolcanatide", "is", "designed", "to", "be", "an", "analog", "of", "uroguanylin", "with", "enhanced", "resistance", "to", "standard", "digestive", "breakdown", "by", "proteases", "in", "the", "intestine."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_16_item1_p35_s0", "idA": "1347613_15_item1_p4_s3", "sentA": "We have also announced the start of a phase 1b proof-of-concept trial of SP-333 in patients with ulcerative colitis.", "sentB": "On January 11, 2016, we announced positive phase 1b data with dolcanatide in a double-blind, placebo-controlled, four-week study evaluating 28 patients with mild-to-moderate ulcerative colitis.", "type": 2, "words": ["<tag1>", "We", "have", "also", "announced", "the", "start", "of", "a", "phase", "1b", "proof-of-concept", "trial", "of", "SP-333", "in", "patients", "with", "ulcerative", "colitis.", "<tag2>", "On", "January", "11,", "2016,", "we", "announced", "positive", "phase", "1b", "data", "with", "dolcanatide", "in", "a", "double-blind,", "placebo-controlled,", "four-week", "study", "evaluating", "28", "patients", "with", "mild-to-moderate", "ulcerative", "colitis.", "<tag3>"], "wordsA": ["We", "have", "also", "announced", "the", "start", "of", "a", "phase", "1b", "proof-of-concept", "trial", "of", "SP-333", "in", "patients", "with", "ulcerative", "colitis."], "wordsB": ["On", "January", "11,", "2016,", "we", "announced", "positive", "phase", "1b", "data", "with", "dolcanatide", "in", "a", "double-blind,", "placebo-controlled,", "four-week", "study", "evaluating", "28", "patients", "with", "mild-to-moderate", "ulcerative", "colitis."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_16_item1_p5_s1", "idA": "1347613_15_item1_p4_s3", "sentA": "We have also announced the start of a phase 1b proof-of-concept trial of SP-333 in patients with ulcerative colitis.", "sentB": "In January 2016, we announced positive phase 1b data with dolcanatide in patients with mild-to-moderate ulcerative colitis and we are presently evaluating plans for further clinical development in IBD.", "type": 2, "words": ["<tag1>", "We", "have", "also", "announced", "the", "start", "of", "a", "phase", "1b", "proof-of-concept", "trial", "of", "SP-333", "in", "patients", "with", "ulcerative", "colitis.", "<tag2>", "In", "January", "2016,", "we", "announced", "positive", "phase", "1b", "data", "with", "dolcanatide", "in", "patients", "with", "mild-to-moderate", "ulcerative", "colitis", "and", "we", "are", "presently", "evaluating", "plans", "for", "further", "clinical", "development", "in", "IBD.", "<tag3>"], "wordsA": ["We", "have", "also", "announced", "the", "start", "of", "a", "phase", "1b", "proof-of-concept", "trial", "of", "SP-333", "in", "patients", "with", "ulcerative", "colitis."], "wordsB": ["In", "January", "2016,", "we", "announced", "positive", "phase", "1b", "data", "with", "dolcanatide", "in", "patients", "with", "mild-to-moderate", "ulcerative", "colitis", "and", "we", "are", "presently", "evaluating", "plans", "for", "further", "clinical", "development", "in", "IBD."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_16_item1_p8_s0", "idA": "1347613_15_item1_p4_s3", "sentA": "We have also announced the start of a phase 1b proof-of-concept trial of SP-333 in patients with ulcerative colitis.", "sentB": "On January 11, 2016, we announced positive phase 1b data with dolcanatide in a double-blind, placebo-controlled, four-week study evaluating 28 patients with mild-to-moderate ulcerative colitis.", "type": 2, "words": ["<tag1>", "We", "have", "also", "announced", "the", "start", "of", "a", "phase", "1b", "proof-of-concept", "trial", "of", "SP-333", "in", "patients", "with", "ulcerative", "colitis.", "<tag2>", "On", "January", "11,", "2016,", "we", "announced", "positive", "phase", "1b", "data", "with", "dolcanatide", "in", "a", "double-blind,", "placebo-controlled,", "four-week", "study", "evaluating", "28", "patients", "with", "mild-to-moderate", "ulcerative", "colitis.", "<tag3>"], "wordsA": ["We", "have", "also", "announced", "the", "start", "of", "a", "phase", "1b", "proof-of-concept", "trial", "of", "SP-333", "in", "patients", "with", "ulcerative", "colitis."], "wordsB": ["On", "January", "11,", "2016,", "we", "announced", "positive", "phase", "1b", "data", "with", "dolcanatide", "in", "a", "double-blind,", "placebo-controlled,", "four-week", "study", "evaluating", "28", "patients", "with", "mild-to-moderate", "ulcerative", "colitis."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_16_item1_p36_s1", "idA": "1347613_15_item1_p4_s4", "sentA": "We have additionally been developing a unique formulation of SP-333 for use in patients with ulcerative colitis.", "sentB": "We are currently evaluating how best to move dolcanatide forward in clinical development to treat ulcerative colitis.", "type": 2, "words": ["<tag1>", "We", "have", "additionally", "been", "developing", "a", "unique", "formulation", "of", "SP-333", "for", "use", "in", "patients", "with", "ulcerative", "colitis.", "<tag2>", "We", "are", "currently", "evaluating", "how", "best", "to", "move", "dolcanatide", "forward", "in", "clinical", "development", "to", "treat", "ulcerative", "colitis.", "<tag3>"], "wordsA": ["We", "have", "additionally", "been", "developing", "a", "unique", "formulation", "of", "SP-333", "for", "use", "in", "patients", "with", "ulcerative", "colitis."], "wordsB": ["We", "are", "currently", "evaluating", "how", "best", "to", "move", "dolcanatide", "forward", "in", "clinical", "development", "to", "treat", "ulcerative", "colitis."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_16_item1_p9_s1", "idA": "1347613_15_item1_p4_s4", "sentA": "We have additionally been developing a unique formulation of SP-333 for use in patients with ulcerative colitis.", "sentB": "We are currently evaluating how best to move dolcanatide forward in clinical development to treat ulcerative colitis.", "type": 2, "words": ["<tag1>", "We", "have", "additionally", "been", "developing", "a", "unique", "formulation", "of", "SP-333", "for", "use", "in", "patients", "with", "ulcerative", "colitis.", "<tag2>", "We", "are", "currently", "evaluating", "how", "best", "to", "move", "dolcanatide", "forward", "in", "clinical", "development", "to", "treat", "ulcerative", "colitis.", "<tag3>"], "wordsA": ["We", "have", "additionally", "been", "developing", "a", "unique", "formulation", "of", "SP-333", "for", "use", "in", "patients", "with", "ulcerative", "colitis."], "wordsB": ["We", "are", "currently", "evaluating", "how", "best", "to", "move", "dolcanatide", "forward", "in", "clinical", "development", "to", "treat", "ulcerative", "colitis."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_16_item1_p39_s1", "idA": "1347613_15_item1_p54_s1", "sentA": "Our competitors include major pharmaceutical and biotechnology companies focusing on GI such as Ironwood Pharmaceuticals, Inc., Actavis plc, Takeda Pharmaceuticals America, Inc., Sucampo Pharmaceuticals, Inc., AstraZeneca, Salix Pharmaceuticals, Inc. and Shire Plc.", "sentB": "Our competitors include major pharmaceutical and biotechnology companies focusing on GI such as Ironwood Pharmaceuticals, Inc., Allergan plc, Takeda Pharmaceuticals America, Inc., Sucampo Pharmaceuticals, Inc., AstraZeneca, Valeant Pharmaceuticals International, Inc. and Shire, Plc.", "type": 2, "words": ["<tag1>", "Our", "competitors", "include", "major", "pharmaceutical", "and", "biotechnology", "companies", "focusing", "on", "GI", "such", "as", "Ironwood", "Pharmaceuticals,", "Inc.,", "Actavis", "plc,", "Takeda", "Pharmaceuticals", "America,", "Inc.,", "Sucampo", "Pharmaceuticals,", "Inc.,", "AstraZeneca,", "Salix", "Pharmaceuticals,", "Inc.", "and", "Shire", "Plc.", "<tag2>", "Our", "competitors", "include", "major", "pharmaceutical", "and", "biotechnology", "companies", "focusing", "on", "GI", "such", "as", "Ironwood", "Pharmaceuticals,", "Inc.,", "Allergan", "plc,", "Takeda", "Pharmaceuticals", "America,", "Inc.,", "Sucampo", "Pharmaceuticals,", "Inc.,", "AstraZeneca,", "Valeant", "Pharmaceuticals", "International,", "Inc.", "and", "Shire,", "Plc.", "<tag3>"], "wordsA": ["Our", "competitors", "include", "major", "pharmaceutical", "and", "biotechnology", "companies", "focusing", "on", "GI", "such", "as", "Ironwood", "Pharmaceuticals,", "Inc.,", "Actavis", "plc,", "Takeda", "Pharmaceuticals", "America,", "Inc.,", "Sucampo", "Pharmaceuticals,", "Inc.,", "AstraZeneca,", "Salix", "Pharmaceuticals,", "Inc.", "and", "Shire", "Plc."], "wordsB": ["Our", "competitors", "include", "major", "pharmaceutical", "and", "biotechnology", "companies", "focusing", "on", "GI", "such", "as", "Ironwood", "Pharmaceuticals,", "Inc.,", "Allergan", "plc,", "Takeda", "Pharmaceuticals", "America,", "Inc.,", "Sucampo", "Pharmaceuticals,", "Inc.,", "AstraZeneca,", "Valeant", "Pharmaceuticals", "International,", "Inc.", "and", "Shire,", "Plc."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_16_item1_p41_s1", "idA": "1347613_15_item1_p56_s1", "sentA": "Research and development expenses for the twelve months ended December 31, 2014 were approximately $83 million, as compared to approximately $51 million and $29 million for the twelve months ended December 31, 2013 and 2012, respectively.", "sentB": "Research and development expenses for the year ended December 31, 2015 were approximately $78 million, as compared to approximately $83.3 million and $50.6 million for the year ended December 31, 2014 and 2013, respectively.", "type": 2, "words": ["<tag1>", "Research", "and", "development", "expenses", "for", "the", "twelve", "months", "ended", "December", "31,", "2014", "were", "approximately", "$83", "million,", "as", "compared", "to", "approximately", "$51", "million", "and", "$29", "million", "for", "the", "twelve", "months", "ended", "December", "31,", "2013", "and", "2012,", "respectively.", "<tag2>", "Research", "and", "development", "expenses", "for", "the", "year", "ended", "December", "31,", "2015", "were", "approximately", "$78", "million,", "as", "compared", "to", "approximately", "$83.3", "million", "and", "$50.6", "million", "for", "the", "year", "ended", "December", "31,", "2014", "and", "2013,", "respectively.", "<tag3>"], "wordsA": ["Research", "and", "development", "expenses", "for", "the", "twelve", "months", "ended", "December", "31,", "2014", "were", "approximately", "$83", "million,", "as", "compared", "to", "approximately", "$51", "million", "and", "$29", "million", "for", "the", "twelve", "months", "ended", "December", "31,", "2013", "and", "2012,", "respectively."], "wordsB": ["Research", "and", "development", "expenses", "for", "the", "year", "ended", "December", "31,", "2015", "were", "approximately", "$78", "million,", "as", "compared", "to", "approximately", "$83.3", "million", "and", "$50.6", "million", "for", "the", "year", "ended", "December", "31,", "2014", "and", "2013,", "respectively."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_16_item1_p42_s0", "idA": "1347613_15_item1_p57_s0", "sentA": "In accordance with FASB ASC Topic 730-10-55, Research and Development, we recorded prepaid research and development costs of approximately $3.6 million as of December 31, 2014 and December 31, 2013, respectively, for nonrefundable pre-payments for production of drug substance, analytical testing services for our drug candidates, and upcoming clinical trials of plecanatide and SP-333.", "sentB": "In accordance with FASB ASC Topic 730-10-55, Research and Development, we recorded prepaid research and development costs of approximately $3.1 million as of December 31, 2015 and $3.7 million as of December 31, 2014, for nonrefundable pre-payments for production of drug substance, analytical testing services and clinical trial costs for our drug candidates.", "type": 2, "words": ["<tag1>", "In", "accordance", "with", "FASB", "ASC", "Topic", "730-10-55,", "Research", "and", "Development,", "we", "recorded", "prepaid", "research", "and", "development", "costs", "of", "approximately", "$3.6", "million", "as", "of", "December", "31,", "2014", "and", "December", "31,", "2013,", "respectively,", "for", "nonrefundable", "pre-payments", "for", "production", "of", "drug", "substance,", "analytical", "testing", "services", "for", "our", "drug", "candidates,", "and", "upcoming", "clinical", "trials", "of", "plecanatide", "and", "SP-333.", "<tag2>", "In", "accordance", "with", "FASB", "ASC", "Topic", "730-10-55,", "Research", "and", "Development,", "we", "recorded", "prepaid", "research", "and", "development", "costs", "of", "approximately", "$3.1", "million", "as", "of", "December", "31,", "2015", "and", "$3.7", "million", "as", "of", "December", "31,", "2014,", "for", "nonrefundable", "pre-payments", "for", "production", "of", "drug", "substance,", "analytical", "testing", "services", "and", "clinical", "trial", "costs", "for", "our", "drug", "candidates.", "<tag3>"], "wordsA": ["In", "accordance", "with", "FASB", "ASC", "Topic", "730-10-55,", "Research", "and", "Development,", "we", "recorded", "prepaid", "research", "and", "development", "costs", "of", "approximately", "$3.6", "million", "as", "of", "December", "31,", "2014", "and", "December", "31,", "2013,", "respectively,", "for", "nonrefundable", "pre-payments", "for", "production", "of", "drug", "substance,", "analytical", "testing", "services", "for", "our", "drug", "candidates,", "and", "upcoming", "clinical", "trials", "of", "plecanatide", "and", "SP-333."], "wordsB": ["In", "accordance", "with", "FASB", "ASC", "Topic", "730-10-55,", "Research", "and", "Development,", "we", "recorded", "prepaid", "research", "and", "development", "costs", "of", "approximately", "$3.1", "million", "as", "of", "December", "31,", "2015", "and", "$3.7", "million", "as", "of", "December", "31,", "2014,", "for", "nonrefundable", "pre-payments", "for", "production", "of", "drug", "substance,", "analytical", "testing", "services", "and", "clinical", "trial", "costs", "for", "our", "drug", "candidates."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_16_item1_p44_s0", "idA": "1347613_15_item1_p59_s0", "sentA": "As of March 6, 2015 we have 15 issued United States patents related to guanylate cyclase agonists.", "sentB": "As of December 31, 2015 we have 16 issued United States patents, and two allowed applications related to guanylate cyclase agonists.", "type": 2, "words": ["<tag1>", "As", "of", "March", "6,", "2015", "we", "have", "15", "issued", "United", "States", "patents", "related", "to", "guanylate", "cyclase", "agonists.", "<tag2>", "As", "of", "December", "31,", "2015", "we", "have", "16", "issued", "United", "States", "patents,", "and", "two", "allowed", "applications", "related", "to", "guanylate", "cyclase", "agonists.", "<tag3>"], "wordsA": ["As", "of", "March", "6,", "2015", "we", "have", "15", "issued", "United", "States", "patents", "related", "to", "guanylate", "cyclase", "agonists."], "wordsB": ["As", "of", "December", "31,", "2015", "we", "have", "16", "issued", "United", "States", "patents,", "and", "two", "allowed", "applications", "related", "to", "guanylate", "cyclase", "agonists."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_16_item1_p44_s11", "idA": "1347613_15_item1_p59_s11", "sentA": "A thirteenth patent granted May 6, 2014 covers certain methods of treating a variety of gastrointestinal and other disorders using SP-333 and will expire in 2029.", "sentB": "A thirteenth patent granted May 6, 2014 covers certain methods of treating a variety of gastrointestinal and other disorders using dolcanatide and will expire in 2029.", "type": 2, "words": ["<tag1>", "A", "thirteenth", "patent", "granted", "May", "6,", "2014", "covers", "certain", "methods", "of", "treating", "a", "variety", "of", "gastrointestinal", "and", "other", "disorders", "using", "SP-333", "and", "will", "expire", "in", "2029.", "<tag2>", "A", "thirteenth", "patent", "granted", "May", "6,", "2014", "covers", "certain", "methods", "of", "treating", "a", "variety", "of", "gastrointestinal", "and", "other", "disorders", "using", "dolcanatide", "and", "will", "expire", "in", "2029.", "<tag3>"], "wordsA": ["A", "thirteenth", "patent", "granted", "May", "6,", "2014", "covers", "certain", "methods", "of", "treating", "a", "variety", "of", "gastrointestinal", "and", "other", "disorders", "using", "SP-333", "and", "will", "expire", "in", "2029."], "wordsB": ["A", "thirteenth", "patent", "granted", "May", "6,", "2014", "covers", "certain", "methods", "of", "treating", "a", "variety", "of", "gastrointestinal", "and", "other", "disorders", "using", "dolcanatide", "and", "will", "expire", "in", "2029."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_16_item1_p44_s12", "idA": "1347613_15_item1_p59_s12", "sentA": "A fourteenth patent granted December 2, 2014 and covers composition-of-matter of SP-333 and expires in 2028.", "sentB": "A fourteenth patent granted December 2, 2014 and covers composition-of-matter of dolcanatide and expires in 2028.", "type": 2, "words": ["<tag1>", "A", "fourteenth", "patent", "granted", "December", "2,", "2014", "and", "covers", "composition-of-matter", "of", "SP-333", "and", "expires", "in", "2028.", "<tag2>", "A", "fourteenth", "patent", "granted", "December", "2,", "2014", "and", "covers", "composition-of-matter", "of", "dolcanatide", "and", "expires", "in", "2028.", "<tag3>"], "wordsA": ["A", "fourteenth", "patent", "granted", "December", "2,", "2014", "and", "covers", "composition-of-matter", "of", "SP-333", "and", "expires", "in", "2028."], "wordsB": ["A", "fourteenth", "patent", "granted", "December", "2,", "2014", "and", "covers", "composition-of-matter", "of", "dolcanatide", "and", "expires", "in", "2028."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_16_item1_p44_s15", "idA": "1347613_15_item1_p59_s12", "sentA": "A fourteenth patent granted December 2, 2014 and covers composition-of-matter of SP-333 and expires in 2028.", "sentB": "One allowed patent application covers composition-of-matter of dolcanatide and is projected to expire in 2028.", "type": 2, "words": ["<tag1>", "A", "fourteenth", "patent", "granted", "December", "2,", "2014", "and", "covers", "composition-of-matter", "of", "SP-333", "and", "expires", "in", "2028.", "<tag2>", "One", "allowed", "patent", "application", "covers", "composition-of-matter", "of", "dolcanatide", "and", "is", "projected", "to", "expire", "in", "2028.", "<tag3>"], "wordsA": ["A", "fourteenth", "patent", "granted", "December", "2,", "2014", "and", "covers", "composition-of-matter", "of", "SP-333", "and", "expires", "in", "2028."], "wordsB": ["One", "allowed", "patent", "application", "covers", "composition-of-matter", "of", "dolcanatide", "and", "is", "projected", "to", "expire", "in", "2028."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_16_item1_p45_s0", "idA": "1347613_15_item1_p59_s14", "sentA": "In addition, we have four granted foreign patents which cover the composition-of-matter of plecanatide and expire in 2022.", "sentB": "In addition, we have seven granted foreign patents which cover the composition-of-matter of plecanatide and expire in 2022.", "type": 2, "words": ["<tag1>", "In", "addition,", "we", "have", "four", "granted", "foreign", "patents", "which", "cover", "the", "composition-of-matter", "of", "plecanatide", "and", "expire", "in", "2022.", "<tag2>", "In", "addition,", "we", "have", "seven", "granted", "foreign", "patents", "which", "cover", "the", "composition-of-matter", "of", "plecanatide", "and", "expire", "in", "2022.", "<tag3>"], "wordsA": ["In", "addition,", "we", "have", "four", "granted", "foreign", "patents", "which", "cover", "the", "composition-of-matter", "of", "plecanatide", "and", "expire", "in", "2022."], "wordsB": ["In", "addition,", "we", "have", "seven", "granted", "foreign", "patents", "which", "cover", "the", "composition-of-matter", "of", "plecanatide", "and", "expire", "in", "2022."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_16_item1_p45_s2", "idA": "1347613_15_item1_p59_s16", "sentA": "We also have six granted foreign patents that cover the composition-of-matter related to SP-333 that expire in 2028.", "sentB": "We also have seven granted foreign patents that cover the composition-of-matter related to dolcanatide that expire in 2028.", "type": 2, "words": ["<tag1>", "We", "also", "have", "six", "granted", "foreign", "patents", "that", "cover", "the", "composition-of-matter", "related", "to", "SP-333", "that", "expire", "in", "2028.", "<tag2>", "We", "also", "have", "seven", "granted", "foreign", "patents", "that", "cover", "the", "composition-of-matter", "related", "to", "dolcanatide", "that", "expire", "in", "2028.", "<tag3>"], "wordsA": ["We", "also", "have", "six", "granted", "foreign", "patents", "that", "cover", "the", "composition-of-matter", "related", "to", "SP-333", "that", "expire", "in", "2028."], "wordsB": ["We", "also", "have", "seven", "granted", "foreign", "patents", "that", "cover", "the", "composition-of-matter", "related", "to", "dolcanatide", "that", "expire", "in", "2028."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_16_item1_p45_s4", "idA": "1347613_15_item1_p59_s18", "sentA": "We also have two foreign patents that cover composition-of-matter of certain analogs related to plecanatide and expire in 2029.", "sentB": "We also have three foreign patents that cover composition-of-matter of certain analogs related to plecanatide and methods of use to treat Ulcerative Colitis that expire in 2029.", "type": 2, "words": ["<tag1>", "We", "also", "have", "two", "foreign", "patents", "that", "cover", "composition-of-matter", "of", "certain", "analogs", "related", "to", "plecanatide", "and", "expire", "in", "2029.", "<tag2>", "We", "also", "have", "three", "foreign", "patents", "that", "cover", "composition-of-matter", "of", "certain", "analogs", "related", "to", "plecanatide", "and", "methods", "of", "use", "to", "treat", "Ulcerative", "Colitis", "that", "expire", "in", "2029.", "<tag3>"], "wordsA": ["We", "also", "have", "two", "foreign", "patents", "that", "cover", "composition-of-matter", "of", "certain", "analogs", "related", "to", "plecanatide", "and", "expire", "in", "2029."], "wordsB": ["We", "also", "have", "three", "foreign", "patents", "that", "cover", "composition-of-matter", "of", "certain", "analogs", "related", "to", "plecanatide", "and", "methods", "of", "use", "to", "treat", "Ulcerative", "Colitis", "that", "expire", "in", "2029."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_16_item1_p45_s6", "idA": "1347613_15_item1_p59_s18", "sentA": "We also have two foreign patents that cover composition-of-matter of certain analogs related to plecanatide and expire in 2029.", "sentB": "We also have two foreign patents that cover composition-of-matter of certain analogs related to dolcanatide and methods of use to treat gastrointestinal disorders and expires in 2029.", "type": 2, "words": ["<tag1>", "We", "also", "have", "two", "foreign", "patents", "that", "cover", "composition-of-matter", "of", "certain", "analogs", "related", "to", "plecanatide", "and", "expire", "in", "2029.", "<tag2>", "We", "also", "have", "two", "foreign", "patents", "that", "cover", "composition-of-matter", "of", "certain", "analogs", "related", "to", "dolcanatide", "and", "methods", "of", "use", "to", "treat", "gastrointestinal", "disorders", "and", "expires", "in", "2029.", "<tag3>"], "wordsA": ["We", "also", "have", "two", "foreign", "patents", "that", "cover", "composition-of-matter", "of", "certain", "analogs", "related", "to", "plecanatide", "and", "expire", "in", "2029."], "wordsB": ["We", "also", "have", "two", "foreign", "patents", "that", "cover", "composition-of-matter", "of", "certain", "analogs", "related", "to", "dolcanatide", "and", "methods", "of", "use", "to", "treat", "gastrointestinal", "disorders", "and", "expires", "in", "2029."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_16_item1_p45_s8", "idA": "1347613_15_item1_p59_s18", "sentA": "We also have two foreign patents that cover composition-of-matter of certain analogs related to plecanatide and expire in 2029.", "sentB": "We also have three foreign patents related to plecanatide that cover treatment and prevention of Hypercholesterolemia and expire in 2030.", "type": 2, "words": ["<tag1>", "We", "also", "have", "two", "foreign", "patents", "that", "cover", "composition-of-matter", "of", "certain", "analogs", "related", "to", "plecanatide", "and", "expire", "in", "2029.", "<tag2>", "We", "also", "have", "three", "foreign", "patents", "related", "to", "plecanatide", "that", "cover", "treatment", "and", "prevention", "of", "Hypercholesterolemia", "and", "expire", "in", "2030.", "<tag3>"], "wordsA": ["We", "also", "have", "two", "foreign", "patents", "that", "cover", "composition-of-matter", "of", "certain", "analogs", "related", "to", "plecanatide", "and", "expire", "in", "2029."], "wordsB": ["We", "also", "have", "three", "foreign", "patents", "related", "to", "plecanatide", "that", "cover", "treatment", "and", "prevention", "of", "Hypercholesterolemia", "and", "expire", "in", "2030."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_16_item1_p45_s5", "idA": "1347613_15_item1_p59_s19", "sentA": "This patent covers Australia, France, Germany, Italy, Spain and the United Kingdom.", "sentB": "These patents cover Australia, Hong Kong, France, Germany, Italy, Spain and the United Kingdom.", "type": 2, "words": ["<tag1>", "This", "patent", "covers", "Australia,", "France,", "Germany,", "Italy,", "Spain", "and", "the", "United", "Kingdom.", "<tag2>", "These", "patents", "cover", "Australia,", "Hong", "Kong,", "France,", "Germany,", "Italy,", "Spain", "and", "the", "United", "Kingdom.", "<tag3>"], "wordsA": ["This", "patent", "covers", "Australia,", "France,", "Germany,", "Italy,", "Spain", "and", "the", "United", "Kingdom."], "wordsB": ["These", "patents", "cover", "Australia,", "Hong", "Kong,", "France,", "Germany,", "Italy,", "Spain", "and", "the", "United", "Kingdom."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_16_item1_p45_s7", "idA": "1347613_15_item1_p59_s19", "sentA": "This patent covers Australia, France, Germany, Italy, Spain and the United Kingdom.", "sentB": "These patents cover Australia, France, Germany, Italy, Spain and the United Kingdom.", "type": 2, "words": ["<tag1>", "This", "patent", "covers", "Australia,", "France,", "Germany,", "Italy,", "Spain", "and", "the", "United", "Kingdom.", "<tag2>", "These", "patents", "cover", "Australia,", "France,", "Germany,", "Italy,", "Spain", "and", "the", "United", "Kingdom.", "<tag3>"], "wordsA": ["This", "patent", "covers", "Australia,", "France,", "Germany,", "Italy,", "Spain", "and", "the", "United", "Kingdom."], "wordsB": ["These", "patents", "cover", "Australia,", "France,", "Germany,", "Italy,", "Spain", "and", "the", "United", "Kingdom."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_16_item1_p45_s9", "idA": "1347613_15_item1_p59_s19", "sentA": "This patent covers Australia, France, Germany, Italy, Spain and the United Kingdom.", "sentB": "These patents cover Japan, Mexico, France, Germany, Italy, Spain and the United Kingdom.", "type": 2, "words": ["<tag1>", "This", "patent", "covers", "Australia,", "France,", "Germany,", "Italy,", "Spain", "and", "the", "United", "Kingdom.", "<tag2>", "These", "patents", "cover", "Japan,", "Mexico,", "France,", "Germany,", "Italy,", "Spain", "and", "the", "United", "Kingdom.", "<tag3>"], "wordsA": ["This", "patent", "covers", "Australia,", "France,", "Germany,", "Italy,", "Spain", "and", "the", "United", "Kingdom."], "wordsB": ["These", "patents", "cover", "Japan,", "Mexico,", "France,", "Germany,", "Italy,", "Spain", "and", "the", "United", "Kingdom."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_16_item1_p44_s3", "idA": "1347613_15_item1_p59_s3", "sentA": "A third patent covers the composition-of-matter of SP-333 issued on February 1, 2011 and expires in 2028.", "sentB": "A third patent covers the composition-of-matter of dolcanatide issued on February 1, 2011 and expires in 2028.", "type": 2, "words": ["<tag1>", "A", "third", "patent", "covers", "the", "composition-of-matter", "of", "SP-333", "issued", "on", "February", "1,", "2011", "and", "expires", "in", "2028.", "<tag2>", "A", "third", "patent", "covers", "the", "composition-of-matter", "of", "dolcanatide", "issued", "on", "February", "1,", "2011", "and", "expires", "in", "2028.", "<tag3>"], "wordsA": ["A", "third", "patent", "covers", "the", "composition-of-matter", "of", "SP-333", "issued", "on", "February", "1,", "2011", "and", "expires", "in", "2028."], "wordsB": ["A", "third", "patent", "covers", "the", "composition-of-matter", "of", "dolcanatide", "issued", "on", "February", "1,", "2011", "and", "expires", "in", "2028."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_16_item1_p44_s4", "idA": "1347613_15_item1_p59_s4", "sentA": "A fourth patent granted October 11, 2011 covers the composition-of-matter of certain analogs related to plecanatide and SP-333 and will expire in 2029.", "sentB": "A fourth patent granted October 11, 2011 covers the composition-of-matter of certain analogs related to plecanatide and dolcanatide and will expire in 2029.", "type": 2, "words": ["<tag1>", "A", "fourth", "patent", "granted", "October", "11,", "2011", "covers", "the", "composition-of-matter", "of", "certain", "analogs", "related", "to", "plecanatide", "and", "SP-333", "and", "will", "expire", "in", "2029.", "<tag2>", "A", "fourth", "patent", "granted", "October", "11,", "2011", "covers", "the", "composition-of-matter", "of", "certain", "analogs", "related", "to", "plecanatide", "and", "dolcanatide", "and", "will", "expire", "in", "2029.", "<tag3>"], "wordsA": ["A", "fourth", "patent", "granted", "October", "11,", "2011", "covers", "the", "composition-of-matter", "of", "certain", "analogs", "related", "to", "plecanatide", "and", "SP-333", "and", "will", "expire", "in", "2029."], "wordsB": ["A", "fourth", "patent", "granted", "October", "11,", "2011", "covers", "the", "composition-of-matter", "of", "certain", "analogs", "related", "to", "plecanatide", "and", "dolcanatide", "and", "will", "expire", "in", "2029."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_16_item1_p33_s0", "idA": "1347613_15_item1_p59_s5", "sentA": "A fifth patent granted February 14, 2012 covers certain methods of treating inflammatory bowel disease using plecanatide and will expire in 2022.", "sentB": "Dolcanatide, our second uroguanylin analog, is currently being explored for inflammatory bowel disease (IBD).", "type": 2, "words": ["<tag1>", "A", "fifth", "patent", "granted", "February", "14,", "2012", "covers", "certain", "methods", "of", "treating", "inflammatory", "bowel", "disease", "using", "plecanatide", "and", "will", "expire", "in", "2022.", "<tag2>", "Dolcanatide,", "our", "second", "uroguanylin", "analog,", "is", "currently", "being", "explored", "for", "inflammatory", "bowel", "disease", "(IBD).", "<tag3>"], "wordsA": ["A", "fifth", "patent", "granted", "February", "14,", "2012", "covers", "certain", "methods", "of", "treating", "inflammatory", "bowel", "disease", "using", "plecanatide", "and", "will", "expire", "in", "2022."], "wordsB": ["Dolcanatide,", "our", "second", "uroguanylin", "analog,", "is", "currently", "being", "explored", "for", "inflammatory", "bowel", "disease", "(IBD)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_16_item1_p4_s0", "idA": "1347613_15_item1_p59_s5", "sentA": "A fifth patent granted February 14, 2012 covers certain methods of treating inflammatory bowel disease using plecanatide and will expire in 2022.", "sentB": "Dolcanatide is our second uroguanylin analog currently being explored for inflammatory bowel disease (IBD).", "type": 2, "words": ["<tag1>", "A", "fifth", "patent", "granted", "February", "14,", "2012", "covers", "certain", "methods", "of", "treating", "inflammatory", "bowel", "disease", "using", "plecanatide", "and", "will", "expire", "in", "2022.", "<tag2>", "Dolcanatide", "is", "our", "second", "uroguanylin", "analog", "currently", "being", "explored", "for", "inflammatory", "bowel", "disease", "(IBD).", "<tag3>"], "wordsA": ["A", "fifth", "patent", "granted", "February", "14,", "2012", "covers", "certain", "methods", "of", "treating", "inflammatory", "bowel", "disease", "using", "plecanatide", "and", "will", "expire", "in", "2022."], "wordsB": ["Dolcanatide", "is", "our", "second", "uroguanylin", "analog", "currently", "being", "explored", "for", "inflammatory", "bowel", "disease", "(IBD)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_16_item1_p44_s14", "idA": "1347613_15_item1_p59_s7", "sentA": "A seventh patent granted June 26, 2012 covers an additional composition-of-matter related to certain analogs of plecanatide and SP-333 and will expire in 2029.", "sentB": "A sixteenth patent granted July 28, 2015 covers an additional composition-of-matter related to certain analogs of plecanatide and dolcanatide and will expire in 2028.", "type": 2, "words": ["<tag1>", "A", "seventh", "patent", "granted", "June", "26,", "2012", "covers", "an", "additional", "composition-of-matter", "related", "to", "certain", "analogs", "of", "plecanatide", "and", "SP-333", "and", "will", "expire", "in", "2029.", "<tag2>", "A", "sixteenth", "patent", "granted", "July", "28,", "2015", "covers", "an", "additional", "composition-of-matter", "related", "to", "certain", "analogs", "of", "plecanatide", "and", "dolcanatide", "and", "will", "expire", "in", "2028.", "<tag3>"], "wordsA": ["A", "seventh", "patent", "granted", "June", "26,", "2012", "covers", "an", "additional", "composition-of-matter", "related", "to", "certain", "analogs", "of", "plecanatide", "and", "SP-333", "and", "will", "expire", "in", "2029."], "wordsB": ["A", "sixteenth", "patent", "granted", "July", "28,", "2015", "covers", "an", "additional", "composition-of-matter", "related", "to", "certain", "analogs", "of", "plecanatide", "and", "dolcanatide", "and", "will", "expire", "in", "2028."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_16_item1_p44_s16", "idA": "1347613_15_item1_p59_s7", "sentA": "A seventh patent granted June 26, 2012 covers an additional composition-of-matter related to certain analogs of plecanatide and SP-333 and will expire in 2029.", "sentB": "Another allowed patent application covers an additional composition-of-matter related to certain analogs of plecanatide and dolcanatide and is projected to expire in 2034.", "type": 2, "words": ["<tag1>", "A", "seventh", "patent", "granted", "June", "26,", "2012", "covers", "an", "additional", "composition-of-matter", "related", "to", "certain", "analogs", "of", "plecanatide", "and", "SP-333", "and", "will", "expire", "in", "2029.", "<tag2>", "Another", "allowed", "patent", "application", "covers", "an", "additional", "composition-of-matter", "related", "to", "certain", "analogs", "of", "plecanatide", "and", "dolcanatide", "and", "is", "projected", "to", "expire", "in", "2034.", "<tag3>"], "wordsA": ["A", "seventh", "patent", "granted", "June", "26,", "2012", "covers", "an", "additional", "composition-of-matter", "related", "to", "certain", "analogs", "of", "plecanatide", "and", "SP-333", "and", "will", "expire", "in", "2029."], "wordsB": ["Another", "allowed", "patent", "application", "covers", "an", "additional", "composition-of-matter", "related", "to", "certain", "analogs", "of", "plecanatide", "and", "dolcanatide", "and", "is", "projected", "to", "expire", "in", "2034."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_16_item1_p44_s7", "idA": "1347613_15_item1_p59_s7", "sentA": "A seventh patent granted June 26, 2012 covers an additional composition-of-matter related to certain analogs of plecanatide and SP-333 and will expire in 2029.", "sentB": "A seventh patent granted June 26, 2012 covers an additional composition-of-matter related to certain analogs of plecanatide and dolcanatide and will expire in 2029.", "type": 2, "words": ["<tag1>", "A", "seventh", "patent", "granted", "June", "26,", "2012", "covers", "an", "additional", "composition-of-matter", "related", "to", "certain", "analogs", "of", "plecanatide", "and", "SP-333", "and", "will", "expire", "in", "2029.", "<tag2>", "A", "seventh", "patent", "granted", "June", "26,", "2012", "covers", "an", "additional", "composition-of-matter", "related", "to", "certain", "analogs", "of", "plecanatide", "and", "dolcanatide", "and", "will", "expire", "in", "2029.", "<tag3>"], "wordsA": ["A", "seventh", "patent", "granted", "June", "26,", "2012", "covers", "an", "additional", "composition-of-matter", "related", "to", "certain", "analogs", "of", "plecanatide", "and", "SP-333", "and", "will", "expire", "in", "2029."], "wordsB": ["A", "seventh", "patent", "granted", "June", "26,", "2012", "covers", "an", "additional", "composition-of-matter", "related", "to", "certain", "analogs", "of", "plecanatide", "and", "dolcanatide", "and", "will", "expire", "in", "2029."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_16_item1_p7_s0", "idA": "1347613_15_item1_p5_s0", "sentA": "On January 8, 2015 and January 29, 2015 we announced that we had completed patient enrollment in the first and second of two pivotal phase 3 trials, respectively, which are evaluating the safety and efficacy of two plecanatide doses (3.0 and 6.0 mg) in patients with CIC.", "sentB": "On January 29, 2016, we announced that we had filed with the FDA our first NDA for plecanatide in CIC.", "type": 2, "words": ["<tag1>", "On", "January", "8,", "2015", "and", "January", "29,", "2015", "we", "announced", "that", "we", "had", "completed", "patient", "enrollment", "in", "the", "first", "and", "second", "of", "two", "pivotal", "phase", "3", "trials,", "respectively,", "which", "are", "evaluating", "the", "safety", "and", "efficacy", "of", "two", "plecanatide", "doses", "(3.0", "and", "6.0", "mg)", "in", "patients", "with", "CIC.", "<tag2>", "On", "January", "29,", "2016,", "we", "announced", "that", "we", "had", "filed", "with", "the", "FDA", "our", "first", "NDA", "for", "plecanatide", "in", "CIC.", "<tag3>"], "wordsA": ["On", "January", "8,", "2015", "and", "January", "29,", "2015", "we", "announced", "that", "we", "had", "completed", "patient", "enrollment", "in", "the", "first", "and", "second", "of", "two", "pivotal", "phase", "3", "trials,", "respectively,", "which", "are", "evaluating", "the", "safety", "and", "efficacy", "of", "two", "plecanatide", "doses", "(3.0", "and", "6.0", "mg)", "in", "patients", "with", "CIC."], "wordsB": ["On", "January", "29,", "2016,", "we", "announced", "that", "we", "had", "filed", "with", "the", "FDA", "our", "first", "NDA", "for", "plecanatide", "in", "CIC."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_16_item1_p3_s2", "idA": "1347613_15_item1_p5_s3", "sentA": "In the fourth quarter of 2015, we plan to file our first new drug application (NDA) with FDA for plecanatide to treat CIC.", "sentB": "In 2015, we announced positive phase 3 data in two CIC clinical trials and on January 29, 2016 we filed a new drug application (NDA) with the U.S. Food and Drug Administration (FDA) with plecanatide for CIC.", "type": 2, "words": ["<tag1>", "In", "the", "fourth", "quarter", "of", "2015,", "we", "plan", "to", "file", "our", "first", "new", "drug", "application", "(NDA)", "with", "FDA", "for", "plecanatide", "to", "treat", "CIC.", "<tag2>", "In", "2015,", "we", "announced", "positive", "phase", "3", "data", "in", "two", "CIC", "clinical", "trials", "and", "on", "January", "29,", "2016", "we", "filed", "a", "new", "drug", "application", "(NDA)", "with", "the", "U.S.", "Food", "and", "Drug", "Administration", "(FDA)", "with", "plecanatide", "for", "CIC.", "<tag3>"], "wordsA": ["In", "the", "fourth", "quarter", "of", "2015,", "we", "plan", "to", "file", "our", "first", "new", "drug", "application", "(NDA)", "with", "FDA", "for", "plecanatide", "to", "treat", "CIC."], "wordsB": ["In", "2015,", "we", "announced", "positive", "phase", "3", "data", "in", "two", "CIC", "clinical", "trials", "and", "on", "January", "29,", "2016", "we", "filed", "a", "new", "drug", "application", "(NDA)", "with", "the", "U.S.", "Food", "and", "Drug", "Administration", "(FDA)", "with", "plecanatide", "for", "CIC."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_16_item1_p46_s0", "idA": "1347613_15_item1_p60_s0", "sentA": "Additionally, as of the date of this report on Form 10-K, we have 13 pending United States utility patent applications; 2 pending U.S. provisional applications; and 66 pending foreign patent applications relating to plecanatide and SP-333, various derivatives and analogs of plecanatide and SP-333, and their uses and manufacture.", "sentB": "Additionally, as of the date of this report on Form 10-K, we have 17 pending United States utility patent applications; 3 pending U.S. provisional applications; and 79 pending foreign patent applications relating to plecanatide and dolcanatide, various derivatives and analogs of plecanatide and dolcanatide, and their uses and manufacture.", "type": 2, "words": ["<tag1>", "Additionally,", "as", "of", "the", "date", "of", "this", "report", "on", "Form", "10-K,", "we", "have", "13", "pending", "United", "States", "utility", "patent", "applications;", "2", "pending", "U.S.", "provisional", "applications;", "and", "66", "pending", "foreign", "patent", "applications", "relating", "to", "plecanatide", "and", "SP-333,", "various", "derivatives", "and", "analogs", "of", "plecanatide", "and", "SP-333,", "and", "their", "uses", "and", "manufacture.", "<tag2>", "Additionally,", "as", "of", "the", "date", "of", "this", "report", "on", "Form", "10-K,", "we", "have", "17", "pending", "United", "States", "utility", "patent", "applications;", "3", "pending", "U.S.", "provisional", "applications;", "and", "79", "pending", "foreign", "patent", "applications", "relating", "to", "plecanatide", "and", "dolcanatide,", "various", "derivatives", "and", "analogs", "of", "plecanatide", "and", "dolcanatide,", "and", "their", "uses", "and", "manufacture.", "<tag3>"], "wordsA": ["Additionally,", "as", "of", "the", "date", "of", "this", "report", "on", "Form", "10-K,", "we", "have", "13", "pending", "United", "States", "utility", "patent", "applications;", "2", "pending", "U.S.", "provisional", "applications;", "and", "66", "pending", "foreign", "patent", "applications", "relating", "to", "plecanatide", "and", "SP-333,", "various", "derivatives", "and", "analogs", "of", "plecanatide", "and", "SP-333,", "and", "their", "uses", "and", "manufacture."], "wordsB": ["Additionally,", "as", "of", "the", "date", "of", "this", "report", "on", "Form", "10-K,", "we", "have", "17", "pending", "United", "States", "utility", "patent", "applications;", "3", "pending", "U.S.", "provisional", "applications;", "and", "79", "pending", "foreign", "patent", "applications", "relating", "to", "plecanatide", "and", "dolcanatide,", "various", "derivatives", "and", "analogs", "of", "plecanatide", "and", "dolcanatide,", "and", "their", "uses", "and", "manufacture."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_16_item1_p48_s0", "idA": "1347613_15_item1_p62_s0", "sentA": "On September 14, 2012 we entered into a binding letter of intent with Ironwood Pharmaceuticals, Inc. ( Ironwood ), pursuant to which we and Ironwood agreed to enter into a definitive license agreement giving us an exclusive worldwide license to Ironwood s method of use patents on plecanatide for the treatment of chronic constipation, or CC.", "sentB": "On September 14, 2012 we entered into a binding letter of intent with Ironwood Pharmaceuticals, Inc. ( Ironwood ), pursuant to which we and Ironwood agreed to enter into a definitive license agreement giving us an exclusive worldwide license to Ironwood s method of use patents on plecanatide.", "type": 2, "words": ["<tag1>", "On", "September", "14,", "2012", "we", "entered", "into", "a", "binding", "letter", "of", "intent", "with", "Ironwood", "Pharmaceuticals,", "Inc.", "(", "Ironwood", "),", "pursuant", "to", "which", "we", "and", "Ironwood", "agreed", "to", "enter", "into", "a", "definitive", "license", "agreement", "giving", "us", "an", "exclusive", "worldwide", "license", "to", "Ironwood", "s", "method", "of", "use", "patents", "on", "plecanatide", "for", "the", "treatment", "of", "chronic", "constipation,", "or", "CC.", "<tag2>", "On", "September", "14,", "2012", "we", "entered", "into", "a", "binding", "letter", "of", "intent", "with", "Ironwood", "Pharmaceuticals,", "Inc.", "(", "Ironwood", "),", "pursuant", "to", "which", "we", "and", "Ironwood", "agreed", "to", "enter", "into", "a", "definitive", "license", "agreement", "giving", "us", "an", "exclusive", "worldwide", "license", "to", "Ironwood", "s", "method", "of", "use", "patents", "on", "plecanatide.", "<tag3>"], "wordsA": ["On", "September", "14,", "2012", "we", "entered", "into", "a", "binding", "letter", "of", "intent", "with", "Ironwood", "Pharmaceuticals,", "Inc.", "(", "Ironwood", "),", "pursuant", "to", "which", "we", "and", "Ironwood", "agreed", "to", "enter", "into", "a", "definitive", "license", "agreement", "giving", "us", "an", "exclusive", "worldwide", "license", "to", "Ironwood", "s", "method", "of", "use", "patents", "on", "plecanatide", "for", "the", "treatment", "of", "chronic", "constipation,", "or", "CC."], "wordsB": ["On", "September", "14,", "2012", "we", "entered", "into", "a", "binding", "letter", "of", "intent", "with", "Ironwood", "Pharmaceuticals,", "Inc.", "(", "Ironwood", "),", "pursuant", "to", "which", "we", "and", "Ironwood", "agreed", "to", "enter", "into", "a", "definitive", "license", "agreement", "giving", "us", "an", "exclusive", "worldwide", "license", "to", "Ironwood", "s", "method", "of", "use", "patents", "on", "plecanatide."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_16_item1_p49_s0", "idA": "1347613_15_item1_p63_s0", "sentA": "During 2013, we transferred ownership of all FV-100 intellectual property rights we acquired from BristolMeyersSquib Company ( BMS ), in August 2012, to ContraVir, our former majority-owned subsidiary which we spun off to our shareholders on February 18, 2014.", "sentB": "During 2013, we transferred ownership of all FV-100 intellectual property rights we acquired from Bristol-Myers Squibb Company ( BMS ), in August 2012, to ContraVir Pharmaceuticals, Inc., our former majority-owned subsidiary which we spun off to our shareholders on February 18, 2014.", "type": 2, "words": ["<tag1>", "During", "2013,", "we", "transferred", "ownership", "of", "all", "FV-100", "intellectual", "property", "rights", "we", "acquired", "from", "BristolMeyersSquib", "Company", "(", "BMS", "),", "in", "August", "2012,", "to", "ContraVir,", "our", "former", "majority-owned", "subsidiary", "which", "we", "spun", "off", "to", "our", "shareholders", "on", "February", "18,", "2014.", "<tag2>", "During", "2013,", "we", "transferred", "ownership", "of", "all", "FV-100", "intellectual", "property", "rights", "we", "acquired", "from", "Bristol-Myers", "Squibb", "Company", "(", "BMS", "),", "in", "August", "2012,", "to", "ContraVir", "Pharmaceuticals,", "Inc.,", "our", "former", "majority-owned", "subsidiary", "which", "we", "spun", "off", "to", "our", "shareholders", "on", "February", "18,", "2014.", "<tag3>"], "wordsA": ["During", "2013,", "we", "transferred", "ownership", "of", "all", "FV-100", "intellectual", "property", "rights", "we", "acquired", "from", "BristolMeyersSquib", "Company", "(", "BMS", "),", "in", "August", "2012,", "to", "ContraVir,", "our", "former", "majority-owned", "subsidiary", "which", "we", "spun", "off", "to", "our", "shareholders", "on", "February", "18,", "2014."], "wordsB": ["During", "2013,", "we", "transferred", "ownership", "of", "all", "FV-100", "intellectual", "property", "rights", "we", "acquired", "from", "Bristol-Myers", "Squibb", "Company", "(", "BMS", "),", "in", "August", "2012,", "to", "ContraVir", "Pharmaceuticals,", "Inc.,", "our", "former", "majority-owned", "subsidiary", "which", "we", "spun", "off", "to", "our", "shareholders", "on", "February", "18,", "2014."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_16_item1_p49_s1", "idA": "1347613_15_item1_p63_s1", "sentA": "The FV-100 assets acquired by ContraVir from us were licensed from University College Cardiff Consultants Limited ( Cardiff ) pursuant to the terms of that certain Patent and Technology License Agreement, dated as of February 2, 2005, between Cardiff and Contravir Research Incorporated, an entity with no prior relationship with the Company ( CRI ), as amended March 27, 2007, which ContraVir assumed from us (the Cardiff Agreement ).", "sentB": "The FV-100 assets acquired by ContraVir from us were licensed from University College Cardiff Consultants Limited ( Cardiff ) pursuant to the terms of that certain Patent and Technology License Agreement, dated as of February 2, 2005, between Cardiff and Contravir Research Incorporated, an entity with no prior relationship with us ( CRI ), as amended March 27, 2007, which ContraVir assumed from us (the Cardiff Agreement ).", "type": 2, "words": ["<tag1>", "The", "FV-100", "assets", "acquired", "by", "ContraVir", "from", "us", "were", "licensed", "from", "University", "College", "Cardiff", "Consultants", "Limited", "(", "Cardiff", ")", "pursuant", "to", "the", "terms", "of", "that", "certain", "Patent", "and", "Technology", "License", "Agreement,", "dated", "as", "of", "February", "2,", "2005,", "between", "Cardiff", "and", "Contravir", "Research", "Incorporated,", "an", "entity", "with", "no", "prior", "relationship", "with", "the", "Company", "(", "CRI", "),", "as", "amended", "March", "27,", "2007,", "which", "ContraVir", "assumed", "from", "us", "(the", "Cardiff", "Agreement", ").", "<tag2>", "The", "FV-100", "assets", "acquired", "by", "ContraVir", "from", "us", "were", "licensed", "from", "University", "College", "Cardiff", "Consultants", "Limited", "(", "Cardiff", ")", "pursuant", "to", "the", "terms", "of", "that", "certain", "Patent", "and", "Technology", "License", "Agreement,", "dated", "as", "of", "February", "2,", "2005,", "between", "Cardiff", "and", "Contravir", "Research", "Incorporated,", "an", "entity", "with", "no", "prior", "relationship", "with", "us", "(", "CRI", "),", "as", "amended", "March", "27,", "2007,", "which", "ContraVir", "assumed", "from", "us", "(the", "Cardiff", "Agreement", ").", "<tag3>"], "wordsA": ["The", "FV-100", "assets", "acquired", "by", "ContraVir", "from", "us", "were", "licensed", "from", "University", "College", "Cardiff", "Consultants", "Limited", "(", "Cardiff", ")", "pursuant", "to", "the", "terms", "of", "that", "certain", "Patent", "and", "Technology", "License", "Agreement,", "dated", "as", "of", "February", "2,", "2005,", "between", "Cardiff", "and", "Contravir", "Research", "Incorporated,", "an", "entity", "with", "no", "prior", "relationship", "with", "the", "Company", "(", "CRI", "),", "as", "amended", "March", "27,", "2007,", "which", "ContraVir", "assumed", "from", "us", "(the", "Cardiff", "Agreement", ")."], "wordsB": ["The", "FV-100", "assets", "acquired", "by", "ContraVir", "from", "us", "were", "licensed", "from", "University", "College", "Cardiff", "Consultants", "Limited", "(", "Cardiff", ")", "pursuant", "to", "the", "terms", "of", "that", "certain", "Patent", "and", "Technology", "License", "Agreement,", "dated", "as", "of", "February", "2,", "2005,", "between", "Cardiff", "and", "Contravir", "Research", "Incorporated,", "an", "entity", "with", "no", "prior", "relationship", "with", "us", "(", "CRI", "),", "as", "amended", "March", "27,", "2007,", "which", "ContraVir", "assumed", "from", "us", "(the", "Cardiff", "Agreement", ")."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_16_item1_p56_s0", "idA": "1347613_15_item1_p69_s2", "sentA": "The FDA has very broad enforcement authority and failure to abide by applicable regulatory requirements can result in administrative or judicial sanctions being imposed on us, including warning letters, refusals of government contracts, clinical holds, civil penalties, injunctions, restitution, disgorgement of profits, recall or seizure of products, total or partial suspension of production or distribution, withdrawal of approval, refusal to approve pending applications, and criminal prosecution.", "sentB": "and failure to abide by applicable regulatory requirements can result in administrative or judicial sanctions being imposed on us, including warning letters, refusals of government contracts, clinical holds, civil penalties, injunctions, restitution, disgorgement of profits, recall or seizure of products, total or partial suspension of production or distribution, withdrawal of approval, refusal to approve pending applications, and criminal prosecution.", "type": 2, "words": ["<tag1>", "The", "FDA", "has", "very", "broad", "enforcement", "authority", "and", "failure", "to", "abide", "by", "applicable", "regulatory", "requirements", "can", "result", "in", "administrative", "or", "judicial", "sanctions", "being", "imposed", "on", "us,", "including", "warning", "letters,", "refusals", "of", "government", "contracts,", "clinical", "holds,", "civil", "penalties,", "injunctions,", "restitution,", "disgorgement", "of", "profits,", "recall", "or", "seizure", "of", "products,", "total", "or", "partial", "suspension", "of", "production", "or", "distribution,", "withdrawal", "of", "approval,", "refusal", "to", "approve", "pending", "applications,", "and", "criminal", "prosecution.", "<tag2>", "and", "failure", "to", "abide", "by", "applicable", "regulatory", "requirements", "can", "result", "in", "administrative", "or", "judicial", "sanctions", "being", "imposed", "on", "us,", "including", "warning", "letters,", "refusals", "of", "government", "contracts,", "clinical", "holds,", "civil", "penalties,", "injunctions,", "restitution,", "disgorgement", "of", "profits,", "recall", "or", "seizure", "of", "products,", "total", "or", "partial", "suspension", "of", "production", "or", "distribution,", "withdrawal", "of", "approval,", "refusal", "to", "approve", "pending", "applications,", "and", "criminal", "prosecution.", "<tag3>"], "wordsA": ["The", "FDA", "has", "very", "broad", "enforcement", "authority", "and", "failure", "to", "abide", "by", "applicable", "regulatory", "requirements", "can", "result", "in", "administrative", "or", "judicial", "sanctions", "being", "imposed", "on", "us,", "including", "warning", "letters,", "refusals", "of", "government", "contracts,", "clinical", "holds,", "civil", "penalties,", "injunctions,", "restitution,", "disgorgement", "of", "profits,", "recall", "or", "seizure", "of", "products,", "total", "or", "partial", "suspension", "of", "production", "or", "distribution,", "withdrawal", "of", "approval,", "refusal", "to", "approve", "pending", "applications,", "and", "criminal", "prosecution."], "wordsB": ["and", "failure", "to", "abide", "by", "applicable", "regulatory", "requirements", "can", "result", "in", "administrative", "or", "judicial", "sanctions", "being", "imposed", "on", "us,", "including", "warning", "letters,", "refusals", "of", "government", "contracts,", "clinical", "holds,", "civil", "penalties,", "injunctions,", "restitution,", "disgorgement", "of", "profits,", "recall", "or", "seizure", "of", "products,", "total", "or", "partial", "suspension", "of", "production", "or", "distribution,", "withdrawal", "of", "approval,", "refusal", "to", "approve", "pending", "applications,", "and", "criminal", "prosecution."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_16_item1_p10_s1", "idA": "1347613_15_item1_p6_s0", "sentA": "On December 18, 2014 we announced the initiation of the first of two planned pivotal phase 3 clinical trials evaluating the safety and efficacy of 3.0 and 6.0 mg plecanatide, once-daily oral tablets, for the treatment of irritable bowel syndrome with constipation (IBS-C).", "sentB": "Patients who completed either of the two 12-week phase 3 CIC trials were allowed to enroll and receive either 3.0 mg or 6.0 mg plecanatide, once-daily, for one year or more.", "type": 2, "words": ["<tag1>", "On", "December", "18,", "2014", "we", "announced", "the", "initiation", "of", "the", "first", "of", "two", "planned", "pivotal", "phase", "3", "clinical", "trials", "evaluating", "the", "safety", "and", "efficacy", "of", "3.0", "and", "6.0", "mg", "plecanatide,", "once-daily", "oral", "tablets,", "for", "the", "treatment", "of", "irritable", "bowel", "syndrome", "with", "constipation", "(IBS-C).", "<tag2>", "Patients", "who", "completed", "either", "of", "the", "two", "12-week", "phase", "3", "CIC", "trials", "were", "allowed", "to", "enroll", "and", "receive", "either", "3.0", "mg", "or", "6.0", "mg", "plecanatide,", "once-daily,", "for", "one", "year", "or", "more.", "<tag3>"], "wordsA": ["On", "December", "18,", "2014", "we", "announced", "the", "initiation", "of", "the", "first", "of", "two", "planned", "pivotal", "phase", "3", "clinical", "trials", "evaluating", "the", "safety", "and", "efficacy", "of", "3.0", "and", "6.0", "mg", "plecanatide,", "once-daily", "oral", "tablets,", "for", "the", "treatment", "of", "irritable", "bowel", "syndrome", "with", "constipation", "(IBS-C)."], "wordsB": ["Patients", "who", "completed", "either", "of", "the", "two", "12-week", "phase", "3", "CIC", "trials", "were", "allowed", "to", "enroll", "and", "receive", "either", "3.0", "mg", "or", "6.0", "mg", "plecanatide,", "once-daily,", "for", "one", "year", "or", "more."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_16_item1_p11_s0", "idA": "1347613_15_item1_p6_s0", "sentA": "On December 18, 2014 we announced the initiation of the first of two planned pivotal phase 3 clinical trials evaluating the safety and efficacy of 3.0 and 6.0 mg plecanatide, once-daily oral tablets, for the treatment of irritable bowel syndrome with constipation (IBS-C).", "sentB": "We are continuing to advance our two pivotal phase 3 clinical trials with plecanatide for IBS-C. Each randomized, 12-week, double-blind placebo-controlled trial is evaluating the efficacy and safety of both 3.0 mg and 6.0 mg plecanatide treatment doses, taken as a tablet once-a-day, in approximately 1,050 adult patients with IBS-C. The IBS-C program is designed to support regulatory submission in the U.S. and we intend to file our second NDA with plecanatide in the IBS-C indication by year-end 2016.", "type": 2, "words": ["<tag1>", "On", "December", "18,", "2014", "we", "announced", "the", "initiation", "of", "the", "first", "of", "two", "planned", "pivotal", "phase", "3", "clinical", "trials", "evaluating", "the", "safety", "and", "efficacy", "of", "3.0", "and", "6.0", "mg", "plecanatide,", "once-daily", "oral", "tablets,", "for", "the", "treatment", "of", "irritable", "bowel", "syndrome", "with", "constipation", "(IBS-C).", "<tag2>", "We", "are", "continuing", "to", "advance", "our", "two", "pivotal", "phase", "3", "clinical", "trials", "with", "plecanatide", "for", "IBS-C.", "Each", "randomized,", "12-week,", "double-blind", "placebo-controlled", "trial", "is", "evaluating", "the", "efficacy", "and", "safety", "of", "both", "3.0", "mg", "and", "6.0", "mg", "plecanatide", "treatment", "doses,", "taken", "as", "a", "tablet", "once-a-day,", "in", "approximately", "1,050", "adult", "patients", "with", "IBS-C.", "The", "IBS-C", "program", "is", "designed", "to", "support", "regulatory", "submission", "in", "the", "U.S.", "and", "we", "intend", "to", "file", "our", "second", "NDA", "with", "plecanatide", "in", "the", "IBS-C", "indication", "by", "year-end", "2016.", "<tag3>"], "wordsA": ["On", "December", "18,", "2014", "we", "announced", "the", "initiation", "of", "the", "first", "of", "two", "planned", "pivotal", "phase", "3", "clinical", "trials", "evaluating", "the", "safety", "and", "efficacy", "of", "3.0", "and", "6.0", "mg", "plecanatide,", "once-daily", "oral", "tablets,", "for", "the", "treatment", "of", "irritable", "bowel", "syndrome", "with", "constipation", "(IBS-C)."], "wordsB": ["We", "are", "continuing", "to", "advance", "our", "two", "pivotal", "phase", "3", "clinical", "trials", "with", "plecanatide", "for", "IBS-C.", "Each", "randomized,", "12-week,", "double-blind", "placebo-controlled", "trial", "is", "evaluating", "the", "efficacy", "and", "safety", "of", "both", "3.0", "mg", "and", "6.0", "mg", "plecanatide", "treatment", "doses,", "taken", "as", "a", "tablet", "once-a-day,", "in", "approximately", "1,050", "adult", "patients", "with", "IBS-C.", "The", "IBS-C", "program", "is", "designed", "to", "support", "regulatory", "submission", "in", "the", "U.S.", "and", "we", "intend", "to", "file", "our", "second", "NDA", "with", "plecanatide", "in", "the", "IBS-C", "indication", "by", "year-end", "2016."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_16_item1_p12_s0", "idA": "1347613_15_item1_p6_s0", "sentA": "On December 18, 2014 we announced the initiation of the first of two planned pivotal phase 3 clinical trials evaluating the safety and efficacy of 3.0 and 6.0 mg plecanatide, once-daily oral tablets, for the treatment of irritable bowel syndrome with constipation (IBS-C).", "sentB": "Plecanatide is our first novel uroguanylin analog currently being evaluated for use as a once-daily tablet for chronic idiopathic constipation (CIC) and irritable bowel syndrome with constipation (IBS-C).", "type": 2, "words": ["<tag1>", "On", "December", "18,", "2014", "we", "announced", "the", "initiation", "of", "the", "first", "of", "two", "planned", "pivotal", "phase", "3", "clinical", "trials", "evaluating", "the", "safety", "and", "efficacy", "of", "3.0", "and", "6.0", "mg", "plecanatide,", "once-daily", "oral", "tablets,", "for", "the", "treatment", "of", "irritable", "bowel", "syndrome", "with", "constipation", "(IBS-C).", "<tag2>", "Plecanatide", "is", "our", "first", "novel", "uroguanylin", "analog", "currently", "being", "evaluated", "for", "use", "as", "a", "once-daily", "tablet", "for", "chronic", "idiopathic", "constipation", "(CIC)", "and", "irritable", "bowel", "syndrome", "with", "constipation", "(IBS-C).", "<tag3>"], "wordsA": ["On", "December", "18,", "2014", "we", "announced", "the", "initiation", "of", "the", "first", "of", "two", "planned", "pivotal", "phase", "3", "clinical", "trials", "evaluating", "the", "safety", "and", "efficacy", "of", "3.0", "and", "6.0", "mg", "plecanatide,", "once-daily", "oral", "tablets,", "for", "the", "treatment", "of", "irritable", "bowel", "syndrome", "with", "constipation", "(IBS-C)."], "wordsB": ["Plecanatide", "is", "our", "first", "novel", "uroguanylin", "analog", "currently", "being", "evaluated", "for", "use", "as", "a", "once-daily", "tablet", "for", "chronic", "idiopathic", "constipation", "(CIC)", "and", "irritable", "bowel", "syndrome", "with", "constipation", "(IBS-C)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_16_item1_p26_s1", "idA": "1347613_15_item1_p6_s0", "sentA": "On December 18, 2014 we announced the initiation of the first of two planned pivotal phase 3 clinical trials evaluating the safety and efficacy of 3.0 and 6.0 mg plecanatide, once-daily oral tablets, for the treatment of irritable bowel syndrome with constipation (IBS-C).", "sentB": "Patients who completed either of the two 12-week phase 3 CIC trials were allowed to enroll and receive either 3.0 mg or 6.0 mg plecanatide, once-daily, for one year or more.", "type": 2, "words": ["<tag1>", "On", "December", "18,", "2014", "we", "announced", "the", "initiation", "of", "the", "first", "of", "two", "planned", "pivotal", "phase", "3", "clinical", "trials", "evaluating", "the", "safety", "and", "efficacy", "of", "3.0", "and", "6.0", "mg", "plecanatide,", "once-daily", "oral", "tablets,", "for", "the", "treatment", "of", "irritable", "bowel", "syndrome", "with", "constipation", "(IBS-C).", "<tag2>", "Patients", "who", "completed", "either", "of", "the", "two", "12-week", "phase", "3", "CIC", "trials", "were", "allowed", "to", "enroll", "and", "receive", "either", "3.0", "mg", "or", "6.0", "mg", "plecanatide,", "once-daily,", "for", "one", "year", "or", "more.", "<tag3>"], "wordsA": ["On", "December", "18,", "2014", "we", "announced", "the", "initiation", "of", "the", "first", "of", "two", "planned", "pivotal", "phase", "3", "clinical", "trials", "evaluating", "the", "safety", "and", "efficacy", "of", "3.0", "and", "6.0", "mg", "plecanatide,", "once-daily", "oral", "tablets,", "for", "the", "treatment", "of", "irritable", "bowel", "syndrome", "with", "constipation", "(IBS-C)."], "wordsB": ["Patients", "who", "completed", "either", "of", "the", "two", "12-week", "phase", "3", "CIC", "trials", "were", "allowed", "to", "enroll", "and", "receive", "either", "3.0", "mg", "or", "6.0", "mg", "plecanatide,", "once-daily,", "for", "one", "year", "or", "more."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_16_item1_p2_s1", "idA": "1347613_15_item1_p6_s0", "sentA": "On December 18, 2014 we announced the initiation of the first of two planned pivotal phase 3 clinical trials evaluating the safety and efficacy of 3.0 and 6.0 mg plecanatide, once-daily oral tablets, for the treatment of irritable bowel syndrome with constipation (IBS-C).", "sentB": "Plecanatide is our first uroguanylin analog currently being evaluated for use as a once-daily tablet for two functional GI disorders, chronic idiopathic constipation (CIC) and irritable bowel syndrome with constipation (IBS-C).", "type": 2, "words": ["<tag1>", "On", "December", "18,", "2014", "we", "announced", "the", "initiation", "of", "the", "first", "of", "two", "planned", "pivotal", "phase", "3", "clinical", "trials", "evaluating", "the", "safety", "and", "efficacy", "of", "3.0", "and", "6.0", "mg", "plecanatide,", "once-daily", "oral", "tablets,", "for", "the", "treatment", "of", "irritable", "bowel", "syndrome", "with", "constipation", "(IBS-C).", "<tag2>", "Plecanatide", "is", "our", "first", "uroguanylin", "analog", "currently", "being", "evaluated", "for", "use", "as", "a", "once-daily", "tablet", "for", "two", "functional", "GI", "disorders,", "chronic", "idiopathic", "constipation", "(CIC)", "and", "irritable", "bowel", "syndrome", "with", "constipation", "(IBS-C).", "<tag3>"], "wordsA": ["On", "December", "18,", "2014", "we", "announced", "the", "initiation", "of", "the", "first", "of", "two", "planned", "pivotal", "phase", "3", "clinical", "trials", "evaluating", "the", "safety", "and", "efficacy", "of", "3.0", "and", "6.0", "mg", "plecanatide,", "once-daily", "oral", "tablets,", "for", "the", "treatment", "of", "irritable", "bowel", "syndrome", "with", "constipation", "(IBS-C)."], "wordsB": ["Plecanatide", "is", "our", "first", "uroguanylin", "analog", "currently", "being", "evaluated", "for", "use", "as", "a", "once-daily", "tablet", "for", "two", "functional", "GI", "disorders,", "chronic", "idiopathic", "constipation", "(CIC)", "and", "irritable", "bowel", "syndrome", "with", "constipation", "(IBS-C)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_16_item1_p57_s0", "idA": "1347613_15_item1_p70_s0", "sentA": "We believe that our product candidates will be regulated by the FDA as drugs.", "sentB": "Our product candidates are regulated by the FDA as drugs.", "type": 2, "words": ["<tag1>", "We", "believe", "that", "our", "product", "candidates", "will", "be", "regulated", "by", "the", "FDA", "as", "drugs.", "<tag2>", "Our", "product", "candidates", "are", "regulated", "by", "the", "FDA", "as", "drugs.", "<tag3>"], "wordsA": ["We", "believe", "that", "our", "product", "candidates", "will", "be", "regulated", "by", "the", "FDA", "as", "drugs."], "wordsB": ["Our", "product", "candidates", "are", "regulated", "by", "the", "FDA", "as", "drugs."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_16_item1_p28_s1", "idA": "1347613_15_item1_p79_s1", "sentA": "FDA approval of the NDA is required before marketing of the product may begin in the U.S.", "sentB": "The phase 3 IBS-C program was designed to support regulatory submissions in the U.S.", "type": 2, "words": ["<tag1>", "FDA", "approval", "of", "the", "NDA", "is", "required", "before", "marketing", "of", "the", "product", "may", "begin", "in", "the", "U.S.", "<tag2>", "The", "phase", "3", "IBS-C", "program", "was", "designed", "to", "support", "regulatory", "submissions", "in", "the", "U.S.", "<tag3>"], "wordsA": ["FDA", "approval", "of", "the", "NDA", "is", "required", "before", "marketing", "of", "the", "product", "may", "begin", "in", "the", "U.S."], "wordsB": ["The", "phase", "3", "IBS-C", "program", "was", "designed", "to", "support", "regulatory", "submissions", "in", "the", "U.S."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_16_item1_p37_s0", "idA": "1347613_15_item1_p7_s0", "sentA": "On November 19, 2014 we announced positive top-line results from a phase 2 trial assessing safety, efficacy and dose-response of three different once-daily oral SP-333 tablets (1.0, 3.0 and 6.0 mg) compared with placebo in 289 patients with opioid-induced constipation (OIC).", "sentB": "On November 19, 2014 we announced positive top-line results from a phase 2 trial assessing safety, efficacy and dose-response of three different once-daily oral dolcanatide tablets (1.0, 3.0 and 6.0 mg) compared with placebo in 289 patients with Opioid Induced Constipation (OIC).", "type": 2, "words": ["<tag1>", "On", "November", "19,", "2014", "we", "announced", "positive", "top-line", "results", "from", "a", "phase", "2", "trial", "assessing", "safety,", "efficacy", "and", "dose-response", "of", "three", "different", "once-daily", "oral", "SP-333", "tablets", "(1.0,", "3.0", "and", "6.0", "mg)", "compared", "with", "placebo", "in", "289", "patients", "with", "opioid-induced", "constipation", "(OIC).", "<tag2>", "On", "November", "19,", "2014", "we", "announced", "positive", "top-line", "results", "from", "a", "phase", "2", "trial", "assessing", "safety,", "efficacy", "and", "dose-response", "of", "three", "different", "once-daily", "oral", "dolcanatide", "tablets", "(1.0,", "3.0", "and", "6.0", "mg)", "compared", "with", "placebo", "in", "289", "patients", "with", "Opioid", "Induced", "Constipation", "(OIC).", "<tag3>"], "wordsA": ["On", "November", "19,", "2014", "we", "announced", "positive", "top-line", "results", "from", "a", "phase", "2", "trial", "assessing", "safety,", "efficacy", "and", "dose-response", "of", "three", "different", "once-daily", "oral", "SP-333", "tablets", "(1.0,", "3.0", "and", "6.0", "mg)", "compared", "with", "placebo", "in", "289", "patients", "with", "opioid-induced", "constipation", "(OIC)."], "wordsB": ["On", "November", "19,", "2014", "we", "announced", "positive", "top-line", "results", "from", "a", "phase", "2", "trial", "assessing", "safety,", "efficacy", "and", "dose-response", "of", "three", "different", "once-daily", "oral", "dolcanatide", "tablets", "(1.0,", "3.0", "and", "6.0", "mg)", "compared", "with", "placebo", "in", "289", "patients", "with", "Opioid", "Induced", "Constipation", "(OIC)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_16_item1_p37_s1", "idA": "1347613_15_item1_p7_s1", "sentA": "Preliminary analysis of the data indicates SP-333 met the study s primary endpoint and demonstrated statistically significant improvement in mean change from baseline in the number of spontaneous bowel movements (SBMs) during Week 4 of the treatment period.", "sentB": "Analysis of the data indicates dolcanatide met the study s primary endpoint and demonstrated statistically significant improvement in mean change from baseline in the number of spontaneous bowel movements (SBMs) during Week 4 of the treatment period.", "type": 2, "words": ["<tag1>", "Preliminary", "analysis", "of", "the", "data", "indicates", "SP-333", "met", "the", "study", "s", "primary", "endpoint", "and", "demonstrated", "statistically", "significant", "improvement", "in", "mean", "change", "from", "baseline", "in", "the", "number", "of", "spontaneous", "bowel", "movements", "(SBMs)", "during", "Week", "4", "of", "the", "treatment", "period.", "<tag2>", "Analysis", "of", "the", "data", "indicates", "dolcanatide", "met", "the", "study", "s", "primary", "endpoint", "and", "demonstrated", "statistically", "significant", "improvement", "in", "mean", "change", "from", "baseline", "in", "the", "number", "of", "spontaneous", "bowel", "movements", "(SBMs)", "during", "Week", "4", "of", "the", "treatment", "period.", "<tag3>"], "wordsA": ["Preliminary", "analysis", "of", "the", "data", "indicates", "SP-333", "met", "the", "study", "s", "primary", "endpoint", "and", "demonstrated", "statistically", "significant", "improvement", "in", "mean", "change", "from", "baseline", "in", "the", "number", "of", "spontaneous", "bowel", "movements", "(SBMs)", "during", "Week", "4", "of", "the", "treatment", "period."], "wordsB": ["Analysis", "of", "the", "data", "indicates", "dolcanatide", "met", "the", "study", "s", "primary", "endpoint", "and", "demonstrated", "statistically", "significant", "improvement", "in", "mean", "change", "from", "baseline", "in", "the", "number", "of", "spontaneous", "bowel", "movements", "(SBMs)", "during", "Week", "4", "of", "the", "treatment", "period."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_16_item1_p17_s1", "idA": "1347613_15_item1_p81_s0", "sentA": "The FDA has agreed to certain performance goals in the review of new drug applications.", "sentB": "The FDA has defined an overall responder as a patient who fulfills both 3 CSBMs per week plus an increase of 1 CSBM from baseline in the same week, for 9 out of the 12 treatment weeks.", "type": 2, "words": ["<tag1>", "The", "FDA", "has", "agreed", "to", "certain", "performance", "goals", "in", "the", "review", "of", "new", "drug", "applications.", "<tag2>", "The", "FDA", "has", "defined", "an", "overall", "responder", "as", "a", "patient", "who", "fulfills", "both", "3", "CSBMs", "per", "week", "plus", "an", "increase", "of", "1", "CSBM", "from", "baseline", "in", "the", "same", "week,", "for", "9", "out", "of", "the", "12", "treatment", "weeks.", "<tag3>"], "wordsA": ["The", "FDA", "has", "agreed", "to", "certain", "performance", "goals", "in", "the", "review", "of", "new", "drug", "applications."], "wordsB": ["The", "FDA", "has", "defined", "an", "overall", "responder", "as", "a", "patient", "who", "fulfills", "both", "3", "CSBMs", "per", "week", "plus", "an", "increase", "of", "1", "CSBM", "from", "baseline", "in", "the", "same", "week,", "for", "9", "out", "of", "the", "12", "treatment", "weeks."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_16_item1_p69_s1", "idA": "1347613_15_item1_p82_s0", "sentA": "The FDA may refer an application to an advisory committee for review, evaluation and recommendation as to whether the application should be approved.", "sentB": "The FDA is not bound by the recommendations of an advisory committee, but it considers such recommendations carefully when making decisions.", "type": 2, "words": ["<tag1>", "The", "FDA", "may", "refer", "an", "application", "to", "an", "advisory", "committee", "for", "review,", "evaluation", "and", "recommendation", "as", "to", "whether", "the", "application", "should", "be", "approved.", "<tag2>", "The", "FDA", "is", "not", "bound", "by", "the", "recommendations", "of", "an", "advisory", "committee,", "but", "it", "considers", "such", "recommendations", "carefully", "when", "making", "decisions.", "<tag3>"], "wordsA": ["The", "FDA", "may", "refer", "an", "application", "to", "an", "advisory", "committee", "for", "review,", "evaluation", "and", "recommendation", "as", "to", "whether", "the", "application", "should", "be", "approved."], "wordsB": ["The", "FDA", "is", "not", "bound", "by", "the", "recommendations", "of", "an", "advisory", "committee,", "but", "it", "considers", "such", "recommendations", "carefully", "when", "making", "decisions."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_16_item1_p38_s1", "idA": "1347613_15_item1_p83_s3", "sentA": "The FDA may also limit the indications for use and/or require post-marketing testing and surveillance to monitor the safety or efficacy of a product.", "sentB": "We will continue to monitor the OIC market opportunity but we currently have no plans to continue dolcanatide development in OIC.", "type": 2, "words": ["<tag1>", "The", "FDA", "may", "also", "limit", "the", "indications", "for", "use", "and/or", "require", "post-marketing", "testing", "and", "surveillance", "to", "monitor", "the", "safety", "or", "efficacy", "of", "a", "product.", "<tag2>", "We", "will", "continue", "to", "monitor", "the", "OIC", "market", "opportunity", "but", "we", "currently", "have", "no", "plans", "to", "continue", "dolcanatide", "development", "in", "OIC.", "<tag3>"], "wordsA": ["The", "FDA", "may", "also", "limit", "the", "indications", "for", "use", "and/or", "require", "post-marketing", "testing", "and", "surveillance", "to", "monitor", "the", "safety", "or", "efficacy", "of", "a", "product."], "wordsB": ["We", "will", "continue", "to", "monitor", "the", "OIC", "market", "opportunity", "but", "we", "currently", "have", "no", "plans", "to", "continue", "dolcanatide", "development", "in", "OIC."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_16_item1_p23_s2", "idA": "1347613_15_item1_p8_s0", "sentA": "SP-333 was safe and well tolerated at all doses.", "sentB": "Importantly, plecanatide was safe and well tolerated at both doses; the most common adverse event was diarrhea, which occurred in 3.2% of patients in 3.0 mg and 4.5% of patients in 6.0 mg dose groups compared to 1.3% of placebo-treated patients.", "type": 2, "words": ["<tag1>", "SP-333", "was", "safe", "and", "well", "tolerated", "at", "all", "doses.", "<tag2>", "Importantly,", "plecanatide", "was", "safe", "and", "well", "tolerated", "at", "both", "doses;", "the", "most", "common", "adverse", "event", "was", "diarrhea,", "which", "occurred", "in", "3.2%", "of", "patients", "in", "3.0", "mg", "and", "4.5%", "of", "patients", "in", "6.0", "mg", "dose", "groups", "compared", "to", "1.3%", "of", "placebo-treated", "patients.", "<tag3>"], "wordsA": ["SP-333", "was", "safe", "and", "well", "tolerated", "at", "all", "doses."], "wordsB": ["Importantly,", "plecanatide", "was", "safe", "and", "well", "tolerated", "at", "both", "doses;", "the", "most", "common", "adverse", "event", "was", "diarrhea,", "which", "occurred", "in", "3.2%", "of", "patients", "in", "3.0", "mg", "and", "4.5%", "of", "patients", "in", "6.0", "mg", "dose", "groups", "compared", "to", "1.3%", "of", "placebo-treated", "patients."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_16_item1_p36_s0", "idA": "1347613_15_item1_p8_s0", "sentA": "SP-333 was safe and well tolerated at all doses.", "sentB": "Dolcanatide was also safe and well-tolerated.", "type": 2, "words": ["<tag1>", "SP-333", "was", "safe", "and", "well", "tolerated", "at", "all", "doses.", "<tag2>", "Dolcanatide", "was", "also", "safe", "and", "well-tolerated.", "<tag3>"], "wordsA": ["SP-333", "was", "safe", "and", "well", "tolerated", "at", "all", "doses."], "wordsB": ["Dolcanatide", "was", "also", "safe", "and", "well-tolerated."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_16_item1_p9_s0", "idA": "1347613_15_item1_p8_s0", "sentA": "SP-333 was safe and well tolerated at all doses.", "sentB": "Dolcanatide was also safe and well-tolerated.", "type": 2, "words": ["<tag1>", "SP-333", "was", "safe", "and", "well", "tolerated", "at", "all", "doses.", "<tag2>", "Dolcanatide", "was", "also", "safe", "and", "well-tolerated.", "<tag3>"], "wordsA": ["SP-333", "was", "safe", "and", "well", "tolerated", "at", "all", "doses."], "wordsB": ["Dolcanatide", "was", "also", "safe", "and", "well-tolerated."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_16_item1_p80_s0", "idA": "1347613_15_item1_p94_s0", "sentA": "As of March 16, 2015, we had 35 full-time employees.", "sentB": "As of February 25, 2016, we had 44 full-time employees.", "type": 2, "words": ["<tag1>", "As", "of", "March", "16,", "2015,", "we", "had", "35", "full-time", "employees.", "<tag2>", "As", "of", "February", "25,", "2016,", "we", "had", "44", "full-time", "employees.", "<tag3>"], "wordsA": ["As", "of", "March", "16,", "2015,", "we", "had", "35", "full-time", "employees."], "wordsB": ["As", "of", "February", "25,", "2016,", "we", "had", "44", "full-time", "employees."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_17_item1_p0_s0", "idA": "1347613_16_item1_p0_s0", "sentA": "Unless the context requires otherwise, the words Synergy, the Company, we, us, refer to Synergy Pharmaceuticals Inc. and Subsidiaries.", "sentB": "Unless the context requires otherwise, the words Synergy, the Company, we, us, refer to Synergy Pharmaceuticals Inc. and, where appropriate, our subsidiaries.", "type": 2, "words": ["<tag1>", "Unless", "the", "context", "requires", "otherwise,", "the", "words", "Synergy,", "the", "Company,", "we,", "us,", "refer", "to", "Synergy", "Pharmaceuticals", "Inc.", "and", "Subsidiaries.", "<tag2>", "Unless", "the", "context", "requires", "otherwise,", "the", "words", "Synergy,", "the", "Company,", "we,", "us,", "refer", "to", "Synergy", "Pharmaceuticals", "Inc.", "and,", "where", "appropriate,", "our", "subsidiaries.", "<tag3>"], "wordsA": ["Unless", "the", "context", "requires", "otherwise,", "the", "words", "Synergy,", "the", "Company,", "we,", "us,", "refer", "to", "Synergy", "Pharmaceuticals", "Inc.", "and", "Subsidiaries."], "wordsB": ["Unless", "the", "context", "requires", "otherwise,", "the", "words", "Synergy,", "the", "Company,", "we,", "us,", "refer", "to", "Synergy", "Pharmaceuticals", "Inc.", "and,", "where", "appropriate,", "our", "subsidiaries."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_17_item1_p1_s0", "idA": "1347613_16_item1_p0_s0", "sentA": "Unless the context requires otherwise, the words Synergy, the Company, we, us, refer to Synergy Pharmaceuticals Inc. and Subsidiaries.", "sentB": "TRULANCE is a trademark of Synergy Pharmaceuticals Inc.", "type": 2, "words": ["<tag1>", "Unless", "the", "context", "requires", "otherwise,", "the", "words", "Synergy,", "the", "Company,", "we,", "us,", "refer", "to", "Synergy", "Pharmaceuticals", "Inc.", "and", "Subsidiaries.", "<tag2>", "TRULANCE", "is", "a", "trademark", "of", "Synergy", "Pharmaceuticals", "Inc.", "<tag3>"], "wordsA": ["Unless", "the", "context", "requires", "otherwise,", "the", "words", "Synergy,", "the", "Company,", "we,", "us,", "refer", "to", "Synergy", "Pharmaceuticals", "Inc.", "and", "Subsidiaries."], "wordsB": ["TRULANCE", "is", "a", "trademark", "of", "Synergy", "Pharmaceuticals", "Inc."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_17_item1_p34_s0", "idA": "1347613_16_item1_p10_s2", "sentA": "The objective of this trial is to evaluate the long-term safety and tolerability of plecanatide in patients with CIC.", "sentB": "Initiated pre-launch multimedia and digital campaigns to drive company awareness and disease education, focusing on current unmet needs of patients with CIC.", "type": 2, "words": ["<tag1>", "The", "objective", "of", "this", "trial", "is", "to", "evaluate", "the", "long-term", "safety", "and", "tolerability", "of", "plecanatide", "in", "patients", "with", "CIC.", "<tag2>", "Initiated", "pre-launch", "multimedia", "and", "digital", "campaigns", "to", "drive", "company", "awareness", "and", "disease", "education,", "focusing", "on", "current", "unmet", "needs", "of", "patients", "with", "CIC.", "<tag3>"], "wordsA": ["The", "objective", "of", "this", "trial", "is", "to", "evaluate", "the", "long-term", "safety", "and", "tolerability", "of", "plecanatide", "in", "patients", "with", "CIC."], "wordsB": ["Initiated", "pre-launch", "multimedia", "and", "digital", "campaigns", "to", "drive", "company", "awareness", "and", "disease", "education,", "focusing", "on", "current", "unmet", "needs", "of", "patients", "with", "CIC."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_17_item1_p10_s0", "idA": "1347613_16_item1_p13_s0", "sentA": "Plecanatide is designed to mimic the function of uroguanylin by working locally in the upper GI tract to stimulate digestive fluid movement and support regular bowel function.", "sentB": "TRULANCE TRULANCE is the first drug designed to replicate the function of uroguanylin.", "type": 2, "words": ["<tag1>", "Plecanatide", "is", "designed", "to", "mimic", "the", "function", "of", "uroguanylin", "by", "working", "locally", "in", "the", "upper", "GI", "tract", "to", "stimulate", "digestive", "fluid", "movement", "and", "support", "regular", "bowel", "function.", "<tag2>", "TRULANCE", "TRULANCE", "is", "the", "first", "drug", "designed", "to", "replicate", "the", "function", "of", "uroguanylin.", "<tag3>"], "wordsA": ["Plecanatide", "is", "designed", "to", "mimic", "the", "function", "of", "uroguanylin", "by", "working", "locally", "in", "the", "upper", "GI", "tract", "to", "stimulate", "digestive", "fluid", "movement", "and", "support", "regular", "bowel", "function."], "wordsB": ["TRULANCE", "TRULANCE", "is", "the", "first", "drug", "designed", "to", "replicate", "the", "function", "of", "uroguanylin."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_17_item1_p14_s0", "idA": "1347613_16_item1_p14_s0", "sentA": "The plecanatide phase 3 CIC program includes two randomized, 12-week, double-blind, placebo-controlled pivotal trials evaluating the efficacy and safety of two different plecanatide treatment doses (3.0 mg and 6.0 mg), taken as a tablet once-a-day, in patients with CIC.", "sentB": "The efficacy and safety of TRULANCE was evaluated in the largest Phase 3 CIC clinical trials to date, which included more than 2,600 patients in two randomized, 12-week, double-blind, placebo-controlled studies of TRULANCE.", "type": 2, "words": ["<tag1>", "The", "plecanatide", "phase", "3", "CIC", "program", "includes", "two", "randomized,", "12-week,", "double-blind,", "placebo-controlled", "pivotal", "trials", "evaluating", "the", "efficacy", "and", "safety", "of", "two", "different", "plecanatide", "treatment", "doses", "(3.0", "mg", "and", "6.0", "mg),", "taken", "as", "a", "tablet", "once-a-day,", "in", "patients", "with", "CIC.", "<tag2>", "The", "efficacy", "and", "safety", "of", "TRULANCE", "was", "evaluated", "in", "the", "largest", "Phase", "3", "CIC", "clinical", "trials", "to", "date,", "which", "included", "more", "than", "2,600", "patients", "in", "two", "randomized,", "12-week,", "double-blind,", "placebo-controlled", "studies", "of", "TRULANCE.", "<tag3>"], "wordsA": ["The", "plecanatide", "phase", "3", "CIC", "program", "includes", "two", "randomized,", "12-week,", "double-blind,", "placebo-controlled", "pivotal", "trials", "evaluating", "the", "efficacy", "and", "safety", "of", "two", "different", "plecanatide", "treatment", "doses", "(3.0", "mg", "and", "6.0", "mg),", "taken", "as", "a", "tablet", "once-a-day,", "in", "patients", "with", "CIC."], "wordsB": ["The", "efficacy", "and", "safety", "of", "TRULANCE", "was", "evaluated", "in", "the", "largest", "Phase", "3", "CIC", "clinical", "trials", "to", "date,", "which", "included", "more", "than", "2,600", "patients", "in", "two", "randomized,", "12-week,", "double-blind,", "placebo-controlled", "studies", "of", "TRULANCE."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_17_item1_p15_s0", "idA": "1347613_16_item1_p17_s0", "sentA": "The primary endpoint for both trials was the proportion of durable overall complete spontaneous bowl movement (CSBM) responders (%), which is the current regulatory endpoint required for U.S. approval in CIC.", "sentB": "Over 12 weeks, patients treated with TRULANCE achieved a significantly greater efficacy responder rate the primary endpoint defined by the FDA for regulatory approval in CIC in both studies compared to placebo (Study 1: 21% vs. 10%; Study 2: 21% vs. 13%, p 0.005 for both studies).", "type": 2, "words": ["<tag1>", "The", "primary", "endpoint", "for", "both", "trials", "was", "the", "proportion", "of", "durable", "overall", "complete", "spontaneous", "bowl", "movement", "(CSBM)", "responders", "(%),", "which", "is", "the", "current", "regulatory", "endpoint", "required", "for", "U.S.", "approval", "in", "CIC.", "<tag2>", "Over", "12", "weeks,", "patients", "treated", "with", "TRULANCE", "achieved", "a", "significantly", "greater", "efficacy", "responder", "rate", "the", "primary", "endpoint", "defined", "by", "the", "FDA", "for", "regulatory", "approval", "in", "CIC", "in", "both", "studies", "compared", "to", "placebo", "(Study", "1:", "21%", "vs.", "10%;", "Study", "2:", "21%", "vs.", "13%,", "p", "0.005", "for", "both", "studies).", "<tag3>"], "wordsA": ["The", "primary", "endpoint", "for", "both", "trials", "was", "the", "proportion", "of", "durable", "overall", "complete", "spontaneous", "bowl", "movement", "(CSBM)", "responders", "(%),", "which", "is", "the", "current", "regulatory", "endpoint", "required", "for", "U.S.", "approval", "in", "CIC."], "wordsB": ["Over", "12", "weeks,", "patients", "treated", "with", "TRULANCE", "achieved", "a", "significantly", "greater", "efficacy", "responder", "rate", "the", "primary", "endpoint", "defined", "by", "the", "FDA", "for", "regulatory", "approval", "in", "CIC", "in", "both", "studies", "compared", "to", "placebo", "(Study", "1:", "21%", "vs.", "10%;", "Study", "2:", "21%", "vs.", "13%,", "p", "0.005", "for", "both", "studies)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_17_item1_p16_s0", "idA": "1347613_16_item1_p17_s1", "sentA": "The FDA has defined an overall responder as a patient who fulfills both 3 CSBMs per week plus an increase of 1 CSBM from baseline in the same week, for 9 out of the 12 treatment weeks.", "sentB": "spontaneous bowel movements (CSBMs) in a given week and an increase of at least one CSBM over baseline in the same week for at least nine weeks out of the 12-week period, including at least three of the last four weeks.", "type": 2, "words": ["<tag1>", "The", "FDA", "has", "defined", "an", "overall", "responder", "as", "a", "patient", "who", "fulfills", "both", "3", "CSBMs", "per", "week", "plus", "an", "increase", "of", "1", "CSBM", "from", "baseline", "in", "the", "same", "week,", "for", "9", "out", "of", "the", "12", "treatment", "weeks.", "<tag2>", "spontaneous", "bowel", "movements", "(CSBMs)", "in", "a", "given", "week", "and", "an", "increase", "of", "at", "least", "one", "CSBM", "over", "baseline", "in", "the", "same", "week", "for", "at", "least", "nine", "weeks", "out", "of", "the", "12-week", "period,", "including", "at", "least", "three", "of", "the", "last", "four", "weeks.", "<tag3>"], "wordsA": ["The", "FDA", "has", "defined", "an", "overall", "responder", "as", "a", "patient", "who", "fulfills", "both", "3", "CSBMs", "per", "week", "plus", "an", "increase", "of", "1", "CSBM", "from", "baseline", "in", "the", "same", "week,", "for", "9", "out", "of", "the", "12", "treatment", "weeks."], "wordsB": ["spontaneous", "bowel", "movements", "(CSBMs)", "in", "a", "given", "week", "and", "an", "increase", "of", "at", "least", "one", "CSBM", "over", "baseline", "in", "the", "same", "week", "for", "at", "least", "nine", "weeks", "out", "of", "the", "12-week", "period,", "including", "at", "least", "three", "of", "the", "last", "four", "weeks."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_17_item1_p21_s0", "idA": "1347613_16_item1_p19_s0", "sentA": "On June 17, 2015 we announced positive top-line results from the first of two pivotal phase 3 clinical trials of plecanatide in 1,346 adult patients with CIC.", "sentB": "TRULANCE for IBS-C On December 9, 2016, we announced top-line results from the first of two pivotal phase 3 trials evaluating the efficacy and safety of TRULANCE in 1,135 adult patients with irritable bowel syndrome with constipation (IBS-C).", "type": 2, "words": ["<tag1>", "On", "June", "17,", "2015", "we", "announced", "positive", "top-line", "results", "from", "the", "first", "of", "two", "pivotal", "phase", "3", "clinical", "trials", "of", "plecanatide", "in", "1,346", "adult", "patients", "with", "CIC.", "<tag2>", "TRULANCE", "for", "IBS-C", "On", "December", "9,", "2016,", "we", "announced", "top-line", "results", "from", "the", "first", "of", "two", "pivotal", "phase", "3", "trials", "evaluating", "the", "efficacy", "and", "safety", "of", "TRULANCE", "in", "1,135", "adult", "patients", "with", "irritable", "bowel", "syndrome", "with", "constipation", "(IBS-C).", "<tag3>"], "wordsA": ["On", "June", "17,", "2015", "we", "announced", "positive", "top-line", "results", "from", "the", "first", "of", "two", "pivotal", "phase", "3", "clinical", "trials", "of", "plecanatide", "in", "1,346", "adult", "patients", "with", "CIC."], "wordsB": ["TRULANCE", "for", "IBS-C", "On", "December", "9,", "2016,", "we", "announced", "top-line", "results", "from", "the", "first", "of", "two", "pivotal", "phase", "3", "trials", "evaluating", "the", "efficacy", "and", "safety", "of", "TRULANCE", "in", "1,135", "adult", "patients", "with", "irritable", "bowel", "syndrome", "with", "constipation", "(IBS-C)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_17_item1_p21_s1", "idA": "1347613_16_item1_p19_s1", "sentA": "Preliminary analysis of the data indicates that both plecanatide 3.0 mg and 6.0 mg doses met the study s primary endpoint and demonstrated statistical significance in the proportion of patients in the intention-to-treat population who were durable overall CSBM responders compared to placebo during the 12-week treatment period (21.0% in 3.0 mg and 19.5% in 6.0 mg dose groups compared to 10.2% in placebo; p 0.001 for both doses).", "sentB": "Preliminary analysis of the data indicates that both TRULANCE 3 mg and 6 mg doses met the study's primary endpoint showing statistical significance in the percentage of patients who were Overall Responders compared to placebo during the 12-week treatment period (21.5% in 3 mg and 24.0% in 6 mg dose groups compared to 14.2% in placebo; p=0.009 for 3 mg and p 0.001 for 6 mg).", "type": 2, "words": ["<tag1>", "Preliminary", "analysis", "of", "the", "data", "indicates", "that", "both", "plecanatide", "3.0", "mg", "and", "6.0", "mg", "doses", "met", "the", "study", "s", "primary", "endpoint", "and", "demonstrated", "statistical", "significance", "in", "the", "proportion", "of", "patients", "in", "the", "intention-to-treat", "population", "who", "were", "durable", "overall", "CSBM", "responders", "compared", "to", "placebo", "during", "the", "12-week", "treatment", "period", "(21.0%", "in", "3.0", "mg", "and", "19.5%", "in", "6.0", "mg", "dose", "groups", "compared", "to", "10.2%", "in", "placebo;", "p", "0.001", "for", "both", "doses).", "<tag2>", "Preliminary", "analysis", "of", "the", "data", "indicates", "that", "both", "TRULANCE", "3", "mg", "and", "6", "mg", "doses", "met", "the", "study's", "primary", "endpoint", "showing", "statistical", "significance", "in", "the", "percentage", "of", "patients", "who", "were", "Overall", "Responders", "compared", "to", "placebo", "during", "the", "12-week", "treatment", "period", "(21.5%", "in", "3", "mg", "and", "24.0%", "in", "6", "mg", "dose", "groups", "compared", "to", "14.2%", "in", "placebo;", "p=0.009", "for", "3", "mg", "and", "p", "0.001", "for", "6", "mg).", "<tag3>"], "wordsA": ["Preliminary", "analysis", "of", "the", "data", "indicates", "that", "both", "plecanatide", "3.0", "mg", "and", "6.0", "mg", "doses", "met", "the", "study", "s", "primary", "endpoint", "and", "demonstrated", "statistical", "significance", "in", "the", "proportion", "of", "patients", "in", "the", "intention-to-treat", "population", "who", "were", "durable", "overall", "CSBM", "responders", "compared", "to", "placebo", "during", "the", "12-week", "treatment", "period", "(21.0%", "in", "3.0", "mg", "and", "19.5%", "in", "6.0", "mg", "dose", "groups", "compared", "to", "10.2%", "in", "placebo;", "p", "0.001", "for", "both", "doses)."], "wordsB": ["Preliminary", "analysis", "of", "the", "data", "indicates", "that", "both", "TRULANCE", "3", "mg", "and", "6", "mg", "doses", "met", "the", "study's", "primary", "endpoint", "showing", "statistical", "significance", "in", "the", "percentage", "of", "patients", "who", "were", "Overall", "Responders", "compared", "to", "placebo", "during", "the", "12-week", "treatment", "period", "(21.5%", "in", "3", "mg", "and", "24.0%", "in", "6", "mg", "dose", "groups", "compared", "to", "14.2%", "in", "placebo;", "p=0.009", "for", "3", "mg", "and", "p", "0.001", "for", "6", "mg)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_17_item1_p23_s0", "idA": "1347613_16_item1_p19_s1", "sentA": "Preliminary analysis of the data indicates that both plecanatide 3.0 mg and 6.0 mg doses met the study s primary endpoint and demonstrated statistical significance in the proportion of patients in the intention-to-treat population who were durable overall CSBM responders compared to placebo during the 12-week treatment period (21.0% in 3.0 mg and 19.5% in 6.0 mg dose groups compared to 10.2% in placebo; p 0.001 for both doses).", "sentB": "On December 22, 2016, we announced top-line results from the second of two pivotal phase 3 trials evaluating the efficacy and safety of TRULANCE in 1,054 adult patients with IBS-C. Preliminary analysis of the data indicates that both TRULANCE 3 mg and 6 mg doses met the study's primary endpoint showing statistical significance in the percentage of patients who were Overall Responders compared to placebo during the 12-week treatment period (30.2% in 3 mg and 29.5% in 6 mg dose groups compared to 17.8% in placebo; p 0.001 for 3 mg and p 0.001 for 6 mg).", "type": 2, "words": ["<tag1>", "Preliminary", "analysis", "of", "the", "data", "indicates", "that", "both", "plecanatide", "3.0", "mg", "and", "6.0", "mg", "doses", "met", "the", "study", "s", "primary", "endpoint", "and", "demonstrated", "statistical", "significance", "in", "the", "proportion", "of", "patients", "in", "the", "intention-to-treat", "population", "who", "were", "durable", "overall", "CSBM", "responders", "compared", "to", "placebo", "during", "the", "12-week", "treatment", "period", "(21.0%", "in", "3.0", "mg", "and", "19.5%", "in", "6.0", "mg", "dose", "groups", "compared", "to", "10.2%", "in", "placebo;", "p", "0.001", "for", "both", "doses).", "<tag2>", "On", "December", "22,", "2016,", "we", "announced", "top-line", "results", "from", "the", "second", "of", "two", "pivotal", "phase", "3", "trials", "evaluating", "the", "efficacy", "and", "safety", "of", "TRULANCE", "in", "1,054", "adult", "patients", "with", "IBS-C.", "Preliminary", "analysis", "of", "the", "data", "indicates", "that", "both", "TRULANCE", "3", "mg", "and", "6", "mg", "doses", "met", "the", "study's", "primary", "endpoint", "showing", "statistical", "significance", "in", "the", "percentage", "of", "patients", "who", "were", "Overall", "Responders", "compared", "to", "placebo", "during", "the", "12-week", "treatment", "period", "(30.2%", "in", "3", "mg", "and", "29.5%", "in", "6", "mg", "dose", "groups", "compared", "to", "17.8%", "in", "placebo;", "p", "0.001", "for", "3", "mg", "and", "p", "0.001", "for", "6", "mg).", "<tag3>"], "wordsA": ["Preliminary", "analysis", "of", "the", "data", "indicates", "that", "both", "plecanatide", "3.0", "mg", "and", "6.0", "mg", "doses", "met", "the", "study", "s", "primary", "endpoint", "and", "demonstrated", "statistical", "significance", "in", "the", "proportion", "of", "patients", "in", "the", "intention-to-treat", "population", "who", "were", "durable", "overall", "CSBM", "responders", "compared", "to", "placebo", "during", "the", "12-week", "treatment", "period", "(21.0%", "in", "3.0", "mg", "and", "19.5%", "in", "6.0", "mg", "dose", "groups", "compared", "to", "10.2%", "in", "placebo;", "p", "0.001", "for", "both", "doses)."], "wordsB": ["On", "December", "22,", "2016,", "we", "announced", "top-line", "results", "from", "the", "second", "of", "two", "pivotal", "phase", "3", "trials", "evaluating", "the", "efficacy", "and", "safety", "of", "TRULANCE", "in", "1,054", "adult", "patients", "with", "IBS-C.", "Preliminary", "analysis", "of", "the", "data", "indicates", "that", "both", "TRULANCE", "3", "mg", "and", "6", "mg", "doses", "met", "the", "study's", "primary", "endpoint", "showing", "statistical", "significance", "in", "the", "percentage", "of", "patients", "who", "were", "Overall", "Responders", "compared", "to", "placebo", "during", "the", "12-week", "treatment", "period", "(30.2%", "in", "3", "mg", "and", "29.5%", "in", "6", "mg", "dose", "groups", "compared", "to", "17.8%", "in", "placebo;", "p", "0.001", "for", "3", "mg", "and", "p", "0.001", "for", "6", "mg)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_17_item1_p25_s3", "idA": "1347613_16_item1_p1_s0", "sentA": "We are a biopharmaceutical company focused on the development and commercialization of novel gastrointestinal (GI) therapies.", "sentB": "We are focused on three key strategic imperatives to achieve our objective of ensuring that TRULANCE is ready for launch this quarter:", "type": 2, "words": ["<tag1>", "We", "are", "a", "biopharmaceutical", "company", "focused", "on", "the", "development", "and", "commercialization", "of", "novel", "gastrointestinal", "(GI)", "therapies.", "<tag2>", "We", "are", "focused", "on", "three", "key", "strategic", "imperatives", "to", "achieve", "our", "objective", "of", "ensuring", "that", "TRULANCE", "is", "ready", "for", "launch", "this", "quarter:", "<tag3>"], "wordsA": ["We", "are", "a", "biopharmaceutical", "company", "focused", "on", "the", "development", "and", "commercialization", "of", "novel", "gastrointestinal", "(GI)", "therapies."], "wordsB": ["We", "are", "focused", "on", "three", "key", "strategic", "imperatives", "to", "achieve", "our", "objective", "of", "ensuring", "that", "TRULANCE", "is", "ready", "for", "launch", "this", "quarter:"], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_17_item1_p2_s0", "idA": "1347613_16_item1_p1_s0", "sentA": "We are a biopharmaceutical company focused on the development and commercialization of novel gastrointestinal (GI) therapies.", "sentB": "Business Overview We are a biopharmaceutical company focused on the development and commercialization of novel gastrointestinal (GI) therapies.", "type": 2, "words": ["<tag1>", "We", "are", "a", "biopharmaceutical", "company", "focused", "on", "the", "development", "and", "commercialization", "of", "novel", "gastrointestinal", "(GI)", "therapies.", "<tag2>", "Business", "Overview", "We", "are", "a", "biopharmaceutical", "company", "focused", "on", "the", "development", "and", "commercialization", "of", "novel", "gastrointestinal", "(GI)", "therapies.", "<tag3>"], "wordsA": ["We", "are", "a", "biopharmaceutical", "company", "focused", "on", "the", "development", "and", "commercialization", "of", "novel", "gastrointestinal", "(GI)", "therapies."], "wordsB": ["Business", "Overview", "We", "are", "a", "biopharmaceutical", "company", "focused", "on", "the", "development", "and", "commercialization", "of", "novel", "gastrointestinal", "(GI)", "therapies."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_17_item1_p18_s0", "idA": "1347613_16_item1_p20_s0", "sentA": "Plecanatide was safe and well tolerated at both doses; the most common adverse event was diarrhea, which occurred in 5.9% of patients in 3.0 mg and 5.5% of patients in 6.0 mg dose groups compared to 1.3% of placebo-treated patients.", "sentB": "In an integrated analysis of both studies, diarrhea was the most common adverse reaction, reported in 5% of patients treated with TRULANCE compared to 1% of patients treated with placebo.", "type": 2, "words": ["<tag1>", "Plecanatide", "was", "safe", "and", "well", "tolerated", "at", "both", "doses;", "the", "most", "common", "adverse", "event", "was", "diarrhea,", "which", "occurred", "in", "5.9%", "of", "patients", "in", "3.0", "mg", "and", "5.5%", "of", "patients", "in", "6.0", "mg", "dose", "groups", "compared", "to", "1.3%", "of", "placebo-treated", "patients.", "<tag2>", "In", "an", "integrated", "analysis", "of", "both", "studies,", "diarrhea", "was", "the", "most", "common", "adverse", "reaction,", "reported", "in", "5%", "of", "patients", "treated", "with", "TRULANCE", "compared", "to", "1%", "of", "patients", "treated", "with", "placebo.", "<tag3>"], "wordsA": ["Plecanatide", "was", "safe", "and", "well", "tolerated", "at", "both", "doses;", "the", "most", "common", "adverse", "event", "was", "diarrhea,", "which", "occurred", "in", "5.9%", "of", "patients", "in", "3.0", "mg", "and", "5.5%", "of", "patients", "in", "6.0", "mg", "dose", "groups", "compared", "to", "1.3%", "of", "placebo-treated", "patients."], "wordsB": ["In", "an", "integrated", "analysis", "of", "both", "studies,", "diarrhea", "was", "the", "most", "common", "adverse", "reaction,", "reported", "in", "5%", "of", "patients", "treated", "with", "TRULANCE", "compared", "to", "1%", "of", "patients", "treated", "with", "placebo."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_17_item1_p24_s0", "idA": "1347613_16_item1_p20_s0", "sentA": "Plecanatide was safe and well tolerated at both doses; the most common adverse event was diarrhea, which occurred in 5.9% of patients in 3.0 mg and 5.5% of patients in 6.0 mg dose groups compared to 1.3% of placebo-treated patients.", "sentB": "The most common adverse event was diarrhea which occurred in 5.4% of patients in 3 mg and 4.3% of patients in 6 mg dose groups compared to 0.6% of placebo-treated patients.", "type": 2, "words": ["<tag1>", "Plecanatide", "was", "safe", "and", "well", "tolerated", "at", "both", "doses;", "the", "most", "common", "adverse", "event", "was", "diarrhea,", "which", "occurred", "in", "5.9%", "of", "patients", "in", "3.0", "mg", "and", "5.5%", "of", "patients", "in", "6.0", "mg", "dose", "groups", "compared", "to", "1.3%", "of", "placebo-treated", "patients.", "<tag2>", "The", "most", "common", "adverse", "event", "was", "diarrhea", "which", "occurred", "in", "5.4%", "of", "patients", "in", "3", "mg", "and", "4.3%", "of", "patients", "in", "6", "mg", "dose", "groups", "compared", "to", "0.6%", "of", "placebo-treated", "patients.", "<tag3>"], "wordsA": ["Plecanatide", "was", "safe", "and", "well", "tolerated", "at", "both", "doses;", "the", "most", "common", "adverse", "event", "was", "diarrhea,", "which", "occurred", "in", "5.9%", "of", "patients", "in", "3.0", "mg", "and", "5.5%", "of", "patients", "in", "6.0", "mg", "dose", "groups", "compared", "to", "1.3%", "of", "placebo-treated", "patients."], "wordsB": ["The", "most", "common", "adverse", "event", "was", "diarrhea", "which", "occurred", "in", "5.4%", "of", "patients", "in", "3", "mg", "and", "4.3%", "of", "patients", "in", "6", "mg", "dose", "groups", "compared", "to", "0.6%", "of", "placebo-treated", "patients."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_17_item1_p24_s1", "idA": "1347613_16_item1_p21_s0", "sentA": "15 patients in the trial (1.1%) experienced serious adverse events but there was no imbalance across treatment groups in either incidences or individual serious adverse events.", "sentB": "Ten patients in the trial ( 1.0%) experienced serious adverse events but there was no imbalance across treatment groups in either incidences or individual serious adverse events.", "type": 2, "words": ["<tag1>", "15", "patients", "in", "the", "trial", "(1.1%)", "experienced", "serious", "adverse", "events", "but", "there", "was", "no", "imbalance", "across", "treatment", "groups", "in", "either", "incidences", "or", "individual", "serious", "adverse", "events.", "<tag2>", "Ten", "patients", "in", "the", "trial", "(", "1.0%)", "experienced", "serious", "adverse", "events", "but", "there", "was", "no", "imbalance", "across", "treatment", "groups", "in", "either", "incidences", "or", "individual", "serious", "adverse", "events.", "<tag3>"], "wordsA": ["15", "patients", "in", "the", "trial", "(1.1%)", "experienced", "serious", "adverse", "events", "but", "there", "was", "no", "imbalance", "across", "treatment", "groups", "in", "either", "incidences", "or", "individual", "serious", "adverse", "events."], "wordsB": ["Ten", "patients", "in", "the", "trial", "(", "1.0%)", "experienced", "serious", "adverse", "events", "but", "there", "was", "no", "imbalance", "across", "treatment", "groups", "in", "either", "incidences", "or", "individual", "serious", "adverse", "events."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_17_item1_p9_s1", "idA": "1347613_16_item1_p21_s0", "sentA": "15 patients in the trial (1.1%) experienced serious adverse events but there was no imbalance across treatment groups in either incidences or individual serious adverse events.", "sentB": "While there are prescription drug options, not all patients find complete relief, and many struggle with adverse events.", "type": 2, "words": ["<tag1>", "15", "patients", "in", "the", "trial", "(1.1%)", "experienced", "serious", "adverse", "events", "but", "there", "was", "no", "imbalance", "across", "treatment", "groups", "in", "either", "incidences", "or", "individual", "serious", "adverse", "events.", "<tag2>", "While", "there", "are", "prescription", "drug", "options,", "not", "all", "patients", "find", "complete", "relief,", "and", "many", "struggle", "with", "adverse", "events.", "<tag3>"], "wordsA": ["15", "patients", "in", "the", "trial", "(1.1%)", "experienced", "serious", "adverse", "events", "but", "there", "was", "no", "imbalance", "across", "treatment", "groups", "in", "either", "incidences", "or", "individual", "serious", "adverse", "events."], "wordsB": ["While", "there", "are", "prescription", "drug", "options,", "not", "all", "patients", "find", "complete", "relief,", "and", "many", "struggle", "with", "adverse", "events."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_17_item1_p22_s0", "idA": "1347613_16_item1_p23_s2", "sentA": "Importantly, plecanatide was safe and well tolerated at both doses; the most common adverse event was diarrhea, which occurred in 3.2% of patients in 3.0 mg and 4.5% of patients in 6.0 mg dose groups compared to 1.3% of placebo-treated patients.", "sentB": "The most common adverse event was diarrhea which occurred in 3.2% of patients in 3 mg and 3.7% of patients in 6 mg dose groups compared to 1.3% of placebo-treated patients.", "type": 2, "words": ["<tag1>", "Importantly,", "plecanatide", "was", "safe", "and", "well", "tolerated", "at", "both", "doses;", "the", "most", "common", "adverse", "event", "was", "diarrhea,", "which", "occurred", "in", "3.2%", "of", "patients", "in", "3.0", "mg", "and", "4.5%", "of", "patients", "in", "6.0", "mg", "dose", "groups", "compared", "to", "1.3%", "of", "placebo-treated", "patients.", "<tag2>", "The", "most", "common", "adverse", "event", "was", "diarrhea", "which", "occurred", "in", "3.2%", "of", "patients", "in", "3", "mg", "and", "3.7%", "of", "patients", "in", "6", "mg", "dose", "groups", "compared", "to", "1.3%", "of", "placebo-treated", "patients.", "<tag3>"], "wordsA": ["Importantly,", "plecanatide", "was", "safe", "and", "well", "tolerated", "at", "both", "doses;", "the", "most", "common", "adverse", "event", "was", "diarrhea,", "which", "occurred", "in", "3.2%", "of", "patients", "in", "3.0", "mg", "and", "4.5%", "of", "patients", "in", "6.0", "mg", "dose", "groups", "compared", "to", "1.3%", "of", "placebo-treated", "patients."], "wordsB": ["The", "most", "common", "adverse", "event", "was", "diarrhea", "which", "occurred", "in", "3.2%", "of", "patients", "in", "3", "mg", "and", "3.7%", "of", "patients", "in", "6", "mg", "dose", "groups", "compared", "to", "1.3%", "of", "placebo-treated", "patients."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_17_item1_p22_s1", "idA": "1347613_16_item1_p24_s0", "sentA": "20 patients in the trial (1.4%) experienced serious adverse events but there was no imbalance across treatment groups in either incidences or individual serious adverse events.", "sentB": "Four patients in the trial (0.4%) experienced serious adverse events but there was no imbalance across treatment groups in either incidences or individual serious adverse events.", "type": 2, "words": ["<tag1>", "20", "patients", "in", "the", "trial", "(1.4%)", "experienced", "serious", "adverse", "events", "but", "there", "was", "no", "imbalance", "across", "treatment", "groups", "in", "either", "incidences", "or", "individual", "serious", "adverse", "events.", "<tag2>", "Four", "patients", "in", "the", "trial", "(0.4%)", "experienced", "serious", "adverse", "events", "but", "there", "was", "no", "imbalance", "across", "treatment", "groups", "in", "either", "incidences", "or", "individual", "serious", "adverse", "events.", "<tag3>"], "wordsA": ["20", "patients", "in", "the", "trial", "(1.4%)", "experienced", "serious", "adverse", "events", "but", "there", "was", "no", "imbalance", "across", "treatment", "groups", "in", "either", "incidences", "or", "individual", "serious", "adverse", "events."], "wordsB": ["Four", "patients", "in", "the", "trial", "(0.4%)", "experienced", "serious", "adverse", "events", "but", "there", "was", "no", "imbalance", "across", "treatment", "groups", "in", "either", "incidences", "or", "individual", "serious", "adverse", "events."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_17_item1_p18_s1", "idA": "1347613_16_item1_p24_s1", "sentA": "Overall, the rates of withdrawal from treatment because of an adverse event were low (3.2% in 3.0 mg and 3.8% in 6.0 mg dose groups compared to 3.0% in placebo) and discontinuations due to diarrhea were infrequent (1.1% in 3.0 mg and 1.1% in 6.0 mg dose groups compared to 0.4% in placebo).", "sentB": "Overall discontinuation rates were low among patients treated with TRULANCE and placebo (4% vs. 2%, respectively) and the most common adverse reaction leading to discontinuation was diarrhea (2% for TRULANCE compared to 0.5% in placebo).", "type": 2, "words": ["<tag1>", "Overall,", "the", "rates", "of", "withdrawal", "from", "treatment", "because", "of", "an", "adverse", "event", "were", "low", "(3.2%", "in", "3.0", "mg", "and", "3.8%", "in", "6.0", "mg", "dose", "groups", "compared", "to", "3.0%", "in", "placebo)", "and", "discontinuations", "due", "to", "diarrhea", "were", "infrequent", "(1.1%", "in", "3.0", "mg", "and", "1.1%", "in", "6.0", "mg", "dose", "groups", "compared", "to", "0.4%", "in", "placebo).", "<tag2>", "Overall", "discontinuation", "rates", "were", "low", "among", "patients", "treated", "with", "TRULANCE", "and", "placebo", "(4%", "vs.", "2%,", "respectively)", "and", "the", "most", "common", "adverse", "reaction", "leading", "to", "discontinuation", "was", "diarrhea", "(2%", "for", "TRULANCE", "compared", "to", "0.5%", "in", "placebo).", "<tag3>"], "wordsA": ["Overall,", "the", "rates", "of", "withdrawal", "from", "treatment", "because", "of", "an", "adverse", "event", "were", "low", "(3.2%", "in", "3.0", "mg", "and", "3.8%", "in", "6.0", "mg", "dose", "groups", "compared", "to", "3.0%", "in", "placebo)", "and", "discontinuations", "due", "to", "diarrhea", "were", "infrequent", "(1.1%", "in", "3.0", "mg", "and", "1.1%", "in", "6.0", "mg", "dose", "groups", "compared", "to", "0.4%", "in", "placebo)."], "wordsB": ["Overall", "discontinuation", "rates", "were", "low", "among", "patients", "treated", "with", "TRULANCE", "and", "placebo", "(4%", "vs.", "2%,", "respectively)", "and", "the", "most", "common", "adverse", "reaction", "leading", "to", "discontinuation", "was", "diarrhea", "(2%", "for", "TRULANCE", "compared", "to", "0.5%", "in", "placebo)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_17_item1_p22_s2", "idA": "1347613_16_item1_p24_s1", "sentA": "Overall, the rates of withdrawal from treatment because of an adverse event were low (3.2% in 3.0 mg and 3.8% in 6.0 mg dose groups compared to 3.0% in placebo) and discontinuations due to diarrhea were infrequent (1.1% in 3.0 mg and 1.1% in 6.0 mg dose groups compared to 0.4% in placebo).", "sentB": "Overall, the rates of withdrawal from treatment because of an adverse event were low (1.9% in 3 mg and 1.8% in 6 mg dose groups compared to 0 in placebo) and discontinuations due to diarrhea were infrequent (0.8% in 3 mg and 1.6% in 6 mg dose groups compared to 0 in placebo).", "type": 2, "words": ["<tag1>", "Overall,", "the", "rates", "of", "withdrawal", "from", "treatment", "because", "of", "an", "adverse", "event", "were", "low", "(3.2%", "in", "3.0", "mg", "and", "3.8%", "in", "6.0", "mg", "dose", "groups", "compared", "to", "3.0%", "in", "placebo)", "and", "discontinuations", "due", "to", "diarrhea", "were", "infrequent", "(1.1%", "in", "3.0", "mg", "and", "1.1%", "in", "6.0", "mg", "dose", "groups", "compared", "to", "0.4%", "in", "placebo).", "<tag2>", "Overall,", "the", "rates", "of", "withdrawal", "from", "treatment", "because", "of", "an", "adverse", "event", "were", "low", "(1.9%", "in", "3", "mg", "and", "1.8%", "in", "6", "mg", "dose", "groups", "compared", "to", "0", "in", "placebo)", "and", "discontinuations", "due", "to", "diarrhea", "were", "infrequent", "(0.8%", "in", "3", "mg", "and", "1.6%", "in", "6", "mg", "dose", "groups", "compared", "to", "0", "in", "placebo).", "<tag3>"], "wordsA": ["Overall,", "the", "rates", "of", "withdrawal", "from", "treatment", "because", "of", "an", "adverse", "event", "were", "low", "(3.2%", "in", "3.0", "mg", "and", "3.8%", "in", "6.0", "mg", "dose", "groups", "compared", "to", "3.0%", "in", "placebo)", "and", "discontinuations", "due", "to", "diarrhea", "were", "infrequent", "(1.1%", "in", "3.0", "mg", "and", "1.1%", "in", "6.0", "mg", "dose", "groups", "compared", "to", "0.4%", "in", "placebo)."], "wordsB": ["Overall,", "the", "rates", "of", "withdrawal", "from", "treatment", "because", "of", "an", "adverse", "event", "were", "low", "(1.9%", "in", "3", "mg", "and", "1.8%", "in", "6", "mg", "dose", "groups", "compared", "to", "0", "in", "placebo)", "and", "discontinuations", "due", "to", "diarrhea", "were", "infrequent", "(0.8%", "in", "3", "mg", "and", "1.6%", "in", "6", "mg", "dose", "groups", "compared", "to", "0", "in", "placebo)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_17_item1_p24_s2", "idA": "1347613_16_item1_p24_s1", "sentA": "Overall, the rates of withdrawal from treatment because of an adverse event were low (3.2% in 3.0 mg and 3.8% in 6.0 mg dose groups compared to 3.0% in placebo) and discontinuations due to diarrhea were infrequent (1.1% in 3.0 mg and 1.1% in 6.0 mg dose groups compared to 0.4% in placebo).", "sentB": "Overall, the rates of withdrawal from treatment because of an adverse event were low (2.6% in 3 mg and 2.3% in 6 mg dose groups compared to 0.8% in placebo) and discontinuations due to diarrhea were infrequent (1.7% in 3 mg and 1.2% in 6 mg dose groups compared to 0 in placebo).", "type": 2, "words": ["<tag1>", "Overall,", "the", "rates", "of", "withdrawal", "from", "treatment", "because", "of", "an", "adverse", "event", "were", "low", "(3.2%", "in", "3.0", "mg", "and", "3.8%", "in", "6.0", "mg", "dose", "groups", "compared", "to", "3.0%", "in", "placebo)", "and", "discontinuations", "due", "to", "diarrhea", "were", "infrequent", "(1.1%", "in", "3.0", "mg", "and", "1.1%", "in", "6.0", "mg", "dose", "groups", "compared", "to", "0.4%", "in", "placebo).", "<tag2>", "Overall,", "the", "rates", "of", "withdrawal", "from", "treatment", "because", "of", "an", "adverse", "event", "were", "low", "(2.6%", "in", "3", "mg", "and", "2.3%", "in", "6", "mg", "dose", "groups", "compared", "to", "0.8%", "in", "placebo)", "and", "discontinuations", "due", "to", "diarrhea", "were", "infrequent", "(1.7%", "in", "3", "mg", "and", "1.2%", "in", "6", "mg", "dose", "groups", "compared", "to", "0", "in", "placebo).", "<tag3>"], "wordsA": ["Overall,", "the", "rates", "of", "withdrawal", "from", "treatment", "because", "of", "an", "adverse", "event", "were", "low", "(3.2%", "in", "3.0", "mg", "and", "3.8%", "in", "6.0", "mg", "dose", "groups", "compared", "to", "3.0%", "in", "placebo)", "and", "discontinuations", "due", "to", "diarrhea", "were", "infrequent", "(1.1%", "in", "3.0", "mg", "and", "1.1%", "in", "6.0", "mg", "dose", "groups", "compared", "to", "0.4%", "in", "placebo)."], "wordsB": ["Overall,", "the", "rates", "of", "withdrawal", "from", "treatment", "because", "of", "an", "adverse", "event", "were", "low", "(2.6%", "in", "3", "mg", "and", "2.3%", "in", "6", "mg", "dose", "groups", "compared", "to", "0.8%", "in", "placebo)", "and", "discontinuations", "due", "to", "diarrhea", "were", "infrequent", "(1.7%", "in", "3", "mg", "and", "1.2%", "in", "6", "mg", "dose", "groups", "compared", "to", "0", "in", "placebo)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_17_item1_p25_s2", "idA": "1347613_16_item1_p27_s0", "sentA": "We plan to present additional data results from both phase 3 CIC trials at appropriate scientific conferences.", "sentB": "We plan to present additional Phase 3 data from the two IBS-C trials at an appropriate scientific meeting later this year.", "type": 2, "words": ["<tag1>", "We", "plan", "to", "present", "additional", "data", "results", "from", "both", "phase", "3", "CIC", "trials", "at", "appropriate", "scientific", "conferences.", "<tag2>", "We", "plan", "to", "present", "additional", "Phase", "3", "data", "from", "the", "two", "IBS-C", "trials", "at", "an", "appropriate", "scientific", "meeting", "later", "this", "year.", "<tag3>"], "wordsA": ["We", "plan", "to", "present", "additional", "data", "results", "from", "both", "phase", "3", "CIC", "trials", "at", "appropriate", "scientific", "conferences."], "wordsB": ["We", "plan", "to", "present", "additional", "Phase", "3", "data", "from", "the", "two", "IBS-C", "trials", "at", "an", "appropriate", "scientific", "meeting", "later", "this", "year."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_17_item1_p33_s0", "idA": "1347613_16_item1_p28_s1", "sentA": "The phase 3 IBS-C program was designed to support regulatory submissions in the U.S.", "sentB": "Since January 2016, our market access team has been meeting with key payer customers that represent over 230 million covered lives in the U.S.", "type": 2, "words": ["<tag1>", "The", "phase", "3", "IBS-C", "program", "was", "designed", "to", "support", "regulatory", "submissions", "in", "the", "U.S.", "<tag2>", "Since", "January", "2016,", "our", "market", "access", "team", "has", "been", "meeting", "with", "key", "payer", "customers", "that", "represent", "over", "230", "million", "covered", "lives", "in", "the", "U.S.", "<tag3>"], "wordsA": ["The", "phase", "3", "IBS-C", "program", "was", "designed", "to", "support", "regulatory", "submissions", "in", "the", "U.S."], "wordsB": ["Since", "January", "2016,", "our", "market", "access", "team", "has", "been", "meeting", "with", "key", "payer", "customers", "that", "represent", "over", "230", "million", "covered", "lives", "in", "the", "U.S."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_17_item1_p6_s1", "idA": "1347613_16_item1_p28_s1", "sentA": "The phase 3 IBS-C program was designed to support regulatory submissions in the U.S.", "sentB": "An estimated 33 million adults suffer from CIC and 12 million adults suffer from IBS-C in the U.S. alone.", "type": 2, "words": ["<tag1>", "The", "phase", "3", "IBS-C", "program", "was", "designed", "to", "support", "regulatory", "submissions", "in", "the", "U.S.", "<tag2>", "An", "estimated", "33", "million", "adults", "suffer", "from", "CIC", "and", "12", "million", "adults", "suffer", "from", "IBS-C", "in", "the", "U.S.", "alone.", "<tag3>"], "wordsA": ["The", "phase", "3", "IBS-C", "program", "was", "designed", "to", "support", "regulatory", "submissions", "in", "the", "U.S."], "wordsB": ["An", "estimated", "33", "million", "adults", "suffer", "from", "CIC", "and", "12", "million", "adults", "suffer", "from", "IBS-C", "in", "the", "U.S.", "alone."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_17_item1_p2_s1", "idA": "1347613_16_item1_p2_s0", "sentA": "Since the company s inception in 2008, we have pioneered discovery, research and development efforts involving uroguanylin analogs for the treatment of functional gastrointestinal (GI) disorders and inflammatory bowel disease.", "sentB": "We have pioneered discovery, research and development efforts around analogs of uroguanylin, a naturally occurring and endogenous human GI peptide, for the treatment of GI diseases and disorders.", "type": 2, "words": ["<tag1>", "Since", "the", "company", "s", "inception", "in", "2008,", "we", "have", "pioneered", "discovery,", "research", "and", "development", "efforts", "involving", "uroguanylin", "analogs", "for", "the", "treatment", "of", "functional", "gastrointestinal", "(GI)", "disorders", "and", "inflammatory", "bowel", "disease.", "<tag2>", "We", "have", "pioneered", "discovery,", "research", "and", "development", "efforts", "around", "analogs", "of", "uroguanylin,", "a", "naturally", "occurring", "and", "endogenous", "human", "GI", "peptide,", "for", "the", "treatment", "of", "GI", "diseases", "and", "disorders.", "<tag3>"], "wordsA": ["Since", "the", "company", "s", "inception", "in", "2008,", "we", "have", "pioneered", "discovery,", "research", "and", "development", "efforts", "involving", "uroguanylin", "analogs", "for", "the", "treatment", "of", "functional", "gastrointestinal", "(GI)", "disorders", "and", "inflammatory", "bowel", "disease."], "wordsB": ["We", "have", "pioneered", "discovery,", "research", "and", "development", "efforts", "around", "analogs", "of", "uroguanylin,", "a", "naturally", "occurring", "and", "endogenous", "human", "GI", "peptide,", "for", "the", "treatment", "of", "GI", "diseases", "and", "disorders."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_17_item1_p3_s0", "idA": "1347613_16_item1_p2_s0", "sentA": "Since the company s inception in 2008, we have pioneered discovery, research and development efforts involving uroguanylin analogs for the treatment of functional gastrointestinal (GI) disorders and inflammatory bowel disease.", "sentB": "Our first and only commercial product, plecanatide, is approved in the United States (U.S.), under the trademark name TRULANCE , for the treatment of adults with chronic idiopathic constipation, or CIC.", "type": 2, "words": ["<tag1>", "Since", "the", "company", "s", "inception", "in", "2008,", "we", "have", "pioneered", "discovery,", "research", "and", "development", "efforts", "involving", "uroguanylin", "analogs", "for", "the", "treatment", "of", "functional", "gastrointestinal", "(GI)", "disorders", "and", "inflammatory", "bowel", "disease.", "<tag2>", "Our", "first", "and", "only", "commercial", "product,", "plecanatide,", "is", "approved", "in", "the", "United", "States", "(U.S.),", "under", "the", "trademark", "name", "TRULANCE", ",", "for", "the", "treatment", "of", "adults", "with", "chronic", "idiopathic", "constipation,", "or", "CIC.", "<tag3>"], "wordsA": ["Since", "the", "company", "s", "inception", "in", "2008,", "we", "have", "pioneered", "discovery,", "research", "and", "development", "efforts", "involving", "uroguanylin", "analogs", "for", "the", "treatment", "of", "functional", "gastrointestinal", "(GI)", "disorders", "and", "inflammatory", "bowel", "disease."], "wordsB": ["Our", "first", "and", "only", "commercial", "product,", "plecanatide,", "is", "approved", "in", "the", "United", "States", "(U.S.),", "under", "the", "trademark", "name", "TRULANCE", ",", "for", "the", "treatment", "of", "adults", "with", "chronic", "idiopathic", "constipation,", "or", "CIC."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_17_item1_p45_s0", "idA": "1347613_16_item1_p33_s0", "sentA": "Dolcanatide, our second uroguanylin analog, is currently being explored for inflammatory bowel disease (IBD).", "sentB": "Dolcanatide (SP-333) Dolcanatide, our second uroguanylin analog, is currently being explored for inflammatory bowel disease (IBD).", "type": 2, "words": ["<tag1>", "Dolcanatide,", "our", "second", "uroguanylin", "analog,", "is", "currently", "being", "explored", "for", "inflammatory", "bowel", "disease", "(IBD).", "<tag2>", "Dolcanatide", "(SP-333)", "Dolcanatide,", "our", "second", "uroguanylin", "analog,", "is", "currently", "being", "explored", "for", "inflammatory", "bowel", "disease", "(IBD).", "<tag3>"], "wordsA": ["Dolcanatide,", "our", "second", "uroguanylin", "analog,", "is", "currently", "being", "explored", "for", "inflammatory", "bowel", "disease", "(IBD)."], "wordsB": ["Dolcanatide", "(SP-333)", "Dolcanatide,", "our", "second", "uroguanylin", "analog,", "is", "currently", "being", "explored", "for", "inflammatory", "bowel", "disease", "(IBD)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_17_item1_p5_s0", "idA": "1347613_16_item1_p33_s0", "sentA": "Dolcanatide, our second uroguanylin analog, is currently being explored for inflammatory bowel disease (IBD).", "sentB": "Dolcanatide, our second product candidate, is being evaluated for inflammatory bowel disease (IBD).", "type": 2, "words": ["<tag1>", "Dolcanatide,", "our", "second", "uroguanylin", "analog,", "is", "currently", "being", "explored", "for", "inflammatory", "bowel", "disease", "(IBD).", "<tag2>", "Dolcanatide,", "our", "second", "product", "candidate,", "is", "being", "evaluated", "for", "inflammatory", "bowel", "disease", "(IBD).", "<tag3>"], "wordsA": ["Dolcanatide,", "our", "second", "uroguanylin", "analog,", "is", "currently", "being", "explored", "for", "inflammatory", "bowel", "disease", "(IBD)."], "wordsB": ["Dolcanatide,", "our", "second", "product", "candidate,", "is", "being", "evaluated", "for", "inflammatory", "bowel", "disease", "(IBD)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_17_item1_p5_s3", "idA": "1347613_16_item1_p35_s0", "sentA": "On January 11, 2016, we announced positive phase 1b data with dolcanatide in a double-blind, placebo-controlled, four-week study evaluating 28 patients with mild-to-moderate ulcerative colitis.", "sentB": "In November 2014, we reported successful proof-of-concept with dolcanatide in a double-blind, placebo-controlled phase 2 trial in 289 patients with OIC, demonstrating the utility of our uroguanylin analog platform in OIC.", "type": 2, "words": ["<tag1>", "On", "January", "11,", "2016,", "we", "announced", "positive", "phase", "1b", "data", "with", "dolcanatide", "in", "a", "double-blind,", "placebo-controlled,", "four-week", "study", "evaluating", "28", "patients", "with", "mild-to-moderate", "ulcerative", "colitis.", "<tag2>", "In", "November", "2014,", "we", "reported", "successful", "proof-of-concept", "with", "dolcanatide", "in", "a", "double-blind,", "placebo-controlled", "phase", "2", "trial", "in", "289", "patients", "with", "OIC,", "demonstrating", "the", "utility", "of", "our", "uroguanylin", "analog", "platform", "in", "OIC.", "<tag3>"], "wordsA": ["On", "January", "11,", "2016,", "we", "announced", "positive", "phase", "1b", "data", "with", "dolcanatide", "in", "a", "double-blind,", "placebo-controlled,", "four-week", "study", "evaluating", "28", "patients", "with", "mild-to-moderate", "ulcerative", "colitis."], "wordsB": ["In", "November", "2014,", "we", "reported", "successful", "proof-of-concept", "with", "dolcanatide", "in", "a", "double-blind,", "placebo-controlled", "phase", "2", "trial", "in", "289", "patients", "with", "OIC,", "demonstrating", "the", "utility", "of", "our", "uroguanylin", "analog", "platform", "in", "OIC."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_17_item1_p17_s0", "idA": "1347613_16_item1_p37_s1", "sentA": "Analysis of the data indicates dolcanatide met the study s primary endpoint and demonstrated statistically significant improvement in mean change from baseline in the number of spontaneous bowel movements (SBMs) during Week 4 of the treatment period.", "sentB": "Over 12 weeks, patients who received TRULANCE in both studies also had improvements as compared to placebo in stool frequency (as measured by the number of spontaneous bowel movements per week), stool consistency (as measured by the Bristol Stool Form Scale) and straining with bowel movements.", "type": 2, "words": ["<tag1>", "Analysis", "of", "the", "data", "indicates", "dolcanatide", "met", "the", "study", "s", "primary", "endpoint", "and", "demonstrated", "statistically", "significant", "improvement", "in", "mean", "change", "from", "baseline", "in", "the", "number", "of", "spontaneous", "bowel", "movements", "(SBMs)", "during", "Week", "4", "of", "the", "treatment", "period.", "<tag2>", "Over", "12", "weeks,", "patients", "who", "received", "TRULANCE", "in", "both", "studies", "also", "had", "improvements", "as", "compared", "to", "placebo", "in", "stool", "frequency", "(as", "measured", "by", "the", "number", "of", "spontaneous", "bowel", "movements", "per", "week),", "stool", "consistency", "(as", "measured", "by", "the", "Bristol", "Stool", "Form", "Scale)", "and", "straining", "with", "bowel", "movements.", "<tag3>"], "wordsA": ["Analysis", "of", "the", "data", "indicates", "dolcanatide", "met", "the", "study", "s", "primary", "endpoint", "and", "demonstrated", "statistically", "significant", "improvement", "in", "mean", "change", "from", "baseline", "in", "the", "number", "of", "spontaneous", "bowel", "movements", "(SBMs)", "during", "Week", "4", "of", "the", "treatment", "period."], "wordsB": ["Over", "12", "weeks,", "patients", "who", "received", "TRULANCE", "in", "both", "studies", "also", "had", "improvements", "as", "compared", "to", "placebo", "in", "stool", "frequency", "(as", "measured", "by", "the", "number", "of", "spontaneous", "bowel", "movements", "per", "week),", "stool", "consistency", "(as", "measured", "by", "the", "Bristol", "Stool", "Form", "Scale)", "and", "straining", "with", "bowel", "movements."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_17_item1_p49_s0", "idA": "1347613_16_item1_p37_s1", "sentA": "Analysis of the data indicates dolcanatide met the study s primary endpoint and demonstrated statistically significant improvement in mean change from baseline in the number of spontaneous bowel movements (SBMs) during Week 4 of the treatment period.", "sentB": "movements (SBMs) during Week 4 of the treatment period.", "type": 2, "words": ["<tag1>", "Analysis", "of", "the", "data", "indicates", "dolcanatide", "met", "the", "study", "s", "primary", "endpoint", "and", "demonstrated", "statistically", "significant", "improvement", "in", "mean", "change", "from", "baseline", "in", "the", "number", "of", "spontaneous", "bowel", "movements", "(SBMs)", "during", "Week", "4", "of", "the", "treatment", "period.", "<tag2>", "movements", "(SBMs)", "during", "Week", "4", "of", "the", "treatment", "period.", "<tag3>"], "wordsA": ["Analysis", "of", "the", "data", "indicates", "dolcanatide", "met", "the", "study", "s", "primary", "endpoint", "and", "demonstrated", "statistically", "significant", "improvement", "in", "mean", "change", "from", "baseline", "in", "the", "number", "of", "spontaneous", "bowel", "movements", "(SBMs)", "during", "Week", "4", "of", "the", "treatment", "period."], "wordsB": ["movements", "(SBMs)", "during", "Week", "4", "of", "the", "treatment", "period."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_17_item1_p12_s0", "idA": "1347613_16_item1_p3_s0", "sentA": "Plecanatide is a 16-amino acid peptide that is structurally identical to uroguanylin with the exception of a single amino acid change.", "sentB": "With the exception of a single amino acid, TRULANCE is structurally identical to uroguanylin and is the only treatment that is thought to replicate the pH-sensitive activity of human uroguanylin.", "type": 2, "words": ["<tag1>", "Plecanatide", "is", "a", "16-amino", "acid", "peptide", "that", "is", "structurally", "identical", "to", "uroguanylin", "with", "the", "exception", "of", "a", "single", "amino", "acid", "change.", "<tag2>", "With", "the", "exception", "of", "a", "single", "amino", "acid,", "TRULANCE", "is", "structurally", "identical", "to", "uroguanylin", "and", "is", "the", "only", "treatment", "that", "is", "thought", "to", "replicate", "the", "pH-sensitive", "activity", "of", "human", "uroguanylin.", "<tag3>"], "wordsA": ["Plecanatide", "is", "a", "16-amino", "acid", "peptide", "that", "is", "structurally", "identical", "to", "uroguanylin", "with", "the", "exception", "of", "a", "single", "amino", "acid", "change."], "wordsB": ["With", "the", "exception", "of", "a", "single", "amino", "acid,", "TRULANCE", "is", "structurally", "identical", "to", "uroguanylin", "and", "is", "the", "only", "treatment", "that", "is", "thought", "to", "replicate", "the", "pH-sensitive", "activity", "of", "human", "uroguanylin."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_17_item1_p12_s1", "idA": "1347613_16_item1_p3_s0", "sentA": "Plecanatide is a 16-amino acid peptide that is structurally identical to uroguanylin with the exception of a single amino acid change.", "sentB": "The single amino acid substitution results in improved (8x) binding affinity and therefore increases the potency of TRULANCE over uroguanylin.", "type": 2, "words": ["<tag1>", "Plecanatide", "is", "a", "16-amino", "acid", "peptide", "that", "is", "structurally", "identical", "to", "uroguanylin", "with", "the", "exception", "of", "a", "single", "amino", "acid", "change.", "<tag2>", "The", "single", "amino", "acid", "substitution", "results", "in", "improved", "(8x)", "binding", "affinity", "and", "therefore", "increases", "the", "potency", "of", "TRULANCE", "over", "uroguanylin.", "<tag3>"], "wordsA": ["Plecanatide", "is", "a", "16-amino", "acid", "peptide", "that", "is", "structurally", "identical", "to", "uroguanylin", "with", "the", "exception", "of", "a", "single", "amino", "acid", "change."], "wordsB": ["The", "single", "amino", "acid", "substitution", "results", "in", "improved", "(8x)", "binding", "affinity", "and", "therefore", "increases", "the", "potency", "of", "TRULANCE", "over", "uroguanylin."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_17_item1_p3_s1", "idA": "1347613_16_item1_p3_s2", "sentA": "In 2015, we announced positive phase 3 data in two CIC clinical trials and on January 29, 2016 we filed a new drug application (NDA) with the U.S. Food and Drug Administration (FDA) with plecanatide for CIC.", "sentB": "The U.S. Food and Drug Administration, or FDA, approved TRULANCE on January 19, 2017.", "type": 2, "words": ["<tag1>", "In", "2015,", "we", "announced", "positive", "phase", "3", "data", "in", "two", "CIC", "clinical", "trials", "and", "on", "January", "29,", "2016", "we", "filed", "a", "new", "drug", "application", "(NDA)", "with", "the", "U.S.", "Food", "and", "Drug", "Administration", "(FDA)", "with", "plecanatide", "for", "CIC.", "<tag2>", "The", "U.S.", "Food", "and", "Drug", "Administration,", "or", "FDA,", "approved", "TRULANCE", "on", "January", "19,", "2017.", "<tag3>"], "wordsA": ["In", "2015,", "we", "announced", "positive", "phase", "3", "data", "in", "two", "CIC", "clinical", "trials", "and", "on", "January", "29,", "2016", "we", "filed", "a", "new", "drug", "application", "(NDA)", "with", "the", "U.S.", "Food", "and", "Drug", "Administration", "(FDA)", "with", "plecanatide", "for", "CIC."], "wordsB": ["The", "U.S.", "Food", "and", "Drug", "Administration,", "or", "FDA,", "approved", "TRULANCE", "on", "January", "19,", "2017."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_17_item1_p53_s1", "idA": "1347613_16_item1_p41_s1", "sentA": "Research and development expenses for the year ended December 31, 2015 were approximately $78 million, as compared to approximately $83.3 million and $50.6 million for the year ended December 31, 2014 and 2013, respectively.", "sentB": "Research and development expenses for the year ended December 31, 2016 were approximately $89.6 million , as compared to approximately $78 million and $83.3 million for the years ended December 31, 2015 and 2014, respectively.", "type": 2, "words": ["<tag1>", "Research", "and", "development", "expenses", "for", "the", "year", "ended", "December", "31,", "2015", "were", "approximately", "$78", "million,", "as", "compared", "to", "approximately", "$83.3", "million", "and", "$50.6", "million", "for", "the", "year", "ended", "December", "31,", "2014", "and", "2013,", "respectively.", "<tag2>", "Research", "and", "development", "expenses", "for", "the", "year", "ended", "December", "31,", "2016", "were", "approximately", "$89.6", "million", ",", "as", "compared", "to", "approximately", "$78", "million", "and", "$83.3", "million", "for", "the", "years", "ended", "December", "31,", "2015", "and", "2014,", "respectively.", "<tag3>"], "wordsA": ["Research", "and", "development", "expenses", "for", "the", "year", "ended", "December", "31,", "2015", "were", "approximately", "$78", "million,", "as", "compared", "to", "approximately", "$83.3", "million", "and", "$50.6", "million", "for", "the", "year", "ended", "December", "31,", "2014", "and", "2013,", "respectively."], "wordsB": ["Research", "and", "development", "expenses", "for", "the", "year", "ended", "December", "31,", "2016", "were", "approximately", "$89.6", "million", ",", "as", "compared", "to", "approximately", "$78", "million", "and", "$83.3", "million", "for", "the", "years", "ended", "December", "31,", "2015", "and", "2014,", "respectively."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_17_item1_p59_s0", "idA": "1347613_16_item1_p44_s0", "sentA": "As of December 31, 2015 we have 16 issued United States patents, and two allowed applications related to guanylate cyclase agonists.", "sentB": "As of December 31, 2016 we have 21 issued United States patents related to guanylate cyclase agonists.", "type": 2, "words": ["<tag1>", "As", "of", "December", "31,", "2015", "we", "have", "16", "issued", "United", "States", "patents,", "and", "two", "allowed", "applications", "related", "to", "guanylate", "cyclase", "agonists.", "<tag2>", "As", "of", "December", "31,", "2016", "we", "have", "21", "issued", "United", "States", "patents", "related", "to", "guanylate", "cyclase", "agonists.", "<tag3>"], "wordsA": ["As", "of", "December", "31,", "2015", "we", "have", "16", "issued", "United", "States", "patents,", "and", "two", "allowed", "applications", "related", "to", "guanylate", "cyclase", "agonists."], "wordsB": ["As", "of", "December", "31,", "2016", "we", "have", "21", "issued", "United", "States", "patents", "related", "to", "guanylate", "cyclase", "agonists."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_17_item1_p59_s1", "idA": "1347613_16_item1_p44_s1", "sentA": "Two of these patents cover the composition-of-matter of plecanatide and were issued on May 9, 2006 and September 21, 2010; they will expire in 2023 and 2022, respectively.", "sentB": "Two of these patents cover the composition-of-matter of TRULANCE and were issued on May 9, 2006 and September 21, 2010; they will expire in 2023 and 2022, respectively.", "type": 2, "words": ["<tag1>", "Two", "of", "these", "patents", "cover", "the", "composition-of-matter", "of", "plecanatide", "and", "were", "issued", "on", "May", "9,", "2006", "and", "September", "21,", "2010;", "they", "will", "expire", "in", "2023", "and", "2022,", "respectively.", "<tag2>", "Two", "of", "these", "patents", "cover", "the", "composition-of-matter", "of", "TRULANCE", "and", "were", "issued", "on", "May", "9,", "2006", "and", "September", "21,", "2010;", "they", "will", "expire", "in", "2023", "and", "2022,", "respectively.", "<tag3>"], "wordsA": ["Two", "of", "these", "patents", "cover", "the", "composition-of-matter", "of", "plecanatide", "and", "were", "issued", "on", "May", "9,", "2006", "and", "September", "21,", "2010;", "they", "will", "expire", "in", "2023", "and", "2022,", "respectively."], "wordsB": ["Two", "of", "these", "patents", "cover", "the", "composition-of-matter", "of", "TRULANCE", "and", "were", "issued", "on", "May", "9,", "2006", "and", "September", "21,", "2010;", "they", "will", "expire", "in", "2023", "and", "2022,", "respectively."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_17_item1_p60_s1", "idA": "1347613_16_item1_p44_s10", "sentA": "Another three patents that also cover compositions-of-matter related to certain analogs of plecanatide were issued on February 5, 2013, October 29, 2013, and March 4, 2014 and will expire in 2029.", "sentB": "Another three patents that also cover compositions-of-matter related to certain analogs of TRULANCE were issued on February 5, 2013, October 29, 2013, and March 4, 2014 and will expire in 2029.", "type": 2, "words": ["<tag1>", "Another", "three", "patents", "that", "also", "cover", "compositions-of-matter", "related", "to", "certain", "analogs", "of", "plecanatide", "were", "issued", "on", "February", "5,", "2013,", "October", "29,", "2013,", "and", "March", "4,", "2014", "and", "will", "expire", "in", "2029.", "<tag2>", "Another", "three", "patents", "that", "also", "cover", "compositions-of-matter", "related", "to", "certain", "analogs", "of", "TRULANCE", "were", "issued", "on", "February", "5,", "2013,", "October", "29,", "2013,", "and", "March", "4,", "2014", "and", "will", "expire", "in", "2029.", "<tag3>"], "wordsA": ["Another", "three", "patents", "that", "also", "cover", "compositions-of-matter", "related", "to", "certain", "analogs", "of", "plecanatide", "were", "issued", "on", "February", "5,", "2013,", "October", "29,", "2013,", "and", "March", "4,", "2014", "and", "will", "expire", "in", "2029."], "wordsB": ["Another", "three", "patents", "that", "also", "cover", "compositions-of-matter", "related", "to", "certain", "analogs", "of", "TRULANCE", "were", "issued", "on", "February", "5,", "2013,", "October", "29,", "2013,", "and", "March", "4,", "2014", "and", "will", "expire", "in", "2029."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_17_item1_p60_s4", "idA": "1347613_16_item1_p44_s13", "sentA": "A fifteenth patent granted on March 3, 2015 and covers methods of use of plecanatide and expires in 2030.", "sentB": "A fifteenth patent granted on March 3, 2015 and covers methods of use of TRULANCE and expires in 2030.", "type": 2, "words": ["<tag1>", "A", "fifteenth", "patent", "granted", "on", "March", "3,", "2015", "and", "covers", "methods", "of", "use", "of", "plecanatide", "and", "expires", "in", "2030.", "<tag2>", "A", "fifteenth", "patent", "granted", "on", "March", "3,", "2015", "and", "covers", "methods", "of", "use", "of", "TRULANCE", "and", "expires", "in", "2030.", "<tag3>"], "wordsA": ["A", "fifteenth", "patent", "granted", "on", "March", "3,", "2015", "and", "covers", "methods", "of", "use", "of", "plecanatide", "and", "expires", "in", "2030."], "wordsB": ["A", "fifteenth", "patent", "granted", "on", "March", "3,", "2015", "and", "covers", "methods", "of", "use", "of", "TRULANCE", "and", "expires", "in", "2030."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_17_item1_p60_s5", "idA": "1347613_16_item1_p44_s14", "sentA": "A sixteenth patent granted July 28, 2015 covers an additional composition-of-matter related to certain analogs of plecanatide and dolcanatide and will expire in 2028.", "sentB": "A sixteenth patent granted July 28, 2015 covers an additional composition-of-matter related to certain analogs of TRULANCE and dolcanatide and will expire in 2028.", "type": 2, "words": ["<tag1>", "A", "sixteenth", "patent", "granted", "July", "28,", "2015", "covers", "an", "additional", "composition-of-matter", "related", "to", "certain", "analogs", "of", "plecanatide", "and", "dolcanatide", "and", "will", "expire", "in", "2028.", "<tag2>", "A", "sixteenth", "patent", "granted", "July", "28,", "2015", "covers", "an", "additional", "composition-of-matter", "related", "to", "certain", "analogs", "of", "TRULANCE", "and", "dolcanatide", "and", "will", "expire", "in", "2028.", "<tag3>"], "wordsA": ["A", "sixteenth", "patent", "granted", "July", "28,", "2015", "covers", "an", "additional", "composition-of-matter", "related", "to", "certain", "analogs", "of", "plecanatide", "and", "dolcanatide", "and", "will", "expire", "in", "2028."], "wordsB": ["A", "sixteenth", "patent", "granted", "July", "28,", "2015", "covers", "an", "additional", "composition-of-matter", "related", "to", "certain", "analogs", "of", "TRULANCE", "and", "dolcanatide", "and", "will", "expire", "in", "2028."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_17_item1_p60_s6", "idA": "1347613_16_item1_p44_s14", "sentA": "A sixteenth patent granted July 28, 2015 covers an additional composition-of-matter related to certain analogs of plecanatide and dolcanatide and will expire in 2028.", "sentB": "Another two patents granted on January 19, 2016 and February 23, 2016 cover composition-of-matter of dolcanatide and certain analogs of TRULANCE and dolcanatide and will expire in 2028.", "type": 2, "words": ["<tag1>", "A", "sixteenth", "patent", "granted", "July", "28,", "2015", "covers", "an", "additional", "composition-of-matter", "related", "to", "certain", "analogs", "of", "plecanatide", "and", "dolcanatide", "and", "will", "expire", "in", "2028.", "<tag2>", "Another", "two", "patents", "granted", "on", "January", "19,", "2016", "and", "February", "23,", "2016", "cover", "composition-of-matter", "of", "dolcanatide", "and", "certain", "analogs", "of", "TRULANCE", "and", "dolcanatide", "and", "will", "expire", "in", "2028.", "<tag3>"], "wordsA": ["A", "sixteenth", "patent", "granted", "July", "28,", "2015", "covers", "an", "additional", "composition-of-matter", "related", "to", "certain", "analogs", "of", "plecanatide", "and", "dolcanatide", "and", "will", "expire", "in", "2028."], "wordsB": ["Another", "two", "patents", "granted", "on", "January", "19,", "2016", "and", "February", "23,", "2016", "cover", "composition-of-matter", "of", "dolcanatide", "and", "certain", "analogs", "of", "TRULANCE", "and", "dolcanatide", "and", "will", "expire", "in", "2028."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_17_item1_p61_s6", "idA": "1347613_16_item1_p44_s15", "sentA": "One allowed patent application covers composition-of-matter of dolcanatide and is projected to expire in 2028.", "sentB": "They are both projected to expire in 2031.", "type": 2, "words": ["<tag1>", "One", "allowed", "patent", "application", "covers", "composition-of-matter", "of", "dolcanatide", "and", "is", "projected", "to", "expire", "in", "2028.", "<tag2>", "They", "are", "both", "projected", "to", "expire", "in", "2031.", "<tag3>"], "wordsA": ["One", "allowed", "patent", "application", "covers", "composition-of-matter", "of", "dolcanatide", "and", "is", "projected", "to", "expire", "in", "2028."], "wordsB": ["They", "are", "both", "projected", "to", "expire", "in", "2031."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_17_item1_p59_s2", "idA": "1347613_16_item1_p44_s2", "sentA": "The patent that issued on May 9, 2006 has claims directed to the species of plecanatide, whereas the patent that issued on September 21, 2010 has claims directed to a genus of peptides that are identical in length to plecanatide and is inclusive of plecanatide.", "sentB": "The patent that issued on May 9, 2006 has claims directed to the species of TRULANCE, whereas the patent that issued on September 21, 2010 has claims directed to a genus of peptides that are identical in length to TRULANCE and is inclusive of TRULANCE.", "type": 2, "words": ["<tag1>", "The", "patent", "that", "issued", "on", "May", "9,", "2006", "has", "claims", "directed", "to", "the", "species", "of", "plecanatide,", "whereas", "the", "patent", "that", "issued", "on", "September", "21,", "2010", "has", "claims", "directed", "to", "a", "genus", "of", "peptides", "that", "are", "identical", "in", "length", "to", "plecanatide", "and", "is", "inclusive", "of", "plecanatide.", "<tag2>", "The", "patent", "that", "issued", "on", "May", "9,", "2006", "has", "claims", "directed", "to", "the", "species", "of", "TRULANCE,", "whereas", "the", "patent", "that", "issued", "on", "September", "21,", "2010", "has", "claims", "directed", "to", "a", "genus", "of", "peptides", "that", "are", "identical", "in", "length", "to", "TRULANCE", "and", "is", "inclusive", "of", "TRULANCE.", "<tag3>"], "wordsA": ["The", "patent", "that", "issued", "on", "May", "9,", "2006", "has", "claims", "directed", "to", "the", "species", "of", "plecanatide,", "whereas", "the", "patent", "that", "issued", "on", "September", "21,", "2010", "has", "claims", "directed", "to", "a", "genus", "of", "peptides", "that", "are", "identical", "in", "length", "to", "plecanatide", "and", "is", "inclusive", "of", "plecanatide."], "wordsB": ["The", "patent", "that", "issued", "on", "May", "9,", "2006", "has", "claims", "directed", "to", "the", "species", "of", "TRULANCE,", "whereas", "the", "patent", "that", "issued", "on", "September", "21,", "2010", "has", "claims", "directed", "to", "a", "genus", "of", "peptides", "that", "are", "identical", "in", "length", "to", "TRULANCE", "and", "is", "inclusive", "of", "TRULANCE."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_17_item1_p59_s4", "idA": "1347613_16_item1_p44_s4", "sentA": "A fourth patent granted October 11, 2011 covers the composition-of-matter of certain analogs related to plecanatide and dolcanatide and will expire in 2029.", "sentB": "A fourth patent granted October 11, 2011 covers the composition-of-matter of certain analogs related to TRULANCE and dolcanatide and will expire in 2029.", "type": 2, "words": ["<tag1>", "A", "fourth", "patent", "granted", "October", "11,", "2011", "covers", "the", "composition-of-matter", "of", "certain", "analogs", "related", "to", "plecanatide", "and", "dolcanatide", "and", "will", "expire", "in", "2029.", "<tag2>", "A", "fourth", "patent", "granted", "October", "11,", "2011", "covers", "the", "composition-of-matter", "of", "certain", "analogs", "related", "to", "TRULANCE", "and", "dolcanatide", "and", "will", "expire", "in", "2029.", "<tag3>"], "wordsA": ["A", "fourth", "patent", "granted", "October", "11,", "2011", "covers", "the", "composition-of-matter", "of", "certain", "analogs", "related", "to", "plecanatide", "and", "dolcanatide", "and", "will", "expire", "in", "2029."], "wordsB": ["A", "fourth", "patent", "granted", "October", "11,", "2011", "covers", "the", "composition-of-matter", "of", "certain", "analogs", "related", "to", "TRULANCE", "and", "dolcanatide", "and", "will", "expire", "in", "2029."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_17_item1_p60_s7", "idA": "1347613_16_item1_p44_s4", "sentA": "A fourth patent granted October 11, 2011 covers the composition-of-matter of certain analogs related to plecanatide and dolcanatide and will expire in 2029.", "sentB": "A nineteenth patent granted November 8, 2016 covers compositions containing TRULANCE or dolcanatide and 5-aminosalicyclic acid and will expire in 2034.", "type": 2, "words": ["<tag1>", "A", "fourth", "patent", "granted", "October", "11,", "2011", "covers", "the", "composition-of-matter", "of", "certain", "analogs", "related", "to", "plecanatide", "and", "dolcanatide", "and", "will", "expire", "in", "2029.", "<tag2>", "A", "nineteenth", "patent", "granted", "November", "8,", "2016", "covers", "compositions", "containing", "TRULANCE", "or", "dolcanatide", "and", "5-aminosalicyclic", "acid", "and", "will", "expire", "in", "2034.", "<tag3>"], "wordsA": ["A", "fourth", "patent", "granted", "October", "11,", "2011", "covers", "the", "composition-of-matter", "of", "certain", "analogs", "related", "to", "plecanatide", "and", "dolcanatide", "and", "will", "expire", "in", "2029."], "wordsB": ["A", "nineteenth", "patent", "granted", "November", "8,", "2016", "covers", "compositions", "containing", "TRULANCE", "or", "dolcanatide", "and", "5-aminosalicyclic", "acid", "and", "will", "expire", "in", "2034."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_17_item1_p60_s8", "idA": "1347613_16_item1_p44_s4", "sentA": "A fourth patent granted October 11, 2011 covers the composition-of-matter of certain analogs related to plecanatide and dolcanatide and will expire in 2029.", "sentB": "A twentieth patent granted November 29, 2016 covers analogs related to TRULANCE and will expire in 2029.", "type": 2, "words": ["<tag1>", "A", "fourth", "patent", "granted", "October", "11,", "2011", "covers", "the", "composition-of-matter", "of", "certain", "analogs", "related", "to", "plecanatide", "and", "dolcanatide", "and", "will", "expire", "in", "2029.", "<tag2>", "A", "twentieth", "patent", "granted", "November", "29,", "2016", "covers", "analogs", "related", "to", "TRULANCE", "and", "will", "expire", "in", "2029.", "<tag3>"], "wordsA": ["A", "fourth", "patent", "granted", "October", "11,", "2011", "covers", "the", "composition-of-matter", "of", "certain", "analogs", "related", "to", "plecanatide", "and", "dolcanatide", "and", "will", "expire", "in", "2029."], "wordsB": ["A", "twentieth", "patent", "granted", "November", "29,", "2016", "covers", "analogs", "related", "to", "TRULANCE", "and", "will", "expire", "in", "2029."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_17_item1_p59_s5", "idA": "1347613_16_item1_p44_s5", "sentA": "A fifth patent granted February 14, 2012 covers certain methods of treating inflammatory bowel disease using plecanatide and will expire in 2022.", "sentB": "A fifth patent granted February 14, 2012 covers certain methods of treating inflammatory bowel disease using TRULANCE and will expire in 2022.", "type": 2, "words": ["<tag1>", "A", "fifth", "patent", "granted", "February", "14,", "2012", "covers", "certain", "methods", "of", "treating", "inflammatory", "bowel", "disease", "using", "plecanatide", "and", "will", "expire", "in", "2022.", "<tag2>", "A", "fifth", "patent", "granted", "February", "14,", "2012", "covers", "certain", "methods", "of", "treating", "inflammatory", "bowel", "disease", "using", "TRULANCE", "and", "will", "expire", "in", "2022.", "<tag3>"], "wordsA": ["A", "fifth", "patent", "granted", "February", "14,", "2012", "covers", "certain", "methods", "of", "treating", "inflammatory", "bowel", "disease", "using", "plecanatide", "and", "will", "expire", "in", "2022."], "wordsB": ["A", "fifth", "patent", "granted", "February", "14,", "2012", "covers", "certain", "methods", "of", "treating", "inflammatory", "bowel", "disease", "using", "TRULANCE", "and", "will", "expire", "in", "2022."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_17_item1_p59_s6", "idA": "1347613_16_item1_p44_s6", "sentA": "A sixth patent granted January 28, 2014 covers methods of stimulating water transport in the gastrointestinal tract using plecanatide and will expire in 2022.", "sentB": "A sixth patent granted January 28, 2014 covers methods of stimulating water transport in the gastrointestinal tract using TRULANCE and will expire in 2022.", "type": 2, "words": ["<tag1>", "A", "sixth", "patent", "granted", "January", "28,", "2014", "covers", "methods", "of", "stimulating", "water", "transport", "in", "the", "gastrointestinal", "tract", "using", "plecanatide", "and", "will", "expire", "in", "2022.", "<tag2>", "A", "sixth", "patent", "granted", "January", "28,", "2014", "covers", "methods", "of", "stimulating", "water", "transport", "in", "the", "gastrointestinal", "tract", "using", "TRULANCE", "and", "will", "expire", "in", "2022.", "<tag3>"], "wordsA": ["A", "sixth", "patent", "granted", "January", "28,", "2014", "covers", "methods", "of", "stimulating", "water", "transport", "in", "the", "gastrointestinal", "tract", "using", "plecanatide", "and", "will", "expire", "in", "2022."], "wordsB": ["A", "sixth", "patent", "granted", "January", "28,", "2014", "covers", "methods", "of", "stimulating", "water", "transport", "in", "the", "gastrointestinal", "tract", "using", "TRULANCE", "and", "will", "expire", "in", "2022."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_17_item1_p60_s9", "idA": "1347613_16_item1_p44_s6", "sentA": "A sixth patent granted January 28, 2014 covers methods of stimulating water transport in the gastrointestinal tract using plecanatide and will expire in 2022.", "sentB": "A twenty-first patent granted January 17, 2017 covers method of colonic cleansing using dolcanatide.", "type": 2, "words": ["<tag1>", "A", "sixth", "patent", "granted", "January", "28,", "2014", "covers", "methods", "of", "stimulating", "water", "transport", "in", "the", "gastrointestinal", "tract", "using", "plecanatide", "and", "will", "expire", "in", "2022.", "<tag2>", "A", "twenty-first", "patent", "granted", "January", "17,", "2017", "covers", "method", "of", "colonic", "cleansing", "using", "dolcanatide.", "<tag3>"], "wordsA": ["A", "sixth", "patent", "granted", "January", "28,", "2014", "covers", "methods", "of", "stimulating", "water", "transport", "in", "the", "gastrointestinal", "tract", "using", "plecanatide", "and", "will", "expire", "in", "2022."], "wordsB": ["A", "twenty-first", "patent", "granted", "January", "17,", "2017", "covers", "method", "of", "colonic", "cleansing", "using", "dolcanatide."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_17_item1_p59_s7", "idA": "1347613_16_item1_p44_s7", "sentA": "A seventh patent granted June 26, 2012 covers an additional composition-of-matter related to certain analogs of plecanatide and dolcanatide and will expire in 2029.", "sentB": "A seventh patent granted June 26, 2012 covers an additional composition-of-matter related to certain analogs of TRULANCE and dolcanatide and will expire in 2029.", "type": 2, "words": ["<tag1>", "A", "seventh", "patent", "granted", "June", "26,", "2012", "covers", "an", "additional", "composition-of-matter", "related", "to", "certain", "analogs", "of", "plecanatide", "and", "dolcanatide", "and", "will", "expire", "in", "2029.", "<tag2>", "A", "seventh", "patent", "granted", "June", "26,", "2012", "covers", "an", "additional", "composition-of-matter", "related", "to", "certain", "analogs", "of", "TRULANCE", "and", "dolcanatide", "and", "will", "expire", "in", "2029.", "<tag3>"], "wordsA": ["A", "seventh", "patent", "granted", "June", "26,", "2012", "covers", "an", "additional", "composition-of-matter", "related", "to", "certain", "analogs", "of", "plecanatide", "and", "dolcanatide", "and", "will", "expire", "in", "2029."], "wordsB": ["A", "seventh", "patent", "granted", "June", "26,", "2012", "covers", "an", "additional", "composition-of-matter", "related", "to", "certain", "analogs", "of", "TRULANCE", "and", "dolcanatide", "and", "will", "expire", "in", "2029."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_17_item1_p59_s8", "idA": "1347613_16_item1_p44_s8", "sentA": "An eighth patent granted on January 22, 2013 covers another composition-of-matter related to certain analogs of plecanatide and will expire in 2029.", "sentB": "An eighth patent granted on January 22, 2013 covers another composition-of-matter related to certain analogs of TRULANCE and will expire in 2029.", "type": 2, "words": ["<tag1>", "An", "eighth", "patent", "granted", "on", "January", "22,", "2013", "covers", "another", "composition-of-matter", "related", "to", "certain", "analogs", "of", "plecanatide", "and", "will", "expire", "in", "2029.", "<tag2>", "An", "eighth", "patent", "granted", "on", "January", "22,", "2013", "covers", "another", "composition-of-matter", "related", "to", "certain", "analogs", "of", "TRULANCE", "and", "will", "expire", "in", "2029.", "<tag3>"], "wordsA": ["An", "eighth", "patent", "granted", "on", "January", "22,", "2013", "covers", "another", "composition-of-matter", "related", "to", "certain", "analogs", "of", "plecanatide", "and", "will", "expire", "in", "2029."], "wordsB": ["An", "eighth", "patent", "granted", "on", "January", "22,", "2013", "covers", "another", "composition-of-matter", "related", "to", "certain", "analogs", "of", "TRULANCE", "and", "will", "expire", "in", "2029."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_17_item1_p60_s0", "idA": "1347613_16_item1_p44_s8", "sentA": "An eighth patent granted on January 22, 2013 covers another composition-of-matter related to certain analogs of plecanatide and will expire in 2029.", "sentB": "2013 covers another composition-of-matter related to certain analogs of TRULANCE and will expire in 2029.", "type": 2, "words": ["<tag1>", "An", "eighth", "patent", "granted", "on", "January", "22,", "2013", "covers", "another", "composition-of-matter", "related", "to", "certain", "analogs", "of", "plecanatide", "and", "will", "expire", "in", "2029.", "<tag2>", "2013", "covers", "another", "composition-of-matter", "related", "to", "certain", "analogs", "of", "TRULANCE", "and", "will", "expire", "in", "2029.", "<tag3>"], "wordsA": ["An", "eighth", "patent", "granted", "on", "January", "22,", "2013", "covers", "another", "composition-of-matter", "related", "to", "certain", "analogs", "of", "plecanatide", "and", "will", "expire", "in", "2029."], "wordsB": ["2013", "covers", "another", "composition-of-matter", "related", "to", "certain", "analogs", "of", "TRULANCE", "and", "will", "expire", "in", "2029."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_17_item1_p61_s3", "idA": "1347613_16_item1_p44_s8", "sentA": "An eighth patent granted on January 22, 2013 covers another composition-of-matter related to certain analogs of plecanatide and will expire in 2029.", "sentB": "The patent will expire in 2032.", "type": 2, "words": ["<tag1>", "An", "eighth", "patent", "granted", "on", "January", "22,", "2013", "covers", "another", "composition-of-matter", "related", "to", "certain", "analogs", "of", "plecanatide", "and", "will", "expire", "in", "2029.", "<tag2>", "The", "patent", "will", "expire", "in", "2032.", "<tag3>"], "wordsA": ["An", "eighth", "patent", "granted", "on", "January", "22,", "2013", "covers", "another", "composition-of-matter", "related", "to", "certain", "analogs", "of", "plecanatide", "and", "will", "expire", "in", "2029."], "wordsB": ["The", "patent", "will", "expire", "in", "2032."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_17_item1_p62_s0", "idA": "1347613_16_item1_p45_s0", "sentA": "In addition, we have seven granted foreign patents which cover the composition-of-matter of plecanatide and expire in 2022.", "sentB": "In addition, we have eight granted foreign patents which cover the composition-of-matter of TRULANCE and expire in 2022.", "type": 2, "words": ["<tag1>", "In", "addition,", "we", "have", "seven", "granted", "foreign", "patents", "which", "cover", "the", "composition-of-matter", "of", "plecanatide", "and", "expire", "in", "2022.", "<tag2>", "In", "addition,", "we", "have", "eight", "granted", "foreign", "patents", "which", "cover", "the", "composition-of-matter", "of", "TRULANCE", "and", "expire", "in", "2022.", "<tag3>"], "wordsA": ["In", "addition,", "we", "have", "seven", "granted", "foreign", "patents", "which", "cover", "the", "composition-of-matter", "of", "plecanatide", "and", "expire", "in", "2022."], "wordsB": ["In", "addition,", "we", "have", "eight", "granted", "foreign", "patents", "which", "cover", "the", "composition-of-matter", "of", "TRULANCE", "and", "expire", "in", "2022."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_17_item1_p62_s12", "idA": "1347613_16_item1_p45_s2", "sentA": "We also have seven granted foreign patents that cover the composition-of-matter related to dolcanatide that expire in 2028.", "sentB": "We also have one patent related to manufacture of TRULANCE.", "type": 2, "words": ["<tag1>", "We", "also", "have", "seven", "granted", "foreign", "patents", "that", "cover", "the", "composition-of-matter", "related", "to", "dolcanatide", "that", "expire", "in", "2028.", "<tag2>", "We", "also", "have", "one", "patent", "related", "to", "manufacture", "of", "TRULANCE.", "<tag3>"], "wordsA": ["We", "also", "have", "seven", "granted", "foreign", "patents", "that", "cover", "the", "composition-of-matter", "related", "to", "dolcanatide", "that", "expire", "in", "2028."], "wordsB": ["We", "also", "have", "one", "patent", "related", "to", "manufacture", "of", "TRULANCE."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_17_item1_p62_s2", "idA": "1347613_16_item1_p45_s2", "sentA": "We also have seven granted foreign patents that cover the composition-of-matter related to dolcanatide that expire in 2028.", "sentB": "We also have nine granted foreign patents that cover the composition-of-matter related to dolcanatide that expire in 2028.", "type": 2, "words": ["<tag1>", "We", "also", "have", "seven", "granted", "foreign", "patents", "that", "cover", "the", "composition-of-matter", "related", "to", "dolcanatide", "that", "expire", "in", "2028.", "<tag2>", "We", "also", "have", "nine", "granted", "foreign", "patents", "that", "cover", "the", "composition-of-matter", "related", "to", "dolcanatide", "that", "expire", "in", "2028.", "<tag3>"], "wordsA": ["We", "also", "have", "seven", "granted", "foreign", "patents", "that", "cover", "the", "composition-of-matter", "related", "to", "dolcanatide", "that", "expire", "in", "2028."], "wordsB": ["We", "also", "have", "nine", "granted", "foreign", "patents", "that", "cover", "the", "composition-of-matter", "related", "to", "dolcanatide", "that", "expire", "in", "2028."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_17_item1_p62_s4", "idA": "1347613_16_item1_p45_s4", "sentA": "We also have three foreign patents that cover composition-of-matter of certain analogs related to plecanatide and methods of use to treat Ulcerative Colitis that expire in 2029.", "sentB": "We also have five foreign patents that cover composition-of-matter of certain analogs related to TRULANCE and methods of use to treat Ulcerative Colitis that expire in 2029.", "type": 2, "words": ["<tag1>", "We", "also", "have", "three", "foreign", "patents", "that", "cover", "composition-of-matter", "of", "certain", "analogs", "related", "to", "plecanatide", "and", "methods", "of", "use", "to", "treat", "Ulcerative", "Colitis", "that", "expire", "in", "2029.", "<tag2>", "We", "also", "have", "five", "foreign", "patents", "that", "cover", "composition-of-matter", "of", "certain", "analogs", "related", "to", "TRULANCE", "and", "methods", "of", "use", "to", "treat", "Ulcerative", "Colitis", "that", "expire", "in", "2029.", "<tag3>"], "wordsA": ["We", "also", "have", "three", "foreign", "patents", "that", "cover", "composition-of-matter", "of", "certain", "analogs", "related", "to", "plecanatide", "and", "methods", "of", "use", "to", "treat", "Ulcerative", "Colitis", "that", "expire", "in", "2029."], "wordsB": ["We", "also", "have", "five", "foreign", "patents", "that", "cover", "composition-of-matter", "of", "certain", "analogs", "related", "to", "TRULANCE", "and", "methods", "of", "use", "to", "treat", "Ulcerative", "Colitis", "that", "expire", "in", "2029."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_17_item1_p62_s6", "idA": "1347613_16_item1_p45_s6", "sentA": "We also have two foreign patents that cover composition-of-matter of certain analogs related to dolcanatide and methods of use to treat gastrointestinal disorders and expires in 2029.", "sentB": "We also have two foreign patents that cover composition-of-matter of certain analogs related to TRULANCE and methods of use to treat gastrointestinal disorders and expires in 2029.", "type": 2, "words": ["<tag1>", "We", "also", "have", "two", "foreign", "patents", "that", "cover", "composition-of-matter", "of", "certain", "analogs", "related", "to", "dolcanatide", "and", "methods", "of", "use", "to", "treat", "gastrointestinal", "disorders", "and", "expires", "in", "2029.", "<tag2>", "We", "also", "have", "two", "foreign", "patents", "that", "cover", "composition-of-matter", "of", "certain", "analogs", "related", "to", "TRULANCE", "and", "methods", "of", "use", "to", "treat", "gastrointestinal", "disorders", "and", "expires", "in", "2029.", "<tag3>"], "wordsA": ["We", "also", "have", "two", "foreign", "patents", "that", "cover", "composition-of-matter", "of", "certain", "analogs", "related", "to", "dolcanatide", "and", "methods", "of", "use", "to", "treat", "gastrointestinal", "disorders", "and", "expires", "in", "2029."], "wordsB": ["We", "also", "have", "two", "foreign", "patents", "that", "cover", "composition-of-matter", "of", "certain", "analogs", "related", "to", "TRULANCE", "and", "methods", "of", "use", "to", "treat", "gastrointestinal", "disorders", "and", "expires", "in", "2029."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_17_item1_p62_s11", "idA": "1347613_16_item1_p45_s7", "sentA": "These patents cover Australia, France, Germany, Italy, Spain and the United Kingdom.", "sentB": "These patents cover Australia, Japan, Germany, France, Italy, Spain and the United Kingdom.", "type": 2, "words": ["<tag1>", "These", "patents", "cover", "Australia,", "France,", "Germany,", "Italy,", "Spain", "and", "the", "United", "Kingdom.", "<tag2>", "These", "patents", "cover", "Australia,", "Japan,", "Germany,", "France,", "Italy,", "Spain", "and", "the", "United", "Kingdom.", "<tag3>"], "wordsA": ["These", "patents", "cover", "Australia,", "France,", "Germany,", "Italy,", "Spain", "and", "the", "United", "Kingdom."], "wordsB": ["These", "patents", "cover", "Australia,", "Japan,", "Germany,", "France,", "Italy,", "Spain", "and", "the", "United", "Kingdom."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_17_item1_p62_s7", "idA": "1347613_16_item1_p45_s7", "sentA": "These patents cover Australia, France, Germany, Italy, Spain and the United Kingdom.", "sentB": "These patents cover Australia, France, Germany, Italy, Spain, United Kingdom and Hong Kong.", "type": 2, "words": ["<tag1>", "These", "patents", "cover", "Australia,", "France,", "Germany,", "Italy,", "Spain", "and", "the", "United", "Kingdom.", "<tag2>", "These", "patents", "cover", "Australia,", "France,", "Germany,", "Italy,", "Spain,", "United", "Kingdom", "and", "Hong", "Kong.", "<tag3>"], "wordsA": ["These", "patents", "cover", "Australia,", "France,", "Germany,", "Italy,", "Spain", "and", "the", "United", "Kingdom."], "wordsB": ["These", "patents", "cover", "Australia,", "France,", "Germany,", "Italy,", "Spain,", "United", "Kingdom", "and", "Hong", "Kong."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_17_item1_p62_s10", "idA": "1347613_16_item1_p45_s8", "sentA": "We also have three foreign patents related to plecanatide that cover treatment and prevention of Hypercholesterolemia and expire in 2030.", "sentB": "We also have three patents related to gastrointestinal specific formulations of TRULANCE and dolcantide.", "type": 2, "words": ["<tag1>", "We", "also", "have", "three", "foreign", "patents", "related", "to", "plecanatide", "that", "cover", "treatment", "and", "prevention", "of", "Hypercholesterolemia", "and", "expire", "in", "2030.", "<tag2>", "We", "also", "have", "three", "patents", "related", "to", "gastrointestinal", "specific", "formulations", "of", "TRULANCE", "and", "dolcantide.", "<tag3>"], "wordsA": ["We", "also", "have", "three", "foreign", "patents", "related", "to", "plecanatide", "that", "cover", "treatment", "and", "prevention", "of", "Hypercholesterolemia", "and", "expire", "in", "2030."], "wordsB": ["We", "also", "have", "three", "patents", "related", "to", "gastrointestinal", "specific", "formulations", "of", "TRULANCE", "and", "dolcantide."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_17_item1_p62_s8", "idA": "1347613_16_item1_p45_s8", "sentA": "We also have three foreign patents related to plecanatide that cover treatment and prevention of Hypercholesterolemia and expire in 2030.", "sentB": "We also have six foreign patents related to TRULANCE that cover treatment and prevention of Hypercholesterolemia and expire in 2030.", "type": 2, "words": ["<tag1>", "We", "also", "have", "three", "foreign", "patents", "related", "to", "plecanatide", "that", "cover", "treatment", "and", "prevention", "of", "Hypercholesterolemia", "and", "expire", "in", "2030.", "<tag2>", "We", "also", "have", "six", "foreign", "patents", "related", "to", "TRULANCE", "that", "cover", "treatment", "and", "prevention", "of", "Hypercholesterolemia", "and", "expire", "in", "2030.", "<tag3>"], "wordsA": ["We", "also", "have", "three", "foreign", "patents", "related", "to", "plecanatide", "that", "cover", "treatment", "and", "prevention", "of", "Hypercholesterolemia", "and", "expire", "in", "2030."], "wordsB": ["We", "also", "have", "six", "foreign", "patents", "related", "to", "TRULANCE", "that", "cover", "treatment", "and", "prevention", "of", "Hypercholesterolemia", "and", "expire", "in", "2030."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_17_item1_p62_s9", "idA": "1347613_16_item1_p45_s9", "sentA": "These patents cover Japan, Mexico, France, Germany, Italy, Spain and the United Kingdom.", "sentB": "These patents cover Australia, China, Japan, Mexico, France, Germany, Italy, Spain and the United Kingdom.", "type": 2, "words": ["<tag1>", "These", "patents", "cover", "Japan,", "Mexico,", "France,", "Germany,", "Italy,", "Spain", "and", "the", "United", "Kingdom.", "<tag2>", "These", "patents", "cover", "Australia,", "China,", "Japan,", "Mexico,", "France,", "Germany,", "Italy,", "Spain", "and", "the", "United", "Kingdom.", "<tag3>"], "wordsA": ["These", "patents", "cover", "Japan,", "Mexico,", "France,", "Germany,", "Italy,", "Spain", "and", "the", "United", "Kingdom."], "wordsB": ["These", "patents", "cover", "Australia,", "China,", "Japan,", "Mexico,", "France,", "Germany,", "Italy,", "Spain", "and", "the", "United", "Kingdom."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_17_item1_p63_s0", "idA": "1347613_16_item1_p46_s0", "sentA": "Additionally, as of the date of this report on Form 10-K, we have 17 pending United States utility patent applications; 3 pending U.S. provisional applications; and 79 pending foreign patent applications relating to plecanatide and dolcanatide, various derivatives and analogs of plecanatide and dolcanatide, and their uses and manufacture.", "sentB": "Additionally, as of the date of this report on Form 10-K, we have 17 pending United States utility patent applications; and 82 pending foreign patent applications relating to TRULANCE and dolcanatide, various derivatives and analogs of TRULANCE and dolcanatide, and their uses and manufacture.", "type": 2, "words": ["<tag1>", "Additionally,", "as", "of", "the", "date", "of", "this", "report", "on", "Form", "10-K,", "we", "have", "17", "pending", "United", "States", "utility", "patent", "applications;", "3", "pending", "U.S.", "provisional", "applications;", "and", "79", "pending", "foreign", "patent", "applications", "relating", "to", "plecanatide", "and", "dolcanatide,", "various", "derivatives", "and", "analogs", "of", "plecanatide", "and", "dolcanatide,", "and", "their", "uses", "and", "manufacture.", "<tag2>", "Additionally,", "as", "of", "the", "date", "of", "this", "report", "on", "Form", "10-K,", "we", "have", "17", "pending", "United", "States", "utility", "patent", "applications;", "and", "82", "pending", "foreign", "patent", "applications", "relating", "to", "TRULANCE", "and", "dolcanatide,", "various", "derivatives", "and", "analogs", "of", "TRULANCE", "and", "dolcanatide,", "and", "their", "uses", "and", "manufacture.", "<tag3>"], "wordsA": ["Additionally,", "as", "of", "the", "date", "of", "this", "report", "on", "Form", "10-K,", "we", "have", "17", "pending", "United", "States", "utility", "patent", "applications;", "3", "pending", "U.S.", "provisional", "applications;", "and", "79", "pending", "foreign", "patent", "applications", "relating", "to", "plecanatide", "and", "dolcanatide,", "various", "derivatives", "and", "analogs", "of", "plecanatide", "and", "dolcanatide,", "and", "their", "uses", "and", "manufacture."], "wordsB": ["Additionally,", "as", "of", "the", "date", "of", "this", "report", "on", "Form", "10-K,", "we", "have", "17", "pending", "United", "States", "utility", "patent", "applications;", "and", "82", "pending", "foreign", "patent", "applications", "relating", "to", "TRULANCE", "and", "dolcanatide,", "various", "derivatives", "and", "analogs", "of", "TRULANCE", "and", "dolcanatide,", "and", "their", "uses", "and", "manufacture."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_17_item1_p64_s2", "idA": "1347613_16_item1_p47_s2", "sentA": "In particular, the composition-of-matter claim covering plecanatide was upheld.", "sentB": "In particular, the composition-of-matter claim covering TRULANCE was upheld.", "type": 2, "words": ["<tag1>", "In", "particular,", "the", "composition-of-matter", "claim", "covering", "plecanatide", "was", "upheld.", "<tag2>", "In", "particular,", "the", "composition-of-matter", "claim", "covering", "TRULANCE", "was", "upheld.", "<tag3>"], "wordsA": ["In", "particular,", "the", "composition-of-matter", "claim", "covering", "plecanatide", "was", "upheld."], "wordsB": ["In", "particular,", "the", "composition-of-matter", "claim", "covering", "TRULANCE", "was", "upheld."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_17_item1_p65_s0", "idA": "1347613_16_item1_p48_s0", "sentA": "On September 14, 2012 we entered into a binding letter of intent with Ironwood Pharmaceuticals, Inc. ( Ironwood ), pursuant to which we and Ironwood agreed to enter into a definitive license agreement giving us an exclusive worldwide license to Ironwood s method of use patents on plecanatide.", "sentB": "On September 14, 2012 we entered into a binding letter of intent with Ironwood Pharmaceuticals, Inc. ( Ironwood ), pursuant to which we and Ironwood agreed to enter into a definitive license agreement giving us an exclusive worldwide license to Ironwood s method of use patents on TRULANCE.", "type": 2, "words": ["<tag1>", "On", "September", "14,", "2012", "we", "entered", "into", "a", "binding", "letter", "of", "intent", "with", "Ironwood", "Pharmaceuticals,", "Inc.", "(", "Ironwood", "),", "pursuant", "to", "which", "we", "and", "Ironwood", "agreed", "to", "enter", "into", "a", "definitive", "license", "agreement", "giving", "us", "an", "exclusive", "worldwide", "license", "to", "Ironwood", "s", "method", "of", "use", "patents", "on", "plecanatide.", "<tag2>", "On", "September", "14,", "2012", "we", "entered", "into", "a", "binding", "letter", "of", "intent", "with", "Ironwood", "Pharmaceuticals,", "Inc.", "(", "Ironwood", "),", "pursuant", "to", "which", "we", "and", "Ironwood", "agreed", "to", "enter", "into", "a", "definitive", "license", "agreement", "giving", "us", "an", "exclusive", "worldwide", "license", "to", "Ironwood", "s", "method", "of", "use", "patents", "on", "TRULANCE.", "<tag3>"], "wordsA": ["On", "September", "14,", "2012", "we", "entered", "into", "a", "binding", "letter", "of", "intent", "with", "Ironwood", "Pharmaceuticals,", "Inc.", "(", "Ironwood", "),", "pursuant", "to", "which", "we", "and", "Ironwood", "agreed", "to", "enter", "into", "a", "definitive", "license", "agreement", "giving", "us", "an", "exclusive", "worldwide", "license", "to", "Ironwood", "s", "method", "of", "use", "patents", "on", "plecanatide."], "wordsB": ["On", "September", "14,", "2012", "we", "entered", "into", "a", "binding", "letter", "of", "intent", "with", "Ironwood", "Pharmaceuticals,", "Inc.", "(", "Ironwood", "),", "pursuant", "to", "which", "we", "and", "Ironwood", "agreed", "to", "enter", "into", "a", "definitive", "license", "agreement", "giving", "us", "an", "exclusive", "worldwide", "license", "to", "Ironwood", "s", "method", "of", "use", "patents", "on", "TRULANCE."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_17_item1_p65_s1", "idA": "1347613_16_item1_p48_s1", "sentA": "The letter of intent contemplates a low single digit royalty on net sales of plecanatide and both parties agreed not to challenge each other s patents covering certain GC-C agonists, except that we retain the right to challenge Ironwood s method of use patents on plecanatide.", "sentB": "The letter of intent contemplates a low single digit royalty on net sales of TRULANCE and both parties agreed not to challenge each other s patents covering certain GC-C agonists, except that we retain the right to challenge Ironwood s method of use patents on TRULANCE.", "type": 2, "words": ["<tag1>", "The", "letter", "of", "intent", "contemplates", "a", "low", "single", "digit", "royalty", "on", "net", "sales", "of", "plecanatide", "and", "both", "parties", "agreed", "not", "to", "challenge", "each", "other", "s", "patents", "covering", "certain", "GC-C", "agonists,", "except", "that", "we", "retain", "the", "right", "to", "challenge", "Ironwood", "s", "method", "of", "use", "patents", "on", "plecanatide.", "<tag2>", "The", "letter", "of", "intent", "contemplates", "a", "low", "single", "digit", "royalty", "on", "net", "sales", "of", "TRULANCE", "and", "both", "parties", "agreed", "not", "to", "challenge", "each", "other", "s", "patents", "covering", "certain", "GC-C", "agonists,", "except", "that", "we", "retain", "the", "right", "to", "challenge", "Ironwood", "s", "method", "of", "use", "patents", "on", "TRULANCE.", "<tag3>"], "wordsA": ["The", "letter", "of", "intent", "contemplates", "a", "low", "single", "digit", "royalty", "on", "net", "sales", "of", "plecanatide", "and", "both", "parties", "agreed", "not", "to", "challenge", "each", "other", "s", "patents", "covering", "certain", "GC-C", "agonists,", "except", "that", "we", "retain", "the", "right", "to", "challenge", "Ironwood", "s", "method", "of", "use", "patents", "on", "plecanatide."], "wordsB": ["The", "letter", "of", "intent", "contemplates", "a", "low", "single", "digit", "royalty", "on", "net", "sales", "of", "TRULANCE", "and", "both", "parties", "agreed", "not", "to", "challenge", "each", "other", "s", "patents", "covering", "certain", "GC-C", "agonists,", "except", "that", "we", "retain", "the", "right", "to", "challenge", "Ironwood", "s", "method", "of", "use", "patents", "on", "TRULANCE."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_17_item1_p67_s0", "idA": "1347613_16_item1_p49_s1", "sentA": "The FV-100 assets acquired by ContraVir from us were licensed from University College Cardiff Consultants Limited ( Cardiff ) pursuant to the terms of that certain Patent and Technology License Agreement, dated as of February 2, 2005, between Cardiff and Contravir Research Incorporated, an entity with no prior relationship with us ( CRI ), as amended March 27, 2007, which ContraVir assumed from us (the Cardiff Agreement ).", "sentB": "relationship with us ( CRI ), as amended March 27, 2007, which ContraVir assumed from us (the Cardiff Agreement ).", "type": 2, "words": ["<tag1>", "The", "FV-100", "assets", "acquired", "by", "ContraVir", "from", "us", "were", "licensed", "from", "University", "College", "Cardiff", "Consultants", "Limited", "(", "Cardiff", ")", "pursuant", "to", "the", "terms", "of", "that", "certain", "Patent", "and", "Technology", "License", "Agreement,", "dated", "as", "of", "February", "2,", "2005,", "between", "Cardiff", "and", "Contravir", "Research", "Incorporated,", "an", "entity", "with", "no", "prior", "relationship", "with", "us", "(", "CRI", "),", "as", "amended", "March", "27,", "2007,", "which", "ContraVir", "assumed", "from", "us", "(the", "Cardiff", "Agreement", ").", "<tag2>", "relationship", "with", "us", "(", "CRI", "),", "as", "amended", "March", "27,", "2007,", "which", "ContraVir", "assumed", "from", "us", "(the", "Cardiff", "Agreement", ").", "<tag3>"], "wordsA": ["The", "FV-100", "assets", "acquired", "by", "ContraVir", "from", "us", "were", "licensed", "from", "University", "College", "Cardiff", "Consultants", "Limited", "(", "Cardiff", ")", "pursuant", "to", "the", "terms", "of", "that", "certain", "Patent", "and", "Technology", "License", "Agreement,", "dated", "as", "of", "February", "2,", "2005,", "between", "Cardiff", "and", "Contravir", "Research", "Incorporated,", "an", "entity", "with", "no", "prior", "relationship", "with", "us", "(", "CRI", "),", "as", "amended", "March", "27,", "2007,", "which", "ContraVir", "assumed", "from", "us", "(the", "Cardiff", "Agreement", ")."], "wordsB": ["relationship", "with", "us", "(", "CRI", "),", "as", "amended", "March", "27,", "2007,", "which", "ContraVir", "assumed", "from", "us", "(the", "Cardiff", "Agreement", ")."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_17_item1_p61_s2", "idA": "1347613_16_item1_p50_s1", "sentA": "Pursuant to the terms of an agreement, dated September 24, 1998, as amended December 23, 2004, Cardiff received from Rega an exclusive, irrevocable worldwide license to manufacture, use, sell, or otherwise deal in or with products utilizing the patent rights, including the right to grant sublicenses thereunder.", "sentB": "According to the issue notification, the patent is expected to grant on February 28, 2017.", "type": 2, "words": ["<tag1>", "Pursuant", "to", "the", "terms", "of", "an", "agreement,", "dated", "September", "24,", "1998,", "as", "amended", "December", "23,", "2004,", "Cardiff", "received", "from", "Rega", "an", "exclusive,", "irrevocable", "worldwide", "license", "to", "manufacture,", "use,", "sell,", "or", "otherwise", "deal", "in", "or", "with", "products", "utilizing", "the", "patent", "rights,", "including", "the", "right", "to", "grant", "sublicenses", "thereunder.", "<tag2>", "According", "to", "the", "issue", "notification,", "the", "patent", "is", "expected", "to", "grant", "on", "February", "28,", "2017.", "<tag3>"], "wordsA": ["Pursuant", "to", "the", "terms", "of", "an", "agreement,", "dated", "September", "24,", "1998,", "as", "amended", "December", "23,", "2004,", "Cardiff", "received", "from", "Rega", "an", "exclusive,", "irrevocable", "worldwide", "license", "to", "manufacture,", "use,", "sell,", "or", "otherwise", "deal", "in", "or", "with", "products", "utilizing", "the", "patent", "rights,", "including", "the", "right", "to", "grant", "sublicenses", "thereunder."], "wordsB": ["According", "to", "the", "issue", "notification,", "the", "patent", "is", "expected", "to", "grant", "on", "February", "28,", "2017."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_17_item1_p61_s1", "idA": "1347613_16_item1_p51_s0", "sentA": "We assumed the obligations under the Cardiff Agreement from BMS pursuant to the terms of the BMS Agreement.", "sentB": "One of the allowed applications (US application number 14/001,638) relates to the methods of manufacture of TRULANCE.", "type": 2, "words": ["<tag1>", "We", "assumed", "the", "obligations", "under", "the", "Cardiff", "Agreement", "from", "BMS", "pursuant", "to", "the", "terms", "of", "the", "BMS", "Agreement.", "<tag2>", "One", "of", "the", "allowed", "applications", "(US", "application", "number", "14/001,638)", "relates", "to", "the", "methods", "of", "manufacture", "of", "TRULANCE.", "<tag3>"], "wordsA": ["We", "assumed", "the", "obligations", "under", "the", "Cardiff", "Agreement", "from", "BMS", "pursuant", "to", "the", "terms", "of", "the", "BMS", "Agreement."], "wordsB": ["One", "of", "the", "allowed", "applications", "(US", "application", "number", "14/001,638)", "relates", "to", "the", "methods", "of", "manufacture", "of", "TRULANCE."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_17_item1_p73_s2", "idA": "1347613_16_item1_p56_s0", "sentA": "and failure to abide by applicable regulatory requirements can result in administrative or judicial sanctions being imposed on us, including warning letters, refusals of government contracts, clinical holds, civil penalties, injunctions, restitution, disgorgement of profits, recall or seizure of products, total or partial suspension of production or distribution, withdrawal of approval, refusal to approve pending applications, and criminal prosecution.", "sentB": "The FDA has very broad enforcement authority and failure to abide by applicable regulatory requirements can result in administrative or judicial sanctions being imposed on us, including warning letters, refusals of government contracts, clinical holds, civil penalties, injunctions, restitution, disgorgement of profits, recall or seizure of products, total or partial suspension of production or distribution, withdrawal of approval, refusal to approve pending applications, and criminal prosecution.", "type": 2, "words": ["<tag1>", "and", "failure", "to", "abide", "by", "applicable", "regulatory", "requirements", "can", "result", "in", "administrative", "or", "judicial", "sanctions", "being", "imposed", "on", "us,", "including", "warning", "letters,", "refusals", "of", "government", "contracts,", "clinical", "holds,", "civil", "penalties,", "injunctions,", "restitution,", "disgorgement", "of", "profits,", "recall", "or", "seizure", "of", "products,", "total", "or", "partial", "suspension", "of", "production", "or", "distribution,", "withdrawal", "of", "approval,", "refusal", "to", "approve", "pending", "applications,", "and", "criminal", "prosecution.", "<tag2>", "The", "FDA", "has", "very", "broad", "enforcement", "authority", "and", "failure", "to", "abide", "by", "applicable", "regulatory", "requirements", "can", "result", "in", "administrative", "or", "judicial", "sanctions", "being", "imposed", "on", "us,", "including", "warning", "letters,", "refusals", "of", "government", "contracts,", "clinical", "holds,", "civil", "penalties,", "injunctions,", "restitution,", "disgorgement", "of", "profits,", "recall", "or", "seizure", "of", "products,", "total", "or", "partial", "suspension", "of", "production", "or", "distribution,", "withdrawal", "of", "approval,", "refusal", "to", "approve", "pending", "applications,", "and", "criminal", "prosecution.", "<tag3>"], "wordsA": ["and", "failure", "to", "abide", "by", "applicable", "regulatory", "requirements", "can", "result", "in", "administrative", "or", "judicial", "sanctions", "being", "imposed", "on", "us,", "including", "warning", "letters,", "refusals", "of", "government", "contracts,", "clinical", "holds,", "civil", "penalties,", "injunctions,", "restitution,", "disgorgement", "of", "profits,", "recall", "or", "seizure", "of", "products,", "total", "or", "partial", "suspension", "of", "production", "or", "distribution,", "withdrawal", "of", "approval,", "refusal", "to", "approve", "pending", "applications,", "and", "criminal", "prosecution."], "wordsB": ["The", "FDA", "has", "very", "broad", "enforcement", "authority", "and", "failure", "to", "abide", "by", "applicable", "regulatory", "requirements", "can", "result", "in", "administrative", "or", "judicial", "sanctions", "being", "imposed", "on", "us,", "including", "warning", "letters,", "refusals", "of", "government", "contracts,", "clinical", "holds,", "civil", "penalties,", "injunctions,", "restitution,", "disgorgement", "of", "profits,", "recall", "or", "seizure", "of", "products,", "total", "or", "partial", "suspension", "of", "production", "or", "distribution,", "withdrawal", "of", "approval,", "refusal", "to", "approve", "pending", "applications,", "and", "criminal", "prosecution."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_17_item1_p25_s0", "idA": "1347613_16_item1_p59_s4", "sentA": "In such a case, we must work with the FDA to resolve any outstanding concerns before clinical trials can proceed.", "sentB": "The IBS-C pre-NDA meeting with the FDA was completed in September 2016.", "type": 2, "words": ["<tag1>", "In", "such", "a", "case,", "we", "must", "work", "with", "the", "FDA", "to", "resolve", "any", "outstanding", "concerns", "before", "clinical", "trials", "can", "proceed.", "<tag2>", "The", "IBS-C", "pre-NDA", "meeting", "with", "the", "FDA", "was", "completed", "in", "September", "2016.", "<tag3>"], "wordsA": ["In", "such", "a", "case,", "we", "must", "work", "with", "the", "FDA", "to", "resolve", "any", "outstanding", "concerns", "before", "clinical", "trials", "can", "proceed."], "wordsB": ["The", "IBS-C", "pre-NDA", "meeting", "with", "the", "FDA", "was", "completed", "in", "September", "2016."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_17_item1_p39_s0", "idA": "1347613_16_item1_p66_s1", "sentA": "FDA approval of the NDA is required before marketing of the product may begin in the U.S.", "sentB": "Less than 20% of prescribers in the U.S. currently account for over 70% of the branded constipation prescription market.", "type": 2, "words": ["<tag1>", "FDA", "approval", "of", "the", "NDA", "is", "required", "before", "marketing", "of", "the", "product", "may", "begin", "in", "the", "U.S.", "<tag2>", "Less", "than", "20%", "of", "prescribers", "in", "the", "U.S.", "currently", "account", "for", "over", "70%", "of", "the", "branded", "constipation", "prescription", "market.", "<tag3>"], "wordsA": ["FDA", "approval", "of", "the", "NDA", "is", "required", "before", "marketing", "of", "the", "product", "may", "begin", "in", "the", "U.S."], "wordsB": ["Less", "than", "20%", "of", "prescribers", "in", "the", "U.S.", "currently", "account", "for", "over", "70%", "of", "the", "branded", "constipation", "prescription", "market."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_17_item1_p13_s0", "idA": "1347613_16_item1_p68_s0", "sentA": "The FDA has agreed to certain performance goals in the review of new drug applications.", "sentB": "TRULANCE for CIC The FDA has approved TRULANCE for the treatment of adults with CIC.", "type": 2, "words": ["<tag1>", "The", "FDA", "has", "agreed", "to", "certain", "performance", "goals", "in", "the", "review", "of", "new", "drug", "applications.", "<tag2>", "TRULANCE", "for", "CIC", "The", "FDA", "has", "approved", "TRULANCE", "for", "the", "treatment", "of", "adults", "with", "CIC.", "<tag3>"], "wordsA": ["The", "FDA", "has", "agreed", "to", "certain", "performance", "goals", "in", "the", "review", "of", "new", "drug", "applications."], "wordsB": ["TRULANCE", "for", "CIC", "The", "FDA", "has", "approved", "TRULANCE", "for", "the", "treatment", "of", "adults", "with", "CIC."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_17_item1_p61_s0", "idA": "1347613_16_item1_p68_s0", "sentA": "The FDA has agreed to certain performance goals in the review of new drug applications.", "sentB": "Furthermore, we have three allowed US applications.", "type": 2, "words": ["<tag1>", "The", "FDA", "has", "agreed", "to", "certain", "performance", "goals", "in", "the", "review", "of", "new", "drug", "applications.", "<tag2>", "Furthermore,", "we", "have", "three", "allowed", "US", "applications.", "<tag3>"], "wordsA": ["The", "FDA", "has", "agreed", "to", "certain", "performance", "goals", "in", "the", "review", "of", "new", "drug", "applications."], "wordsB": ["Furthermore,", "we", "have", "three", "allowed", "US", "applications."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_17_item1_p4_s3", "idA": "1347613_16_item1_p79_s0", "sentA": "We are also subject to various environmental, health and safety regulations including those governing laboratory procedures and the handling, use, storage, treatment, and disposal of hazardous materials.", "sentB": "We are also exploring opioid-induced constipation (OIC) as a potential lifecycle growth opportunity for TRULANCE.", "type": 2, "words": ["<tag1>", "We", "are", "also", "subject", "to", "various", "environmental,", "health", "and", "safety", "regulations", "including", "those", "governing", "laboratory", "procedures", "and", "the", "handling,", "use,", "storage,", "treatment,", "and", "disposal", "of", "hazardous", "materials.", "<tag2>", "We", "are", "also", "exploring", "opioid-induced", "constipation", "(OIC)", "as", "a", "potential", "lifecycle", "growth", "opportunity", "for", "TRULANCE.", "<tag3>"], "wordsA": ["We", "are", "also", "subject", "to", "various", "environmental,", "health", "and", "safety", "regulations", "including", "those", "governing", "laboratory", "procedures", "and", "the", "handling,", "use,", "storage,", "treatment,", "and", "disposal", "of", "hazardous", "materials."], "wordsB": ["We", "are", "also", "exploring", "opioid-induced", "constipation", "(OIC)", "as", "a", "potential", "lifecycle", "growth", "opportunity", "for", "TRULANCE."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_17_item1_p20_s0", "idA": "1347613_16_item1_p7_s2", "sentA": "If approved, we plan to launch plecanatide with the CIC indication in the first quarter of 2017.", "sentB": "TRULANCE will be available in the U.S. in the first quarter of 2017.", "type": 2, "words": ["<tag1>", "If", "approved,", "we", "plan", "to", "launch", "plecanatide", "with", "the", "CIC", "indication", "in", "the", "first", "quarter", "of", "2017.", "<tag2>", "TRULANCE", "will", "be", "available", "in", "the", "U.S.", "in", "the", "first", "quarter", "of", "2017.", "<tag3>"], "wordsA": ["If", "approved,", "we", "plan", "to", "launch", "plecanatide", "with", "the", "CIC", "indication", "in", "the", "first", "quarter", "of", "2017."], "wordsB": ["TRULANCE", "will", "be", "available", "in", "the", "U.S.", "in", "the", "first", "quarter", "of", "2017."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_17_item1_p25_s1", "idA": "1347613_16_item1_p7_s2", "sentA": "If approved, we plan to launch plecanatide with the CIC indication in the first quarter of 2017.", "sentB": "We plan to file a New Drug Application Supplement with Clinical Data (sNDA) for TRULANCE in IBS-C in the first quarter of 2017 and we expect a 10-month review period from submission.", "type": 2, "words": ["<tag1>", "If", "approved,", "we", "plan", "to", "launch", "plecanatide", "with", "the", "CIC", "indication", "in", "the", "first", "quarter", "of", "2017.", "<tag2>", "We", "plan", "to", "file", "a", "New", "Drug", "Application", "Supplement", "with", "Clinical", "Data", "(sNDA)", "for", "TRULANCE", "in", "IBS-C", "in", "the", "first", "quarter", "of", "2017", "and", "we", "expect", "a", "10-month", "review", "period", "from", "submission.", "<tag3>"], "wordsA": ["If", "approved,", "we", "plan", "to", "launch", "plecanatide", "with", "the", "CIC", "indication", "in", "the", "first", "quarter", "of", "2017."], "wordsB": ["We", "plan", "to", "file", "a", "New", "Drug", "Application", "Supplement", "with", "Clinical", "Data", "(sNDA)", "for", "TRULANCE", "in", "IBS-C", "in", "the", "first", "quarter", "of", "2017", "and", "we", "expect", "a", "10-month", "review", "period", "from", "submission."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_17_item1_p4_s1", "idA": "1347613_16_item1_p7_s2", "sentA": "If approved, we plan to launch plecanatide with the CIC indication in the first quarter of 2017.", "sentB": "TRULANCE will be available in the U.S. the first quarter of 2017.", "type": 2, "words": ["<tag1>", "If", "approved,", "we", "plan", "to", "launch", "plecanatide", "with", "the", "CIC", "indication", "in", "the", "first", "quarter", "of", "2017.", "<tag2>", "TRULANCE", "will", "be", "available", "in", "the", "U.S.", "the", "first", "quarter", "of", "2017.", "<tag3>"], "wordsA": ["If", "approved,", "we", "plan", "to", "launch", "plecanatide", "with", "the", "CIC", "indication", "in", "the", "first", "quarter", "of", "2017."], "wordsB": ["TRULANCE", "will", "be", "available", "in", "the", "U.S.", "the", "first", "quarter", "of", "2017."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_17_item1_p4_s2", "idA": "1347613_16_item1_p7_s2", "sentA": "If approved, we plan to launch plecanatide with the CIC indication in the first quarter of 2017.", "sentB": "In addition, we are developing TRULANCE for the treatment of adults with irritable bowel syndrome with constipation (IBS-C) and plan to file a new drug application supplement with clinical data (sNDA) for TRULANCE in IBS-C in the first quarter of 2017.", "type": 2, "words": ["<tag1>", "If", "approved,", "we", "plan", "to", "launch", "plecanatide", "with", "the", "CIC", "indication", "in", "the", "first", "quarter", "of", "2017.", "<tag2>", "In", "addition,", "we", "are", "developing", "TRULANCE", "for", "the", "treatment", "of", "adults", "with", "irritable", "bowel", "syndrome", "with", "constipation", "(IBS-C)", "and", "plan", "to", "file", "a", "new", "drug", "application", "supplement", "with", "clinical", "data", "(sNDA)", "for", "TRULANCE", "in", "IBS-C", "in", "the", "first", "quarter", "of", "2017.", "<tag3>"], "wordsA": ["If", "approved,", "we", "plan", "to", "launch", "plecanatide", "with", "the", "CIC", "indication", "in", "the", "first", "quarter", "of", "2017."], "wordsB": ["In", "addition,", "we", "are", "developing", "TRULANCE", "for", "the", "treatment", "of", "adults", "with", "irritable", "bowel", "syndrome", "with", "constipation", "(IBS-C)", "and", "plan", "to", "file", "a", "new", "drug", "application", "supplement", "with", "clinical", "data", "(sNDA)", "for", "TRULANCE", "in", "IBS-C", "in", "the", "first", "quarter", "of", "2017."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_17_item1_p97_s0", "idA": "1347613_16_item1_p80_s0", "sentA": "As of February 25, 2016, we had 44 full-time employees.", "sentB": "Employees As of March 1, 2017 , we had 116 employees.", "type": 2, "words": ["<tag1>", "As", "of", "February", "25,", "2016,", "we", "had", "44", "full-time", "employees.", "<tag2>", "Employees", "As", "of", "March", "1,", "2017", ",", "we", "had", "116", "employees.", "<tag3>"], "wordsA": ["As", "of", "February", "25,", "2016,", "we", "had", "44", "full-time", "employees."], "wordsB": ["Employees", "As", "of", "March", "1,", "2017", ",", "we", "had", "116", "employees."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_17_item1_p57_s2", "idA": "1347613_16_item1_p80_s1", "sentA": "We believe our employee relations are satisfactory.", "sentB": "We believe our commercial suppliers will have the capabilities to produce TRULANCE in accordance with current good manufacturing practices, or GMP, on a sufficient scale to meet our commercial needs.", "type": 2, "words": ["<tag1>", "We", "believe", "our", "employee", "relations", "are", "satisfactory.", "<tag2>", "We", "believe", "our", "commercial", "suppliers", "will", "have", "the", "capabilities", "to", "produce", "TRULANCE", "in", "accordance", "with", "current", "good", "manufacturing", "practices,", "or", "GMP,", "on", "a", "sufficient", "scale", "to", "meet", "our", "commercial", "needs.", "<tag3>"], "wordsA": ["We", "believe", "our", "employee", "relations", "are", "satisfactory."], "wordsB": ["We", "believe", "our", "commercial", "suppliers", "will", "have", "the", "capabilities", "to", "produce", "TRULANCE", "in", "accordance", "with", "current", "good", "manufacturing", "practices,", "or", "GMP,", "on", "a", "sufficient", "scale", "to", "meet", "our", "commercial", "needs."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_17_item1_p97_s2", "idA": "1347613_16_item1_p80_s1", "sentA": "We believe our employee relations are satisfactory.", "sentB": "None of our employees are represented by a labor union, and we consider our employee relations to be good.", "type": 2, "words": ["<tag1>", "We", "believe", "our", "employee", "relations", "are", "satisfactory.", "<tag2>", "None", "of", "our", "employees", "are", "represented", "by", "a", "labor", "union,", "and", "we", "consider", "our", "employee", "relations", "to", "be", "good.", "<tag3>"], "wordsA": ["We", "believe", "our", "employee", "relations", "are", "satisfactory."], "wordsB": ["None", "of", "our", "employees", "are", "represented", "by", "a", "labor", "union,", "and", "we", "consider", "our", "employee", "relations", "to", "be", "good."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_17_item1_p47_s1", "idA": "1347613_16_item1_p8_s0", "sentA": "On January 11, 2016, we announced positive phase 1b data with dolcanatide in a double-blind, placebo-controlled, four-week study evaluating 28 patients with mild-to-moderate ulcerative colitis.", "sentB": "We plan to meet with regulatory agencies to discuss next steps in development for dolcanatide in mild-to-moderate ulcerative colitis.", "type": 2, "words": ["<tag1>", "On", "January", "11,", "2016,", "we", "announced", "positive", "phase", "1b", "data", "with", "dolcanatide", "in", "a", "double-blind,", "placebo-controlled,", "four-week", "study", "evaluating", "28", "patients", "with", "mild-to-moderate", "ulcerative", "colitis.", "<tag2>", "We", "plan", "to", "meet", "with", "regulatory", "agencies", "to", "discuss", "next", "steps", "in", "development", "for", "dolcanatide", "in", "mild-to-moderate", "ulcerative", "colitis.", "<tag3>"], "wordsA": ["On", "January", "11,", "2016,", "we", "announced", "positive", "phase", "1b", "data", "with", "dolcanatide", "in", "a", "double-blind,", "placebo-controlled,", "four-week", "study", "evaluating", "28", "patients", "with", "mild-to-moderate", "ulcerative", "colitis."], "wordsB": ["We", "plan", "to", "meet", "with", "regulatory", "agencies", "to", "discuss", "next", "steps", "in", "development", "for", "dolcanatide", "in", "mild-to-moderate", "ulcerative", "colitis."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_17_item1_p5_s1", "idA": "1347613_16_item1_p8_s0", "sentA": "On January 11, 2016, we announced positive phase 1b data with dolcanatide in a double-blind, placebo-controlled, four-week study evaluating 28 patients with mild-to-moderate ulcerative colitis.", "sentB": "In January 2016, we announced positive proof-of-concept with dolcanatide in a phase 1b trial evaluating 28 patients with mild-to-moderate ulcerative colitis.", "type": 2, "words": ["<tag1>", "On", "January", "11,", "2016,", "we", "announced", "positive", "phase", "1b", "data", "with", "dolcanatide", "in", "a", "double-blind,", "placebo-controlled,", "four-week", "study", "evaluating", "28", "patients", "with", "mild-to-moderate", "ulcerative", "colitis.", "<tag2>", "In", "January", "2016,", "we", "announced", "positive", "proof-of-concept", "with", "dolcanatide", "in", "a", "phase", "1b", "trial", "evaluating", "28", "patients", "with", "mild-to-moderate", "ulcerative", "colitis.", "<tag3>"], "wordsA": ["On", "January", "11,", "2016,", "we", "announced", "positive", "phase", "1b", "data", "with", "dolcanatide", "in", "a", "double-blind,", "placebo-controlled,", "four-week", "study", "evaluating", "28", "patients", "with", "mild-to-moderate", "ulcerative", "colitis."], "wordsB": ["In", "January", "2016,", "we", "announced", "positive", "proof-of-concept", "with", "dolcanatide", "in", "a", "phase", "1b", "trial", "evaluating", "28", "patients", "with", "mild-to-moderate", "ulcerative", "colitis."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_17_item1_p5_s2", "idA": "1347613_16_item1_p8_s0", "sentA": "On January 11, 2016, we announced positive phase 1b data with dolcanatide in a double-blind, placebo-controlled, four-week study evaluating 28 patients with mild-to-moderate ulcerative colitis.", "sentB": "We plan to meet with regulatory agencies to discuss next steps in development for dolcanatide in mild-to-moderate ulcerative colitis.", "type": 2, "words": ["<tag1>", "On", "January", "11,", "2016,", "we", "announced", "positive", "phase", "1b", "data", "with", "dolcanatide", "in", "a", "double-blind,", "placebo-controlled,", "four-week", "study", "evaluating", "28", "patients", "with", "mild-to-moderate", "ulcerative", "colitis.", "<tag2>", "We", "plan", "to", "meet", "with", "regulatory", "agencies", "to", "discuss", "next", "steps", "in", "development", "for", "dolcanatide", "in", "mild-to-moderate", "ulcerative", "colitis.", "<tag3>"], "wordsA": ["On", "January", "11,", "2016,", "we", "announced", "positive", "phase", "1b", "data", "with", "dolcanatide", "in", "a", "double-blind,", "placebo-controlled,", "four-week", "study", "evaluating", "28", "patients", "with", "mild-to-moderate", "ulcerative", "colitis."], "wordsB": ["We", "plan", "to", "meet", "with", "regulatory", "agencies", "to", "discuss", "next", "steps", "in", "development", "for", "dolcanatide", "in", "mild-to-moderate", "ulcerative", "colitis."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_18_item1_p7_s0", "idA": "1347613_17_item1_p11_s0", "sentA": "Uroguanylin, a guanylate cyclase-C (GC-C) receptor agonist, is thought to work in a pH-sensitive manner primarily in the small intestine to stimulate fluid secretion.", "sentB": "Uroguanylin activates GC-C receptors in a pH-sensitive manner primarily in the small intestine, stimulating fluid secretion and maintaining stool consistency necessary for regular bowel function.", "type": 2, "words": ["<tag1>", "Uroguanylin,", "a", "guanylate", "cyclase-C", "(GC-C)", "receptor", "agonist,", "is", "thought", "to", "work", "in", "a", "pH-sensitive", "manner", "primarily", "in", "the", "small", "intestine", "to", "stimulate", "fluid", "secretion.", "<tag2>", "Uroguanylin", "activates", "GC-C", "receptors", "in", "a", "pH-sensitive", "manner", "primarily", "in", "the", "small", "intestine,", "stimulating", "fluid", "secretion", "and", "maintaining", "stool", "consistency", "necessary", "for", "regular", "bowel", "function.", "<tag3>"], "wordsA": ["Uroguanylin,", "a", "guanylate", "cyclase-C", "(GC-C)", "receptor", "agonist,", "is", "thought", "to", "work", "in", "a", "pH-sensitive", "manner", "primarily", "in", "the", "small", "intestine", "to", "stimulate", "fluid", "secretion."], "wordsB": ["Uroguanylin", "activates", "GC-C", "receptors", "in", "a", "pH-sensitive", "manner", "primarily", "in", "the", "small", "intestine,", "stimulating", "fluid", "secretion", "and", "maintaining", "stool", "consistency", "necessary", "for", "regular", "bowel", "function."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_18_item1_p6_s0", "idA": "1347613_17_item1_p12_s0", "sentA": "With the exception of a single amino acid, TRULANCE is structurally identical to uroguanylin and is the only treatment that is thought to replicate the pH-sensitive activity of human uroguanylin.", "sentB": "TRULANCE (plecanatide) With the exception of a single amino acid substitution for greater binding affinity, TRULANCE is structurally identical to human uroguanylin and is the only treatment thought to replicate the pH-sensitive activity of uroguanylin.", "type": 2, "words": ["<tag1>", "With", "the", "exception", "of", "a", "single", "amino", "acid,", "TRULANCE", "is", "structurally", "identical", "to", "uroguanylin", "and", "is", "the", "only", "treatment", "that", "is", "thought", "to", "replicate", "the", "pH-sensitive", "activity", "of", "human", "uroguanylin.", "<tag2>", "TRULANCE", "(plecanatide)", "With", "the", "exception", "of", "a", "single", "amino", "acid", "substitution", "for", "greater", "binding", "affinity,", "TRULANCE", "is", "structurally", "identical", "to", "human", "uroguanylin", "and", "is", "the", "only", "treatment", "thought", "to", "replicate", "the", "pH-sensitive", "activity", "of", "uroguanylin.", "<tag3>"], "wordsA": ["With", "the", "exception", "of", "a", "single", "amino", "acid,", "TRULANCE", "is", "structurally", "identical", "to", "uroguanylin", "and", "is", "the", "only", "treatment", "that", "is", "thought", "to", "replicate", "the", "pH-sensitive", "activity", "of", "human", "uroguanylin."], "wordsB": ["TRULANCE", "(plecanatide)", "With", "the", "exception", "of", "a", "single", "amino", "acid", "substitution", "for", "greater", "binding", "affinity,", "TRULANCE", "is", "structurally", "identical", "to", "human", "uroguanylin", "and", "is", "the", "only", "treatment", "thought", "to", "replicate", "the", "pH-sensitive", "activity", "of", "uroguanylin."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_18_item1_p8_s0", "idA": "1347613_17_item1_p13_s0", "sentA": "TRULANCE for CIC The FDA has approved TRULANCE for the treatment of adults with CIC.", "sentB": "In January 2017, the FDA approved TRULANCE 3 mg tablets for the once-daily treatment of adults with CIC.", "type": 2, "words": ["<tag1>", "TRULANCE", "for", "CIC", "The", "FDA", "has", "approved", "TRULANCE", "for", "the", "treatment", "of", "adults", "with", "CIC.", "<tag2>", "In", "January", "2017,", "the", "FDA", "approved", "TRULANCE", "3", "mg", "tablets", "for", "the", "once-daily", "treatment", "of", "adults", "with", "CIC.", "<tag3>"], "wordsA": ["TRULANCE", "for", "CIC", "The", "FDA", "has", "approved", "TRULANCE", "for", "the", "treatment", "of", "adults", "with", "CIC."], "wordsB": ["In", "January", "2017,", "the", "FDA", "approved", "TRULANCE", "3", "mg", "tablets", "for", "the", "once-daily", "treatment", "of", "adults", "with", "CIC."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_18_item1_p8_s2", "idA": "1347613_17_item1_p13_s0", "sentA": "TRULANCE for CIC The FDA has approved TRULANCE for the treatment of adults with CIC.", "sentB": "In January 2018, the FDA approved TRULANCE for the treatment of adults with IBS-C. The efficacy and safety of TRULANCE for the treatment of CIC and IBS-C was established in four 12-week, double-blind, placebo-controlled, randomized, multicenter clinical studies involving over 3,100 patients.", "type": 2, "words": ["<tag1>", "TRULANCE", "for", "CIC", "The", "FDA", "has", "approved", "TRULANCE", "for", "the", "treatment", "of", "adults", "with", "CIC.", "<tag2>", "In", "January", "2018,", "the", "FDA", "approved", "TRULANCE", "for", "the", "treatment", "of", "adults", "with", "IBS-C.", "The", "efficacy", "and", "safety", "of", "TRULANCE", "for", "the", "treatment", "of", "CIC", "and", "IBS-C", "was", "established", "in", "four", "12-week,", "double-blind,", "placebo-controlled,", "randomized,", "multicenter", "clinical", "studies", "involving", "over", "3,100", "patients.", "<tag3>"], "wordsA": ["TRULANCE", "for", "CIC", "The", "FDA", "has", "approved", "TRULANCE", "for", "the", "treatment", "of", "adults", "with", "CIC."], "wordsB": ["In", "January", "2018,", "the", "FDA", "approved", "TRULANCE", "for", "the", "treatment", "of", "adults", "with", "IBS-C.", "The", "efficacy", "and", "safety", "of", "TRULANCE", "for", "the", "treatment", "of", "CIC", "and", "IBS-C", "was", "established", "in", "four", "12-week,", "double-blind,", "placebo-controlled,", "randomized,", "multicenter", "clinical", "studies", "involving", "over", "3,100", "patients."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_18_item1_p8_s3", "idA": "1347613_17_item1_p17_s0", "sentA": "Over 12 weeks, patients who received TRULANCE in both studies also had improvements as compared to placebo in stool frequency (as measured by the number of spontaneous bowel movements per week), stool consistency (as measured by the Bristol Stool Form Scale) and straining with bowel movements.", "sentB": "TRULANCE demonstrated improvement in the abdominal pain, constipation, stool consistency and straining with bowel movements associated with IBS-C, as well as in the constipation, stool consistency and straining with bowel movements associated with CIC.", "type": 2, "words": ["<tag1>", "Over", "12", "weeks,", "patients", "who", "received", "TRULANCE", "in", "both", "studies", "also", "had", "improvements", "as", "compared", "to", "placebo", "in", "stool", "frequency", "(as", "measured", "by", "the", "number", "of", "spontaneous", "bowel", "movements", "per", "week),", "stool", "consistency", "(as", "measured", "by", "the", "Bristol", "Stool", "Form", "Scale)", "and", "straining", "with", "bowel", "movements.", "<tag2>", "TRULANCE", "demonstrated", "improvement", "in", "the", "abdominal", "pain,", "constipation,", "stool", "consistency", "and", "straining", "with", "bowel", "movements", "associated", "with", "IBS-C,", "as", "well", "as", "in", "the", "constipation,", "stool", "consistency", "and", "straining", "with", "bowel", "movements", "associated", "with", "CIC.", "<tag3>"], "wordsA": ["Over", "12", "weeks,", "patients", "who", "received", "TRULANCE", "in", "both", "studies", "also", "had", "improvements", "as", "compared", "to", "placebo", "in", "stool", "frequency", "(as", "measured", "by", "the", "number", "of", "spontaneous", "bowel", "movements", "per", "week),", "stool", "consistency", "(as", "measured", "by", "the", "Bristol", "Stool", "Form", "Scale)", "and", "straining", "with", "bowel", "movements."], "wordsB": ["TRULANCE", "demonstrated", "improvement", "in", "the", "abdominal", "pain,", "constipation,", "stool", "consistency", "and", "straining", "with", "bowel", "movements", "associated", "with", "IBS-C,", "as", "well", "as", "in", "the", "constipation,", "stool", "consistency", "and", "straining", "with", "bowel", "movements", "associated", "with", "CIC."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_18_item1_p8_s1", "idA": "1347613_17_item1_p20_s0", "sentA": "TRULANCE will be available in the U.S. in the first quarter of 2017.", "sentB": "We began commercializing TRULANCE in the U.S. in March 2017.", "type": 2, "words": ["<tag1>", "TRULANCE", "will", "be", "available", "in", "the", "U.S.", "in", "the", "first", "quarter", "of", "2017.", "<tag2>", "We", "began", "commercializing", "TRULANCE", "in", "the", "U.S.", "in", "March", "2017.", "<tag3>"], "wordsA": ["TRULANCE", "will", "be", "available", "in", "the", "U.S.", "in", "the", "first", "quarter", "of", "2017."], "wordsB": ["We", "began", "commercializing", "TRULANCE", "in", "the", "U.S.", "in", "March", "2017."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_18_item1_p12_s0", "idA": "1347613_17_item1_p21_s0", "sentA": "TRULANCE for IBS-C On December 9, 2016, we announced top-line results from the first of two pivotal phase 3 trials evaluating the efficacy and safety of TRULANCE in 1,135 adult patients with irritable bowel syndrome with constipation (IBS-C).", "sentB": "Under the Pediatric Research Equity Act (PREA) (21 U.S.C. 355c), clinical studies are underway assessing the efficacy and safety of TRULANCE in pediatric patients with CIC and in late planning stages for assessment of the efficacy and safety of TRULANCE in pediatric patients with IBS-C.", "type": 2, "words": ["<tag1>", "TRULANCE", "for", "IBS-C", "On", "December", "9,", "2016,", "we", "announced", "top-line", "results", "from", "the", "first", "of", "two", "pivotal", "phase", "3", "trials", "evaluating", "the", "efficacy", "and", "safety", "of", "TRULANCE", "in", "1,135", "adult", "patients", "with", "irritable", "bowel", "syndrome", "with", "constipation", "(IBS-C).", "<tag2>", "Under", "the", "Pediatric", "Research", "Equity", "Act", "(PREA)", "(21", "U.S.C.", "355c),", "clinical", "studies", "are", "underway", "assessing", "the", "efficacy", "and", "safety", "of", "TRULANCE", "in", "pediatric", "patients", "with", "CIC", "and", "in", "late", "planning", "stages", "for", "assessment", "of", "the", "efficacy", "and", "safety", "of", "TRULANCE", "in", "pediatric", "patients", "with", "IBS-C.", "<tag3>"], "wordsA": ["TRULANCE", "for", "IBS-C", "On", "December", "9,", "2016,", "we", "announced", "top-line", "results", "from", "the", "first", "of", "two", "pivotal", "phase", "3", "trials", "evaluating", "the", "efficacy", "and", "safety", "of", "TRULANCE", "in", "1,135", "adult", "patients", "with", "irritable", "bowel", "syndrome", "with", "constipation", "(IBS-C)."], "wordsB": ["Under", "the", "Pediatric", "Research", "Equity", "Act", "(PREA)", "(21", "U.S.C.", "355c),", "clinical", "studies", "are", "underway", "assessing", "the", "efficacy", "and", "safety", "of", "TRULANCE", "in", "pediatric", "patients", "with", "CIC", "and", "in", "late", "planning", "stages", "for", "assessment", "of", "the", "efficacy", "and", "safety", "of", "TRULANCE", "in", "pediatric", "patients", "with", "IBS-C."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_18_item1_p9_s0", "idA": "1347613_17_item1_p22_s0", "sentA": "The most common adverse event was diarrhea which occurred in 3.2% of patients in 3 mg and 3.7% of patients in 6 mg dose groups compared to 1.3% of placebo-treated patients.", "sentB": "The most common adverse event in both CIC and IBS-C studies was diarrhea ( 5.0% vs. 1.0% placebo).", "type": 2, "words": ["<tag1>", "The", "most", "common", "adverse", "event", "was", "diarrhea", "which", "occurred", "in", "3.2%", "of", "patients", "in", "3", "mg", "and", "3.7%", "of", "patients", "in", "6", "mg", "dose", "groups", "compared", "to", "1.3%", "of", "placebo-treated", "patients.", "<tag2>", "The", "most", "common", "adverse", "event", "in", "both", "CIC", "and", "IBS-C", "studies", "was", "diarrhea", "(", "5.0%", "vs.", "1.0%", "placebo).", "<tag3>"], "wordsA": ["The", "most", "common", "adverse", "event", "was", "diarrhea", "which", "occurred", "in", "3.2%", "of", "patients", "in", "3", "mg", "and", "3.7%", "of", "patients", "in", "6", "mg", "dose", "groups", "compared", "to", "1.3%", "of", "placebo-treated", "patients."], "wordsB": ["The", "most", "common", "adverse", "event", "in", "both", "CIC", "and", "IBS-C", "studies", "was", "diarrhea", "(", "5.0%", "vs.", "1.0%", "placebo)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_18_item1_p11_s0", "idA": "1347613_17_item1_p29_s0", "sentA": "Launching TRULANCE 3 mg in an innovative 30-count blister pack.", "sentB": "TRULANCE is packaged in a unique, 30-day calendar blister pack.", "type": 2, "words": ["<tag1>", "Launching", "TRULANCE", "3", "mg", "in", "an", "innovative", "30-count", "blister", "pack.", "<tag2>", "TRULANCE", "is", "packaged", "in", "a", "unique,", "30-day", "calendar", "blister", "pack.", "<tag3>"], "wordsA": ["Launching", "TRULANCE", "3", "mg", "in", "an", "innovative", "30-count", "blister", "pack."], "wordsB": ["TRULANCE", "is", "packaged", "in", "a", "unique,", "30-day", "calendar", "blister", "pack."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_18_item1_p2_s0", "idA": "1347613_17_item1_p2_s0", "sentA": "Business Overview We are a biopharmaceutical company focused on the development and commercialization of novel gastrointestinal (GI) therapies.", "sentB": "Business Overview Synergy Pharmaceuticals Inc. is a biopharmaceutical company focused on the development and commercialization of novel gastrointestinal (GI) therapies.", "type": 2, "words": ["<tag1>", "Business", "Overview", "We", "are", "a", "biopharmaceutical", "company", "focused", "on", "the", "development", "and", "commercialization", "of", "novel", "gastrointestinal", "(GI)", "therapies.", "<tag2>", "Business", "Overview", "Synergy", "Pharmaceuticals", "Inc.", "is", "a", "biopharmaceutical", "company", "focused", "on", "the", "development", "and", "commercialization", "of", "novel", "gastrointestinal", "(GI)", "therapies.", "<tag3>"], "wordsA": ["Business", "Overview", "We", "are", "a", "biopharmaceutical", "company", "focused", "on", "the", "development", "and", "commercialization", "of", "novel", "gastrointestinal", "(GI)", "therapies."], "wordsB": ["Business", "Overview", "Synergy", "Pharmaceuticals", "Inc.", "is", "a", "biopharmaceutical", "company", "focused", "on", "the", "development", "and", "commercialization", "of", "novel", "gastrointestinal", "(GI)", "therapies."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_18_item1_p2_s2", "idA": "1347613_17_item1_p2_s2", "sentA": "We discovered, are developing and control 100% worldwide rights to our proprietary uroguanylin analog platform.", "sentB": "We discovered and own 100% worldwide rights to our proprietary uroguanylin based GI platform which includes one commercial product and one development stage compound.", "type": 2, "words": ["<tag1>", "We", "discovered,", "are", "developing", "and", "control", "100%", "worldwide", "rights", "to", "our", "proprietary", "uroguanylin", "analog", "platform.", "<tag2>", "We", "discovered", "and", "own", "100%", "worldwide", "rights", "to", "our", "proprietary", "uroguanylin", "based", "GI", "platform", "which", "includes", "one", "commercial", "product", "and", "one", "development", "stage", "compound.", "<tag3>"], "wordsA": ["We", "discovered,", "are", "developing", "and", "control", "100%", "worldwide", "rights", "to", "our", "proprietary", "uroguanylin", "analog", "platform."], "wordsB": ["We", "discovered", "and", "own", "100%", "worldwide", "rights", "to", "our", "proprietary", "uroguanylin", "based", "GI", "platform", "which", "includes", "one", "commercial", "product", "and", "one", "development", "stage", "compound."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_18_item1_p3_s0", "idA": "1347613_17_item1_p3_s0", "sentA": "Our first and only commercial product, plecanatide, is approved in the United States (U.S.), under the trademark name TRULANCE , for the treatment of adults with chronic idiopathic constipation, or CIC.", "sentB": "Our first and only commercial product, plecanatide, is available and being marketed by us in the United States (U.S.), under the trademark name TRULANCE , for the treatment of adults with chronic idiopathic constipation (CIC) and irritable bowel syndrome with constipation (IBS-C).", "type": 2, "words": ["<tag1>", "Our", "first", "and", "only", "commercial", "product,", "plecanatide,", "is", "approved", "in", "the", "United", "States", "(U.S.),", "under", "the", "trademark", "name", "TRULANCE", ",", "for", "the", "treatment", "of", "adults", "with", "chronic", "idiopathic", "constipation,", "or", "CIC.", "<tag2>", "Our", "first", "and", "only", "commercial", "product,", "plecanatide,", "is", "available", "and", "being", "marketed", "by", "us", "in", "the", "United", "States", "(U.S.),", "under", "the", "trademark", "name", "TRULANCE", ",", "for", "the", "treatment", "of", "adults", "with", "chronic", "idiopathic", "constipation", "(CIC)", "and", "irritable", "bowel", "syndrome", "with", "constipation", "(IBS-C).", "<tag3>"], "wordsA": ["Our", "first", "and", "only", "commercial", "product,", "plecanatide,", "is", "approved", "in", "the", "United", "States", "(U.S.),", "under", "the", "trademark", "name", "TRULANCE", ",", "for", "the", "treatment", "of", "adults", "with", "chronic", "idiopathic", "constipation,", "or", "CIC."], "wordsB": ["Our", "first", "and", "only", "commercial", "product,", "plecanatide,", "is", "available", "and", "being", "marketed", "by", "us", "in", "the", "United", "States", "(U.S.),", "under", "the", "trademark", "name", "TRULANCE", ",", "for", "the", "treatment", "of", "adults", "with", "chronic", "idiopathic", "constipation", "(CIC)", "and", "irritable", "bowel", "syndrome", "with", "constipation", "(IBS-C)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_18_item1_p17_s0", "idA": "1347613_17_item1_p45_s1", "sentA": "Dolcanatide is designed to be an analog of uroguanylin with enhanced resistance to standard digestive breakdown by proteases in the intestine.", "sentB": "Dolcanatide (SP-333) Dolcanatide is designed to be an analog of uroguanylin with enhanced resistance to standard digestive breakdown by proteases in the intestine.", "type": 2, "words": ["<tag1>", "Dolcanatide", "is", "designed", "to", "be", "an", "analog", "of", "uroguanylin", "with", "enhanced", "resistance", "to", "standard", "digestive", "breakdown", "by", "proteases", "in", "the", "intestine.", "<tag2>", "Dolcanatide", "(SP-333)", "Dolcanatide", "is", "designed", "to", "be", "an", "analog", "of", "uroguanylin", "with", "enhanced", "resistance", "to", "standard", "digestive", "breakdown", "by", "proteases", "in", "the", "intestine.", "<tag3>"], "wordsA": ["Dolcanatide", "is", "designed", "to", "be", "an", "analog", "of", "uroguanylin", "with", "enhanced", "resistance", "to", "standard", "digestive", "breakdown", "by", "proteases", "in", "the", "intestine."], "wordsB": ["Dolcanatide", "(SP-333)", "Dolcanatide", "is", "designed", "to", "be", "an", "analog", "of", "uroguanylin", "with", "enhanced", "resistance", "to", "standard", "digestive", "breakdown", "by", "proteases", "in", "the", "intestine."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_18_item1_p10_s0", "idA": "1347613_17_item1_p4_s0", "sentA": "The recommended adult dosage of TRULANCE is 3 mg taken orally, once daily, with or without food.", "sentB": "TRULANCE is the only prescription medication for adults with CIC and IBS-C that can be taken once-daily, with or without food, at any time of the day.", "type": 2, "words": ["<tag1>", "The", "recommended", "adult", "dosage", "of", "TRULANCE", "is", "3", "mg", "taken", "orally,", "once", "daily,", "with", "or", "without", "food.", "<tag2>", "TRULANCE", "is", "the", "only", "prescription", "medication", "for", "adults", "with", "CIC", "and", "IBS-C", "that", "can", "be", "taken", "once-daily,", "with", "or", "without", "food,", "at", "any", "time", "of", "the", "day.", "<tag3>"], "wordsA": ["The", "recommended", "adult", "dosage", "of", "TRULANCE", "is", "3", "mg", "taken", "orally,", "once", "daily,", "with", "or", "without", "food."], "wordsB": ["TRULANCE", "is", "the", "only", "prescription", "medication", "for", "adults", "with", "CIC", "and", "IBS-C", "that", "can", "be", "taken", "once-daily,", "with", "or", "without", "food,", "at", "any", "time", "of", "the", "day."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_18_item1_p18_s1", "idA": "1347613_17_item1_p50_s1", "sentA": "We are exploring OIC as a potential lifecycle growth opportunity for TRULANCE.", "sentB": "We are exploring business development opportunities to further advance dolcanatide development in ulcerative colitis.", "type": 2, "words": ["<tag1>", "We", "are", "exploring", "OIC", "as", "a", "potential", "lifecycle", "growth", "opportunity", "for", "TRULANCE.", "<tag2>", "We", "are", "exploring", "business", "development", "opportunities", "to", "further", "advance", "dolcanatide", "development", "in", "ulcerative", "colitis.", "<tag3>"], "wordsA": ["We", "are", "exploring", "OIC", "as", "a", "potential", "lifecycle", "growth", "opportunity", "for", "TRULANCE."], "wordsB": ["We", "are", "exploring", "business", "development", "opportunities", "to", "further", "advance", "dolcanatide", "development", "in", "ulcerative", "colitis."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_18_item1_p3_s3", "idA": "1347613_17_item1_p50_s1", "sentA": "We are exploring OIC as a potential lifecycle growth opportunity for TRULANCE.", "sentB": "We are continuing to evaluate other potential ex-US business development opportunities for TRULANCE.", "type": 2, "words": ["<tag1>", "We", "are", "exploring", "OIC", "as", "a", "potential", "lifecycle", "growth", "opportunity", "for", "TRULANCE.", "<tag2>", "We", "are", "continuing", "to", "evaluate", "other", "potential", "ex-US", "business", "development", "opportunities", "for", "TRULANCE.", "<tag3>"], "wordsA": ["We", "are", "exploring", "OIC", "as", "a", "potential", "lifecycle", "growth", "opportunity", "for", "TRULANCE."], "wordsB": ["We", "are", "continuing", "to", "evaluate", "other", "potential", "ex-US", "business", "development", "opportunities", "for", "TRULANCE."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_18_item1_p5_s1", "idA": "1347613_17_item1_p50_s1", "sentA": "We are exploring OIC as a potential lifecycle growth opportunity for TRULANCE.", "sentB": "We are considering OIC as a potential lifecycle growth opportunity for TRULANCE.", "type": 2, "words": ["<tag1>", "We", "are", "exploring", "OIC", "as", "a", "potential", "lifecycle", "growth", "opportunity", "for", "TRULANCE.", "<tag2>", "We", "are", "considering", "OIC", "as", "a", "potential", "lifecycle", "growth", "opportunity", "for", "TRULANCE.", "<tag3>"], "wordsA": ["We", "are", "exploring", "OIC", "as", "a", "potential", "lifecycle", "growth", "opportunity", "for", "TRULANCE."], "wordsB": ["We", "are", "considering", "OIC", "as", "a", "potential", "lifecycle", "growth", "opportunity", "for", "TRULANCE."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_18_item1_p19_s1", "idA": "1347613_17_item1_p51_s1", "sentA": "Our competitors include major pharmaceutical and biotechnology companies focusing on GI such as Ironwood Pharmaceuticals, Inc., Allergan plc, Takeda Pharmaceuticals America, Inc., Sucampo Pharmaceuticals, Inc., AstraZeneca, Valeant Pharmaceuticals International, Inc. and Shire, Plc.", "sentB": "Our competitors include major pharmaceutical and biotechnology companies focusing on GI such as Ironwood Pharmaceuticals, Inc., Allergan plc, Takeda Pharmaceuticals America, Inc., Sucampo Pharmaceuticals, Inc. (acquired by Mallinckrodt plc), AstraZeneca, Valeant Pharmaceuticals International, Inc. and Shire, Plc.", "type": 2, "words": ["<tag1>", "Our", "competitors", "include", "major", "pharmaceutical", "and", "biotechnology", "companies", "focusing", "on", "GI", "such", "as", "Ironwood", "Pharmaceuticals,", "Inc.,", "Allergan", "plc,", "Takeda", "Pharmaceuticals", "America,", "Inc.,", "Sucampo", "Pharmaceuticals,", "Inc.,", "AstraZeneca,", "Valeant", "Pharmaceuticals", "International,", "Inc.", "and", "Shire,", "Plc.", "<tag2>", "Our", "competitors", "include", "major", "pharmaceutical", "and", "biotechnology", "companies", "focusing", "on", "GI", "such", "as", "Ironwood", "Pharmaceuticals,", "Inc.,", "Allergan", "plc,", "Takeda", "Pharmaceuticals", "America,", "Inc.,", "Sucampo", "Pharmaceuticals,", "Inc.", "(acquired", "by", "Mallinckrodt", "plc),", "AstraZeneca,", "Valeant", "Pharmaceuticals", "International,", "Inc.", "and", "Shire,", "Plc.", "<tag3>"], "wordsA": ["Our", "competitors", "include", "major", "pharmaceutical", "and", "biotechnology", "companies", "focusing", "on", "GI", "such", "as", "Ironwood", "Pharmaceuticals,", "Inc.,", "Allergan", "plc,", "Takeda", "Pharmaceuticals", "America,", "Inc.,", "Sucampo", "Pharmaceuticals,", "Inc.,", "AstraZeneca,", "Valeant", "Pharmaceuticals", "International,", "Inc.", "and", "Shire,", "Plc."], "wordsB": ["Our", "competitors", "include", "major", "pharmaceutical", "and", "biotechnology", "companies", "focusing", "on", "GI", "such", "as", "Ironwood", "Pharmaceuticals,", "Inc.,", "Allergan", "plc,", "Takeda", "Pharmaceuticals", "America,", "Inc.,", "Sucampo", "Pharmaceuticals,", "Inc.", "(acquired", "by", "Mallinckrodt", "plc),", "AstraZeneca,", "Valeant", "Pharmaceuticals", "International,", "Inc.", "and", "Shire,", "Plc."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_18_item1_p21_s1", "idA": "1347613_17_item1_p53_s1", "sentA": "Research and development expenses for the year ended December 31, 2016 were approximately $89.6 million , as compared to approximately $78 million and $83.3 million for the years ended December 31, 2015 and 2014, respectively.", "sentB": "Research and development expenses for the year ended December 31, 2017 were approximately $48.3 million , as compared to approximately $87.1 million and $78.0 million for the years ended December 31, 2016 and 2015, respectively.", "type": 2, "words": ["<tag1>", "Research", "and", "development", "expenses", "for", "the", "year", "ended", "December", "31,", "2016", "were", "approximately", "$89.6", "million", ",", "as", "compared", "to", "approximately", "$78", "million", "and", "$83.3", "million", "for", "the", "years", "ended", "December", "31,", "2015", "and", "2014,", "respectively.", "<tag2>", "Research", "and", "development", "expenses", "for", "the", "year", "ended", "December", "31,", "2017", "were", "approximately", "$48.3", "million", ",", "as", "compared", "to", "approximately", "$87.1", "million", "and", "$78.0", "million", "for", "the", "years", "ended", "December", "31,", "2016", "and", "2015,", "respectively.", "<tag3>"], "wordsA": ["Research", "and", "development", "expenses", "for", "the", "year", "ended", "December", "31,", "2016", "were", "approximately", "$89.6", "million", ",", "as", "compared", "to", "approximately", "$78", "million", "and", "$83.3", "million", "for", "the", "years", "ended", "December", "31,", "2015", "and", "2014,", "respectively."], "wordsB": ["Research", "and", "development", "expenses", "for", "the", "year", "ended", "December", "31,", "2017", "were", "approximately", "$48.3", "million", ",", "as", "compared", "to", "approximately", "$87.1", "million", "and", "$78.0", "million", "for", "the", "years", "ended", "December", "31,", "2016", "and", "2015,", "respectively."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_18_item1_p25_s5", "idA": "1347613_17_item1_p59_s0", "sentA": "As of December 31, 2016 we have 21 issued United States patents related to guanylate cyclase agonists.", "sentB": "As of December 31, 2017 we have 24 issued United States patents related to guanylate cyclase agonists.", "type": 2, "words": ["<tag1>", "As", "of", "December", "31,", "2016", "we", "have", "21", "issued", "United", "States", "patents", "related", "to", "guanylate", "cyclase", "agonists.", "<tag2>", "As", "of", "December", "31,", "2017", "we", "have", "24", "issued", "United", "States", "patents", "related", "to", "guanylate", "cyclase", "agonists.", "<tag3>"], "wordsA": ["As", "of", "December", "31,", "2016", "we", "have", "21", "issued", "United", "States", "patents", "related", "to", "guanylate", "cyclase", "agonists."], "wordsB": ["As", "of", "December", "31,", "2017", "we", "have", "24", "issued", "United", "States", "patents", "related", "to", "guanylate", "cyclase", "agonists."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_18_item1_p25_s8", "idA": "1347613_17_item1_p59_s0", "sentA": "As of December 31, 2016 we have 21 issued United States patents related to guanylate cyclase agonists.", "sentB": "In addition, we have several granted United States patents that cover methods of using TRULANCE.", "type": 2, "words": ["<tag1>", "As", "of", "December", "31,", "2016", "we", "have", "21", "issued", "United", "States", "patents", "related", "to", "guanylate", "cyclase", "agonists.", "<tag2>", "In", "addition,", "we", "have", "several", "granted", "United", "States", "patents", "that", "cover", "methods", "of", "using", "TRULANCE.", "<tag3>"], "wordsA": ["As", "of", "December", "31,", "2016", "we", "have", "21", "issued", "United", "States", "patents", "related", "to", "guanylate", "cyclase", "agonists."], "wordsB": ["In", "addition,", "we", "have", "several", "granted", "United", "States", "patents", "that", "cover", "methods", "of", "using", "TRULANCE."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_18_item1_p26_s4", "idA": "1347613_17_item1_p59_s3", "sentA": "A third patent covers the composition-of-matter of dolcanatide issued on February 1, 2011 and expires in 2028.", "sentB": "We also have an issued United States patent that covers the composition-of-matter of dolcanatide which issued on February 1, 2011 and expires in 2028.", "type": 2, "words": ["<tag1>", "A", "third", "patent", "covers", "the", "composition-of-matter", "of", "dolcanatide", "issued", "on", "February", "1,", "2011", "and", "expires", "in", "2028.", "<tag2>", "We", "also", "have", "an", "issued", "United", "States", "patent", "that", "covers", "the", "composition-of-matter", "of", "dolcanatide", "which", "issued", "on", "February", "1,", "2011", "and", "expires", "in", "2028.", "<tag3>"], "wordsA": ["A", "third", "patent", "covers", "the", "composition-of-matter", "of", "dolcanatide", "issued", "on", "February", "1,", "2011", "and", "expires", "in", "2028."], "wordsB": ["We", "also", "have", "an", "issued", "United", "States", "patent", "that", "covers", "the", "composition-of-matter", "of", "dolcanatide", "which", "issued", "on", "February", "1,", "2011", "and", "expires", "in", "2028."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_18_item1_p26_s10", "idA": "1347613_17_item1_p59_s4", "sentA": "A fourth patent granted October 11, 2011 covers the composition-of-matter of certain analogs related to TRULANCE and dolcanatide and will expire in 2029.", "sentB": "One patent was granted October 11, 2011 and covers the composition-of-matter of certain analogs related to TRULANCE and dolcanatide and will expire in 2029.", "type": 2, "words": ["<tag1>", "A", "fourth", "patent", "granted", "October", "11,", "2011", "covers", "the", "composition-of-matter", "of", "certain", "analogs", "related", "to", "TRULANCE", "and", "dolcanatide", "and", "will", "expire", "in", "2029.", "<tag2>", "One", "patent", "was", "granted", "October", "11,", "2011", "and", "covers", "the", "composition-of-matter", "of", "certain", "analogs", "related", "to", "TRULANCE", "and", "dolcanatide", "and", "will", "expire", "in", "2029.", "<tag3>"], "wordsA": ["A", "fourth", "patent", "granted", "October", "11,", "2011", "covers", "the", "composition-of-matter", "of", "certain", "analogs", "related", "to", "TRULANCE", "and", "dolcanatide", "and", "will", "expire", "in", "2029."], "wordsB": ["One", "patent", "was", "granted", "October", "11,", "2011", "and", "covers", "the", "composition-of-matter", "of", "certain", "analogs", "related", "to", "TRULANCE", "and", "dolcanatide", "and", "will", "expire", "in", "2029."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_18_item1_p25_s9", "idA": "1347613_17_item1_p59_s5", "sentA": "A fifth patent granted February 14, 2012 covers certain methods of treating inflammatory bowel disease using TRULANCE and will expire in 2022.", "sentB": "One patent, which issued February 14, 2012, covers certain methods of treating inflammatory bowel disease using TRULANCE and will expire in 2022.", "type": 2, "words": ["<tag1>", "A", "fifth", "patent", "granted", "February", "14,", "2012", "covers", "certain", "methods", "of", "treating", "inflammatory", "bowel", "disease", "using", "TRULANCE", "and", "will", "expire", "in", "2022.", "<tag2>", "One", "patent,", "which", "issued", "February", "14,", "2012,", "covers", "certain", "methods", "of", "treating", "inflammatory", "bowel", "disease", "using", "TRULANCE", "and", "will", "expire", "in", "2022.", "<tag3>"], "wordsA": ["A", "fifth", "patent", "granted", "February", "14,", "2012", "covers", "certain", "methods", "of", "treating", "inflammatory", "bowel", "disease", "using", "TRULANCE", "and", "will", "expire", "in", "2022."], "wordsB": ["One", "patent,", "which", "issued", "February", "14,", "2012,", "covers", "certain", "methods", "of", "treating", "inflammatory", "bowel", "disease", "using", "TRULANCE", "and", "will", "expire", "in", "2022."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_18_item1_p25_s10", "idA": "1347613_17_item1_p59_s6", "sentA": "A sixth patent granted January 28, 2014 covers methods of stimulating water transport in the gastrointestinal tract using TRULANCE and will expire in 2022.", "sentB": "Another issued patent was granted January 28, 2014 and covers methods of stimulating water transport in the gastrointestinal tract using TRULANCE and will expire in 2022.", "type": 2, "words": ["<tag1>", "A", "sixth", "patent", "granted", "January", "28,", "2014", "covers", "methods", "of", "stimulating", "water", "transport", "in", "the", "gastrointestinal", "tract", "using", "TRULANCE", "and", "will", "expire", "in", "2022.", "<tag2>", "Another", "issued", "patent", "was", "granted", "January", "28,", "2014", "and", "covers", "methods", "of", "stimulating", "water", "transport", "in", "the", "gastrointestinal", "tract", "using", "TRULANCE", "and", "will", "expire", "in", "2022.", "<tag3>"], "wordsA": ["A", "sixth", "patent", "granted", "January", "28,", "2014", "covers", "methods", "of", "stimulating", "water", "transport", "in", "the", "gastrointestinal", "tract", "using", "TRULANCE", "and", "will", "expire", "in", "2022."], "wordsB": ["Another", "issued", "patent", "was", "granted", "January", "28,", "2014", "and", "covers", "methods", "of", "stimulating", "water", "transport", "in", "the", "gastrointestinal", "tract", "using", "TRULANCE", "and", "will", "expire", "in", "2022."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_18_item1_p26_s11", "idA": "1347613_17_item1_p59_s7", "sentA": "A seventh patent granted June 26, 2012 covers an additional composition-of-matter related to certain analogs of TRULANCE and dolcanatide and will expire in 2029.", "sentB": "Another patent, granted on June 26, 2012, covers an additional composition-of-matter related to certain analogs of TRULANCE and dolcanatide and will expire in 2029.", "type": 2, "words": ["<tag1>", "A", "seventh", "patent", "granted", "June", "26,", "2012", "covers", "an", "additional", "composition-of-matter", "related", "to", "certain", "analogs", "of", "TRULANCE", "and", "dolcanatide", "and", "will", "expire", "in", "2029.", "<tag2>", "Another", "patent,", "granted", "on", "June", "26,", "2012,", "covers", "an", "additional", "composition-of-matter", "related", "to", "certain", "analogs", "of", "TRULANCE", "and", "dolcanatide", "and", "will", "expire", "in", "2029.", "<tag3>"], "wordsA": ["A", "seventh", "patent", "granted", "June", "26,", "2012", "covers", "an", "additional", "composition-of-matter", "related", "to", "certain", "analogs", "of", "TRULANCE", "and", "dolcanatide", "and", "will", "expire", "in", "2029."], "wordsB": ["Another", "patent,", "granted", "on", "June", "26,", "2012,", "covers", "an", "additional", "composition-of-matter", "related", "to", "certain", "analogs", "of", "TRULANCE", "and", "dolcanatide", "and", "will", "expire", "in", "2029."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_18_item1_p26_s12", "idA": "1347613_17_item1_p59_s8", "sentA": "An eighth patent granted on January 22, 2013 covers another composition-of-matter related to certain analogs of TRULANCE and will expire in 2029.", "sentB": "A further patent, granted on January 22, 2013, covers another composition-of-matter related to certain analogs of TRULANCE and will expire in 2029.", "type": 2, "words": ["<tag1>", "An", "eighth", "patent", "granted", "on", "January", "22,", "2013", "covers", "another", "composition-of-matter", "related", "to", "certain", "analogs", "of", "TRULANCE", "and", "will", "expire", "in", "2029.", "<tag2>", "A", "further", "patent,", "granted", "on", "January", "22,", "2013,", "covers", "another", "composition-of-matter", "related", "to", "certain", "analogs", "of", "TRULANCE", "and", "will", "expire", "in", "2029.", "<tag3>"], "wordsA": ["An", "eighth", "patent", "granted", "on", "January", "22,", "2013", "covers", "another", "composition-of-matter", "related", "to", "certain", "analogs", "of", "TRULANCE", "and", "will", "expire", "in", "2029."], "wordsB": ["A", "further", "patent,", "granted", "on", "January", "22,", "2013,", "covers", "another", "composition-of-matter", "related", "to", "certain", "analogs", "of", "TRULANCE", "and", "will", "expire", "in", "2029."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_18_item1_p4_s0", "idA": "1347613_17_item1_p5_s1", "sentA": "In January 2016, we announced positive proof-of-concept with dolcanatide in a phase 1b trial evaluating 28 patients with mild-to-moderate ulcerative colitis.", "sentB": "Dolcanatide is our development stage compound that has demonstrated proof-of-concept in treating patients with ulcerative colitis.", "type": 2, "words": ["<tag1>", "In", "January", "2016,", "we", "announced", "positive", "proof-of-concept", "with", "dolcanatide", "in", "a", "phase", "1b", "trial", "evaluating", "28", "patients", "with", "mild-to-moderate", "ulcerative", "colitis.", "<tag2>", "Dolcanatide", "is", "our", "development", "stage", "compound", "that", "has", "demonstrated", "proof-of-concept", "in", "treating", "patients", "with", "ulcerative", "colitis.", "<tag3>"], "wordsA": ["In", "January", "2016,", "we", "announced", "positive", "proof-of-concept", "with", "dolcanatide", "in", "a", "phase", "1b", "trial", "evaluating", "28", "patients", "with", "mild-to-moderate", "ulcerative", "colitis."], "wordsB": ["Dolcanatide", "is", "our", "development", "stage", "compound", "that", "has", "demonstrated", "proof-of-concept", "in", "treating", "patients", "with", "ulcerative", "colitis."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_18_item1_p5_s0", "idA": "1347613_17_item1_p5_s3", "sentA": "In November 2014, we reported successful proof-of-concept with dolcanatide in a double-blind, placebo-controlled phase 2 trial in 289 patients with OIC, demonstrating the utility of our uroguanylin analog platform in OIC.", "sentB": "In addition, we have shown proof-of-concept with dolcanatide in treating patients with opioid-induced constipation (OIC), demonstrating the utility of our uroguanylin based platform in OIC.", "type": 2, "words": ["<tag1>", "In", "November", "2014,", "we", "reported", "successful", "proof-of-concept", "with", "dolcanatide", "in", "a", "double-blind,", "placebo-controlled", "phase", "2", "trial", "in", "289", "patients", "with", "OIC,", "demonstrating", "the", "utility", "of", "our", "uroguanylin", "analog", "platform", "in", "OIC.", "<tag2>", "In", "addition,", "we", "have", "shown", "proof-of-concept", "with", "dolcanatide", "in", "treating", "patients", "with", "opioid-induced", "constipation", "(OIC),", "demonstrating", "the", "utility", "of", "our", "uroguanylin", "based", "platform", "in", "OIC.", "<tag3>"], "wordsA": ["In", "November", "2014,", "we", "reported", "successful", "proof-of-concept", "with", "dolcanatide", "in", "a", "double-blind,", "placebo-controlled", "phase", "2", "trial", "in", "289", "patients", "with", "OIC,", "demonstrating", "the", "utility", "of", "our", "uroguanylin", "analog", "platform", "in", "OIC."], "wordsB": ["In", "addition,", "we", "have", "shown", "proof-of-concept", "with", "dolcanatide", "in", "treating", "patients", "with", "opioid-induced", "constipation", "(OIC),", "demonstrating", "the", "utility", "of", "our", "uroguanylin", "based", "platform", "in", "OIC."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_18_item1_p26_s13", "idA": "1347613_17_item1_p60_s0", "sentA": "2013 covers another composition-of-matter related to certain analogs of TRULANCE and will expire in 2029.", "sentB": "A further patent, granted on July 30, 2013, covers another composition-of-matter related to certain analogs of TRULANCE and will expire in 2029.", "type": 2, "words": ["<tag1>", "2013", "covers", "another", "composition-of-matter", "related", "to", "certain", "analogs", "of", "TRULANCE", "and", "will", "expire", "in", "2029.", "<tag2>", "A", "further", "patent,", "granted", "on", "July", "30,", "2013,", "covers", "another", "composition-of-matter", "related", "to", "certain", "analogs", "of", "TRULANCE", "and", "will", "expire", "in", "2029.", "<tag3>"], "wordsA": ["2013", "covers", "another", "composition-of-matter", "related", "to", "certain", "analogs", "of", "TRULANCE", "and", "will", "expire", "in", "2029."], "wordsB": ["A", "further", "patent,", "granted", "on", "July", "30,", "2013,", "covers", "another", "composition-of-matter", "related", "to", "certain", "analogs", "of", "TRULANCE", "and", "will", "expire", "in", "2029."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_18_item1_p26_s7", "idA": "1347613_17_item1_p60_s2", "sentA": "A thirteenth patent granted May 6, 2014 covers certain methods of treating a variety of gastrointestinal and other disorders using dolcanatide and will expire in 2029.", "sentB": "In addition we have another patent, granted May 6, 2014, that covers certain methods of treating a variety of gastrointestinal and other disorders using dolcanatide and will expire in 2029.", "type": 2, "words": ["<tag1>", "A", "thirteenth", "patent", "granted", "May", "6,", "2014", "covers", "certain", "methods", "of", "treating", "a", "variety", "of", "gastrointestinal", "and", "other", "disorders", "using", "dolcanatide", "and", "will", "expire", "in", "2029.", "<tag2>", "In", "addition", "we", "have", "another", "patent,", "granted", "May", "6,", "2014,", "that", "covers", "certain", "methods", "of", "treating", "a", "variety", "of", "gastrointestinal", "and", "other", "disorders", "using", "dolcanatide", "and", "will", "expire", "in", "2029.", "<tag3>"], "wordsA": ["A", "thirteenth", "patent", "granted", "May", "6,", "2014", "covers", "certain", "methods", "of", "treating", "a", "variety", "of", "gastrointestinal", "and", "other", "disorders", "using", "dolcanatide", "and", "will", "expire", "in", "2029."], "wordsB": ["In", "addition", "we", "have", "another", "patent,", "granted", "May", "6,", "2014,", "that", "covers", "certain", "methods", "of", "treating", "a", "variety", "of", "gastrointestinal", "and", "other", "disorders", "using", "dolcanatide", "and", "will", "expire", "in", "2029."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_18_item1_p26_s5", "idA": "1347613_17_item1_p60_s3", "sentA": "A fourteenth patent granted December 2, 2014 and covers composition-of-matter of dolcanatide and expires in 2028.", "sentB": "Another patent was granted December 2, 2014 and covers composition-of-matter of dolcanatide and expires in 2028.", "type": 2, "words": ["<tag1>", "A", "fourteenth", "patent", "granted", "December", "2,", "2014", "and", "covers", "composition-of-matter", "of", "dolcanatide", "and", "expires", "in", "2028.", "<tag2>", "Another", "patent", "was", "granted", "December", "2,", "2014", "and", "covers", "composition-of-matter", "of", "dolcanatide", "and", "expires", "in", "2028.", "<tag3>"], "wordsA": ["A", "fourteenth", "patent", "granted", "December", "2,", "2014", "and", "covers", "composition-of-matter", "of", "dolcanatide", "and", "expires", "in", "2028."], "wordsB": ["Another", "patent", "was", "granted", "December", "2,", "2014", "and", "covers", "composition-of-matter", "of", "dolcanatide", "and", "expires", "in", "2028."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_18_item1_p25_s11", "idA": "1347613_17_item1_p60_s4", "sentA": "A fifteenth patent granted on March 3, 2015 and covers methods of use of TRULANCE and expires in 2030.", "sentB": "Another patent, granted on March 3, 2015, covers methods of use of TRULANCE and expires in 2030.", "type": 2, "words": ["<tag1>", "A", "fifteenth", "patent", "granted", "on", "March", "3,", "2015", "and", "covers", "methods", "of", "use", "of", "TRULANCE", "and", "expires", "in", "2030.", "<tag2>", "Another", "patent,", "granted", "on", "March", "3,", "2015,", "covers", "methods", "of", "use", "of", "TRULANCE", "and", "expires", "in", "2030.", "<tag3>"], "wordsA": ["A", "fifteenth", "patent", "granted", "on", "March", "3,", "2015", "and", "covers", "methods", "of", "use", "of", "TRULANCE", "and", "expires", "in", "2030."], "wordsB": ["Another", "patent,", "granted", "on", "March", "3,", "2015,", "covers", "methods", "of", "use", "of", "TRULANCE", "and", "expires", "in", "2030."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_18_item1_p26_s15", "idA": "1347613_17_item1_p60_s5", "sentA": "A sixteenth patent granted July 28, 2015 covers an additional composition-of-matter related to certain analogs of TRULANCE and dolcanatide and will expire in 2028.", "sentB": "A further patent, granted July 28, 2015, covers an additional composition-of-matter related to certain analogs of TRULANCE and dolcanatide and will expire in 2028.", "type": 2, "words": ["<tag1>", "A", "sixteenth", "patent", "granted", "July", "28,", "2015", "covers", "an", "additional", "composition-of-matter", "related", "to", "certain", "analogs", "of", "TRULANCE", "and", "dolcanatide", "and", "will", "expire", "in", "2028.", "<tag2>", "A", "further", "patent,", "granted", "July", "28,", "2015,", "covers", "an", "additional", "composition-of-matter", "related", "to", "certain", "analogs", "of", "TRULANCE", "and", "dolcanatide", "and", "will", "expire", "in", "2028.", "<tag3>"], "wordsA": ["A", "sixteenth", "patent", "granted", "July", "28,", "2015", "covers", "an", "additional", "composition-of-matter", "related", "to", "certain", "analogs", "of", "TRULANCE", "and", "dolcanatide", "and", "will", "expire", "in", "2028."], "wordsB": ["A", "further", "patent,", "granted", "July", "28,", "2015,", "covers", "an", "additional", "composition-of-matter", "related", "to", "certain", "analogs", "of", "TRULANCE", "and", "dolcanatide", "and", "will", "expire", "in", "2028."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_18_item1_p25_s12", "idA": "1347613_17_item1_p60_s7", "sentA": "A nineteenth patent granted November 8, 2016 covers compositions containing TRULANCE or dolcanatide and 5-aminosalicyclic acid and will expire in 2034.", "sentB": "We also have a patent, granted November 8, 2016, that covers compositions containing TRULANCE or dolcanatide and 5-aminosalicyclic acid and will expire in 2034.", "type": 2, "words": ["<tag1>", "A", "nineteenth", "patent", "granted", "November", "8,", "2016", "covers", "compositions", "containing", "TRULANCE", "or", "dolcanatide", "and", "5-aminosalicyclic", "acid", "and", "will", "expire", "in", "2034.", "<tag2>", "We", "also", "have", "a", "patent,", "granted", "November", "8,", "2016,", "that", "covers", "compositions", "containing", "TRULANCE", "or", "dolcanatide", "and", "5-aminosalicyclic", "acid", "and", "will", "expire", "in", "2034.", "<tag3>"], "wordsA": ["A", "nineteenth", "patent", "granted", "November", "8,", "2016", "covers", "compositions", "containing", "TRULANCE", "or", "dolcanatide", "and", "5-aminosalicyclic", "acid", "and", "will", "expire", "in", "2034."], "wordsB": ["We", "also", "have", "a", "patent,", "granted", "November", "8,", "2016,", "that", "covers", "compositions", "containing", "TRULANCE", "or", "dolcanatide", "and", "5-aminosalicyclic", "acid", "and", "will", "expire", "in", "2034."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_18_item1_p26_s16", "idA": "1347613_17_item1_p60_s8", "sentA": "A twentieth patent granted November 29, 2016 covers analogs related to TRULANCE and will expire in 2029.", "sentB": "Another patent, granted November 29, 2016, covers analogs related to TRULANCE and will expire in 2029.", "type": 2, "words": ["<tag1>", "A", "twentieth", "patent", "granted", "November", "29,", "2016", "covers", "analogs", "related", "to", "TRULANCE", "and", "will", "expire", "in", "2029.", "<tag2>", "Another", "patent,", "granted", "November", "29,", "2016,", "covers", "analogs", "related", "to", "TRULANCE", "and", "will", "expire", "in", "2029.", "<tag3>"], "wordsA": ["A", "twentieth", "patent", "granted", "November", "29,", "2016", "covers", "analogs", "related", "to", "TRULANCE", "and", "will", "expire", "in", "2029."], "wordsB": ["Another", "patent,", "granted", "November", "29,", "2016,", "covers", "analogs", "related", "to", "TRULANCE", "and", "will", "expire", "in", "2029."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_18_item1_p26_s8", "idA": "1347613_17_item1_p60_s9", "sentA": "A twenty-first patent granted January 17, 2017 covers method of colonic cleansing using dolcanatide.", "sentB": "Another patent, granted January 17, 2017, covers method of colonic cleansing using dolcanatide.", "type": 2, "words": ["<tag1>", "A", "twenty-first", "patent", "granted", "January", "17,", "2017", "covers", "method", "of", "colonic", "cleansing", "using", "dolcanatide.", "<tag2>", "Another", "patent,", "granted", "January", "17,", "2017,", "covers", "method", "of", "colonic", "cleansing", "using", "dolcanatide.", "<tag3>"], "wordsA": ["A", "twenty-first", "patent", "granted", "January", "17,", "2017", "covers", "method", "of", "colonic", "cleansing", "using", "dolcanatide."], "wordsB": ["Another", "patent,", "granted", "January", "17,", "2017,", "covers", "method", "of", "colonic", "cleansing", "using", "dolcanatide."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_18_item1_p26_s0", "idA": "1347613_17_item1_p61_s1", "sentA": "One of the allowed applications (US application number 14/001,638) relates to the methods of manufacture of TRULANCE.", "sentB": "relates to the methods of manufacture of TRULANCE was issued on February 28, 2017 and will expire in 2032.", "type": 2, "words": ["<tag1>", "One", "of", "the", "allowed", "applications", "(US", "application", "number", "14/001,638)", "relates", "to", "the", "methods", "of", "manufacture", "of", "TRULANCE.", "<tag2>", "relates", "to", "the", "methods", "of", "manufacture", "of", "TRULANCE", "was", "issued", "on", "February", "28,", "2017", "and", "will", "expire", "in", "2032.", "<tag3>"], "wordsA": ["One", "of", "the", "allowed", "applications", "(US", "application", "number", "14/001,638)", "relates", "to", "the", "methods", "of", "manufacture", "of", "TRULANCE."], "wordsB": ["relates", "to", "the", "methods", "of", "manufacture", "of", "TRULANCE", "was", "issued", "on", "February", "28,", "2017", "and", "will", "expire", "in", "2032."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_18_item1_p26_s1", "idA": "1347613_17_item1_p61_s4", "sentA": "The two other allowed applications relate to the formulations and method of using TRULANCE for treating constipation.", "sentB": "The two other granted patents relate to the formulations and method of using TRULANCE for treating constipation.", "type": 2, "words": ["<tag1>", "The", "two", "other", "allowed", "applications", "relate", "to", "the", "formulations", "and", "method", "of", "using", "TRULANCE", "for", "treating", "constipation.", "<tag2>", "The", "two", "other", "granted", "patents", "relate", "to", "the", "formulations", "and", "method", "of", "using", "TRULANCE", "for", "treating", "constipation.", "<tag3>"], "wordsA": ["The", "two", "other", "allowed", "applications", "relate", "to", "the", "formulations", "and", "method", "of", "using", "TRULANCE", "for", "treating", "constipation."], "wordsB": ["The", "two", "other", "granted", "patents", "relate", "to", "the", "formulations", "and", "method", "of", "using", "TRULANCE", "for", "treating", "constipation."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_18_item1_p26_s17", "idA": "1347613_17_item1_p62_s0", "sentA": "In addition, we have eight granted foreign patents which cover the composition-of-matter of TRULANCE and expire in 2022.", "sentB": "In addition, we have numerous granted foreign patents which cover the composition-of-matter of TRULANCE and expire in 2022.", "type": 2, "words": ["<tag1>", "In", "addition,", "we", "have", "eight", "granted", "foreign", "patents", "which", "cover", "the", "composition-of-matter", "of", "TRULANCE", "and", "expire", "in", "2022.", "<tag2>", "In", "addition,", "we", "have", "numerous", "granted", "foreign", "patents", "which", "cover", "the", "composition-of-matter", "of", "TRULANCE", "and", "expire", "in", "2022.", "<tag3>"], "wordsA": ["In", "addition,", "we", "have", "eight", "granted", "foreign", "patents", "which", "cover", "the", "composition-of-matter", "of", "TRULANCE", "and", "expire", "in", "2022."], "wordsB": ["In", "addition,", "we", "have", "numerous", "granted", "foreign", "patents", "which", "cover", "the", "composition-of-matter", "of", "TRULANCE", "and", "expire", "in", "2022."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_18_item1_p26_s9", "idA": "1347613_17_item1_p62_s10", "sentA": "We also have three patents related to gastrointestinal specific formulations of TRULANCE and dolcantide.", "sentB": "We also have several issued United States patents that cover analogs of TRULANCE and dolcanatide.", "type": 2, "words": ["<tag1>", "We", "also", "have", "three", "patents", "related", "to", "gastrointestinal", "specific", "formulations", "of", "TRULANCE", "and", "dolcantide.", "<tag2>", "We", "also", "have", "several", "issued", "United", "States", "patents", "that", "cover", "analogs", "of", "TRULANCE", "and", "dolcanatide.", "<tag3>"], "wordsA": ["We", "also", "have", "three", "patents", "related", "to", "gastrointestinal", "specific", "formulations", "of", "TRULANCE", "and", "dolcantide."], "wordsB": ["We", "also", "have", "several", "issued", "United", "States", "patents", "that", "cover", "analogs", "of", "TRULANCE", "and", "dolcanatide."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_18_item1_p26_s29", "idA": "1347613_17_item1_p62_s12", "sentA": "We also have one patent related to manufacture of TRULANCE.", "sentB": "We also have one patent family related to manufacture of TRULANCE.", "type": 2, "words": ["<tag1>", "We", "also", "have", "one", "patent", "related", "to", "manufacture", "of", "TRULANCE.", "<tag2>", "We", "also", "have", "one", "patent", "family", "related", "to", "manufacture", "of", "TRULANCE.", "<tag3>"], "wordsA": ["We", "also", "have", "one", "patent", "related", "to", "manufacture", "of", "TRULANCE."], "wordsB": ["We", "also", "have", "one", "patent", "family", "related", "to", "manufacture", "of", "TRULANCE."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_18_item1_p8_s4", "idA": "1347613_17_item1_p62_s12", "sentA": "We also have one patent related to manufacture of TRULANCE.", "sentB": "These patient-reported symptoms returned within one week following discontinuation of TRULANCE.", "type": 2, "words": ["<tag1>", "We", "also", "have", "one", "patent", "related", "to", "manufacture", "of", "TRULANCE.", "<tag2>", "These", "patient-reported", "symptoms", "returned", "within", "one", "week", "following", "discontinuation", "of", "TRULANCE.", "<tag3>"], "wordsA": ["We", "also", "have", "one", "patent", "related", "to", "manufacture", "of", "TRULANCE."], "wordsB": ["These", "patient-reported", "symptoms", "returned", "within", "one", "week", "following", "discontinuation", "of", "TRULANCE."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_18_item1_p26_s19", "idA": "1347613_17_item1_p62_s2", "sentA": "We also have nine granted foreign patents that cover the composition-of-matter related to dolcanatide that expire in 2028.", "sentB": "We also have numerous granted foreign patents that cover the composition-of-matter related to dolcanatide that expire in 2028.", "type": 2, "words": ["<tag1>", "We", "also", "have", "nine", "granted", "foreign", "patents", "that", "cover", "the", "composition-of-matter", "related", "to", "dolcanatide", "that", "expire", "in", "2028.", "<tag2>", "We", "also", "have", "numerous", "granted", "foreign", "patents", "that", "cover", "the", "composition-of-matter", "related", "to", "dolcanatide", "that", "expire", "in", "2028.", "<tag3>"], "wordsA": ["We", "also", "have", "nine", "granted", "foreign", "patents", "that", "cover", "the", "composition-of-matter", "related", "to", "dolcanatide", "that", "expire", "in", "2028."], "wordsB": ["We", "also", "have", "numerous", "granted", "foreign", "patents", "that", "cover", "the", "composition-of-matter", "related", "to", "dolcanatide", "that", "expire", "in", "2028."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_18_item1_p26_s23", "idA": "1347613_17_item1_p62_s6", "sentA": "We also have two foreign patents that cover composition-of-matter of certain analogs related to TRULANCE and methods of use to treat gastrointestinal disorders and expires in 2029.", "sentB": "We also have several foreign patents that cover composition-of-matter of certain analogs related to TRULANCE and methods of use to treat gastrointestinal disorders and expires in 2029.", "type": 2, "words": ["<tag1>", "We", "also", "have", "two", "foreign", "patents", "that", "cover", "composition-of-matter", "of", "certain", "analogs", "related", "to", "TRULANCE", "and", "methods", "of", "use", "to", "treat", "gastrointestinal", "disorders", "and", "expires", "in", "2029.", "<tag2>", "We", "also", "have", "several", "foreign", "patents", "that", "cover", "composition-of-matter", "of", "certain", "analogs", "related", "to", "TRULANCE", "and", "methods", "of", "use", "to", "treat", "gastrointestinal", "disorders", "and", "expires", "in", "2029.", "<tag3>"], "wordsA": ["We", "also", "have", "two", "foreign", "patents", "that", "cover", "composition-of-matter", "of", "certain", "analogs", "related", "to", "TRULANCE", "and", "methods", "of", "use", "to", "treat", "gastrointestinal", "disorders", "and", "expires", "in", "2029."], "wordsB": ["We", "also", "have", "several", "foreign", "patents", "that", "cover", "composition-of-matter", "of", "certain", "analogs", "related", "to", "TRULANCE", "and", "methods", "of", "use", "to", "treat", "gastrointestinal", "disorders", "and", "expires", "in", "2029."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_18_item1_p25_s13", "idA": "1347613_17_item1_p62_s8", "sentA": "We also have six foreign patents related to TRULANCE that cover treatment and prevention of Hypercholesterolemia and expire in 2030.", "sentB": "Furthermore, in 2017 we received three additional granted US patents related to TRULANCE.", "type": 2, "words": ["<tag1>", "We", "also", "have", "six", "foreign", "patents", "related", "to", "TRULANCE", "that", "cover", "treatment", "and", "prevention", "of", "Hypercholesterolemia", "and", "expire", "in", "2030.", "<tag2>", "Furthermore,", "in", "2017", "we", "received", "three", "additional", "granted", "US", "patents", "related", "to", "TRULANCE.", "<tag3>"], "wordsA": ["We", "also", "have", "six", "foreign", "patents", "related", "to", "TRULANCE", "that", "cover", "treatment", "and", "prevention", "of", "Hypercholesterolemia", "and", "expire", "in", "2030."], "wordsB": ["Furthermore,", "in", "2017", "we", "received", "three", "additional", "granted", "US", "patents", "related", "to", "TRULANCE."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_18_item1_p26_s30", "idA": "1347613_17_item1_p63_s0", "sentA": "Additionally, as of the date of this report on Form 10-K, we have 17 pending United States utility patent applications; and 82 pending foreign patent applications relating to TRULANCE and dolcanatide, various derivatives and analogs of TRULANCE and dolcanatide, and their uses and manufacture.", "sentB": "Additionally, as of the date of this report on Form 10-K, we have 19 pending United States utility patent applications; and 98 pending foreign patent applications relating to TRULANCE and dolcanatide, various derivatives and analogs of TRULANCE and dolcanatide, and their uses and manufacture.", "type": 2, "words": ["<tag1>", "Additionally,", "as", "of", "the", "date", "of", "this", "report", "on", "Form", "10-K,", "we", "have", "17", "pending", "United", "States", "utility", "patent", "applications;", "and", "82", "pending", "foreign", "patent", "applications", "relating", "to", "TRULANCE", "and", "dolcanatide,", "various", "derivatives", "and", "analogs", "of", "TRULANCE", "and", "dolcanatide,", "and", "their", "uses", "and", "manufacture.", "<tag2>", "Additionally,", "as", "of", "the", "date", "of", "this", "report", "on", "Form", "10-K,", "we", "have", "19", "pending", "United", "States", "utility", "patent", "applications;", "and", "98", "pending", "foreign", "patent", "applications", "relating", "to", "TRULANCE", "and", "dolcanatide,", "various", "derivatives", "and", "analogs", "of", "TRULANCE", "and", "dolcanatide,", "and", "their", "uses", "and", "manufacture.", "<tag3>"], "wordsA": ["Additionally,", "as", "of", "the", "date", "of", "this", "report", "on", "Form", "10-K,", "we", "have", "17", "pending", "United", "States", "utility", "patent", "applications;", "and", "82", "pending", "foreign", "patent", "applications", "relating", "to", "TRULANCE", "and", "dolcanatide,", "various", "derivatives", "and", "analogs", "of", "TRULANCE", "and", "dolcanatide,", "and", "their", "uses", "and", "manufacture."], "wordsB": ["Additionally,", "as", "of", "the", "date", "of", "this", "report", "on", "Form", "10-K,", "we", "have", "19", "pending", "United", "States", "utility", "patent", "applications;", "and", "98", "pending", "foreign", "patent", "applications", "relating", "to", "TRULANCE", "and", "dolcanatide,", "various", "derivatives", "and", "analogs", "of", "TRULANCE", "and", "dolcanatide,", "and", "their", "uses", "and", "manufacture."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_18_item1_p3_s1", "idA": "1347613_17_item1_p65_s0", "sentA": "On September 14, 2012 we entered into a binding letter of intent with Ironwood Pharmaceuticals, Inc. ( Ironwood ), pursuant to which we and Ironwood agreed to enter into a definitive license agreement giving us an exclusive worldwide license to Ironwood s method of use patents on TRULANCE.", "sentB": "On February 27, 2018 we entered into a definitive licensing agreement with Cipher Pharmaceuticals under which we granted Cipher the exclusive right to develop, market, distribute and sell TRULANCE in Canada.", "type": 2, "words": ["<tag1>", "On", "September", "14,", "2012", "we", "entered", "into", "a", "binding", "letter", "of", "intent", "with", "Ironwood", "Pharmaceuticals,", "Inc.", "(", "Ironwood", "),", "pursuant", "to", "which", "we", "and", "Ironwood", "agreed", "to", "enter", "into", "a", "definitive", "license", "agreement", "giving", "us", "an", "exclusive", "worldwide", "license", "to", "Ironwood", "s", "method", "of", "use", "patents", "on", "TRULANCE.", "<tag2>", "On", "February", "27,", "2018", "we", "entered", "into", "a", "definitive", "licensing", "agreement", "with", "Cipher", "Pharmaceuticals", "under", "which", "we", "granted", "Cipher", "the", "exclusive", "right", "to", "develop,", "market,", "distribute", "and", "sell", "TRULANCE", "in", "Canada.", "<tag3>"], "wordsA": ["On", "September", "14,", "2012", "we", "entered", "into", "a", "binding", "letter", "of", "intent", "with", "Ironwood", "Pharmaceuticals,", "Inc.", "(", "Ironwood", "),", "pursuant", "to", "which", "we", "and", "Ironwood", "agreed", "to", "enter", "into", "a", "definitive", "license", "agreement", "giving", "us", "an", "exclusive", "worldwide", "license", "to", "Ironwood", "s", "method", "of", "use", "patents", "on", "TRULANCE."], "wordsB": ["On", "February", "27,", "2018", "we", "entered", "into", "a", "definitive", "licensing", "agreement", "with", "Cipher", "Pharmaceuticals", "under", "which", "we", "granted", "Cipher", "the", "exclusive", "right", "to", "develop,", "market,", "distribute", "and", "sell", "TRULANCE", "in", "Canada."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_18_item1_p3_s2", "idA": "1347613_17_item1_p69_s0", "sentA": "We assumed the obligations under the Cardiff Agreement from BMS pursuant to the terms of the BMS Agreement.", "sentB": "Under the terms of the licensing agreement, Synergy received an upfront payment of $5.0 million and is eligible for an additional milestone payment, as well as royalties from product sales in Canada.", "type": 2, "words": ["<tag1>", "We", "assumed", "the", "obligations", "under", "the", "Cardiff", "Agreement", "from", "BMS", "pursuant", "to", "the", "terms", "of", "the", "BMS", "Agreement.", "<tag2>", "Under", "the", "terms", "of", "the", "licensing", "agreement,", "Synergy", "received", "an", "upfront", "payment", "of", "$5.0", "million", "and", "is", "eligible", "for", "an", "additional", "milestone", "payment,", "as", "well", "as", "royalties", "from", "product", "sales", "in", "Canada.", "<tag3>"], "wordsA": ["We", "assumed", "the", "obligations", "under", "the", "Cardiff", "Agreement", "from", "BMS", "pursuant", "to", "the", "terms", "of", "the", "BMS", "Agreement."], "wordsB": ["Under", "the", "terms", "of", "the", "licensing", "agreement,", "Synergy", "received", "an", "upfront", "payment", "of", "$5.0", "million", "and", "is", "eligible", "for", "an", "additional", "milestone", "payment,", "as", "well", "as", "royalties", "from", "product", "sales", "in", "Canada."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_18_item1_p13_s0", "idA": "1347613_17_item1_p6_s0", "sentA": "CIC and IBS-C CIC and IBS-C are chronic, functional GI disorders that afflict millions of people worldwide.", "sentB": "CIC and IBS-C are chronic, functional GI disorders that afflict millions of people worldwide.", "type": 2, "words": ["<tag1>", "CIC", "and", "IBS-C", "CIC", "and", "IBS-C", "are", "chronic,", "functional", "GI", "disorders", "that", "afflict", "millions", "of", "people", "worldwide.", "<tag2>", "CIC", "and", "IBS-C", "are", "chronic,", "functional", "GI", "disorders", "that", "afflict", "millions", "of", "people", "worldwide.", "<tag3>"], "wordsA": ["CIC", "and", "IBS-C", "CIC", "and", "IBS-C", "are", "chronic,", "functional", "GI", "disorders", "that", "afflict", "millions", "of", "people", "worldwide."], "wordsB": ["CIC", "and", "IBS-C", "are", "chronic,", "functional", "GI", "disorders", "that", "afflict", "millions", "of", "people", "worldwide."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_18_item1_p29_s0", "idA": "1347613_17_item1_p71_s2", "sentA": "Our employees and consultants also sign agreements requiring that they assign to us their interests in intellectual property arising from their work for us.", "sentB": "interests in intellectual property arising from their work for us.", "type": 2, "words": ["<tag1>", "Our", "employees", "and", "consultants", "also", "sign", "agreements", "requiring", "that", "they", "assign", "to", "us", "their", "interests", "in", "intellectual", "property", "arising", "from", "their", "work", "for", "us.", "<tag2>", "interests", "in", "intellectual", "property", "arising", "from", "their", "work", "for", "us.", "<tag3>"], "wordsA": ["Our", "employees", "and", "consultants", "also", "sign", "agreements", "requiring", "that", "they", "assign", "to", "us", "their", "interests", "in", "intellectual", "property", "arising", "from", "their", "work", "for", "us."], "wordsB": ["interests", "in", "intellectual", "property", "arising", "from", "their", "work", "for", "us."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_18_item1_p54_s2", "idA": "1347613_17_item1_p97_s0", "sentA": "Employees As of March 1, 2017 , we had 116 employees.", "sentB": "Employees As of March 1, 2018 , we had 313 employees.", "type": 2, "words": ["<tag1>", "Employees", "As", "of", "March", "1,", "2017", ",", "we", "had", "116", "employees.", "<tag2>", "Employees", "As", "of", "March", "1,", "2018", ",", "we", "had", "313", "employees.", "<tag3>"], "wordsA": ["Employees", "As", "of", "March", "1,", "2017", ",", "we", "had", "116", "employees."], "wordsB": ["Employees", "As", "of", "March", "1,", "2018", ",", "we", "had", "313", "employees."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_18_item1_p54_s3", "idA": "1347613_17_item1_p97_s1", "sentA": "Approximately 20 were in our scientific and drug development organization, 12 were in technical operations and quality assurance, 56 were in our sales and commercial team, and 28 were in general and administrative functions.", "sentB": "Approximately 16 were in our scientific and drug development organization, 15 were in technical operations and quality assurance, 254 were in our sales and commercial team, and 26 were in general and administrative functions.", "type": 2, "words": ["<tag1>", "Approximately", "20", "were", "in", "our", "scientific", "and", "drug", "development", "organization,", "12", "were", "in", "technical", "operations", "and", "quality", "assurance,", "56", "were", "in", "our", "sales", "and", "commercial", "team,", "and", "28", "were", "in", "general", "and", "administrative", "functions.", "<tag2>", "Approximately", "16", "were", "in", "our", "scientific", "and", "drug", "development", "organization,", "15", "were", "in", "technical", "operations", "and", "quality", "assurance,", "254", "were", "in", "our", "sales", "and", "commercial", "team,", "and", "26", "were", "in", "general", "and", "administrative", "functions.", "<tag3>"], "wordsA": ["Approximately", "20", "were", "in", "our", "scientific", "and", "drug", "development", "organization,", "12", "were", "in", "technical", "operations", "and", "quality", "assurance,", "56", "were", "in", "our", "sales", "and", "commercial", "team,", "and", "28", "were", "in", "general", "and", "administrative", "functions."], "wordsB": ["Approximately", "16", "were", "in", "our", "scientific", "and", "drug", "development", "organization,", "15", "were", "in", "technical", "operations", "and", "quality", "assurance,", "254", "were", "in", "our", "sales", "and", "commercial", "team,", "and", "26", "were", "in", "general", "and", "administrative", "functions."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
